{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Rosario Garcia Campelo", "first_name": "Rosario", "last_name": "Campelo", "second_name": "Garcia", "country": "Spain", "city": "A Coruña", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Justin F. Gainor", "first_name": "Justin", "last_name": "Gainor", "second_name": "F.", "country": "A", "city": "Boston", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Jesus Corral Jaime", "first_name": "Jesus", "last_name": "Jaime", "second_name": "Corral", "country": "Spain", "city": "Pamplona", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Todd Bauer", "first_name": "Todd", "last_name": "Bauer", "second_name": "", "country": "United States of America", "city": "Nashville", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Amanda Drury", "first_name": "Amanda", "last_name": "Drury", "second_name": "", "country": "Ireland", "city": "Dublin", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Johan De Munter", "first_name": "Johan", "last_name": "De Munter", "second_name": "", "country": "Belgium", "city": "Gent", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Yvonne Becque", "first_name": "Yvonne", "last_name": "Becque", "second_name": "", "country": "Netherlands", "city": "Rotterdam", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Antonis Tryphonos", "first_name": "Antonis", "last_name": "Tryphonos", "second_name": "", "country": "Cyprus", "city": "Nicosia", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Tsitsi A. Theologia", "first_name": "Tsitsi", "last_name": "Theologia", "second_name": "A.", "country": "Cyprus", "city": "Limassol", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Fiona Blackhall", "first_name": "Fiona", "last_name": "Blackhall", "second_name": "", "country": "United Kingdom", "city": "Manchester", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Fabrice Barlesi", "first_name": "Fabrice", "last_name": "Barlesi", "second_name": "", "country": "France", "city": "Villejuif", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Maximilian J. Hochmair", "first_name": "Maximilian", "last_name": "Hochmair", "second_name": "J.", "country": "Austria", "city": "Vienna", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Antonio Llombart Cussac", "first_name": "Antonio", "last_name": "Cussac", "second_name": "Llombart", "country": "Spain", "city": "Valencia", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Adam M. Brufsky", "first_name": "Adam", "last_name": "Brufsky", "second_name": "M.", "country": "P", "city": "Pittsburgh", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Suzette Delaloge", "first_name": "Suzette", "last_name": "Delaloge", "second_name": "", "country": "France", "city": "Villejuif", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Amanda Psyrri", "first_name": "Amanda", "last_name": "Psyrri", "second_name": "", "country": "Greece", "city": "Athens", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Ezra Cohen", "first_name": "Ezra", "last_name": "Cohen", "second_name": "", "country": "I", "city": "La Jolla", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Jean-Pascal Machiels", "first_name": "Jean-Pascal", "last_name": "Machiels", "second_name": "", "country": "Belgium", "city": "Woluwe-Saint-Lambert", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Nils Wilking", "first_name": "Nils", "last_name": "Wilking", "second_name": "", "country": "Sweden", "city": "Stockholm", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Andreas Dietz", "first_name": "Andreas", "last_name": "Dietz", "second_name": "", "country": "Germany", "city": "Leipzig", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Javier Cortés", "first_name": "Javier", "last_name": "Cortés", "second_name": "", "country": "Spain", "city": "Barcelona", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Giuseppe Viale", "first_name": "Giuseppe", "last_name": "Viale", "second_name": "", "country": "Italy", "city": "Milan", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Sara A. Hurvitz", "first_name": "Sara", "last_name": "Hurvitz", "second_name": "A.", "country": "C", "city": "Santa Monica", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Kohei Shitara", "first_name": "Kohei", "last_name": "Shitara", "second_name": "", "country": "Chib", "city": "Kashiwa", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Egbert F. Smit", "first_name": "Egbert", "last_name": "Smit", "second_name": "F.", "country": "Netherlands", "city": "Amsterdam", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Salah-Eddin Al-Batran", "first_name": "Salah-Eddin", "last_name": "Al-Batran", "second_name": "", "country": "Germany", "city": "Frankfurt am Main", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Lorenza Rimassa", "first_name": "Lorenza", "last_name": "Rimassa", "second_name": "", "country": "(MI", "city": "Rozzano", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Ming Shi", "first_name": "Ming", "last_name": "Shi", "second_name": "", "country": "China", "city": "Guangzhou", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Daniel J. Renouf", "first_name": "Daniel", "last_name": "Renouf", "second_name": "J.", "country": "Canada", "city": "Vancouver", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Knox", "first_name": "J.", "last_name": "Knox", "second_name": "", "title": " Research grant/Funding (self): AstraZeneca; Advisory/Consultancy, Research grant/Funding (self): Merck; Research grant/Funding (self): Ipsen; Advisory/Consultancy, Research grant/Funding (self): Roche; Advisory/Consultancy: Eisai."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Tehfe", "first_name": "M.", "last_name": "Tehfe", "second_name": "", "title": " Honoraria (institution), Research grant/Funding (self): Celgene; Honoraria (self), Advisory/Consultancy: AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "N. Aucoin", "first_name": "N.", "last_name": "Aucoin", "second_name": "", "title": " Advisory/Consultancy: Celgene; Advisory/Consultancy: AstraZeneca; Advisory/Consultancy: BMS; Advisory/Consultancy: Amgen; Advisory/Consultancy: Pfizer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. Ramjeesingh", "first_name": "R.", "last_name": "Ramjeesingh", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy: Celgene; Honoraria (self): Astrazeneca; Advisory/Consultancy, Travel/Accommodation/Expenses: Ipsen; Advisory/Consultancy: Servier."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Thorsten O. Götze", "first_name": "Thorsten", "last_name": "Götze", "second_name": "O.", "country": "Germany", "city": "Frankfurt am Main", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Siegler", "first_name": "M.", "last_name": "Siegler", "second_name": "", "title": " Honoraria (self): medizinwelten services GmbH; Honoraria (self): Shire; Honoraria (self): Eisai; Honoraria (self), Research grant/Funding (institution): Roche; Honoraria (self), Advisory/Consultancy: Janssen-Cilag; Research grant/Funding (institution): Servier; Research grant/Funding (institution): Beigene; Research grant/Funding (institution): Roche-Genentech; Research grant/Funding (institution): Celgene; Research grant/Funding (institution): Isofol Medical; Research grant/Funding (institution): Nutricia; Research grant/Funding (institution): Mologen; Research grant/Funding (institution): Sanofi; Travel/Accommodation/Expenses: Lilly."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "O. Waidmann", "first_name": "O.", "last_name": "Waidmann", "second_name": "", "title": " Advisory/Consultancy: Amgen; Advisory/Consultancy, Speaker Bureau/Expert testimony: Bayer; Advisory/Consultancy, Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: BMS; Advisory/Consultancy, Speaker Bureau/Expert testimony: Celgene; Advisory/Consultancy: Eisai; Advisory/Consultancy, Investigator: Incyte; Advisory/Consultancy, Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: Ipsen; Advisory/Consultancy, Investigator: Merck kGA; Advisory/Consultancy, Investigator: MSD; Advisory/Consultancy, Speaker Bureau/Expert testimony: Novartis; Advisory/Consultancy, Speaker Bureau/Expert testimony, Investigator: Roche; Advisory/Consultancy, Speaker Bureau/Expert testimony: Servier; Advisory/Consultancy: Shire; Travel/Accommodation/Expenses: Abbvie; Travel/Accommodation/Expenses: Gilead; Travel/Accommodation/Expenses: Merck Serono; Travel/Accommodation/Expenses: Medac; Advisory/Consultancy, Investigator: Basilea; Advisory/Consultancy, Investigator: Lilly."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Pink", "first_name": "D.", "last_name": "Pink", "second_name": "", "title": " Full/Part-time employment: Helios Kliniken GmbH; Advisory/Consultancy, Research grant/Funding (institution): Lilly; Advisory/Consultancy, Research grant/Funding (institution): Clinigen Group; Advisory/Consultancy, Research grant/Funding (institution): Roche; Research grant/Funding (institution): PharmaMar; Research grant/Funding (institution): Novartis pharma SAS."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Vogel", "first_name": "A.", "last_name": "Vogel", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Research grant/Funding (self): Novartis; Honoraria (self), Advisory/Consultancy: Lilly; Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Roche; Honoraria (self), Advisory/Consultancy: Amgen; Advisory/Consultancy, Travel/Accommodation/Expenses: Bayer; Advisory/Consultancy: Baxalta; Advisory/Consultancy: AstraZeneca; Advisory/Consultancy: EISAI; Advisory/Consultancy: BTG; Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Ipsen; Honoraria (self), Advisory/Consultancy: Pierre Fabre; Honoraria (self): Sanofi; Honoraria (self): Delcath Systems; Honoraria (self): Bristol-Myers Squibb; Honoraria (self): MSD; Honoraria (self): Janssen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Ettrich", "first_name": "J.", "last_name": "Ettrich", "second_name": "", "title": " Advisory/Consultancy: Merck Serono; Advisory/Consultancy: Sanofi; Advisory/Consultancy: Bristol-Myers Squibb; Advisory/Consultancy: Bayer; Advisory/Consultancy: Roche; Advisory/Consultancy: Lilly; Advisory/Consultancy: Eisai; Advisory/Consultancy: Safoni/Aventis; Advisory/Consultancy: MSD; Travel/Accommodation/Expenses: Ipsen; Research grant/Funding (self): Baxalta/Shire."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "G. zur Hausen", "first_name": "G.", "last_name": "Hausen", "second_name": "zur", "title": " Honoraria (self), Travel/Accommodation/Expenses: Celgene."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Eileen M. O'Reilly", "first_name": "Eileen", "last_name": "O'Reilly", "second_name": "M.", "country": "N", "city": "New York", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Alberto Sobrero", "first_name": "Alberto", "last_name": "Sobrero", "second_name": "", "country": "Italy", "city": "Genova", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Jesus Garcia Foncillas", "first_name": "Jesus", "last_name": "Foncillas", "second_name": "Garcia", "country": "Spain", "city": "Madrid", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Julien Taieb", "first_name": "Julien", "last_name": "Taieb", "second_name": "", "country": "France", "city": "Paris", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Sebastian Stintzing", "first_name": "Sebastian", "last_name": "Stintzing", "second_name": "", "country": "Germany", "city": "Berlin", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Luis Paz-Ares", "first_name": "Luis", "last_name": "Paz-Ares", "second_name": "", "country": "Spain", "city": "Madrid", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Keith M. Kerr", "first_name": "Keith", "last_name": "Kerr", "second_name": "M.", "country": "United Kingdom", "city": "Aberdeen", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Juergen Wolf", "first_name": "Juergen", "last_name": "Wolf", "second_name": "", "country": "Germany", "city": "Cologne", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Neal Shore", "first_name": "Neal", "last_name": "Shore", "second_name": "", "country": "United States of America", "city": "Myrtle Beach", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Joaquin Mateo", "first_name": "Joaquin", "last_name": "Mateo", "second_name": "", "country": "Spain", "city": "Barcelona", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Alexander W. Wyatt", "first_name": "Alexander", "last_name": "Wyatt", "second_name": "W.", "country": "Canada", "city": "Vancouver", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Manuela Eicher", "first_name": "Manuela", "last_name": "Eicher", "second_name": "", "country": "Switzerland", "city": "Lausanne", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Claudia M. Witt", "first_name": "Claudia", "last_name": "Witt", "second_name": "M.", "country": "Switzerland", "city": "Zurich", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Alex Molasiotis", "first_name": "Alex", "last_name": "Molasiotis", "second_name": "", "country": "Pokfula", "city": "Sha Tin", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Dimitrios Protogiros", "first_name": "Dimitrios", "last_name": "Protogiros", "second_name": "", "country": "Greece", "city": "Athens", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Reinhard Dummer", "first_name": "Reinhard", "last_name": "Dummer", "second_name": "", "country": "Switzerland", "city": "Zurich", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Caroline Robert", "first_name": "Caroline", "last_name": "Robert", "second_name": "", "country": "France", "city": "Villejuif", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Dirk Schadendorf", "first_name": "Dirk", "last_name": "Schadendorf", "second_name": "", "country": "Germany", "city": "Essen", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Wendy H. Oldenmenger", "first_name": "Wendy", "last_name": "Oldenmenger", "second_name": "H.", "country": "Netherlands", "city": "Rotterdam", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Christine Bienvenu", "first_name": "Christine", "last_name": "Bienvenu", "second_name": "", "country": "Switzerland", "city": "Lausanne", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Theresa Wiseman", "first_name": "Theresa", "last_name": "Wiseman", "second_name": "", "country": "United Kingdom", "city": "London", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Andreas Charalambous", "first_name": "Andreas", "last_name": "Charalambous", "second_name": "", "country": "Cyprus", "city": "Limassol", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Daniel Kelly", "first_name": "Daniel", "last_name": "Kelly", "second_name": "", "country": "United Kingdom", "city": "London", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Aileen O'Meara", "first_name": "Aileen", "last_name": "O'Meara", "second_name": "", "country": "Ireland", "city": "Dublin", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Suzanne George", "first_name": "Suzanne", "last_name": "George", "second_name": "", "country": "M", "city": "Boston", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Cesar Serrano", "first_name": "Cesar", "last_name": "Serrano", "second_name": "", "country": "Barcelon", "city": "Barcelona", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Neeltje Steeghs", "first_name": "Neeltje", "last_name": "Steeghs", "second_name": "", "country": "Netherlands", "city": "Amsterdam", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Axel Le Cesne", "first_name": "Axel", "last_name": "Le Cesne", "second_name": "", "country": "CEDE", "city": "Villejuif", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Mansoor Raza Mirza", "first_name": "Mansoor", "last_name": "Mirza", "second_name": "Raza", "country": "Denmark", "city": "Copenhagen", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Susana Banerjee", "first_name": "Susana", "last_name": "Banerjee", "second_name": "", "country": "United Kingdom", "city": "London", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Iain McNeish", "first_name": "Iain", "last_name": "McNeish", "second_name": "", "country": "United Kingdom", "city": "London", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Sandro Pignata", "first_name": "Sandro", "last_name": "Pignata", "second_name": "", "country": "Italy", "city": "Napoli", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "George Coukos", "first_name": "George", "last_name": "Coukos", "second_name": "", "country": "Switzerland", "city": "Epalinges", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Samra Turajlic", "first_name": "Samra", "last_name": "Turajlic", "second_name": "", "country": "United Kingdom", "city": "London", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Robert A. Gatenby", "first_name": "Robert", "last_name": "Gatenby", "second_name": "A.", "country": "F", "city": "Tampa", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Roland Rad", "first_name": "Roland", "last_name": "Rad", "second_name": "", "country": "Germany", "city": "Munich", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Martin Schaefer", "first_name": "Martin", "last_name": "Schaefer", "second_name": "", "country": "Italy", "city": "Milan", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Nicola Fazio", "first_name": "Nicola", "last_name": "Fazio", "second_name": "", "country": "Italy", "city": "Milan", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Rocio Garcia-Carbonero", "first_name": "Rocio", "last_name": "Garcia-Carbonero", "second_name": "", "country": "Spain", "city": "Madrid", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Jean-Yves Scoazec", "first_name": "Jean-Yves", "last_name": "Scoazec", "second_name": "", "country": "France", "city": "Villejuif", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Jonathan Strosberg", "first_name": "Jonathan", "last_name": "Strosberg", "second_name": "", "country": "United States of America", "city": "Tampa", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Halfdan Sorbye", "first_name": "Halfdan", "last_name": "Sorbye", "second_name": "", "country": "Norway", "city": "Bergen", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Daniel Shao Weng Tan", "first_name": "Daniel", "last_name": "Tan", "second_name": "Shao Weng", "country": "Singapore", "city": "Singapore", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Céline Mascaux", "first_name": "Céline", "last_name": "Mascaux", "second_name": "", "country": "Ontari", "city": "Strasbourg", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Albrecht Stenzinger", "first_name": "Albrecht", "last_name": "Stenzinger", "second_name": "", "country": "Germany", "city": "Heidelberg", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Charles M. Rudin", "first_name": "Charles", "last_name": "Rudin", "second_name": "M.", "country": "United States of America", "city": "New York", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Kevin J. Harrington", "first_name": "Kevin", "last_name": "Harrington", "second_name": "J.", "country": "United Kingdom", "city": "London", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Ignacio Melero", "first_name": "Ignacio", "last_name": "Melero", "second_name": "", "country": "Spain", "city": "Pamplona", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Aurélien Marabelle", "first_name": "Aurélien", "last_name": "Marabelle", "second_name": "", "country": "France", "city": "Villejuif", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Sandra Demaria", "first_name": "Sandra", "last_name": "Demaria", "second_name": "", "country": "United States of America", "city": "New York", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Charles G. Drake", "first_name": "Charles", "last_name": "Drake", "second_name": "G.", "country": "United States of America", "city": "New York", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Itay Tirosh", "first_name": "Itay", "last_name": "Tirosh", "second_name": "", "country": "Israel", "city": "Rehovot", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Leila Akkari", "first_name": "Leila", "last_name": "Akkari", "second_name": "", "country": "Netherlands", "city": "Amsterdam", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Victoria Sanz-Moreno", "first_name": "Victoria", "last_name": "Sanz-Moreno", "second_name": "", "country": "United Kingdom", "city": "London", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "David Liu", "first_name": "David", "last_name": "Liu", "second_name": "", "country": "United States of America", "city": "Boston", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Thomas B. Powles", "first_name": "Thomas", "last_name": "Powles", "second_name": "B.", "country": "United Kingdom", "city": "London", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Manuela Schmidinger", "first_name": "Manuela", "last_name": "Schmidinger", "second_name": "", "country": "Austria", "city": "Vienna", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Viktor Gruenwald", "first_name": "Viktor", "last_name": "Gruenwald", "second_name": "", "country": "Germany", "city": "Essen", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Bernard Escudier", "first_name": "Bernard", "last_name": "Escudier", "second_name": "", "country": "CEDE", "city": "Villejuif", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Andrea Necchi", "first_name": "Andrea", "last_name": "Necchi", "second_name": "", "country": "Italy", "city": "Milan", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Marina C. Garassino", "first_name": "Marina", "last_name": "Garassino", "second_name": "C.", "country": "Italy", "city": "Milan", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Natasha Leighl", "first_name": "Natasha", "last_name": "Leighl", "second_name": "", "country": "Canada", "city": "Toronto", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Naiyer Rizvi", "first_name": "Naiyer", "last_name": "Rizvi", "second_name": "", "country": "N", "city": "New York", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Pilar Garrido Lopez", "first_name": "Pilar", "last_name": "Lopez", "second_name": "Garrido", "country": "Spain", "city": "Madrid", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Solange Peters", "first_name": "Solange", "last_name": "Peters", "second_name": "", "country": "Switzerland", "city": "Lausanne", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Charles Craddock", "first_name": "Charles", "last_name": "Craddock", "second_name": "", "country": "United Kingdom", "city": "Birmingham", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Uwe Platzbecker", "first_name": "Uwe", "last_name": "Platzbecker", "second_name": "", "country": "Germany", "city": "Leipzig", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Luca Malcovati", "first_name": "Luca", "last_name": "Malcovati", "second_name": "", "country": "Italy", "city": "Pavia", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Carla I. Ripamonti", "first_name": "Carla", "last_name": "Ripamonti", "second_name": "I.", "country": "Italy", "city": "Milan", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Christoph Stein", "first_name": "Christoph", "last_name": "Stein", "second_name": "", "country": "Germany", "city": "Berlin", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Per Sjøgren", "first_name": "Per", "last_name": "Sjøgren", "second_name": "", "country": "Denmark", "city": "Copenhagen", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Marie T. Fallon", "first_name": "Marie", "last_name": "Fallon", "second_name": "T.", "country": "United Kingdom", "city": "Edinburgh", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Nathan I. Cherny", "first_name": "Nathan", "last_name": "Cherny", "second_name": "I.", "country": "Israel", "city": "Jerusalem", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Dan Landau", "first_name": "Dan", "last_name": "Landau", "second_name": "", "country": "United States of America", "city": "New York", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Pierre Laurent-Puig", "first_name": "Pierre", "last_name": "Laurent-Puig", "second_name": "", "country": "France", "city": "Paris", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Joan Seoane", "first_name": "Joan", "last_name": "Seoane", "second_name": "", "country": "Spain", "city": "Barcelona", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Daniel De Carvalho", "first_name": "Daniel", "last_name": "De Carvalho", "second_name": "", "country": "Canada", "city": "Toronto", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Nitzan Rosenfeld", "first_name": "Nitzan", "last_name": "Rosenfeld", "second_name": "", "country": "United Kingdom", "city": "Cambridge", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Charles J. Ryan", "first_name": "Charles", "last_name": "Ryan", "second_name": "J.", "country": "C", "city": "Minneapolis", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Niven Mehra", "first_name": "Niven", "last_name": "Mehra", "second_name": "", "country": "Belgium", "city": "Nijmegen", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Gerhardt Attard", "first_name": "Gerhardt", "last_name": "Attard", "second_name": "", "country": "United Kingdom", "city": "London", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Susan Slovin", "first_name": "Susan", "last_name": "Slovin", "second_name": "", "country": "United States of America", "city": "New York", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Maarten Lambrecht", "first_name": "Maarten", "last_name": "Lambrecht", "second_name": "", "country": "Belgium", "city": "Leuven", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Julie R. Brahmer", "first_name": "Julie", "last_name": "Brahmer", "second_name": "R.", "country": "M", "city": "Baltimore", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Lizza E. Hendriks", "first_name": "Lizza", "last_name": "Hendriks", "second_name": "E.", "country": "Netherlands", "city": "Maastricht", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Dirk De Ruysscher", "first_name": "Dirk", "last_name": "De Ruysscher", "second_name": "", "country": "Netherlands", "city": "Maastricht", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Camilla Zimmermann", "first_name": "Camilla", "last_name": "Zimmermann", "second_name": "", "country": "Canada", "city": "Toronto", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Karin Jordan", "first_name": "Karin", "last_name": "Jordan", "second_name": "", "country": "Germany", "city": "Heidelberg", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Olivier Mir", "first_name": "Olivier", "last_name": "Mir", "second_name": "", "country": "France", "city": "Villejuif", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Stein Kaasa", "first_name": "Stein", "last_name": "Kaasa", "second_name": "", "country": "Norway", "city": "Oslo", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "David Hui", "first_name": "David", "last_name": "Hui", "second_name": "", "country": "T", "city": "Houston", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Serena Nik-Zainal", "first_name": "Serena", "last_name": "Nik-Zainal", "second_name": "", "country": "United Kingdom", "city": "Cambridge", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Thanos Halazonetis", "first_name": "Thanos", "last_name": "Halazonetis", "second_name": "", "country": "Switzerland", "city": "Geneva", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Oscar Fernandez-Capetillo", "first_name": "Oscar", "last_name": "Fernandez-Capetillo", "second_name": "", "country": "Spain", "city": "Madrid", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "David SP Tan", "first_name": "David", "last_name": "Tan", "second_name": "SP", "country": "Singapore", "city": "Singapore", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Lisa F. Licitra", "first_name": "Lisa", "last_name": "Licitra", "second_name": "F.", "country": "Italy", "city": "Milan", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Lieping Chen", "first_name": "Lieping", "last_name": "Chen", "second_name": "", "country": "United States of America", "city": "New Haven", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Emiliano Calvo", "first_name": "Emiliano", "last_name": "Calvo", "second_name": "", "country": "Spain", "city": "Madrid", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Christophe Massard", "first_name": "Christophe", "last_name": "Massard", "second_name": "", "country": "CEDE", "city": "Villejuif", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Eric Deutsch", "first_name": "Eric", "last_name": "Deutsch", "second_name": "", "country": "France", "city": "Villejuif", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Bissan Al-Lazikani", "first_name": "Bissan", "last_name": "Al-Lazikani", "second_name": "", "country": "United Kingdom", "city": "Sutton", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Christian U. Blank", "first_name": "Christian", "last_name": "Blank", "second_name": "U.", "country": "Netherlands", "city": "Amsterdam", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Georgina V. Long", "first_name": "Georgina", "last_name": "Long", "second_name": "V.", "country": "NS", "city": "Wollstonecraft", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Merrick Ross", "first_name": "Merrick", "last_name": "Ross", "second_name": "", "country": "United States of America", "city": "Houston", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Roger K. Henriksson", "first_name": "Roger", "last_name": "Henriksson", "second_name": "K.", "country": "Sweden", "city": "Umea", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Kathy R. Oliver", "first_name": "Kathy", "last_name": "Oliver", "second_name": "R.", "country": "United Kingdom", "city": "Tadworth", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Lena Sharp", "first_name": "Lena", "last_name": "Sharp", "second_name": "", "country": "Sweden", "city": "Stockholm", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Robin Grant", "first_name": "Robin", "last_name": "Grant", "second_name": "", "country": "United Kingdom", "city": "Edinburgh", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Linda Dirven", "first_name": "Linda", "last_name": "Dirven", "second_name": "", "country": "Netherlands", "city": "Leiden", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Andrea Pace", "first_name": "Andrea", "last_name": "Pace", "second_name": "", "country": "Italy", "city": "Rome", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Giuseppe Curigliano", "first_name": "Giuseppe", "last_name": "Curigliano", "second_name": "", "country": "Italy", "city": "Milan", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Nadia Harbeck", "first_name": "Nadia", "last_name": "Harbeck", "second_name": "", "country": "Germany", "city": "Munich", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Marleen Kok", "first_name": "Marleen", "last_name": "Kok", "second_name": "", "country": "Netherlands", "city": "Amsterdam", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Wilbert Zwart", "first_name": "Wilbert", "last_name": "Zwart", "second_name": "", "country": "Netherlands", "city": "Amsterdam", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Nicholas McGranahan", "first_name": "Nicholas", "last_name": "McGranahan", "second_name": "", "country": "United Kingdom", "city": "London", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Marisol Soengas", "first_name": "Marisol", "last_name": "Soengas", "second_name": "", "country": "Spain", "city": "Madrid", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Douglas Hanahan", "first_name": "Douglas", "last_name": "Hanahan", "second_name": "", "country": "Switzerland", "city": "Lausanne", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Yardena Samuels", "first_name": "Yardena", "last_name": "Samuels", "second_name": "", "country": "M", "city": "Rehovot", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Ulrich-Frank Pape", "first_name": "Ulrich-Frank", "last_name": "Pape", "second_name": "", "country": "Germany", "city": "Hamburg", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Andreas Kjaer", "first_name": "Andreas", "last_name": "Kjaer", "second_name": "", "country": "Denmark", "city": "Copenhagen", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Simron Singh", "first_name": "Simron", "last_name": "Singh", "second_name": "", "country": "Ontari", "city": "Toronto", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Emilio Bertani", "first_name": "Emilio", "last_name": "Bertani", "second_name": "", "country": "Italy", "city": "Milan", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Nick Pavlakis", "first_name": "Nick", "last_name": "Pavlakis", "second_name": "", "country": "NS", "city": "St Leonards", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Ana Martins Ferreira Castro", "first_name": "Ana", "last_name": "Castro", "second_name": "Martins Ferreira", "country": "Portugal", "city": "Espargo-Santa Maria da Feira", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Brigette B. Ma", "first_name": "Brigette", "last_name": "B.", "second_name": "", "country": "Hong Kong PRC", "city": "Sha Tin", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Jacco Van Rheenen", "first_name": "Jacco", "last_name": "Van Rheenen", "second_name": "", "country": "Netherlands", "city": "Amsterdam", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Daniel Peeper", "first_name": "Daniel", "last_name": "Peeper", "second_name": "", "country": "Netherlands", "city": "Amsterdam", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Anthony Rongvaux", "first_name": "Anthony", "last_name": "Rongvaux", "second_name": "", "country": "United States of America", "city": "Seattle", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Eduard Batlle", "first_name": "Eduard", "last_name": "Batlle", "second_name": "", "country": "Spain", "city": "Barcelona", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Joachim G. Aerts", "first_name": "Joachim", "last_name": "Aerts", "second_name": "G.", "country": "Noord Braban", "city": "Rotterdam", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Michael Thomas", "first_name": "Michael", "last_name": "Thomas", "second_name": "", "country": "Germany", "city": "Heidelberg", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Isabelle Opitz", "first_name": "Isabelle", "last_name": "Opitz", "second_name": "", "country": "Switzerland", "city": "Zurich", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Alberto Revelant", "first_name": "Alberto", "last_name": "Revelant", "second_name": "", "country": "Italy", "city": "Aviano", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Alison Birtle", "first_name": "Alison", "last_name": "Birtle", "second_name": "", "country": "United Kingdom", "city": "Preston", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Aristotelis Bamias", "first_name": "Aristotelis", "last_name": "Bamias", "second_name": "", "country": "Attik", "city": "Athens", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Holger Moch", "first_name": "Holger", "last_name": "Moch", "second_name": "", "country": "Switzerland", "city": "Zurich", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "David Chang", "first_name": "David", "last_name": "Chang", "second_name": "", "country": "United Kingdom", "city": "Glasgow", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Thierry Conroy", "first_name": "Thierry", "last_name": "Conroy", "second_name": "", "country": "CEDE", "city": "Vandoeuvre-lès-Nancy", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Jörg Trojan", "first_name": "Jörg", "last_name": "Trojan", "second_name": "", "country": "Germany", "city": "Frankfurt am Main", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Christina Messiou", "first_name": "Christina", "last_name": "Messiou", "second_name": "", "country": "United Kingdom", "city": "London", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Olivier Delattre", "first_name": "Olivier", "last_name": "Delattre", "second_name": "", "country": "France", "city": "Paris", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Hans-Ulrich Schildhaus", "first_name": "Hans-Ulrich", "last_name": "Schildhaus", "second_name": "", "country": "Germany", "city": "Essen", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Bernd Kasper", "first_name": "Bernd", "last_name": "Kasper", "second_name": "", "country": "Germany", "city": "Mannheim", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Jordi Rodon", "first_name": "Jordi", "last_name": "Rodon", "second_name": "", "country": "United States of America", "city": "Houston", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Jayesh Desai", "first_name": "Jayesh", "last_name": "Desai", "second_name": "", "country": "VI", "city": "Melbourne", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Yohann Loriot", "first_name": "Yohann", "last_name": "Loriot", "second_name": "", "country": "France", "city": "Villejuif", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Victor Moreno Garcia", "first_name": "Victor", "last_name": "Garcia", "second_name": "Moreno", "country": "Spain", "city": "Madrid", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Sophie Postel-Vinay", "first_name": "Sophie", "last_name": "Postel-Vinay", "second_name": "", "country": "France", "city": "Villejuif", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Fernanda Herrera", "first_name": "Fernanda", "last_name": "Herrera", "second_name": "", "country": "Switzerland", "city": "Lausanne", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Christian Chabannon", "first_name": "Christian", "last_name": "Chabannon", "second_name": "", "country": "CEDEX ", "city": "Marseille", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Markus G. Manz", "first_name": "Markus", "last_name": "Manz", "second_name": "G.", "country": "Switzerland", "city": "Zurich", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Margaret Shipp", "first_name": "Margaret", "last_name": "Shipp", "second_name": "", "country": "United States of America", "city": "Boston", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Qasim Waseem", "first_name": "Qasim", "last_name": "Waseem", "second_name": "", "country": "United Kingdom", "city": "London", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Rebecca Dent", "first_name": "Rebecca", "last_name": "Dent", "second_name": "", "country": "Singapore", "city": "Singapore", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Veronique Dieras", "first_name": "Veronique", "last_name": "Dieras", "second_name": "", "country": "France", "city": "Paris", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Cristina Saura Manich", "first_name": "Cristina", "last_name": "Manich", "second_name": "Saura", "country": "Spain", "city": "Barcelona", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Veronique C. Dieras", "first_name": "Veronique", "last_name": "Dieras", "second_name": "C.", "country": "CEDEX ", "city": "Rennes", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Karim Fizazi", "first_name": "Karim", "last_name": "Fizazi", "second_name": "", "country": "France", "city": "Villejuif", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Tapio Visakorpi", "first_name": "Tapio", "last_name": "Visakorpi", "second_name": "", "country": "Finland", "city": "Tampere", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Bertrand F. Tombal", "first_name": "Bertrand", "last_name": "Tombal", "second_name": "F.", "country": "Belgium", "city": "Brussels", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Alicia K. Morgans", "first_name": "Alicia", "last_name": "Morgans", "second_name": "K.", "country": "United States of America", "city": "Chicago", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Elena Castro Marcos", "first_name": "Elena", "last_name": "Marcos", "second_name": "Castro", "country": "Spain", "city": "Madrid", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Clara Montagut Viladot", "first_name": "Clara", "last_name": "Viladot", "second_name": "Montagut", "country": "Spain", "city": "Barcelona", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Timothy J. Price", "first_name": "Timothy", "last_name": "Price", "second_name": "J.", "country": "S", "city": "Woodville", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Niels Pallisgaard", "first_name": "Niels", "last_name": "Pallisgaard", "second_name": "", "country": "Denmark", "city": "Roskilde", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Jeanne Tie", "first_name": "Jeanne", "last_name": "Tie", "second_name": "", "country": "VI", "city": "Melbourne", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "William Sellers", "first_name": "William", "last_name": "Sellers", "second_name": "", "country": "United States of America", "city": "Cambridge", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Gul Basaran", "first_name": "Gul", "last_name": "Basaran", "second_name": "", "country": "Turkey", "city": "Istanbul", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Peter Schmid", "first_name": "Peter", "last_name": "Schmid", "second_name": "", "country": "United Kingdom", "city": "London", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Monica Arnedos", "first_name": "Monica", "last_name": "Arnedos", "second_name": "", "country": "France", "city": "Villejuif", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Isabelle L. Ray-Coquard", "first_name": "Isabelle", "last_name": "Ray-Coquard", "second_name": "L.", "country": "CEDE", "city": "Lyon", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Nicole Concin", "first_name": "Nicole", "last_name": "Concin", "second_name": "", "country": "Austria", "city": "Innsbruck", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Antonio Jose Gonzalez Martin", "first_name": "Antonio", "last_name": "Martin", "second_name": "Jose Gonzalez", "country": "Spain", "city": "Madrid", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Kathleen N. Moore", "first_name": "Kathleen", "last_name": "Moore", "second_name": "N.", "country": "Oklahom", "city": "Oklahoma City", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Michel P. Ducreux", "first_name": "Michel", "last_name": "Ducreux", "second_name": "P.", "country": "CEDE", "city": "Villejuif", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Jennifer Wargo", "first_name": "Jennifer", "last_name": "Wargo", "second_name": "", "country": "United States of America", "city": "Houston", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Dung T. Le", "first_name": "Dung", "last_name": "Le", "second_name": "T.", "country": "M", "city": "Baltimore", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Myriam Chalabi", "first_name": "Myriam", "last_name": "Chalabi", "second_name": "", "country": "Netherlands", "city": "Amsterdam", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Jerome Galon", "first_name": "Jerome", "last_name": "Galon", "second_name": "", "country": "France", "city": "Paris", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Guillem Argiles Martinez", "first_name": "Guillem", "last_name": "Martinez", "second_name": "Argiles", "country": "Spain", "city": "Barcelona", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Eleni M. Tomazou", "first_name": "Eleni", "last_name": "Tomazou", "second_name": "M.", "country": "Austria", "city": "Vienna", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Winette T. Van Der Graaf", "first_name": "Winette", "last_name": "Van Der Graaf", "second_name": "T.", "country": "Surre", "city": "Amsterdam", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Nicolas Penel", "first_name": "Nicolas", "last_name": "Penel", "second_name": "", "country": "CEDE", "city": "Lille", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Eva Wardelmann", "first_name": "Eva", "last_name": "Wardelmann", "second_name": "", "country": "Germany", "city": "Münster", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Martin McCabe", "first_name": "Martin", "last_name": "McCabe", "second_name": "", "country": "United Kingdom", "city": "Manchester", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Zuhir Bodalal", "first_name": "Zuhir", "last_name": "Bodalal", "second_name": "", "country": "Netherlands", "city": "Amsterdam", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "David Adams", "first_name": "David", "last_name": "Adams", "second_name": "", "country": "United Kingdom", "city": "Cambridge", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Rolf Bjerkvig", "first_name": "Rolf", "last_name": "Bjerkvig", "second_name": "", "country": "Norway", "city": "Bergen", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Roberta Rudà", "first_name": "Roberta", "last_name": "Rudà", "second_name": "", "country": "Italy", "city": "Torino", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Isabella Salzer", "first_name": "Isabella", "last_name": "Salzer", "second_name": "", "country": "Austria", "city": "Wien", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Silvia Giordano", "first_name": "Silvia", "last_name": "Giordano", "second_name": "", "country": "Italy", "city": "Candiolo", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Yelena Y. Janjigian", "first_name": "Yelena", "last_name": "Janjigian", "second_name": "Y.", "country": "N", "city": "New York", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Nicole C. Van Grieken", "first_name": "Nicole", "last_name": "Van Grieken", "second_name": "C.", "country": "Netherlands", "city": "Amsterdam", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Kei Muro", "first_name": "Kei", "last_name": "Muro", "second_name": "", "country": "Aich", "city": "Nagoya", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Arndt Vogel", "first_name": "Arndt", "last_name": "Vogel", "second_name": "", "country": "Germany", "city": "Hannover", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Olivier A. Michielin", "first_name": "Olivier", "last_name": "Michielin", "second_name": "A.", "country": "Switzerland", "city": "Lausanne", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Thomas F. Gajewski", "first_name": "Thomas", "last_name": "Gajewski", "second_name": "F.", "country": "United States of America", "city": "Chicago", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Paolo A. Ascierto", "first_name": "Paolo", "last_name": "Ascierto", "second_name": "A.", "country": "Italy", "city": "Napoli", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Lecia V. Sequist", "first_name": "Lecia", "last_name": "Sequist", "second_name": "V.", "country": "M", "city": "Boston", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Alona Zer", "first_name": "Alona", "last_name": "Zer", "second_name": "", "country": "Israel", "city": "Petah Tikva", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Pasi A. Jänne", "first_name": "Pasi", "last_name": "Jänne", "second_name": "A.", "country": "M", "city": "Boston", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Tony S.K. Mok", "first_name": "Tony", "last_name": "Mok", "second_name": "S.K.", "country": "Hong Kong PRC", "city": "Shatin", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Enriqueta Felip", "first_name": "Enriqueta", "last_name": "Felip", "second_name": "", "country": "Spain", "city": "Barcelona", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Benjamin Besse", "first_name": "Benjamin", "last_name": "Besse", "second_name": "", "country": "CEDE", "city": "Villejuif", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Thales Papagiannakopoulos", "first_name": "Thales", "last_name": "Papagiannakopoulos", "second_name": "", "country": "United States of America", "city": "New York", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Ping-Chih Ho", "first_name": "Ping-Chih", "last_name": "Ho", "second_name": "", "country": "Switzerland", "city": "Epalinges", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Chi Van Dang", "first_name": "Chi", "last_name": "Van Dang", "second_name": "", "country": "United States of America", "city": "New York", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Guido Kroemer", "first_name": "Guido", "last_name": "Kroemer", "second_name": "", "country": "CEDE", "city": "Paris", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Fortunato Ciardiello", "first_name": "Fortunato", "last_name": "Ciardiello", "second_name": "", "country": "Italy", "city": "Napoli", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Thierry André", "first_name": "Thierry", "last_name": "André", "second_name": "", "country": "CEDEX 1", "city": "Paris", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Mark P. Saunders", "first_name": "Mark", "last_name": "Saunders", "second_name": "P.", "country": "United Kingdom", "city": "Manchester", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Per Pfeiffer", "first_name": "Per", "last_name": "Pfeiffer", "second_name": "", "country": "Denmark", "city": "Odense C", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Nancy U. Lin", "first_name": "Nancy", "last_name": "Lin", "second_name": "U.", "country": "United States of America", "city": "Boston", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Riccardo Soffietti", "first_name": "Riccardo", "last_name": "Soffietti", "second_name": "", "country": "Italy", "city": "Torino", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Emilie Le Rhun", "first_name": "Emilie", "last_name": "Le Rhun", "second_name": "", "country": "CEDE", "city": "Zurich", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Jan B. Vermorken", "first_name": "Jan", "last_name": "Vermorken", "second_name": "B.", "country": "Belgium", "city": "Edegem", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Miren Taberna", "first_name": "Miren", "last_name": "Taberna", "second_name": "", "country": "Spain", "city": "Hospitalet de Llobregat", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Ghassan K. Abou-Alfa", "first_name": "Ghassan", "last_name": "Abou-Alfa", "second_name": "K.", "country": "N", "city": "New York", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Peter R. Galle", "first_name": "Peter", "last_name": "Galle", "second_name": "R.", "country": "Germany", "city": "Mainz", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Bruno Sangro", "first_name": "Bruno", "last_name": "Sangro", "second_name": "", "country": "Spain", "city": "Pamplona", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Enrique Grande", "first_name": "Enrique", "last_name": "Grande", "second_name": "", "country": "Spain", "city": "Madrid", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Johann De Bono", "first_name": "Johann", "last_name": "De Bono", "second_name": "", "country": "United Kingdom", "city": "London", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Bettina Ryll", "first_name": "Bettina", "last_name": "Ryll", "second_name": "", "country": "Sweden", "city": "Uppsala", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Tim Wilsdon", "first_name": "Tim", "last_name": "Wilsdon", "second_name": "", "country": "United Kingdom", "city": "London", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Deepak Khanna", "first_name": "Deepak", "last_name": "Khanna", "second_name": "", "country": "Sweden", "city": "Stockholm", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Marianne E. Pavel", "first_name": "Marianne", "last_name": "Pavel", "second_name": "E.", "country": "Germany", "city": "Erlangen", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Angela Lamarca", "first_name": "Angela", "last_name": "Lamarca", "second_name": "", "country": "United Kingdom", "city": "Manchester", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "David J. Pinato", "first_name": "David", "last_name": "Pinato", "second_name": "J.", "country": "United Kingdom", "city": "London", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Andrew X. Zhu", "first_name": "Andrew", "last_name": "Zhu", "second_name": "X.", "country": "United States of America", "city": "Boston", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Philippe Merle", "first_name": "Philippe", "last_name": "Merle", "second_name": "", "country": "CEDEX ", "city": "Lyon", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Giorgio Scagliotti", "first_name": "Giorgio", "last_name": "Scagliotti", "second_name": "", "country": "T", "city": "Orbassano", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Raffaele Califano", "first_name": "Raffaele", "last_name": "Califano", "second_name": "", "country": "United Kingdom", "city": "Manchester", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Anne-Marie C. Dingemans", "first_name": "Anne-Marie", "last_name": "Dingemans", "second_name": "C.", "country": "Netherlands", "city": "Rotterdam", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Nicholas D. James", "first_name": "Nicholas", "last_name": "James", "second_name": "D.", "country": "United Kingdom", "city": "London", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Michael J. Morris", "first_name": "Michael", "last_name": "Morris", "second_name": "J.", "country": "N", "city": "New York", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "David Cameron", "first_name": "David", "last_name": "Cameron", "second_name": "", "country": "Midlothia", "city": "Edinburgh", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Véronique Diéras", "first_name": "Véronique", "last_name": "Diéras", "second_name": "", "country": "France", "city": "Rennes", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Volkmar Müller", "first_name": "Volkmar", "last_name": "Müller", "second_name": "", "country": "Germany", "city": "Hamburg", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Jean-Yves Blay", "first_name": "Jean-Yves", "last_name": "Blay", "second_name": "", "country": "CEDE", "city": "Lyon", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Gilad Vainer", "first_name": "Gilad", "last_name": "Vainer", "second_name": "", "country": "Palestinian Territor", "city": "Jerusalem", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Marcia S. Brose", "first_name": "Marcia", "last_name": "Brose", "second_name": "S.", "country": "P", "city": "Philadelphia", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Brian I. Rini", "first_name": "Brian", "last_name": "Rini", "second_name": "I.", "country": "T", "city": "Nashville", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Peter O'Donnell", "first_name": "Peter", "last_name": "O'Donnell", "second_name": "", "country": "I", "city": "Chicago", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Ajjai Alva", "first_name": "Ajjai", "last_name": "Alva", "second_name": "", "country": "M", "city": "Ann Arbor", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Marc Peeters", "first_name": "Marc", "last_name": "Peeters", "second_name": "", "country": "Belgium", "city": "Edegem", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "David Planchard", "first_name": "David", "last_name": "Planchard", "second_name": "", "country": "France", "city": "Villejuif", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Mark Pegram", "first_name": "Mark", "last_name": "Pegram", "second_name": "", "country": "United States of America", "city": "Stanford", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "François Bocquet", "first_name": "François", "last_name": "Bocquet", "second_name": "", "country": "France", "city": "Paris", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "João Gonçalves", "first_name": "João", "last_name": "Gonçalves", "second_name": "", "country": "Portugal", "city": "Lisbon", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Sandra M. Swain", "first_name": "Sandra", "last_name": "Swain", "second_name": "M.", "country": "D", "city": "Washington", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Carlos H. Barrios", "first_name": "Carlos", "last_name": "Barrios", "second_name": "H.", "country": "Brazil", "city": "Porto Alegre", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Eva M. Ciruelos", "first_name": "Eva", "last_name": "Ciruelos", "second_name": "M.", "country": "Spain", "city": "Madrid", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Andrew M. Wardley", "first_name": "Andrew", "last_name": "Wardley", "second_name": "M.", "country": "United Kingdom", "city": "Manchester", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Christian Jackisch", "first_name": "Christian", "last_name": "Jackisch", "second_name": "", "country": "Germany", "city": "Offenbach am Main", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Paolo Marchetti", "first_name": "Paolo", "last_name": "Marchetti", "second_name": "", "country": "Italy", "city": "Rome", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Xavier Pivot", "first_name": "Xavier", "last_name": "Pivot", "second_name": "", "country": "France", "city": "Strasbourg", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Joyce O'Shaughnessy", "first_name": "Joyce", "last_name": "O'Shaughnessy", "second_name": "", "country": "United States of America", "city": "Dallas", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Cristina Saura", "first_name": "Cristina", "last_name": "Saura", "second_name": "", "country": "Spain", "city": "Barcelona", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Pilar Garrido", "first_name": "Pilar", "last_name": "Garrido", "second_name": "", "country": "Spain", "city": "Madrid", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Matthew Krebs", "first_name": "Matthew", "last_name": "Krebs", "second_name": "", "country": "United Kingdom", "city": "Manchester", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Zofia Piotrowska", "first_name": "Zofia", "last_name": "Piotrowska", "second_name": "", "country": "United States of America", "city": "Boston", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Cristina Suarez", "first_name": "Cristina", "last_name": "Suarez", "second_name": "", "country": "Spain", "city": "Barcelona", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Toni K. Choueiri", "first_name": "Toni", "last_name": "Choueiri", "second_name": "K.", "country": "United States of America", "city": "Boston", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Camillo Guglielmo Porta", "first_name": "Camillo", "last_name": "Porta", "second_name": "Guglielmo", "country": "Italy", "city": "Pavia", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Howard Gurney", "first_name": "Howard", "last_name": "Gurney", "second_name": "", "country": "NS", "city": "Sydney", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Cristina Suarez Rodriguez", "first_name": "Cristina", "last_name": "Rodriguez", "second_name": "Suarez", "country": "Spain", "city": "Barcelona", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Juan W. Valle", "first_name": "Juan", "last_name": "Valle", "second_name": "W.", "country": "United Kingdom", "city": "Manchester", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Helen Morement", "first_name": "Helen", "last_name": "Morement", "second_name": "", "country": "United Kingdom", "city": "Stansted Mountfitchet", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Peter Schirmacher", "first_name": "Peter", "last_name": "Schirmacher", "second_name": "", "country": "Germany", "city": "Heidelberg", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Philip Jermann", "first_name": "Philip", "last_name": "Jermann", "second_name": "", "country": "Switzerland", "city": "Basel", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Luca Quagliata", "first_name": "Luca", "last_name": "Quagliata", "second_name": "", "country": "Switzerland", "city": "Basel", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Gabriela Fernandes", "first_name": "Gabriela", "last_name": "Fernandes", "second_name": "", "country": "Portugal", "city": "Porto", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Koichi Goto", "first_name": "Koichi", "last_name": "Goto", "second_name": "", "country": "Japan", "city": "Kashiwa", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Cristiana Sessa", "first_name": "Cristiana", "last_name": "Sessa", "second_name": "", "country": "Switzerland", "city": "Bellinzona", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Nicoletta Colombo", "first_name": "Nicoletta", "last_name": "Colombo", "second_name": "", "country": "Italy", "city": "Milan", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Jose Alejandro Pérez-Fidalgo", "first_name": "Jose", "last_name": "Pérez-Fidalgo", "second_name": "Alejandro", "country": "Spain", "city": "Valencia", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Stephanie De Boer", "first_name": "Stephanie", "last_name": "De Boer", "second_name": "", "country": "Netherlands", "city": "Leiden", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Myung-Ju Ahn", "first_name": "Myung-Ju", "last_name": "Ahn", "second_name": "", "country": "Kore", "city": "Seoul", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Martin Reck", "first_name": "Martin", "last_name": "Reck", "second_name": "", "country": "Germany", "city": "Grosshansdorf", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Ross Soo", "first_name": "Ross", "last_name": "Soo", "second_name": "", "country": "Singapore", "city": "Singapore", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Edward B. Garon", "first_name": "Edward", "last_name": "Garon", "second_name": "B.", "country": "C", "city": "Santa Monica", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Alexander Drilon", "first_name": "Alexander", "last_name": "Drilon", "second_name": "", "country": "N", "city": "New York", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Lori J. Wirth", "first_name": "Lori", "last_name": "Wirth", "second_name": "J.", "country": "M", "city": "Boston", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Matthew N. Fowler", "first_name": "Matthew", "last_name": "Fowler", "second_name": "N.", "country": "United Kingdom", "city": "Birmingham", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Eric Van Cutsem", "first_name": "Eric", "last_name": "Van Cutsem", "second_name": "", "country": "Belgium", "city": "Leuven", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Alfredo Falcone", "first_name": "Alfredo", "last_name": "Falcone", "second_name": "", "country": "Italy", "city": "Pisa", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Cora N. Sternberg", "first_name": "Cora", "last_name": "Sternberg", "second_name": "N.", "country": "United States of America", "city": "New York", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Viktor Grünwald", "first_name": "Viktor", "last_name": "Grünwald", "second_name": "", "country": "Germany", "city": "Essen", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Nicolas Mottet", "first_name": "Nicolas", "last_name": "Mottet", "second_name": "", "country": "cédex ", "city": "Saint-Étienne", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Christopher Sweeney", "first_name": "Christopher", "last_name": "Sweeney", "second_name": "", "country": "M", "city": "Boston", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Chirstian Thomas", "first_name": "Chirstian", "last_name": "Thomas", "second_name": "", "country": "Germany", "city": "Dresden", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Bradley J. Monk", "first_name": "Bradley", "last_name": "Monk", "second_name": "J.", "country": "United States of America", "city": "Phoenix", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Bradley Monk", "first_name": "Bradley", "last_name": "Monk", "second_name": "", "country": "United States of America", "city": "Phoenix", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Jonathan A. Ledermann", "first_name": "Jonathan", "last_name": "Ledermann", "second_name": "A.", "country": "Londo", "city": "London", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Gero Kramer", "first_name": "Gero", "last_name": "Kramer", "second_name": "", "country": "Austria", "city": "Vienna", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Jennifer Sutton", "first_name": "Jennifer", "last_name": "Sutton", "second_name": "", "country": "United States of America", "city": "Myrtle Beach", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Ana Oaknin", "first_name": "Ana", "last_name": "Oaknin", "second_name": "", "country": "Spain", "city": "Barcelona", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Thomas Herzog", "first_name": "Thomas", "last_name": "Herzog", "second_name": "", "country": "United States of America", "city": "Cincinnati", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Ignace B. Vergote", "first_name": "Ignace", "last_name": "Vergote", "second_name": "B.", "country": "Belgium", "city": "Leuven", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "David R. Spigel", "first_name": "David", "last_name": "Spigel", "second_name": "R.", "country": "T", "city": "Nashville", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Johan F. Vansteenkiste", "first_name": "Johan", "last_name": "Vansteenkiste", "second_name": "F.", "country": "Belgium", "city": "Leuven", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Tom John", "first_name": "Tom", "last_name": "John", "second_name": "", "country": "VI", "city": "Heidelberg", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Boris A. Hadaschik", "first_name": "Boris", "last_name": "Hadaschik", "second_name": "A.", "country": "Germany", "city": "Essen", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Eleni Efstathiou", "first_name": "Eleni", "last_name": "Efstathiou", "second_name": "", "country": "T", "city": "Houston", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Kim N. Chi", "first_name": "Kim", "last_name": "N.", "second_name": "", "country": "British Columbi", "city": "Vancouver", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Daniel J. George", "first_name": "Daniel", "last_name": "George", "second_name": "J.", "country": "N", "city": "Durham", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Arnulf Stenzl", "first_name": "Arnulf", "last_name": "Stenzl", "second_name": "", "country": "Germany", "city": "Tuebingen", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Hannes Arnold", "first_name": "Hannes", "last_name": "Arnold", "second_name": "", "country": "Netherlands", "city": "Leiden", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Stephen Hague", "first_name": "Stephen", "last_name": "Hague", "second_name": "", "country": "Netherlands", "city": "Leiden", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Thomas Wu", "first_name": "Thomas", "last_name": "Wu", "second_name": "", "country": "United States of America", "city": "South San Francisco", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Graham Collins", "first_name": "Graham", "last_name": "Collins", "second_name": "", "country": "United Kingdom", "city": "Oxford", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Stephen Scowcroft", "first_name": "Stephen", "last_name": "Scowcroft", "second_name": "", "country": "United Kingdom", "city": "Harpenden", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Òrla Stewart", "first_name": "Òrla", "last_name": "Stewart", "second_name": "", "country": "United Kingdom", "city": "London", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Surabhi Chaturvedi", "first_name": "Surabhi", "last_name": "Chaturvedi", "second_name": "", "country": "United Kingdom", "city": "London", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Claire Roddie", "first_name": "Claire", "last_name": "Roddie", "second_name": "", "country": "United Kingdom", "city": "London", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Jackie Chappel", "first_name": "Jackie", "last_name": "Chappel", "second_name": "", "country": "United Kingdom", "city": "London", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Anthony Wilson", "first_name": "Anthony", "last_name": "Wilson", "second_name": "", "country": "United Kingdom", "city": "Manchester", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Tanja Cufer", "first_name": "Tanja", "last_name": "Cufer", "second_name": "", "country": "Slovenia", "city": "Golnik", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Silvia Novello", "first_name": "Silvia", "last_name": "Novello", "second_name": "", "country": "Italy", "city": "Orbassano", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Xiuning Le", "first_name": "Xiuning", "last_name": "Le", "second_name": "", "country": "T", "city": "Houston", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Melissa Johnson", "first_name": "Melissa", "last_name": "Johnson", "second_name": "", "country": "T", "city": "Nashville", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Robert L. Coleman", "first_name": "Robert", "last_name": "Coleman", "second_name": "L.", "country": "T", "city": "The Woodlands", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Amit Oza", "first_name": "Amit", "last_name": "Oza", "second_name": "", "country": "O", "city": "Toronto", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Renaud Sabatier", "first_name": "Renaud", "last_name": "Sabatier", "second_name": "", "country": "France", "city": "Marseille", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Chrysalyne D. Schmults", "first_name": "Chrysalyne", "last_name": "Schmults", "second_name": "D.", "country": "M", "city": "Harvard", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Susana Puig", "first_name": "Susana", "last_name": "Puig", "second_name": "", "country": "Spain", "city": "Barcelona", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Fatima Cardoso", "first_name": "Fatima", "last_name": "Cardoso", "second_name": "", "country": "Portugal", "city": "Lisbon", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Erika P. Hamilton", "first_name": "Erika", "last_name": "Hamilton", "second_name": "P.", "country": "United States of America", "city": "Nashville", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Karen A. Gelmon", "first_name": "Karen", "last_name": "Gelmon", "second_name": "A.", "country": "British Columbi", "city": "Vancouver", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Thomas Yau", "first_name": "Thomas", "last_name": "Yau", "second_name": "", "country": "Pokfula", "city": "Hong Kong", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Hope S. Rugo", "first_name": "Hope", "last_name": "Rugo", "second_name": "S.", "country": "C", "city": "San Francisco", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Michelino De Laurentiis", "first_name": "Michelino", "last_name": "De Laurentiis", "second_name": "", "country": "Italy", "city": "Napoli", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Tina Cascone", "first_name": "Tina", "last_name": "Cascone", "second_name": "", "country": "M", "city": "Houston", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Paul Baas", "first_name": "Paul", "last_name": "Baas", "second_name": "", "country": "Netherlands", "city": "Amsterdam", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "James Larkin", "first_name": "James", "last_name": "Larkin", "second_name": "", "country": "United Kingdom", "city": "London", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Pippa Corrie", "first_name": "Pippa", "last_name": "Corrie", "second_name": "", "country": "United Kingdom", "city": "Cambridge", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Gerald Prager", "first_name": "Gerald", "last_name": "Prager", "second_name": "", "country": "Austria", "city": "Vienna", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Norbert W. Marschner", "first_name": "Norbert", "last_name": "Marschner", "second_name": "W.", "country": "Germany", "city": "Freiburg im Breisgau", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Junji Furuse", "first_name": "Junji", "last_name": "Furuse", "second_name": "", "country": "Toky", "city": "Tokyo", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Cindy Neuzillet", "first_name": "Cindy", "last_name": "Neuzillet", "second_name": "", "country": "France", "city": "Clichy", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Ticiana A Leal", "first_name": "Ticiana", "last_name": "Leal", "second_name": "A", "country": "W", "city": "Madison", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Richard Cathomas", "first_name": "Richard", "last_name": "Cathomas", "second_name": "", "country": "Switzerland", "city": "Chur", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Lisa M. Pickering", "first_name": "Lisa", "last_name": "Pickering", "second_name": "M.", "country": "United Kingdom", "city": "London", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Ozguroglu", "first_name": "M.", "last_name": "Ozguroglu", "second_name": "", "title": " Honoraria (self): Roche; Honoraria (self), Advisory/Consultancy: Sanofi; Honoraria (self), Advisory/Consultancy: Astellas; Honoraria (institution), Advisory/Consultancy, Travel/Accommodation/Expenses: Janssen; Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: AstraZeneca; Travel/Accommodation/Expenses: BMS; Research grant/Funding (institution): Merck Sharp & Dohme Corp."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "N. Matsubara", "first_name": "N.", "last_name": "Matsubara", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (institution): Janssen; Advisory/Consultancy, Research grant/Funding (institution): MSD, a subsidiary of Merck & Co."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "L. Geczi", "first_name": "L.", "last_name": "Geczi", "second_name": "", "title": " Research grant/Funding (institution): Merck Sharp & Dohme Corp."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Cheng", "first_name": "S.", "last_name": "Cheng", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (institution): Merck & Co."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Y. Fradet", "first_name": "Y.", "last_name": "Fradet", "second_name": "", "title": " Advisory/Consultancy: Merck & Co."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Oudard", "first_name": "S.", "last_name": "Oudard", "second_name": "", "title": " Honoraria (self), Research grant/Funding (self), Travel/Accommodation/Expenses: BMS; Honoraria (self), Travel/Accommodation/Expenses: Merck & Co."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Vulsteke", "first_name": "C.", "last_name": "Vulsteke", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution): Merck Sharp & Dohme Corp."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. Morales Barrera", "first_name": "R.", "last_name": "Barrera", "second_name": "Morales", "title": " Honoraria (self), Advisory/Consultancy: Sanofi Aventis; Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Roche; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: MSD, a subsidiary of Merck & Co."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Gunduz", "first_name": "S.", "last_name": "Gunduz", "second_name": "", "title": " Travel/Accommodation/Expenses: Roche; Research grant/Funding (institution): Merck Sharp & Dohme Corp."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Y. Loriot", "first_name": "Y.", "last_name": "Loriot", "second_name": "", "title": " Honoraria (self), Travel/Accommodation/Expenses: Roche; Honoraria (self): Astellas; Honoraria (self), Honoraria (institution), Research grant/Funding (institution), Travel/Accommodation/Expenses: Janssen; Honoraria (self): Seattle Genetics; Honoraria (self), Travel/Accommodation/Expenses: AstraZeneca; Honoraria (self): BMS; Honoraria (self), Research grant/Funding (institution), Travel/Accommodation/Expenses: Merck Sharp & Dohme Corp."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. Mamtani", "first_name": "R.", "last_name": "Mamtani", "second_name": "", "title": " Honoraria (self): Med Learning Group; Advisory/Consultancy: Flatiron Health; Advisory/Consultancy: Roche/Genetech; Advisory/Consultancy: Seattle Genetics/Astellas; Research grant/Funding (institution): Merck Sharp & Dohme Corp."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Y. Yu", "first_name": "Y.", "last_name": "Yu", "second_name": "", "title": " Advisory/Consultancy: AbbVie; Advisory/Consultancy: Advanced Accelerator Applications; Advisory/Consultancy, Research grant/Funding (institution): Bayer; Advisory/Consultancy: Clovis; Advisory/Consultancy: Janssen; Advisory/Consultancy, Research grant/Funding (institution): Merck Sharp & Dohme, a subsidiary of Merck & Co."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "K. Nam", "first_name": "K.", "last_name": "Nam", "second_name": "", "title": " Full/Part-time employment: Merck & Co."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "K. Imai", "first_name": "K.", "last_name": "Imai", "second_name": "", "title": " Full/Part-time employment: Merck & C."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "H. Moreno", "first_name": "H.", "last_name": "Moreno", "second_name": "", "title": " Full/Part-time employment: Merck & Co."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "B. Powles", "first_name": "B.", "last_name": "Powles", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: AstraZeneca; Honoraria (institution), Advisory/Consultancy: BMS; Honoraria (institution), Advisory/Consultancy: Seattle Genetics; Honoraria (institution), Advisory/Consultancy: Ipsen; Honoraria (institution), Advisory/Consultancy: MSD, a subsidiary of Merck & Co."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. van der Heijden", "first_name": "S.", "last_name": "van der Heijden", "second_name": "", "title": " Advisory/Consultancy: AstraZeneca/MedImmune; Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Astellas Pharma; Advisory/Consultancy, Research grant/Funding (institution): Bristol-Myers Squibb; Advisory/Consultancy, Travel/Accommodation/Expenses: MSD Oncology ; Advisory/Consultancy: Roche/Genentech ; Advisory/Consultancy: Seattle Genetics ; Research grant/Funding (institution), Travel/Accommodation/Expenses: Roche; Travel/Accommodation/Expenses: Novartis."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Castellano Gauna", "first_name": "D.", "last_name": "Gauna", "second_name": "Castellano", "title": " Advisory/Consultancy: Astellas Pharma; Advisory/Consultancy: AstraZeneca; Travel/Accommodation/Expenses: AstraZeneca Spain; Advisory/Consultancy: Bayer; Advisory/Consultancy: Boehringer Ingelheim; Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: Bristol-Myers Squibb; Advisory/Consultancy: Ipsen; Advisory/Consultancy: Janssen Oncology; Advisory/Consultancy: Lilly; Advisory/Consultancy: MSD Oncology; Advisory/Consultancy: Novartis; Advisory/Consultancy, Travel/Accommodation/Expenses: Pfizer; Advisory/Consultancy: Pierre Fabre; Advisory/Consultancy: Roche/Genentech; Advisory/Consultancy: Sanofi; Research grant/Funding (institution): Janssen Oncology; Travel/Accommodation/Expenses: Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Galsky", "first_name": "D.", "last_name": "Galsky", "second_name": "", "title": " Shareholder/Stockholder/Stock options: Rappta Therapeutics; Advisory/Consultancy: Aileron Therapeutics; Advisory/Consultancy: Astellas Pharma; Advisory/Consultancy, Research grant/Funding (institution): AstraZeneca; Advisory/Consultancy: BioMotiv; Advisory/Consultancy, Research grant/Funding (institution): Bristol-Myers Squibb; Advisory/Consultancy, Research grant/Funding (institution): Dendreon; Advisory/Consultancy: Dracen; Advisory/Consultancy: EMD Serono; Advisory/Consultancy: Genentech; Research grant/Funding (institution): Genentech/Roche; Advisory/Consultancy: GlaxoSmithKline; Advisory/Consultancy: Incyte; Advisory/Consultancy: Inovio Pharmaceuticals; Advisory/Consultancy: Janssen; Advisory/Consultancy: Lilly; Advisory/Consultancy: Merck; Advisory/Consultancy, Research grant/Funding (institution): Novartis; Advisory/Consultancy: NuMab; Advisory/Consultancy: Pfizer; Advisory/Consultancy: Seattle Genetics; Research grant/Funding (institution): Janssen Oncology ; Research grant/Funding (institution): Merck ."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "P. Petrylak", "first_name": "P.", "last_name": "Petrylak", "second_name": "", "title": " Shareholder/Stockholder/Stock options: Bellicum Pharmaceuticals; Advisory/Consultancy, Shareholder/Stockholder/Stock options: TYME; Advisory/Consultancy, Research grant/Funding (self): Astellas Pharma; Advisory/Consultancy, Research grant/Funding (self): AstraZeneca; Advisory/Consultancy, Research grant/Funding (self): Bayer; Advisory/Consultancy: Bellicum Pharmaceuticals; Advisory/Consultancy, Research grant/Funding (self): Dendreon; Advisory/Consultancy: Exelixis; Advisory/Consultancy: Ferring; Advisory/Consultancy, Research grant/Funding (self): Johnson & Johnson; Advisory/Consultancy, Research grant/Funding (self): Lilly; Advisory/Consultancy: Medivation; Advisory/Consultancy, Research grant/Funding (self): Millennium; Advisory/Consultancy, Research grant/Funding (self): Pfizer; Advisory/Consultancy, Research grant/Funding (self): Roche; Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (self): Sanofi; Research grant/Funding (self): Agensys; Research grant/Funding (self): Clovis Oncology; Research grant/Funding (self): Endocyte; Research grant/Funding (self): Genentech; Research grant/Funding (self): Innocrin Pharma; Research grant/Funding (self): MedImmune; Research grant/Funding (self): Merck; Research grant/Funding (self): Novartis; Research grant/Funding (self): Progenics; Research grant/Funding (self): Seattle Genetics; Research grant/Funding (self): Sotio; Speaker Bureau/Expert testimony: Celgene."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "H. Park", "first_name": "H.", "last_name": "Park", "second_name": "", "title": " Advisory/Consultancy: Lilly."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Necchi", "first_name": "A.", "last_name": "Necchi", "second_name": "", "title": " Advisory/Consultancy, Shareholder/Stockholder/Stock options, Full/Part-time employment: Bayer; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: AstraZeneca; Honoraria (self): Foundation Medicine; Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Janssen; Honoraria (self): Merck; Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Roche; Advisory/Consultancy: Bristol-Myers Squibb; Advisory/Consultancy: Clovis Oncology; Advisory/Consultancy: Incyte; Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Merck Sharp & Dohme; Advisory/Consultancy: Rainier Therapeutics; Advisory/Consultancy: Seattle Genetics/Astellas."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "L. Lee", "first_name": "L.", "last_name": "Lee", "second_name": "", "title": " Honoraria (self): Amgen Korea; Honoraria (self): Astellas Pharma; Honoraria (self), Research grant/Funding (institution): Bristol-Myers Squibb; Advisory/Consultancy: BMS Korea; Advisory/Consultancy: Eisai; Advisory/Consultancy: Pfizer Korea; Advisory/Consultancy: Sanofi Aventis Korea; Research grant/Funding (institution): AstraZeneca/MedImmune ; Research grant/Funding (institution): Janssen; Research grant/Funding (institution): MSD; Research grant/Funding (institution): Novartis; Research grant/Funding (institution): Pfizer; Research grant/Funding (institution): Roche/Genentech."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "U. De Giorgi", "first_name": "U.", "last_name": "De Giorgi", "second_name": "", "title": " Advisory/Consultancy: Astellas Pharma; Advisory/Consultancy: Bayer; Advisory/Consultancy: Bristol-Myers Squibb; Advisory/Consultancy: Ipsen; Advisory/Consultancy: Janssen; Advisory/Consultancy: Pfizer; Advisory/Consultancy: Sanofi."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Bamias", "first_name": "A.", "last_name": "Bamias", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (self): Bristol-Myers Squibb; Honoraria (self), Speaker Bureau/Expert testimony, Research grant/Funding (self), Travel/Accommodation/Expenses: Novartis; Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (self): AstraZeneca; Advisory/Consultancy: MSD; Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (self), Travel/Accommodation/Expenses: Pfizer; Advisory/Consultancy: Pierre; Advisory/Consultancy: Fabre; Research grant/Funding (self): Roche; Research grant/Funding (self): Sanofi."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "P. Fay", "first_name": "P.", "last_name": "Fay", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy: AstraZeneca; Honoraria (self): Bristol-Myers Squibb; Honoraria (self), Advisory/Consultancy: Novartis; Honoraria (self), Advisory/Consultancy: Pfizer; Honoraria (self), Advisory/Consultancy: Roche; Advisory/Consultancy: Merck Sharp & Dohme."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "I. Duran", "first_name": "I.", "last_name": "Duran", "second_name": "", "title": " Honoraria (self), Research grant/Funding (institution): Astellas Pharma; Honoraria (self), Advisory/Consultancy: Bristol-Myers Squibb; Honoraria (self): Ipsen; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution): Janssen Oncology; Honoraria (self), Advisory/Consultancy: MSD Oncology; Advisory/Consultancy: Bayer; Advisory/Consultancy: Novartis; Advisory/Consultancy: Pharmacyclics; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Roche/Genentech; Advisory/Consultancy: Seattle Genetics; Research grant/Funding (institution), Travel/Accommodation/Expenses: AstraZeneca Spain."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "N. Angra", "first_name": "N.", "last_name": "Angra", "second_name": "", "title": " Travel/Accommodation/Expenses, Shareholder/Stockholder/Stock options, Full/Part-time employment: MedImmune."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "K. Gupta", "first_name": "K.", "last_name": "Gupta", "second_name": "", "title": " Advisory/Consultancy, Shareholder/Stockholder/Stock options, Full/Part-time employment: AstraZeneca; Shareholder/Stockholder/Stock options, Licensing/Royalties: Brystol-Myers-Squibb."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "P. He", "first_name": "P.", "last_name": "He", "second_name": "", "title": " Travel/Accommodation/Expenses, Full/Part-time employment: AstraZeneca; Travel/Accommodation/Expenses, Shareholder/Stockholder/Stock options, Full/Part-time employment: Celldex; Shareholder/Stockholder/Stock options, Full/Part-time employment: Sanofi."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "W. Levin", "first_name": "W.", "last_name": "Levin", "second_name": "", "title": " Full/Part-time employment: AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Bellmunt", "first_name": "J.", "last_name": "Bellmunt", "second_name": "", "title": " Advisory/Consultancy: Astellas Pharma; Advisory/Consultancy: AstraZeneca/MedImmune; Advisory/Consultancy: Bristol-Myers Squibb; Advisory/Consultancy: Genentech; Advisory/Consultancy: Merck; Advisory/Consultancy: Novartis; Advisory/Consultancy, Travel/Accommodation/Expenses: Pfizer; Advisory/Consultancy: Pierre Fabre; Research grant/Funding (institution): Millennium; Research grant/Funding (institution): Sanofi; Travel/Accommodation/Expenses: MSD Oncology; Honoraria (self): UpToDate; Shareholder/Stockholder/Stock options: Rainier; Research grant/Funding (institution): Pfizer/EMD Serono; Travel/Accommodation/Expenses: Ipsen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "V. Balar", "first_name": "V.", "last_name": "Balar", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (institution): Genentech; Honoraria (self), Advisory/Consultancy: Incyte; Honoraria (self), Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (institution): Merck; Honoraria (self), Advisory/Consultancy: Janssen; Honoraria (self), Advisory/Consultancy: Pfizer; Honoraria (self), Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (institution): AstraZeneca/MedImmune; Honoraria (self), Advisory/Consultancy, Research grant/Funding (self): Nektar; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution): Seattle Genetics; Research grant/Funding (institution): Immunomedics."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "T. Tagawa", "first_name": "T.", "last_name": "Tagawa", "second_name": "", "title": " Honoraria (self), Research grant/Funding (institution): Immunomedics."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Rezazadeh", "first_name": "A.", "last_name": "Rezazadeh", "second_name": "", "title": " Shareholder/Stockholder/Stock options: ECOM Medical; Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (institution), Travel/Accommodation/Expenses: Exelixis; Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (institution), Travel/Accommodation/Expenses: AstraZeneca; Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Bayer; Advisory/Consultancy, Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: Pfizer; Advisory/Consultancy, Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: Novartis; Advisory/Consultancy, Travel/Accommodation/Expenses: Genentech; Advisory/Consultancy: BMS; Advisory/Consultancy: EMD Serono; Speaker Bureau/Expert testimony, Research grant/Funding (institution), Travel/Accommodation/Expenses: Janssen; Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: Astellas Medivation; Speaker Bureau/Expert testimony: Sanofi; Speaker Bureau/Expert testimony: Genentech/Roche; Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: Eisai; Speaker Bureau/Expert testimony, Research grant/Funding (institution): BMS; Speaker Bureau/Expert testimony: Amgen; Speaker Bureau/Expert testimony: EMD Serono; Speaker Bureau/Expert testimony: Merck; Speaker Bureau/Expert testimony: Seattle Genetics/Astellas; Research grant/Funding (institution): Genentech; Research grant/Funding (institution): Eisai; Research grant/Funding (institution): Macrogenics; Research grant/Funding (institution): Astellas Pharma; Research grant/Funding (institution): Beyond Spring; Research grant/Funding (institution): BioClin Therapeutics; Research grant/Funding (institution): Clovis Oncology; Research grant/Funding (institution): Bavarian Nordic; Research grant/Funding (institution): Seattle Genetics; Research grant/Funding (institution): Immunomedics, Epizy; Travel/Accommodation/Expenses: Prometheus Laboratories."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. Jain", "first_name": "R.", "last_name": "Jain", "second_name": "", "title": " Honoraria (self), Speaker Bureau/Expert testimony: Astellas; Honoraria (self), Speaker Bureau/Expert testimony: Pfizer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "N. Agarwal", "first_name": "N.", "last_name": "Agarwal", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (institution): Pfizer; Advisory/Consultancy, Research grant/Funding (institution): Exelixis; Advisory/Consultancy: Argos; Advisory/Consultancy: EMD Serono; Advisory/Consultancy, Research grant/Funding (institution): Eisai; Advisory/Consultancy, Research grant/Funding (institution): Bayer; Advisory/Consultancy, Research grant/Funding (institution): Novartis; Advisory/Consultancy, Research grant/Funding (institution): Genentech; Advisory/Consultancy, Research grant/Funding (institution): BMS; Advisory/Consultancy, Research grant/Funding (institution): AstraZeneca; Advisory/Consultancy, Research grant/Funding (institution): Medivation; Advisory/Consultancy: Clovis; Advisory/Consultancy: Foundation One, Seattle Genetics; Advisory/Consultancy: Astellas; Advisory/Consultancy: Eli Lilly; Advisory/Consultancy: Nektar; Research grant/Funding (institution): Active Biotech; Research grant/Funding (institution): Bavarian Nordic; Research grant/Funding (institution): Calithera; Research grant/Funding (institution): Celldex; Research grant/Funding (institution): GlaxoSmithKline; Research grant/Funding (institution): Immunomedics; Research grant/Funding (institution): Janssen; Research grant/Funding (institution): Merck; Research grant/Funding (institution): New Link Genetics; Research grant/Funding (institution): Prometheus; Research grant/Funding (institution): Rexahn; Research grant/Funding (institution): Sanofi; Research grant/Funding (institution): Takeda; Research grant/Funding (institution): Tracon."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Bupathi", "first_name": "M.", "last_name": "Bupathi", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Speaker Bureau/Expert testimony: BMS; Honoraria (self), Advisory/Consultancy, Speaker Bureau/Expert testimony: Exelixis; Honoraria (self), Advisory/Consultancy, Speaker Bureau/Expert testimony: AstraZeneca; Honoraria (self), Speaker Bureau/Expert testimony: Pfizer; Honoraria (self), Speaker Bureau/Expert testimony: Astellas."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "L. Palmbos", "first_name": "L.", "last_name": "Palmbos", "second_name": "", "title": " Research grant/Funding (institution): Immunomedics."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Pouessel", "first_name": "D.", "last_name": "Pouessel", "second_name": "", "title": " Honoraria (self), Research grant/Funding (institution), Non-remunerated activity/ies: AstraZeneca; Honoraria (self): Sanofi; Honoraria (self): Merck; Honoraria (self): Astellas; Honoraria (self): Janssen; Research grant/Funding (institution): MSD; Research grant/Funding (institution): Roche; Research grant/Funding (institution): Incyte; Research grant/Funding (institution), Non-remunerated activity/ies: Janssen; Honoraria (self), Research grant/Funding (institution): BMS; Honoraria (self): Ipsen; Honoraria (self), Non-remunerated activity/ies: Pfizer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "N. Sternberg", "first_name": "N.", "last_name": "Sternberg", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy: Pfizer; Honoraria (self), Advisory/Consultancy: Merck; Honoraria (self), Advisory/Consultancy: Incyte; Honoraria (self), Advisory/Consultancy: BMS; Honoraria (self), Advisory/Consultancy: AstraZeneca; Honoraria (self), Advisory/Consultancy: UroToday."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Q. Hong", "first_name": "Q.", "last_name": "Hong", "second_name": "", "title": " Leadership role, Travel/Accommodation/Expenses, Shareholder/Stockholder/Stock options, Full/Part-time employment: Immunomedics."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "T. Goswami", "first_name": "T.", "last_name": "Goswami", "second_name": "", "title": " Leadership role, Travel/Accommodation/Expenses, Shareholder/Stockholder/Stock options, Full/Part-time employment: Immunomedics."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Itri", "first_name": "M.", "last_name": "Itri", "second_name": "", "title": " Advisory/Consultancy, Leadership role, Shareholder/Stockholder/Stock options, Full/Part-time employment: Immunomedics; Advisory/Consultancy, Leadership role, Shareholder/Stockholder/Stock options, Full/Part-time employment: The Medicines Company; Shareholder/Stockholder/Stock options, Immediate Family Member: MSKCC."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "P. Grivas", "first_name": "P.", "last_name": "Grivas", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (institution): Genentech; Honoraria (self), Research grant/Funding (institution): Bayer; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution): Merck; Honoraria (self), Research grant/Funding (institution): Mirati Therapeutics; Research grant/Funding (institution): Oncogenex; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution): Pfizer; Honoraria (self), Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (institution): BMS; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Non-remunerated activity/ies: AstraZeneca; Honoraria (self), Advisory/Consultancy: Biocept; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution): ClovisOncology; Honoraria (self), Advisory/Consultancy: EMD Serono; Honoraria (self), Advisory/Consultancy: Seattle Genetics; Honoraria (self), Advisory/Consultancy: Foundation Medicine; Honoraria (self), Advisory/Consultancy: Driver Inc."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. De Santis", "first_name": "M.", "last_name": "De Santis", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Astellas Pharma; Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Bayer; Honoraria (self): Novartis; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution): Pierre Fabre; Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Roche/Genentech; Advisory/Consultancy: Amgen; Advisory/Consultancy: AstraZeneca; Advisory/Consultancy: Basilea; Advisory/Consultancy: BioClin Therapeutics; Advisory/Consultancy: BioSyn Healthy Pharma Co; Advisory/Consultancy, Travel/Accommodation/Expenses: Bristol-Myers Squibb; Advisory/Consultancy: Ferring; Advisory/Consultancy: GlaxoSmithKline; Advisory/Consultancy, Travel/Accommodation/Expenses: Ipsen; Advisory/Consultancy, Travel/Accommodation/Expenses: Janssen; Advisory/Consultancy: Merck Sharp & Dohme; Advisory/Consultancy: Sandoz-Novartis; Advisory/Consultancy, Travel/Accommodation/Expenses: Sanofi; Advisory/Consultancy: Seattle Genetics; Advisory/Consultancy: Synthon; Advisory/Consultancy: Takeda."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "E. Grande", "first_name": "E.", "last_name": "Grande", "second_name": "", "title": " Honoraria (self): Adacap; Honoraria (self): Astellas Pharma; Honoraria (self), Travel/Accommodation/Expenses: Bristol-Myers Squibb; Honoraria (self): Celgene; Honoraria (self): Eisai; Honoraria (self): Eusa Pharma; Honoraria (self): Genzyme; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution): Ipsen; Honoraria (self), Travel/Accommodation/Expenses: Janssen-Cilag; Honoraria (self): Lexicon; Honoraria (self), Advisory/Consultancy: MSD; Honoraria (self): Novartis; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Pfizer; Honoraria (self): Pierre Fabre; Honoraria (self), Research grant/Funding (institution): Roche; Research grant/Funding (institution): Molecular Templates; Research grant/Funding (institution): AstraZeneca ; Travel/Accommodation/Expenses: Roche/Genentech."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "E. Kikuchi", "first_name": "E.", "last_name": "Kikuchi", "second_name": "", "title": " Honoraria (self), Research grant/Funding (institution): Astellas; Honoraria (self), Research grant/Funding (institution): AstraZeneca; Honoraria (self): Bristol; Honoraria (self), Research grant/Funding (institution): Chugai; Honoraria (self): Fuso; Honoraria (self): Janssen; Research grant/Funding (institution): Kissei; Honoraria (self), Research grant/Funding (institution): Kyorin; Honoraria (self), Research grant/Funding (institution): MSD; Honoraria (self), Research grant/Funding (institution): Nippon Kayaku; Research grant/Funding (institution): Nippon Shinyaku; Honoraria (self), Research grant/Funding (institution): Novartis; Honoraria (self), Research grant/Funding (institution): Ono; Honoraria (self), Research grant/Funding (institution): Pfizer; Honoraria (self), Research grant/Funding (institution): Sanofi; Research grant/Funding (institution): Taiho; Honoraria (self), Research grant/Funding (institution): Takeda."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "X. Garcia del Muro", "first_name": "X.", "last_name": "del Muro", "second_name": "Garcia", "title": " Advisory/Consultancy, Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: Bristol-Myers Squibb; Advisory/Consultancy: Eusa Pharma; Advisory/Consultancy, Speaker Bureau/Expert testimony: Ipsen; Advisory/Consultancy: Lilly; Advisory/Consultancy, Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: Pfizer; Advisory/Consultancy, Speaker Bureau/Expert testimony: PharmaMar; Advisory/Consultancy: Roche; Research grant/Funding (institution): AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Mencinger", "first_name": "M.", "last_name": "Mencinger", "second_name": "", "title": " Honoraria (self): Roche; Honoraria (self): Swiss Pharma; Advisory/Consultancy: MSD; Advisory/Consultancy, Travel/Accommodation/Expenses: Sanofi; Travel/Accommodation/Expenses: Astellas Pharma; Travel/Accommodation/Expenses: Pfizer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "B. Alekseev", "first_name": "B.", "last_name": "Alekseev", "second_name": "", "title": " Speaker Bureau/Expert testimony: Astellas; Speaker Bureau/Expert testimony: AstraZeneca; Speaker Bureau/Expert testimony: Bayer; Speaker Bureau/Expert testimony: BMS; Speaker Bureau/Expert testimony: Eisai; Speaker Bureau/Expert testimony: Ferring; Speaker Bureau/Expert testimony: Janssen; Speaker Bureau/Expert testimony: Ipsen; Speaker Bureau/Expert testimony: MSD; Speaker Bureau/Expert testimony: Pfizer; Speaker Bureau/Expert testimony: Roche; Speaker Bureau/Expert testimony: Sanofi."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Puente", "first_name": "J.", "last_name": "Puente", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution): Astellas Pharma; Honoraria (self): AstraZeneca; Honoraria (self), Advisory/Consultancy: Bayer; Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Bristol-Myers Squibb; Honoraria (self), Advisory/Consultancy: Eisai; Honoraria (self): EUSA Pharma; Honoraria (self), Advisory/Consultancy: Ipsen; Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Janssen-Cilag; Honoraria (self), Travel/Accommodation/Expenses: MSD Oncology; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Pfizer; Honoraria (self): Pierre Fabre; Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Roche; Honoraria (self), Advisory/Consultancy: Sanofi; Advisory/Consultancy: Clovis Oncology; Advisory/Consultancy: Merck Sharp & Dohme."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "K. Izumi", "first_name": "K.", "last_name": "Izumi", "second_name": "", "title": " Research grant/Funding (institution): Chugai Pharmaceutical."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Gumus", "first_name": "M.", "last_name": "Gumus", "second_name": "", "title": " Honoraria (institution), Advisory/Consultancy, Travel/Accommodation/Expenses: Roche; Honoraria (institution): Novartis; Honoraria (institution): BMS; Honoraria (institution): MSD; Honoraria (institution): Amgen; Honoraria (institution), Travel/Accommodation/Expenses: Pfizer; Advisory/Consultancy: Gen İlac; Advisory/Consultancy: Astellas."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "B. Mellado Gonzalez", "first_name": "B.", "last_name": "Gonzalez", "second_name": "Mellado", "title": " Speaker Bureau/Expert testimony, Research grant/Funding (institution): Astellas Pharma; Speaker Bureau/Expert testimony, Research grant/Funding (institution): Bayer; Speaker Bureau/Expert testimony: Bristol-Myers Squibb; Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: Ipsen; Speaker Bureau/Expert testimony, Research grant/Funding (institution), Travel/Accommodation/Expenses: Janssen; Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: Pfizer; Speaker Bureau/Expert testimony, Research grant/Funding (institution), Travel/Accommodation/Expenses: Roche; Speaker Bureau/Expert testimony, Research grant/Funding (institution): Sanofi."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. Li", "first_name": "R.", "last_name": "Li", "second_name": "", "title": " Honoraria (self): Amgen; Honoraria (self): Astellas Pharma; Honoraria (self): AstraZeneca; Honoraria (self): Bayer ; Honoraria (self): Bristol-Myers Squibb; Honoraria (self): Ipsen; Honoraria (self): Johnson & Johnson; Honoraria (self): MSD; Honoraria (self): Ono Pharmaceutical; Honoraria (self): Pfizer; Honoraria (self): Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Quach", "first_name": "C.", "last_name": "Quach", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Genentech."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "B. Ding", "first_name": "B.", "last_name": "Ding", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Roche/Genentech."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Bernhard", "first_name": "S.", "last_name": "Bernhard", "second_name": "", "title": " Full/Part-time employment: Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Davis", "first_name": "D.", "last_name": "Davis", "second_name": "", "title": " Research grant/Funding (institution): Amgen; Research grant/Funding (institution): Astellas Pharma; Research grant/Funding (institution): AstraZeneca; Research grant/Funding (institution): Bayer; Research grant/Funding (institution): Bristol-Myers Squibb; Research grant/Funding (institution): Eisai; Research grant/Funding (institution): Janssen Oncology; Research grant/Funding (institution): MSD Oncology; Research grant/Funding (institution): Pfizer; Research grant/Funding (institution): Roche/Genentech; Licensing/Royalties: International Patent Application No: PCT /US2004/032147 (NY-ESO-1) through Ludwig Institute for Cancer Research."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Srikala Sridhar", "first_name": "Srikala", "last_name": "Sridhar", "second_name": "", "country": "O", "city": "Toronto", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Sridhar", "first_name": "S.", "last_name": "Sridhar", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy: AstraZeneca; Honoraria (self), Advisory/Consultancy: Roche; Honoraria (self), Advisory/Consultancy: Merck; Honoraria (self), Advisory/Consultancy: Pfizer; Honoraria (self), Advisory/Consultancy: Janssen; Honoraria (self), Advisory/Consultancy: Astellas."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Dourthe", "first_name": "M.", "last_name": "Dourthe", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy: Astellas ; Honoraria (self), Advisory/Consultancy: Bayer; Travel/Accommodation/Expenses: Janssen; Advisory/Consultancy, Travel/Accommodation/Expenses: Pfizer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Mu", "first_name": "J.", "last_name": "Mu", "second_name": "", "title": " Research grant/Funding (self), Shareholder/Stockholder/Stock options, Full/Part-time employment: Pfizer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Ching", "first_name": "A.", "last_name": "Ching", "second_name": "", "title": " Research grant/Funding (self), Research grant/Funding (institution), Travel/Accommodation/Expenses, Shareholder/Stockholder/Stock options, Licensing/Royalties, Full/Part-time employment: Pfizer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Pu", "first_name": "J.", "last_name": "Pu", "second_name": "", "title": " Travel/Accommodation/Expenses, Full/Part-time employment: Roche; Full/Part-time employment: Pfizer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Roychoudhury", "first_name": "S.", "last_name": "Roychoudhury", "second_name": "", "title": " Full/Part-time employment: Pfizer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "B. Davis", "first_name": "B.", "last_name": "Davis", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Pfizer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. di Pietro", "first_name": "A.", "last_name": "di Pietro", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Pfizer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Jürgen Gschwend", "first_name": "Jürgen", "last_name": "Gschwend", "second_name": "", "country": "Germany", "city": "Munich", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Rodabe Amaria", "first_name": "Rodabe", "last_name": "Amaria", "second_name": "", "country": "United States of America", "city": "Houston", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Paul Nathan", "first_name": "Paul", "last_name": "Nathan", "second_name": "", "country": "Middlese", "city": "Northwood", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. Dummer", "first_name": "R.", "last_name": "Dummer", "second_name": "", "title": " Advisory/Consultancy: Novartis; Advisory/Consultancy: Merck Sharp & Dohme; Advisory/Consultancy: Bristol-Myers Squibb; Advisory/Consultancy: Roche; Advisory/Consultancy: Amgen; Advisory/Consultancy: Takeda; Advisory/Consultancy: Pierre Fabre; Advisory/Consultancy: Sun Pharma; Advisory/Consultancy: Sanofi; Advisory/Consultancy: Catalym; Advisory/Consultancy: Second Genome; Advisory/Consultancy: Regeneron; Advisory/Consultancy: Alligator."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "V. Long", "first_name": "V.", "last_name": "Long", "second_name": "", "title": " Advisory/Consultancy: Aduro; Advisory/Consultancy: Amgen; Advisory/Consultancy: Bristol-Myers Squibb; Advisory/Consultancy: Mass-Array; Advisory/Consultancy: Merck; Advisory/Consultancy: Merck Sharp & Dohme; Advisory/Consultancy: Novartis; Advisory/Consultancy: OncoSec Medical; Advisory/Consultancy: Pierre Fabre; Advisory/Consultancy: Roche; Advisory/Consultancy: Sandoz."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Ascierto", "first_name": "A.", "last_name": "Ascierto", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (institution): Bristol-Myers Squibb; Advisory/Consultancy, Research grant/Funding (institution): Roche-Genentech; Advisory/Consultancy, Travel/Accommodation/Expenses: Merck Sharp & Dohme; Advisory/Consultancy: Novartis; Advisory/Consultancy, Research grant/Funding (institution): Array; Advisory/Consultancy: Merck Serono; Advisory/Consultancy: Pierre Fabre; Advisory/Consultancy: Incyte; Advisory/Consultancy: NewLink Genetics; Advisory/Consultancy: Genmad; Advisory/Consultancy: Medimmune; Advisory/Consultancy: AstraZeneca; Advisory/Consultancy: Syndax; Advisory/Consultancy: Sun Pharma; Advisory/Consultancy: Sanofi; Advisory/Consultancy: Idera; Advisory/Consultancy: Ultimovacs; Advisory/Consultancy: Sandoz; Advisory/Consultancy: Immunocore; Advisory/Consultancy: 4SC; Shareholder/Stockholder/Stock options: PrimeVax; Advisory/Consultancy: Alkermes; Advisory/Consultancy: Italfarmaco; Advisory/Consultancy: Nektar; Advisory/Consultancy: Boehringer-Ingelheim; Leadership role: Fondazione Melanoma; Leadership role: Campania Society of ImmunoTherapy of Cancer; Leadership role: Society of Melanoma Research; Leadership role: Cancer Development Drug Forum; Leadership role: Society of Immuno Therapy of Cancer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Tawbi", "first_name": "A.", "last_name": "Tawbi", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution): Bristol-Myers Squibb; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution): Novartis; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution): Merck; Honoraria (self), Advisory/Consultancy: Array; Research grant/Funding (institution): Celgene; Research grant/Funding (institution): GlaxoSmithKline."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Robert", "first_name": "C.", "last_name": "Robert", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy: Bristol-Myers Squibb; Honoraria (self), Advisory/Consultancy: Pierre Fabre; Honoraria (self), Advisory/Consultancy: Novartis; Honoraria (self), Advisory/Consultancy: Amgen; Honoraria (self), Advisory/Consultancy: Merck; Honoraria (self), Advisory/Consultancy: Merck Sharp & Dohme; Honoraria (self), Advisory/Consultancy: Roche; Honoraria (self), Advisory/Consultancy: Sanofi; Honoraria (self), Advisory/Consultancy: Biothera."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "P. Rutkowski", "first_name": "P.", "last_name": "Rutkowski", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Speaker Bureau/Expert testimony: Merck Sharp & Dohme; Honoraria (self), Advisory/Consultancy, Speaker Bureau/Expert testimony: Bristol-Myers Squibb; Honoraria (self), Advisory/Consultancy: Novartis; Honoraria (self): Roche; Honoraria (self), Speaker Bureau/Expert testimony: Pierre Fabre; Honoraria (self): Amgen; Honoraria (self): Blueprint Medicines; Honoraria (self): Eli Lilly; Speaker Bureau/Expert testimony: Pfizer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Dutriaux", "first_name": "C.", "last_name": "Dutriaux", "second_name": "", "title": " Advisory/Consultancy, Travel/Accommodation/Expenses: Bristol-Myers Squibb; Advisory/Consultancy, Travel/Accommodation/Expenses: Merck Sharp & Dohme; Advisory/Consultancy, Travel/Accommodation/Expenses: Novartis; Advisory/Consultancy, Travel/Accommodation/Expenses: Pierre Fabre; Advisory/Consultancy, Travel/Accommodation/Expenses: Merck."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "P. Lorigan", "first_name": "P.", "last_name": "Lorigan", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Speaker Bureau/Expert testimony: Novartis; Honoraria (self), Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (institution), Travel/Accommodation/Expenses: Bristol-Myers Squibb; Honoraria (self), Advisory/Consultancy, Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: Merck Sharp & Dohme; Honoraria (self), Advisory/Consultancy, Speaker Bureau/Expert testimony: Pierre Fabre; Advisory/Consultancy: Amgen; Non-remunerated activity/ies: Roche; Advisory/Consultancy: NeraCare GmbH."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "F. Ferrucci", "first_name": "F.", "last_name": "Ferrucci", "second_name": "", "title": " Advisory/Consultancy: Roche; Advisory/Consultancy: Novartis; Advisory/Consultancy: Bristol-Myers Squibb; Advisory/Consultancy: Merck Sharp & Dohme; Advisory/Consultancy: Pierre Fabre."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "T. Flaherty", "first_name": "T.", "last_name": "Flaherty", "second_name": "", "title": " Officer/Board of Directors: Clovis Oncology; Officer/Board of Directors: Strata Oncology; Officer/Board of Directors: Vivid Biosciences; Officer/Board of Directors: Checkmate Pharmaceuticals; Advisory/Consultancy: X4 Pharmaceuticials; Advisory/Consultancy: PIC Therapeautics; Advisory/Consultancy, Research grant/Funding (institution): Sanofi; Advisory/Consultancy: Amgen; Advisory/Consultancy: Asana BioSciences; Advisory/Consultancy: Adaptimmune; Advisory/Consultancy: Fount Therapeutics; Advisory/Consultancy: Aeglea BioTherapeutics; Advisory/Consultancy: Shattuck Labs; Advisory/Consultancy: Tolero Pharmaceuticals; Advisory/Consultancy: Apricity Therapeutics; Advisory/Consultancy: Oncoceutics; Advisory/Consultancy: FogPharma; Advisory/Consultancy: Neon Therapeutics; Advisory/Consultancy: Tvardi Therapeutics; Advisory/Consultancy: xCures; Advisory/Consultancy: Monopteros Therapeutics; Advisory/Consultancy: Vibliome Therapeutics; Advisory/Consultancy: Eli Lilly; Advisory/Consultancy, Research grant/Funding (institution): Novartis; Advisory/Consultancy: Genentech; Advisory/Consultancy: Bristol-Myers Squibb; Advisory/Consultancy: Merck; Advisory/Consultancy: Takeda; Advisory/Consultancy: Verastem Oncology; Advisory/Consultancy: Boston Biomedical; Advisory/Consultancy: Pierre Fabre; Advisory/Consultancy: Debiopharm."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Brase", "first_name": "C.", "last_name": "Brase", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Novartis."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Green", "first_name": "S.", "last_name": "Green", "second_name": "", "title": " Full/Part-time employment: Novartis."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "T. Haas", "first_name": "T.", "last_name": "Haas", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Novartis."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Masood", "first_name": "A.", "last_name": "Masood", "second_name": "", "title": " Full/Part-time employment: Novartis."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "E. Gasal", "first_name": "E.", "last_name": "Gasal", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Novartis."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Ribas", "first_name": "A.", "last_name": "Ribas", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy: Amgen; Honoraria (self), Advisory/Consultancy: Chugai; Honoraria (self), Advisory/Consultancy: Merck; Honoraria (self), Advisory/Consultancy: Novartis; Honoraria (self), Advisory/Consultancy: Sanofi; Honoraria (self), Advisory/Consultancy: Compugen; Honoraria (self), Advisory/Consultancy: CytomX Therapeutics; Honoraria (self), Advisory/Consultancy: Highlight Therapeutics; Honoraria (self), Advisory/Consultancy: ImaginAb; Honoraria (self), Advisory/Consultancy: Isoplexis; Honoraria (self), Advisory/Consultancy: Merus; Honoraria (self), Advisory/Consultancy: RAPT Therapeutics; Honoraria (self), Advisory/Consultancy: Rgenix; Honoraria (self), Advisory/Consultancy: Tango Therapeutics; Honoraria (self), Advisory/Consultancy, Officer/Board of Directors: Arcus Biosciences; Honoraria (self), Advisory/Consultancy, Officer/Board of Directors: Lutris Pharma; Honoraria (self), Advisory/Consultancy, Officer/Board of Directors: PACT Pharma."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Schadendorf", "first_name": "D.", "last_name": "Schadendorf", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (institution), Travel/Accommodation/Expenses: Novartis; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Bristol-Myers Squibb; Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Merck Sharp & Dohme ; Honoraria (self), Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (institution), Travel/Accommodation/Expenses: Sanofi; Honoraria (self), Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (institution), Travel/Accommodation/Expenses: Regeneron; Honoraria (self), Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (institution): Pierre Fabre; Honoraria (self), Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (institution): Array; Honoraria (self), Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (institution): Pfizer; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Roche; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Genentech; Honoraria (institution), Advisory/Consultancy, Travel/Accommodation/Expenses: Merck EMR; Advisory/Consultancy: Immunocore; Honoraria (institution), Advisory/Consultancy: Nektar; Honoraria (self), Advisory/Consultancy: 4SC."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Ana Maria Arance Fernandez", "first_name": "Ana", "last_name": "Fernandez", "second_name": "Maria Arance", "country": "Spain", "city": "Barcelona", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "L. de la Cruz Merino", "first_name": "L.", "last_name": "de la Cruz Merino", "second_name": "", "title": " Advisory/Consultancy: Pfizer; Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Roche; Advisory/Consultancy, Research grant/Funding (institution): MSD; Advisory/Consultancy: Novartis; Advisory/Consultancy: Pierre Fabre; Advisory/Consultancy, Travel/Accommodation/Expenses: Bristol-Myers Squibb; Advisory/Consultancy: Amgen; Research grant/Funding (institution): Eisai Ltd."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "T. Petrella", "first_name": "T.", "last_name": "Petrella", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution): MSD; Honoraria (self), Advisory/Consultancy, Research grant/Funding (self): Novartis; Honoraria (self), Advisory/Consultancy: BMS; Honoraria (self), Advisory/Consultancy: Sanofi; Honoraria (self), Advisory/Consultancy: Pfizer; Research grant/Funding (self): Roche; Research grant/Funding (institution): Eisai Ltd."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. Jamal", "first_name": "R.", "last_name": "Jamal", "second_name": "", "title": " Honoraria (institution), Advisory/Consultancy, Research grant/Funding (institution): Bristol Myers Squibb; Advisory/Consultancy, unpaid: Merck; Research grant/Funding (institution): Merck Sharp & Dohme Corp."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "L. Ny", "first_name": "L.", "last_name": "Ny", "second_name": "", "title": " Advisory/Consultancy, Speaker Bureau/Expert testimony: Bristol-Myers Squibb; Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (institution): MSD; Advisory/Consultancy, Speaker Bureau/Expert testimony: Novartis; Advisory/Consultancy: Pfizer; Advisory/Consultancy: Pierre-Fabré; Advisory/Consultancy: Sanofi; Speaker Bureau/Expert testimony: AstraZeneca; Speaker Bureau/Expert testimony: Leo Pharma; Research grant/Funding (institution): Syndax Pharmaceuticals; Research grant/Funding (institution): Eisai Ltd."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Carneiro", "first_name": "A.", "last_name": "Carneiro", "second_name": "", "title": " Research grant/Funding (institution): MSD; Research grant/Funding (institution): Eisai Ltd."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Berrocal", "first_name": "A.", "last_name": "Berrocal", "second_name": "", "title": " Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (institution): MSD; Advisory/Consultancy, Speaker Bureau/Expert testimony: BMS; Advisory/Consultancy, Speaker Bureau/Expert testimony: Novartis; Advisory/Consultancy, Speaker Bureau/Expert testimony: Roche; Advisory/Consultancy, Speaker Bureau/Expert testimony: Pierre Fabre; Advisory/Consultancy, Speaker Bureau/Expert testimony: Sanofi; Research grant/Funding (institution): Eisai Ltd."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Spreafico", "first_name": "A.", "last_name": "Spreafico", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (institution): MSD; Advisory/Consultancy, Research grant/Funding (institution): Bristol-Myers Squibb; Advisory/Consultancy, Research grant/Funding (institution): Novartis; Advisory/Consultancy: Oncorus; Advisory/Consultancy: Janssen; Research grant/Funding (institution): Symphogen; Research grant/Funding (institution): AstraZeneca/MedImmune; Research grant/Funding (institution): Surface Oncology; Research grant/Funding (institution): Eisai Ltd."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "V. Victoria Atkinson", "first_name": "V.", "last_name": "Atkinson", "second_name": "Victoria", "title": " Honoraria (self), Advisory/Consultancy, Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: Bristol Myers Squibb; Honoraria (self), Advisory/Consultancy, Speaker Bureau/Expert testimony: Novartis; Honoraria (self), Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (institution), Travel/Accommodation/Expenses: MSD; Honoraria (self), Advisory/Consultancy, Speaker Bureau/Expert testimony: Merck; Honoraria (self), Advisory/Consultancy: Pierre Fabre; Honoraria (self), Advisory/Consultancy, Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: Roche; Advisory/Consultancy, Travel/Accommodation/Expenses: Nektar; Research grant/Funding (institution): Eisai Ltd."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "F. Costa Svedman", "first_name": "F.", "last_name": "Svedman", "second_name": "Costa", "title": " Research grant/Funding (institution): MSD; Research grant/Funding (institution): Eisai Ltd."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Smith", "first_name": "D.", "last_name": "Smith", "second_name": "", "title": " Full/Part-time employment: Eisai Ltd."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "K. Chen", "first_name": "K.", "last_name": "Chen", "second_name": "", "title": " Full/Part-time employment: Merck & Co."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Krepler", "first_name": "C.", "last_name": "Krepler", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Merck & Co."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Mandala", "first_name": "M.", "last_name": "Mandala", "second_name": "", "title": " Advisory/Consultancy: Bristol Myers Squibb; Advisory/Consultancy: Merck Sharp & Dohme; Advisory/Consultancy: Novartis; Advisory/Consultancy: Roche; Advisory/Consultancy: Sanofi; Advisory/Consultancy: Pierre Fabre; Advisory/Consultancy: Merck Serono."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Guidoboni", "first_name": "M.", "last_name": "Guidoboni", "second_name": "", "title": " Advisory/Consultancy: Bristol Myers Squibb; Advisory/Consultancy: Merck Sharp & Dohme; Advisory/Consultancy: Pierre Fabre; Advisory/Consultancy: Novartis; Research grant/Funding (institution): Merck Sharp & Dohme."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Arance Fernandez", "first_name": "M.", "last_name": "Fernandez", "second_name": "Arance", "title": " Advisory/Consultancy, Speaker Bureau/Expert testimony: Pierre Fabre; Advisory/Consultancy, Speaker Bureau/Expert testimony: Novartis; Advisory/Consultancy, Speaker Bureau/Expert testimony: Roche; Advisory/Consultancy, Speaker Bureau/Expert testimony: Bristol Myers Squibb; Advisory/Consultancy, Speaker Bureau/Expert testimony: Merck Sharp & Dohme; Advisory/Consultancy, Speaker Bureau/Expert testimony: Merck Serono; Advisory/Consultancy, Speaker Bureau/Expert testimony: Sanofi; Advisory/Consultancy, Speaker Bureau/Expert testimony: Amgen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "V. Ferraresi", "first_name": "V.", "last_name": "Ferraresi", "second_name": "", "title": " Advisory/Consultancy: Bristol Myers Squibb; Advisory/Consultancy: Merck Sharp & Dohme; Advisory/Consultancy: Novartis; Advisory/Consultancy: Pierre Fabre."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "E. Maiello", "first_name": "E.", "last_name": "Maiello", "second_name": "", "title": " Advisory/Consultancy: AstraZeneca; Advisory/Consultancy: Eli Lilly; Advisory/Consultancy: Servier; Advisory/Consultancy: Sanofi Genzyme; Advisory/Consultancy: Roche; Advisory/Consultancy: Merck; Advisory/Consultancy: Eisai; Advisory/Consultancy: Pfizer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Guida", "first_name": "M.", "last_name": "Guida", "second_name": "", "title": " Advisory/Consultancy: Bristol Myers Squibb; Advisory/Consultancy: Merck Sharp & Dohme; Advisory/Consultancy: Novartis; Advisory/Consultancy: Pierre Fabre."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Del Vecchio", "first_name": "M.", "last_name": "Del Vecchio", "second_name": "", "title": " Advisory/Consultancy: Bristol Myers Squibb; Advisory/Consultancy: Merck Sharp & Dohme; Advisory/Consultancy: Novartis; Advisory/Consultancy: Pierre Fabre; Advisory/Consultancy: Sanofi."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "T. Fierro", "first_name": "T.", "last_name": "Fierro", "second_name": "", "title": " Advisory/Consultancy, Speaker Bureau/Expert testimony: Bristol Myers Squibb; Advisory/Consultancy, Speaker Bureau/Expert testimony: Novartis; Advisory/Consultancy, Speaker Bureau/Expert testimony: Pierre Fabre."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "P. Queirolo", "first_name": "P.", "last_name": "Queirolo", "second_name": "", "title": " Advisory/Consultancy: Roche; Advisory/Consultancy: Bristol Myers Squibb; Advisory/Consultancy: Merck Sharp & Dohme; Advisory/Consultancy: Merck; Advisory/Consultancy: Novartis; Advisory/Consultancy: Pierre Fabre; Advisory/Consultancy: Sun Pharma; Advisory/Consultancy: Sanofi."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "I. Melero", "first_name": "I.", "last_name": "Melero", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Part of AstraZeneca partners of choice: AstraZeneca; Honoraria (self), Advisory/Consultancy, Research grant/Funding (self), Part of BMS I-ON consortium: Bristol Myers Squibb; Honoraria (self), Advisory/Consultancy, Research grant/Funding (self): Bioncotech; Honoraria (self), Advisory/Consultancy, Research grant/Funding (self): Alligator; Honoraria (self): Numab; Honoraria (self), Advisory/Consultancy: F-Star; Honoraria (self), Advisory/Consultancy, Research grant/Funding (self), Part of Roche imCORE: Roche; Honoraria (self): Bayer; Honoraria (self), Research grant/Funding (self): Merck Serono; Honoraria (self), Advisory/Consultancy: Merck Sharp & Dohme; Honoraria (self): Boston Pharmaceuticals; Honoraria (self): Servier; Research grant/Funding (self): Palo Biopharma."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "G. Palmieri", "first_name": "G.", "last_name": "Palmieri", "second_name": "", "title": " Advisory/Consultancy: Bristol Myers Squibb; Advisory/Consultancy: Incyte; Advisory/Consultancy: Merck Sharp & Dohme; Advisory/Consultancy: Novartis; Advisory/Consultancy: Pierre Fabre; Advisory/Consultancy: Roche Genentech."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Grimaldi", "first_name": "M.", "last_name": "Grimaldi", "second_name": "", "title": " Advisory/Consultancy, Travel/Accommodation/Expenses: Bristol Myers Squibb; Honoraria (self), Advisory/Consultancy: Merck Sharp & Dohme; Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Novartis; Honoraria (self): Roche; Travel/Accommodation/Expenses: Sun Pharma; Travel/Accommodation/Expenses: Pierre Fabre; Honoraria (self), Travel/Accommodation/Expenses: Merck Serono."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "V. Chiarion Sileni", "first_name": "V.", "last_name": "Sileni", "second_name": "Chiarion", "title": " Speaker Bureau/Expert testimony: Novartis; Travel/Accommodation/Expenses: Bristol Myers Squibb; Advisory/Consultancy, Travel/Accommodation/Expenses: Pierre Fabre; Speaker Bureau/Expert testimony: Merck Sharp & Dohme."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Bartosz Chmielowski", "first_name": "Bartosz", "last_name": "Chmielowski", "second_name": "", "country": "United States of America", "city": "Los Angeles", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Alexander M. Eggermont", "first_name": "Alexander", "last_name": "Eggermont", "second_name": "M.", "country": "Netherlands", "city": "Utrecht", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "U. Blank", "first_name": "U.", "last_name": "Blank", "second_name": "", "title": " Honoraria (institution): MSD; Honoraria (institution): BMS; Honoraria (institution): Roche; Honoraria (institution): Novartis; Honoraria (institution): Pfizer; Honoraria (institution): Lilly; Honoraria (institution): GSK."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Dalle", "first_name": "S.", "last_name": "Dalle", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Spouse/Financial dependant: Sanofi; Advisory/Consultancy, Travel/Accommodation/Expenses: BMS; Travel/Accommodation/Expenses: Pierre Fabre."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Haydon", "first_name": "M.", "last_name": "Haydon", "second_name": "", "title": " Honoraria (self): Merck."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Meshcheryakov", "first_name": "A.", "last_name": "Meshcheryakov", "second_name": "", "title": " Advisory/Consultancy: Lilly Pharma; Advisory/Consultancy: AstraZeneca; Advisory/Consultancy, Travel/Accommodation/Expenses: Merck; Advisory/Consultancy: BMS; Advisory/Consultancy, Travel/Accommodation/Expenses: Sanofi; Travel/Accommodation/Expenses: Biocad; Travel/Accommodation/Expenses: Servier; Travel/Accommodation/Expenses: Merck Serono; Travel/Accommodation/Expenses: Lilly Pharma."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Khattak", "first_name": "A.", "last_name": "Khattak", "second_name": "", "title": " Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: MSD."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Carlino", "first_name": "M.", "last_name": "Carlino", "second_name": "", "title": " Honoraria (self): Amgen; Honoraria (self): BMS; Honoraria (self): Ideaya Biosciences; Honoraria (self): MSD; Honoraria (self): Novartis; Honoraria (self): Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Sandhu", "first_name": "S.", "last_name": "Sandhu", "second_name": "", "title": " Research grant/Funding (institution): Amgen; Research grant/Funding (institution): AstraZeneca; Research grant/Funding (institution): BMS; Research grant/Funding (institution): Endocyte; Research grant/Funding (institution): MSD."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Puig Sarda", "first_name": "S.", "last_name": "Sarda", "second_name": "Puig", "title": " Advisory/Consultancy: Isdin; Advisory/Consultancy, Research grant/Funding (institution): Leo Pharma; Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Almirall; Advisory/Consultancy, Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: Sanofi; Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: Bioderma; Speaker Bureau/Expert testimony: La Roche Posay; Speaker Bureau/Expert testimony: Roche; Speaker Bureau/Expert testimony: BMS; Speaker Bureau/Expert testimony: Pierre Fabre; Research grant/Funding (institution): Castle Bioscience; Research grant/Funding (institution): AMLO Bioscience; Research grant/Funding (institution): Melagenics."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. van Akkooi", "first_name": "J.", "last_name": "van Akkooi", "second_name": "", "title": " Honoraria (institution), Research grant/Funding (institution): Amgen; Honoraria (institution), Research grant/Funding (institution): BMS; Honoraria (institution), Research grant/Funding (institution): Novartis; Honoraria (institution), Research grant/Funding (institution): MSD; Honoraria (institution), Research grant/Funding (institution): Pfizer; Honoraria (institution), Research grant/Funding (institution): Sanofi; Honoraria (institution), Research grant/Funding (institution): 4SC."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "N. Ibrahim", "first_name": "N.", "last_name": "Ibrahim", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Merck; Shareholder/Stockholder/Stock options: GSK."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Kicinski", "first_name": "M.", "last_name": "Kicinski", "second_name": "", "title": " Research grant/Funding (institution): MSD."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Suciu", "first_name": "S.", "last_name": "Suciu", "second_name": "", "title": " Research grant/Funding (institution): MSD."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Jeffrey Weber", "first_name": "Jeffrey", "last_name": "Weber", "second_name": "", "country": "N", "city": "New York", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "H. Gogas", "first_name": "H.", "last_name": "Gogas", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: BMS; Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: MSD; Honoraria (self): Novartis; Honoraria (self), Travel/Accommodation/Expenses: Pierre Fabre; Advisory/Consultancy: Amgen; Travel/Accommodation/Expenses: Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "L. Cowey", "first_name": "L.", "last_name": "Cowey", "second_name": "", "title": " Research grant/Funding (institution): BMS; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Regeneron; Research grant/Funding (institution): Merck; Research grant/Funding (institution): Novartis; Research grant/Funding (institution): Genentech; Research grant/Funding (institution): Caudex; Research grant/Funding (institution): Array; Research grant/Funding (institution): Amgen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Schenker", "first_name": "M.", "last_name": "Schenker", "second_name": "", "title": " Research grant/Funding (self), Research grant/Funding (institution): Bristol-Myers Squibb; Research grant/Funding (self), Research grant/Funding (institution): MSD; Research grant/Funding (self), Research grant/Funding (institution): Roche; Research grant/Funding (self), Research grant/Funding (institution): AstraZeneca; Research grant/Funding (self), Research grant/Funding (institution): Novartis; Research grant/Funding (self), Research grant/Funding (institution): Eli Lilly; Research grant/Funding (self), Research grant/Funding (institution): AbbVie; Research grant/Funding (self), Research grant/Funding (institution): Regeneron; Research grant/Funding (self), Research grant/Funding (institution): Pfizer; Research grant/Funding (self), Research grant/Funding (institution): Merck Serono; Research grant/Funding (self), Research grant/Funding (institution): Mylan; Research grant/Funding (self), Research grant/Funding (institution): Samsung; Research grant/Funding (self), Research grant/Funding (institution): Gilead; Research grant/Funding (self), Research grant/Funding (institution): Amgen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Grob", "first_name": "J.", "last_name": "Grob", "second_name": "", "title": " Advisory/Consultancy, Travel/Accommodation/Expenses: BMS; Advisory/Consultancy, Travel/Accommodation/Expenses: Novartis; Advisory/Consultancy, Travel/Accommodation/Expenses: MSD; Advisory/Consultancy: Roche; Advisory/Consultancy: Amgen; Advisory/Consultancy: Pierre Fabre; Advisory/Consultancy: Merck; Advisory/Consultancy: Pfizer; Advisory/Consultancy: Sanofi."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "O. Butler", "first_name": "O.", "last_name": "Butler", "second_name": "", "title": " Advisory/Consultancy: Merck & Co."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Maio", "first_name": "M.", "last_name": "Maio", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Patient Fees to my institution: Bristol-Myers Squibb; Honoraria (institution), Advisory/Consultancy: AstraZeneca; Honoraria (institution), Advisory/Consultancy: Roche; Honoraria (institution), Advisory/Consultancy: Merck Sharp & Dohme; Honoraria (institution), Advisory/Consultancy: Merck Serono; Honoraria (institution), Advisory/Consultancy: GlaxoSmithKline; Honoraria (institution), Advisory/Consultancy: Incyte."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Middleton", "first_name": "M.", "last_name": "Middleton", "second_name": "", "title": " Advisory/Consultancy: Amgen; Honoraria (self), Research grant/Funding (institution): Roche; Research grant/Funding (institution): AstraZeneca; Honoraria (self), Research grant/Funding (institution): GlaxoSmithKline; Advisory/Consultancy, Research grant/Funding (institution): Novartis; Research grant/Funding (institution): Millennium; Research grant/Funding (institution), Travel/Accommodation/Expenses: Immunocore; Advisory/Consultancy, Research grant/Funding (institution): Bristol-Myers Squibb; Research grant/Funding (institution): Pfizer; Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses, IDSMC: Merck/Merck Sharp & Dohme; Advisory/Consultancy, Research grant/Funding (institution): Rigontec (acquired by MSD); Research grant/Funding (institution): Regeneron; Advisory/Consultancy, Research grant/Funding (institution): BioLineRx; Advisory/Consultancy, Research grant/Funding (institution): Array Biopharma (now Pfizer)); Advisory/Consultancy: Kineta; Advisory/Consultancy: Silicon Therapeutics; Research grant/Funding (self), Travel/Accommodation/Expenses: Replimune."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Lobo", "first_name": "M.", "last_name": "Lobo", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Bristol-Myers Squibb; Shareholder/Stockholder/Stock options: Advaxis Immunotherapies."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "V. de Pril", "first_name": "V.", "last_name": "de Pril", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Bristol-Myers Squibb."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Larkin", "first_name": "J.", "last_name": "Larkin", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (institution): Achilles Therapeutics; Advisory/Consultancy, Research grant/Funding (institution): Bristol-Myers Squibb; Advisory/Consultancy: AstraZeneca; Advisory/Consultancy: Boston Biomedical; Advisory/Consultancy: Eisai; Advisory/Consultancy: EUSA Pharma; Advisory/Consultancy: GlaxoSmithKline; Advisory/Consultancy: Ipsen; Advisory/Consultancy: Imugene; Advisory/Consultancy: Incyte; Advisory/Consultancy: iOnctura; Advisory/Consultancy: Kymab; Advisory/Consultancy: Merck Serono; Advisory/Consultancy, Research grant/Funding (self): Merck Sharp & Dohme; Advisory/Consultancy, Research grant/Funding (self): Nektar; Advisory/Consultancy, Research grant/Funding (self): Novartis; Advisory/Consultancy: Pierre Fabre; Advisory/Consultancy, Research grant/Funding (self): Pfizer; Advisory/Consultancy, Research grant/Funding (self): Roche; Advisory/Consultancy: Secarma; Advisory/Consultancy: Vitaccess; Advisory/Consultancy: Covance; Advisory/Consultancy, Research grant/Funding (self): Immunocore; Advisory/Consultancy: Aveo; Advisory/Consultancy: Pharmacyclics."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Evandro De Azambuja", "first_name": "Evandro", "last_name": "De Azambuja", "second_name": "", "country": "Belgium", "city": "Brussels", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Benjamin Solomon", "first_name": "Benjamin", "last_name": "Solomon", "second_name": "", "country": "VI", "city": "Melbourne", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Florence Joly", "first_name": "Florence", "last_name": "Joly", "second_name": "", "country": "France", "city": "Caen", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Oing", "first_name": "C.", "last_name": "Oing", "second_name": "", "title": " Research grant/Funding (institution): PharmaMar; Travel/Accommodation/Expenses: Ipsen; Travel/Accommodation/Expenses: PharmaMar; Travel/Accommodation/Expenses: Medac."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "K. Punie", "first_name": "K.", "last_name": "Punie", "second_name": "", "title": " Honoraria (self): AstraZeneca; Honoraria (self): Eli Lilly; Honoraria (self): Novartis; Honoraria (self): Pfizer; Honoraria (self): Pierre Fabre; Honoraria (self): Hoffmann La Roche; Honoraria (self): Vifor Pharma; Speaker Bureau/Expert testimony: Eli Lilly; Speaker Bureau/Expert testimony: Mundi Pharma; Speaker Bureau/Expert testimony: Novartis; Speaker Bureau/Expert testimony: Pfizer; Speaker Bureau/Expert testimony: Hoffmann La Roche; Honoraria (self): Teva; Research grant/Funding (institution): Sanofi; Travel/Accommodation/Expenses: AstraZeneca; Travel/Accommodation/Expenses: Novartis; Travel/Accommodation/Expenses: Pfizer; Travel/Accommodation/Expenses: PharmaMar; Travel/Accommodation/Expenses: Hoffmann La Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Lambertini", "first_name": "M.", "last_name": "Lambertini", "second_name": "", "title": " Advisory/Consultancy: Roche; Advisory/Consultancy: Novartis; Honoraria (institution): Theramex; Honoraria (institution): Takeda; Honoraria (institution): Roche; Honoraria (institution): Lilly; Honoraria (institution): Pfizer; Honoraria (institution): Novartis."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Benedikt Westphalen", "first_name": "C.", "last_name": "Westphalen", "second_name": "Benedikt", "title": " Honoraria (institution), Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: Bayer; Honoraria (self), Honoraria (institution), Travel/Accommodation/Expenses: Celgene; Honoraria (self), Honoraria (institution), Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: Ipsen; Honoraria (self), Honoraria (institution), Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: MedScape; Honoraria (self), Honoraria (institution), Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: Rafael Pharmaceuticals; Honoraria (self), Honoraria (institution), Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: RedHIll; Honoraria (self), Honoraria (institution), Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: Roche; Honoraria (self), Honoraria (institution), Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: Servier; Honoraria (self), Honoraria (institution), Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: Shire; Honoraria (self), Honoraria (institution), Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: Taiho; Research grant/Funding (institution): Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "P. Garrido Lopez", "first_name": "P.", "last_name": "Lopez", "second_name": "Garrido", "title": " Advisory/Consultancy: AbbVie; Speaker Bureau/Expert testimony: AstraZeneca; Advisory/Consultancy: BluePrint Medicine; Advisory/Consultancy, Speaker Bureau/Expert testimony: Boerhinger Ingelheim; Advisory/Consultancy, Speaker Bureau/Expert testimony: BMS; Advisory/Consultancy: Gilead; Advisory/Consultancy: Guardant Health; Advisory/Consultancy: Janssen; Advisory/Consultancy: Lilly; Advisory/Consultancy, Speaker Bureau/Expert testimony: MSD; Advisory/Consultancy, Speaker Bureau/Expert testimony: Novartis; Advisory/Consultancy, Speaker Bureau/Expert testimony: Pfizer; Advisory/Consultancy, Speaker Bureau/Expert testimony: Roche; Advisory/Consultancy, Speaker Bureau/Expert testimony: Takeda; Speaker Bureau/Expert testimony: Rovi; Speaker Bureau/Expert testimony: Sysmex."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Amaral", "first_name": "S.", "last_name": "Amaral", "second_name": "", "title": " Honoraria (self), Travel/Accommodation/Expenses: BMS; Honoraria (self), Travel/Accommodation/Expenses: Novartis; Honoraria (self): PIerre Fabre; Honoraria (institution): Neracare; Honoraria (institution): Sanofi."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "G. Haanen", "first_name": "G.", "last_name": "Haanen", "second_name": "", "title": " Advisory/Consultancy: AIMM THerapeutics; Advisory/Consultancy: Amgen; Advisory/Consultancy: AZ; Advisory/Consultancy: Bayer; Advisory/Consultancy: BioNtech; Advisory/Consultancy: BMS; Advisory/Consultancy: GSK; Advisory/Consultancy: Gateta; Advisory/Consultancy: Immunocore; Advisory/Consultancy: Ipsen; Advisory/Consultancy: Merck Serono; Advisory/Consultancy: MSD; Advisory/Consultancy: Molecular Partners; Advisory/Consultancy: Roche; Advisory/Consultancy: Sanofi; Advisory/Consultancy: Seattle Genetics; Advisory/Consultancy: Third Rock Venture; Advisory/Consultancy: Vaximm; Research grant/Funding (institution): Neogene; Research grant/Funding (institution): Amgen; Research grant/Funding (institution): BMS; Research grant/Funding (institution): BIoNthech; Research grant/Funding (institution): MSD; Research grant/Funding (institution): Novartis; Advisory/Consultancy: Genentech."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Trisha M. Wise-draper", "first_name": "Trisha", "last_name": "Wise-draper", "second_name": "M.", "country": "United States of America", "city": "Cincinnati", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "I. Rini", "first_name": "I.", "last_name": "Rini", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (self), Travel/Accommodation/Expenses: Merck; Advisory/Consultancy, Research grant/Funding (self): Roche; Advisory/Consultancy, Research grant/Funding (self), Travel/Accommodation/Expenses: Pfizer; Advisory/Consultancy, Research grant/Funding (self): AVEO; Advisory/Consultancy, Research grant/Funding (self), Travel/Accommodation/Expenses: BMS; Advisory/Consultancy: arravive; Advisory/Consultancy: 3D medicines; Advisory/Consultancy: Synthorx; Advisory/Consultancy: Surface Oncology; Shareholder/Stockholder/Stock options: PTC Therapeutics; Research grant/Funding (self): AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "B. Johnson", "first_name": "B.", "last_name": "Johnson", "second_name": "", "title": " Advisory/Consultancy: Array Biopharma; Advisory/Consultancy, Research grant/Funding (self): BMS; Advisory/Consultancy: Janssen; Advisory/Consultancy: Merck; Advisory/Consultancy: Novartis; Research grant/Funding (self): Incyte; Leadership role: ASCO melanoma scientific committee chair; Leadership role: NCCN Melanoma committee."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "G. Lopes", "first_name": "G.", "last_name": "Lopes", "second_name": "", "title": " Honoraria (self), Travel/Accommodation/Expenses: Boehringer Ingelheim; Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Pfizer; Advisory/Consultancy, Research grant/Funding (self), Research grant/Funding (institution): AstraZeneca; Research grant/Funding (institution): Merck; Research grant/Funding (institution): EMD Serono; Research grant/Funding (institution): Blueprint Medicine; Research grant/Funding (institution): Tesaro; Research grant/Funding (institution): Bavarian Nordic; Research grant/Funding (institution): Novartis; Research grant/Funding (institution): GI Therapeutics; Research grant/Funding (institution): adaptimmune; Research grant/Funding (institution): BMS; Research grant/Funding (institution): GSK; Research grant/Funding (institution): AbbVie; Research grant/Funding (institution): Rgenix; Research grant/Funding (institution): Roche; Research grant/Funding (institution): Genentech; Research grant/Funding (institution): Lilly; Research grant/Funding (institution), Travel/Accommodation/Expenses: Janssen; Travel/Accommodation/Expenses: E."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Thompson", "first_name": "A.", "last_name": "Thompson", "second_name": "", "title": " Honoraria (self): AbbVie; Honoraria (self): BMS; Honoraria (self): Crab CTC; Honoraria (self): Denovo; Honoraria (self): Hoosier Research Network; Honoraria (self): Lilly; Honoraria (self): LynxBio; Honoraria (self): Strata Oncology; Honoraria (self), Advisory/Consultancy: Takeda; Honoraria (self): TG Therapeutics; Advisory/Consultancy: Adaptive; Advisory/Consultancy: AIM Specialty Health; Advisory/Consultancy: Cellgene (BMS); Advisory/Consultancy: GSK; Advisory/Consultancy: Via Oncology; Travel/Accommodation/Expenses, Shareholder/Stockholder/Stock options: Doximity; Travel/Accommodation/Expenses: Syapse; Licensing/Royalties: Uptodate."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Peters", "first_name": "S.", "last_name": "Peters", "second_name": "", "title": " Honoraria (self), Honoraria (institution), Advisory/Consultancy: AbbVie; Honoraria (self), Honoraria (institution), Advisory/Consultancy, Research grant/Funding (self): Amgen; Honoraria (self), Honoraria (institution), Advisory/Consultancy, Research grant/Funding (self), Travel/Accommodation/Expenses: AstraZeneca; Honoraria (self), Honoraria (institution), Advisory/Consultancy: Bayer; Honoraria (self), Honoraria (institution), Advisory/Consultancy: Biocartis; Honoraria (self), Honoraria (institution), Advisory/Consultancy: Bioinvent; Honoraria (self), Honoraria (institution), Advisory/Consultancy: Blueprint Medicines; Honoraria (self), Honoraria (institution), Advisory/Consultancy, Research grant/Funding (self): Boehringer-Ingelheim; Honoraria (self), Honoraria (institution), Advisory/Consultancy, Research grant/Funding (self), Travel/Accommodation/Expenses: Bristol-Myers Squibb; Honoraria (self), Honoraria (institution), Advisory/Consultancy, Research grant/Funding (self): Clovis; Honoraria (self), Honoraria (institution), Advisory/Consultancy, Travel/Accommodation/Expenses: Daiichi Sankyo; Honoraria (self), Honoraria (institution), Advisory/Consultancy: Debiopharm; Honoraria (self), Honoraria (institution), Advisory/Consultancy: Eli Lilly; Honoraria (self), Honoraria (institution), Advisory/Consultancy, Research grant/Funding (self), Travel/Accommodation/Expenses: F."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Kuderer", "first_name": "M.", "last_name": "Kuderer", "second_name": "", "title": " Advisory/Consultancy, Travel/Accommodation/Expenses: BMS; Advisory/Consultancy, Travel/Accommodation/Expenses: Janssen; Honoraria (self), Advisory/Consultancy: Celldex; Honoraria (self), Advisory/Consultancy: Invitae; Honoraria (self), Advisory/Consultancy: Total Health; Honoraria (self), Advisory/Consultancy: Beyond Springs; Honoraria (self), Advisory/Consultancy: BAyer; Honoraria (self), Advisory/Consultancy: Spectrum Pharmaceuticals."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Gulati", "first_name": "S.", "last_name": "Gulati", "second_name": "", "title": " Advisory/Consultancy: Puma Biotechnology; Travel/Accommodation/Expenses: ASCO; Research grant/Funding (self): AstraZeneca; Research grant/Funding (self): IsoRay."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "K. Choueiri", "first_name": "K.", "last_name": "Choueiri", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Research grant/Funding (self): AstraZeneca; Honoraria (self), Advisory/Consultancy, Research grant/Funding (self): Alexion; Honoraria (self), Advisory/Consultancy, Research grant/Funding (self): Bayer; Honoraria (self), Advisory/Consultancy, Research grant/Funding (self): BMS; Honoraria (self), Advisory/Consultancy, Research grant/Funding (self): Cerulean; Honoraria (self), Advisory/Consultancy, Research grant/Funding (self): Eisai; Honoraria (self), Advisory/Consultancy, Research grant/Funding (self): Foundation Medicine; Honoraria (self), Advisory/Consultancy, Research grant/Funding (self): Exelixis; Advisory/Consultancy, Research grant/Funding (self): Ipsen; Research grant/Funding (self): Tracon; Honoraria (self), Advisory/Consultancy, Research grant/Funding (self): Genentech; Honoraria (self), Advisory/Consultancy, Research grant/Funding (self): Roche; Honoraria (self), Advisory/Consultancy, Research grant/Funding (self): GSK; Honoraria (self), Advisory/Consultancy, Research grant/Funding (self): Lilly; Honoraria (self), Advisory/Consultancy, Research grant/Funding (self): Merck; Honoraria (self), Advisory/Consultancy, Research grant/Funding (self): Novartis; Honoraria (self), Advisory/Consultancy, Research grant/Funding (self): Peloton; Honoraria (self), Advisory/Consultancy, Research grant/Funding (self): Pfizer; Honoraria (self), Advisory/Consultancy, Research grant/Funding (self): Promethius Labs; Advisory/Consultancy, Research grant/Funding (self): Corvus; Research grant/Funding (self): Calithera; Honoraria (self), Advisory/Consultancy, Research grant/Funding (self): Analysis Group; Honoraria (self), Research grant/Funding (self): Sanofi/Aventis; Research grant/Funding (self): Takeda; Honoraria (self): EMD Serono; Honoraria (self): Navinata Healthcare; Honoraria (self), Advisory/Consultancy: NCCN; Honoraria (self): Michael J."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Warner", "first_name": "J.", "last_name": "Warner", "second_name": "", "title": " Advisory/Consultancy: BM Watson Health; Advisory/Consultancy: westat; Leadership role, Shareholder/Stockholder/Stock options: HemOnc."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Carlo Palmieri", "first_name": "Carlo", "last_name": "Palmieri", "second_name": "", "country": "United Kingdom", "city": "Liverpool", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Anthony T.C. T. Chan", "first_name": "Anthony", "last_name": "Chan", "second_name": "T.C. T.", "country": "Hong Kong PRC", "city": "Sha Tin", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Sjoukje Oosting", "first_name": "Sjoukje", "last_name": "Oosting", "second_name": "", "country": "Netherlands", "city": "Groningen", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Yungan Tao", "first_name": "Yungan", "last_name": "Tao", "second_name": "", "country": "France", "city": "Villejuif", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Ezra E. Cohen", "first_name": "Ezra", "last_name": "Cohen", "second_name": "E.", "country": "C", "city": "San Diego", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "L. Ferris", "first_name": "L.", "last_name": "Ferris", "second_name": "", "title": " Advisory/Consultancy: Aduro Biotech, Inc; Advisory/Consultancy: Amgen; Advisory/Consultancy, Research grant/Funding (institution): AstraZeneca/MedImmune; Advisory/Consultancy: Bain Capital Life Sciences; Advisory/Consultancy, Research grant/Funding (institution): Bristol-Myers Squibb; Advisory/Consultancy: EMD Serono; Advisory/Consultancy: GlaxoSmithKline; Advisory/Consultancy: Iovance Biotherapeutics, Inc; Advisory/Consultancy: Lilly; Advisory/Consultancy: MacroGenics, Inc."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Psyrri", "first_name": "A.", "last_name": "Psyrri", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Research grant/Funding (self): BMS; Honoraria (self), Advisory/Consultancy: MSD; Honoraria (self), Research grant/Funding (self), Travel/Accommodation/Expenses: Roche; Honoraria (self), Advisory/Consultancy: Merck Serono; Honoraria (self), Advisory/Consultancy: Pfizer; Advisory/Consultancy, Research grant/Funding (self): KURA; Research grant/Funding (self): Genesis; Research grant/Funding (self): DEMO; Travel/Accommodation/Expenses: Ipsen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. Haddad", "first_name": "R.", "last_name": "Haddad", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (self): Merck; Advisory/Consultancy, Research grant/Funding (self): BMS; Advisory/Consultancy, Research grant/Funding (self): Pfizer; Advisory/Consultancy, Research grant/Funding (self): Genentech; Advisory/Consultancy, Research grant/Funding (self): GSK; Advisory/Consultancy, Research grant/Funding (self): AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Tahara", "first_name": "M.", "last_name": "Tahara", "second_name": "", "title": " Honoraria (self): Eisai; Honoraria (self): Merck Serono; Honoraria (self), Advisory/Consultancy, Research grant/Funding (self): Ono; Honoraria (self): BMS; Honoraria (self), Advisory/Consultancy, Research grant/Funding (self): AstraZeneca; Advisory/Consultancy, Research grant/Funding (self): MSD; Advisory/Consultancy, Research grant/Funding (self): Bayer; Advisory/Consultancy, Research grant/Funding (self): Pfizer; Advisory/Consultancy, Research grant/Funding (self): Rakuten Medical; Advisory/Consultancy: Celgene; Advisory/Consultancy: Amgen; Research grant/Funding (self): Novartis."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Harrington", "first_name": "J.", "last_name": "Harrington", "second_name": "", "title": " Honoraria (institution), Advisory/Consultancy, Research grant/Funding (institution): AstraZeneca; Honoraria (institution), Advisory/Consultancy, Speaker Bureau/Expert testimony: BMS; Honoraria (institution), Advisory/Consultancy, Speaker Bureau/Expert testimony: MSD; Honoraria (institution), Advisory/Consultancy, Speaker Bureau/Expert testimony: Merck-Serono; Honoraria (institution), Advisory/Consultancy: Pfizer; Honoraria (institution), Research grant/Funding (institution): Regimmune; Advisory/Consultancy, Research grant/Funding (institution): BI."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Lin", "first_name": "C.", "last_name": "Lin", "second_name": "", "title": " Travel/Accommodation/Expenses: Taiwan Merck; Travel/Accommodation/Expenses: ONO; Travel/Accommodation/Expenses: MSD."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Razaq", "first_name": "M.", "last_name": "Razaq", "second_name": "", "title": " Advisory/Consultancy: AstraZeneca; Advisory/Consultancy: Merck; Advisory/Consultancy: Aspyrian; Speaker Bureau/Expert testimony, Shareholder/Stockholder/Stock options: Merck & co; Shareholder/Stockholder/Stock options: AbbVie."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Lovey", "first_name": "J.", "last_name": "Lovey", "second_name": "", "title": " Honoraria (self): Nutricia; Honoraria (self): Merck."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Chamois", "first_name": "J.", "last_name": "Chamois", "second_name": "", "title": " Travel/Accommodation/Expenses: Amgen; Travel/Accommodation/Expenses: Astellas; Travel/Accommodation/Expenses: MSD."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Rueda Dominguez", "first_name": "A.", "last_name": "Dominguez", "second_name": "Rueda", "title": " Advisory/Consultancy, Speaker Bureau/Expert testimony: Merck; Advisory/Consultancy, Speaker Bureau/Expert testimony: BMS; Advisory/Consultancy, Speaker Bureau/Expert testimony: Roche; Speaker Bureau/Expert testimony: Takeda."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "H. Thurm", "first_name": "H.", "last_name": "Thurm", "second_name": "", "title": " Full/Part-time employment: Pfizer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Pavlov", "first_name": "D.", "last_name": "Pavlov", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Pfizer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "N. Lee", "first_name": "N.", "last_name": "Lee", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (self): Pfizer; Advisory/Consultancy, Research grant/Funding (self): Merck; Advisory/Consultancy: Merck Serono; Advisory/Consultancy: Lilly; Research grant/Funding (self): AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Jean Bourhis", "first_name": "Jean", "last_name": "Bourhis", "second_name": "", "country": "Switzerland", "city": "Lausanne", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Le Tourneau", "first_name": "C.", "last_name": "Le Tourneau", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy: BMS; Honoraria (self), Advisory/Consultancy: MSD; Honoraria (self), Advisory/Consultancy: Merck Serono; Honoraria (self), Advisory/Consultancy: AstraZeneca; Honoraria (self): Rakuten; Honoraria (self), Advisory/Consultancy: Nanobiotix; Honoraria (self), Advisory/Consultancy: GSK; Honoraria (self), Advisory/Consultancy: Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Y. Pointreau", "first_name": "Y.", "last_name": "Pointreau", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy: MSD; Honoraria (self), Advisory/Consultancy: Merck; Honoraria (self), Advisory/Consultancy: BMS."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "P. Boisselier", "first_name": "P.", "last_name": "Boisselier", "second_name": "", "title": " Honoraria (institution), Advisory/Consultancy: Merck; Advisory/Consultancy: BMS; Advisory/Consultancy: Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "P. Delord", "first_name": "P.", "last_name": "Delord", "second_name": "", "title": " Advisory/Consultancy: BMS; Advisory/Consultancy: Roche; Advisory/Consultancy: MSD; Advisory/Consultancy: Novartis; Advisory/Consultancy: Merck."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "F. Clatot", "first_name": "F.", "last_name": "Clatot", "second_name": "", "title": " Advisory/Consultancy: Merck; Advisory/Consultancy: BMS; Advisory/Consultancy: Lilly."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "F. Rolland", "first_name": "F.", "last_name": "Rolland", "second_name": "", "title": " Advisory/Consultancy: BMS; Advisory/Consultancy: Novartis; Advisory/Consultancy: Ipsen; Advisory/Consultancy: Pfizer; Advisory/Consultancy: Merck."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "K. Gollmer", "first_name": "K.", "last_name": "Gollmer", "second_name": "", "title": " Full/Part-time employment: Debiopharm."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Szyldergemajn", "first_name": "A.", "last_name": "Szyldergemajn", "second_name": "", "title": " Full/Part-time employment: Debiopharm."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Even", "first_name": "C.", "last_name": "Even", "second_name": "", "title": " Advisory/Consultancy: BMS; Advisory/Consultancy: Merck; Advisory/Consultancy: MSD; Advisory/Consultancy: Innate Pharma."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Lotje Zuur", "first_name": "Lotje", "last_name": "Zuur", "second_name": "", "country": "Netherlands", "city": "Amsterdam", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "W. van den Brekel", "first_name": "W.", "last_name": "van den Brekel", "second_name": "", "title": " Research grant/Funding (institution), Travel/Accommodation/Expenses: ATOS Medical."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Willems", "first_name": "M.", "last_name": "Willems", "second_name": "", "title": " Research grant/Funding (institution): Roche; Research grant/Funding (institution): Pfizer; Research grant/Funding (institution): MSD; Research grant/Funding (institution): Bayer; Research grant/Funding (institution): Amgen; Research grant/Funding (institution): BMS; Research grant/Funding (institution): Nextcure."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "N. Schumacher", "first_name": "N.", "last_name": "Schumacher", "second_name": "", "title": " Full/Part-time employment: Kite Pharma; Leadership role: Kite Pharma; Shareholder/Stockholder/Stock options: AIMM Therapeutics; Shareholder/Stockholder/Stock options: Allogene; Shareholder/Stockholder/Stock options: Merus; Shareholder/Stockholder/Stock options: Kite Pharma; Shareholder/Stockholder/Stock options: Neon Therapeutics; Shareholder/Stockholder/Stock options: Neogene Therapeutics; Shareholder/Stockholder/Stock options: Scenic Biotech; Advisory/Consultancy: AIMM Therapeutics; Advisory/Consultancy: Allogene; Advisory/Consultancy: Merus; Advisory/Consultancy: Neon Therapeutics; Advisory/Consultancy: Neogene Therapeutics; Advisory/Consultancy: Scenic Biotech; Research grant/Funding (self): Merck KgGA; Research grant/Funding (self): MSD; Licensing/Royalties: Kite Pharma; Licensing/Royalties: Neon Therapeutics; Licensing/Royalties: Scenic Biotech; Licensing/Royalties: Immatics."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Lisa A. Carey", "first_name": "Lisa", "last_name": "Carey", "second_name": "A.", "country": "N", "city": "Chapel Hill", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "David W. Miles", "first_name": "David", "last_name": "Miles", "second_name": "W.", "country": "Middlese", "city": "Northwood", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Gligorov", "first_name": "J.", "last_name": "Gligorov", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (institution): Daichi; Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Eisai; Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Genomic Health; Advisory/Consultancy: Ipsen; Advisory/Consultancy: Macrogenics; Advisory/Consultancy: MSD; Advisory/Consultancy: Mylan; Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Novartis; Advisory/Consultancy: Onxeo; Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Pfizer; Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Roche/Genentech; Research grant/Funding (institution): Immunomedics."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Cameron", "first_name": "D.", "last_name": "Cameron", "second_name": "", "title": " Honoraria (institution), Advisory/Consultancy: Roche; Honoraria (institution), Advisory/Consultancy: AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Schneeweiss", "first_name": "A.", "last_name": "Schneeweiss", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Roche; Honoraria (self), Advisory/Consultancy: AstraZeneca; Honoraria (self), Research grant/Funding (institution), Travel/Accommodation/Expenses: Celgene; Research grant/Funding (institution): AbbVie; Research grant/Funding (institution): Molecular Partner; Honoraria (self), Travel/Accommodation/Expenses: Pfizer; Honoraria (self): Novartis; Honoraria (self): MSD; Honoraria (self): Tesaro; Honoraria (self): Lilly."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "H. Barrios", "first_name": "H.", "last_name": "Barrios", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Boehringer Ingelheim; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Roche/Genentech; Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: GlaxoSmithKline; Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Eisai; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Pfizer; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: AstraZeneca; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Novartis; Research grant/Funding (institution): Amgen; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Lilly; Research grant/Funding (institution): AbbVie; Research grant/Funding (institution): Astellas Pharma; Research grant/Funding (institution): Bristol-Myers Squibb; Research grant/Funding (institution): Medivation; Research grant/Funding (institution): Covance; Research grant/Funding (institution): Celgene; Research grant/Funding (institution): Merck Serono; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: MSD; Research grant/Funding (institution): PharmaMar; Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Bayer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "B. Xu", "first_name": "B.", "last_name": "Xu", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (institution): Novartis; Advisory/Consultancy, Research grant/Funding (institution): Roche; Advisory/Consultancy, Research grant/Funding (institution): AstraZeneca; Research grant/Funding (institution): Pfizer; Research grant/Funding (institution): Daiichi-Sankyo."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Wardley", "first_name": "M.", "last_name": "Wardley", "second_name": "", "title": " Honoraria (self), Honoraria (institution), Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (institution), Travel/Accommodation/Expenses: Roche; Honoraria (self), Honoraria (institution), Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (institution): Novartis; Honoraria (self), Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (institution): Pfizer; Honoraria (self), Honoraria (institution), Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (institution): Lilly; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Daiichi-Sankyo; Honoraria (self), Travel/Accommodation/Expenses: MSD; Honoraria (self), Honoraria (institution), Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (institution): AstraZeneca; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution): Athenex; Honoraria (self), Advisory/Consultancy: Gerson Lehrman Group; Honoraria (self), Advisory/Consultancy: Guidepoint Global; Honoraria (self): Coleman Expert Network; Honoraria (self): Helios; Honoraria (self): Health Care America; Advisory/Consultancy, Research grant/Funding (institution): MSD Oncology; Advisory/Consultancy: NAPP Pharma; Advisory/Consultancy, Research grant/Funding (institution): Accord Research; Advisory/Consultancy: Coleman Research; Leadership role, Full/Part-time employment, Medical Director: NIHR Manchester Clinical Research Facility at The Christie; Leadership role, Strategy Director: Association of Cancer Physicians; Leadership role, Committee Member: UK Breast Cancer Group; Leadership role, Committee Member: NHS England Chemotherapy Clinical Reference Group; Leadership role, Faculty: ESMO Breast cancer; Research grant/Funding (institution): Seattle Genetics; Research grant/Funding (institution): 1G1 Therapeutics; Shareholder/Stockholder/Stock options, Officer/Board of Directors, Spouse/Financial dependant: Andrew Wardley Limited; Shareholder/Stockholder/Stock options, Officer/Board of Directors: Manchester Cancer Academy; Shareholder/Stockholder/Stock options, Officer/Board of Directors: Outreach Research & Innovation Group Limited; Speaker Bureau/Expert testimony: Eisai; Research grant/Funding (self): NIHR."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Kaen", "first_name": "D.", "last_name": "Kaen", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution): Roche; Honoraria (self), Advisory/Consultancy: Boehringer Ingelheim; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution): Pfizer; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution): MSD; Honoraria (self), Advisory/Consultancy: BMS; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution): Novartis; Honoraria (self), Advisory/Consultancy: AstraZeneca; Honoraria (self), Advisory/Consultancy: Raffo-Tecnofarma; Honoraria (self), Advisory/Consultancy: Varifarma; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution): Takeda; Research grant/Funding (institution): Lilly Oncology; Research grant/Funding (institution): Clovis; Research grant/Funding (institution): AbbVie; Research grant/Funding (institution): Array BioPharma Inc."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "L. Andrade", "first_name": "L.", "last_name": "Andrade", "second_name": "", "title": " Advisory/Consultancy, Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: Zodiac Pharma; Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (institution): Janssen-Cilag; Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (institution): Roche/Genentech; Speaker Bureau/Expert testimony: Merck Sharp Dohme; Speaker Bureau/Expert testimony: Novartis; Research grant/Funding (institution): Bayer; Research grant/Funding (institution): Regeneron."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Reinisch", "first_name": "M.", "last_name": "Reinisch", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy: Roche Pharma AG; Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Novartis; Honoraria (self), Advisory/Consultancy: MSD; Honoraria (self), Advisory/Consultancy: AstraZeneca; Honoraria (self), Advisory/Consultancy: Hexal; Honoraria (self), Advisory/Consultancy: Lilly; Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Pfizer; Travel/Accommodation/Expenses: Celgene."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Patre", "first_name": "M.", "last_name": "Patre", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "L. Morales", "first_name": "L.", "last_name": "Morales", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "K. Russell", "first_name": "K.", "last_name": "Russell", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Donica", "first_name": "M.", "last_name": "Donica", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Leisha A. Emens", "first_name": "Leisha", "last_name": "Emens", "second_name": "A.", "country": "United States of America", "city": "Pittsburgh", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Adams", "first_name": "S.", "last_name": "Adams", "second_name": "", "title": " Research grant/Funding (institution): Genentech; Research grant/Funding (institution): Merck, Amgen, BMS, Novartis, Celgene, Daiichi Sankyo."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Dieras", "first_name": "C.", "last_name": "Dieras", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy: Roche/Genentech, Pfizer, Lilly, Novartis, Daiichi Sankyo, AstraZeneca, AbbVie, Seattle Genetics, Odonate, MSD."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "H. Iwata", "first_name": "H.", "last_name": "Iwata", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy: Chugai; Honoraria (self), Advisory/Consultancy: Novartis, AstraZeneca, Pfizer, Lilly, Daiichi-Sankyo, Eisai, Kyowa Kirin; Non-remunerated activity/ies: MSD, Bayer, BI, Nihon, Kayaku, Sanofi."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Loi", "first_name": "S.", "last_name": "Loi", "second_name": "", "title": " Research grant/Funding (institution), Non-remunerated activity/ies: Novartis, BMS, Roche-Genentech, Merck; Research grant/Funding (institution): Puma, Eli Lilly, Pfizer; Unpaid consultant: Seattle Genetics; Unpaid consultant: Pfizer; Unpaid consultant: Novartis; Unpaid consultant: BMS; Unpaid consultant: AstraZeneca; Unpaid consultant: Roche/Genentech; Advisory/Consultancy (institution): Aduro Biotechnology."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Rugo", "first_name": "S.", "last_name": "Rugo", "second_name": "", "title": " Research grant/Funding (institution): Pfizer, Novartis, Lilly, Genentech/Roche, Merck, OBI, Eisai, Plexxikon, Immunomedics; Research grant/Funding (institution), Travel/Accommodation/Expenses: Macrogeneics, Daiichi; Travel/Accommodation/Expenses: Puma, Mylan, Genentech/Roche, Novartis, Pfizer; Honoraria (self): Celltrion."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "P. Winer", "first_name": "P.", "last_name": "Winer", "second_name": "", "title": " Honoraria (self): Lilly, Genentech, Infinite MD, Carrick Therapeutics, GSK, Jounce, Genomic HEalth, Merck, Seattle Genetics; Honoraria (self), Leadership role: Leap."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Patel", "first_name": "S.", "last_name": "Patel", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: F."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "V. Henschel", "first_name": "V.", "last_name": "Henschel", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: F."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Swat", "first_name": "A.", "last_name": "Swat", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: F."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Kaul", "first_name": "M.", "last_name": "Kaul", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: F."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "L. Molinero", "first_name": "L.", "last_name": "Molinero", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: F."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Y. Chui", "first_name": "Y.", "last_name": "Chui", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Genentech/Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "P. Schmid", "first_name": "P.", "last_name": "Schmid", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Spouse/Financial dependant, spouse -- consulting for Genentech: Roche; Honoraria (self): Medscape; Honoraria (self), Advisory/Consultancy: AstraZeneca; Honoraria (self): GI Therapeutics; Honoraria (self): Health Interactions; Advisory/Consultancy: Pfizer; Advisory/Consultancy, Research grant/Funding (institution): Novartis; Advisory/Consultancy: Merck; Advisory/Consultancy: Boehringer Ingelheim; Advisory/Consultancy: Bayer; Advisory/Consultancy: EISAI; Advisory/Consultancy: Celegence; Advisory/Consultancy: Puma; Research grant/Funding (institution), Spouse/Financial dependant, spouse -- consulting for Genentech: Genentech; Research grant/Funding (institution): Oncogenex."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Aditya Bardia", "first_name": "Aditya", "last_name": "Bardia", "second_name": "", "country": "United States of America", "city": "Boston", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Tolaney", "first_name": "M.", "last_name": "Tolaney", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: AstraZeneca; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Eli Lilly; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Merck; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Nektar; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Novartis; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Pfizer; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Genentech; Research grant/Funding (institution): Exelixis; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Bristol-Myers Squibb; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Eisai; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: NanoString; Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Puma; Research grant/Funding (institution): Cyclacel; Honoraria (self), Advisory/Consultancy: Sanofi; Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Celldex; Honoraria (self), Advisory/Consultancy: Paxman; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution): Odonate; Honoraria (self): Seattle Genetics; Honoraria (self), Advisory/Consultancy: Silverback Therapeutics; Honoraria (self), Advisory/Consultancy: G1 Therapeutics; Honoraria (self), Advisory/Consultancy: AbbVie; Honoraria (self), Advisory/Consultancy: Anthenex."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Loirat", "first_name": "D.", "last_name": "Loirat", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Roche; Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Merck Sharp & Dohme; Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Bristol-Myers Squibb; Honoraria (self): Amgen; Travel/Accommodation/Expenses: AstraZeneca; Advisory/Consultancy: Immunomedics; Advisory/Consultancy: Novartis."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "P. de Boer", "first_name": "P.", "last_name": "de Boer", "second_name": "", "title": " Advisory/Consultancy: MSD; Research grant/Funding (self), Paid to the institute: Merck KgGa; Travel/Accommodation/Expenses: MSD."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Christian Simon", "first_name": "Christian", "last_name": "Simon", "second_name": "", "country": "Switzerland", "city": "Lausanne", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Oliveira", "first_name": "M.", "last_name": "Oliveira", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Roche/Genentech; Honoraria (self), Travel/Accommodation/Expenses: Novartis; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution): Seattle Genetics; Advisory/Consultancy, Research grant/Funding (institution): GlaxoSmithKline; Advisory/Consultancy, Research grant/Funding (institution): Puma Biotechnology; Advisory/Consultancy, Research grant/Funding (institution): AstraZeneca; Research grant/Funding (institution): Philips Healthcare; Research grant/Funding (institution): Novartis; Research grant/Funding (institution): Immunomedics; Research grant/Funding (institution): Boehringer Ingelheim; Research grant/Funding (institution): Cascadian Therapeutics; Research grant/Funding (institution): Sanofi; Research grant/Funding (institution): Celldex; Research grant/Funding (institution): Bayer; Research grant/Funding (institution): Piqur; Research grant/Funding (institution): Zenith Epigenetics; Travel/Accommodation/Expenses: Grunenthal Group; Travel/Accommodation/Expenses: Pierre Fabre; Travel/Accommodation/Expenses: GP Pharm; Travel/Accommodation/Expenses: Eisai."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Brufsky", "first_name": "A.", "last_name": "Brufsky", "second_name": "", "title": " Advisory/Consultancy: Pfizer; Advisory/Consultancy: Genentech/Roche; Advisory/Consultancy: Agendia; Advisory/Consultancy: Celgene; Speaker Bureau/Expert testimony: Novartis; Advisory/Consultancy: Bayer; Advisory/Consultancy: Eli Lilly; Advisory/Consultancy: Biotheranostics; Advisory/Consultancy: NanoString Technologies; Advisory/Consultancy: Genomic Health; Advisory/Consultancy: Puma Biotechnology; Advisory/Consultancy: Bioarray Therapeutics; Advisory/Consultancy: Merck Sharp & Dohme; Advisory/Consultancy: Myriad Pharmaceuticals; Advisory/Consultancy: Eisai; Advisory/Consultancy: Immunomedics; Advisory/Consultancy: Seattle Genetics; Advisory/Consultancy: Daiichi Sankyo/Lilly."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "K. Kalinsky", "first_name": "K.", "last_name": "Kalinsky", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (institution): Immunomedics; Advisory/Consultancy, Research grant/Funding (institution), Spouse/Financial dependant: Novartis; Research grant/Funding (institution): Incyte; Research grant/Funding (institution): Genentech/Roche; Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (institution), Travel/Accommodation/Expenses: Eli Lilly; Advisory/Consultancy, Research grant/Funding (institution), Spouse/Financial dependant: Pfizer; Research grant/Funding (institution): Calithera Biosciences; Research grant/Funding (institution): Acetylon; Research grant/Funding (institution): Seattle Genetics; Advisory/Consultancy, Research grant/Funding (institution): Amgen; Research grant/Funding (institution): Zentalis Pharmaceuticals; Research grant/Funding (institution): CytomX Therapeutics; Advisory/Consultancy, Travel/Accommodation/Expenses: AstraZeneca; Spouse/Financial dependant: Array Biopharma."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Carey", "first_name": "A.", "last_name": "Carey", "second_name": "", "title": " Research grant/Funding (institution): Innocrin Pharma; Research grant/Funding (institution): Syndax; Research grant/Funding (institution): Immunomedics; Research grant/Funding (institution), Non-remunerated activity/ies: Novartis; Research grant/Funding (institution): NanoString Technologies; Licensing/Royalties, Spouse/Financial dependant: Falcon Therapeutics; Non-remunerated activity/ies: Sanofi-Aventis; Non-remunerated activity/ies: G1 Therapeutics; Non-remunerated activity/ies: Genentech/Roche; Non-remunerated activity/ies: GlaxoSmithKline."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "L. Gianni", "first_name": "L.", "last_name": "Gianni", "second_name": "", "title": " Advisory/Consultancy, Travel/Accommodation/Expenses, Licensing/Royalties: Roche; Advisory/Consultancy, Travel/Accommodation/Expenses: Pfizer; Advisory/Consultancy: AstraZeneca; Advisory/Consultancy: Genomic Health; Advisory/Consultancy: Merck Sharp & Dohme; Advisory/Consultancy: Synaffix; Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Celgene; Advisory/Consultancy: Eli Lilly; Advisory/Consultancy: ADC Therapeutics; Advisory/Consultancy: Odonate Therapeutics; Advisory/Consultancy: Oncolytics; Advisory/Consultancy: Genenta; Advisory/Consultancy: Sandoz; Advisory/Consultancy: MetIS; Advisory/Consultancy: Novartis; Advisory/Consultancy, Research grant/Funding (institution): Revolution Medicine; Advisory/Consultancy, Research grant/Funding (institution): Zymeworks; Advisory/Consultancy: Daiichi Sankyo; Advisory/Consultancy: G1 Therapeutics; Advisory/Consultancy: Genentech; Advisory/Consultancy: Onkaido Therapeutics; Advisory/Consultancy: Taiho Pharmaceutical; Advisory/Consultancy: Seattle Genetics; Advisory/Consultancy: Synthon; Advisory/Consultancy: FortySeven; Travel/Accommodation/Expenses: Chugai Pharmaceutical."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Piccart", "first_name": "M.", "last_name": "Piccart", "second_name": "", "title": " Honoraria (self), Research grant/Funding (self): Immunomedics; Honoraria (self), Research grant/Funding (self): AstraZeneca; Honoraria (self): Camel-IDS; Honoraria (self): Crescendo Biologics; Honoraria (self): Debiopharm; Honoraria (self): G1 Therapeutics; Honoraria (self), Research grant/Funding (self): Roche-Genentech; Honoraria (self): Huya; Honoraria (self), Research grant/Funding (self): Eli Lilly; Honoraria (self): Menarini; Honoraria (self), Research grant/Funding (self): Merck Sharp & Dohme; Honoraria (self), Research grant/Funding (self): Novartis; Honoraria (self): Odonate; Honoraria (self): Periphagen; Honoraria (self), Research grant/Funding (self): Pfizer; Honoraria (self): Seattle Genetics; Research grant/Funding (self): Radius; Research grant/Funding (self): Servier; Research grant/Funding (self): Synthon."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Loibl", "first_name": "S.", "last_name": "Loibl", "second_name": "", "title": " Honoraria (institution), Research grant/Funding (self): AbbVie; Honoraria (institution), Research grant/Funding (self): Amgen; Honoraria (institution), Research grant/Funding (self): AstraZeneca; Honoraria (institution), Research grant/Funding (self): Celgene; Honoraria (institution), Research grant/Funding (self): Novartis; Honoraria (institution), Research grant/Funding (self): Pfizer; Honoraria (institution), Research grant/Funding (self): Roche; Honoraria (institution): Seattle Genetics; Honoraria (institution): PriME/ Medscape; Honoraria (self): Chugai; Honoraria (self): Teva; Honoraria (self): Vifor; Honoraria (institution), Research grant/Funding (self): Daiichi-Sankyo; Honoraria (institution): Eli Lilly; Honoraria (institution): Samsung; Advisory/Consultancy, Advisory fee paid to institute: Eirgenix; Advisory/Consultancy, advisory fee paid to institute: Bristol-Myers Squibb; Advisory/Consultancy, Advisory fee paid to institute: Puma; Honoraria (institution): Merck Sharp & Dohme; Research grant/Funding (self): Immunomedics; Licensing/Royalties, Immunsignature in TNBC: EP14153692."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Goldenberg", "first_name": "D.", "last_name": "Goldenberg", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Licensing/Royalties: Immunomedics; Leadership role: Center for Molecular Medicine & Immunology."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Olivo", "first_name": "S.", "last_name": "Olivo", "second_name": "", "title": " Full/Part-time employment: Immunomedics."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Hurvitz", "first_name": "A.", "last_name": "Hurvitz", "second_name": "", "title": " Research grant/Funding (institution), Travel/Accommodation/Expenses: Genentech/Roche; Research grant/Funding (institution): Novartis; Research grant/Funding (institution): GlaxoSmithKline; Research grant/Funding (institution): Sanofi; Research grant/Funding (institution), Travel/Accommodation/Expenses: Pfizer; Research grant/Funding (institution): Amgen; Research grant/Funding (institution): OBI Pharma; Research grant/Funding (institution): Puma Biotechnology; Research grant/Funding (institution): Dignitana; Research grant/Funding (institution): Bayer; Research grant/Funding (institution): Biomarin; Research grant/Funding (institution): Eli Lilly; Research grant/Funding (institution): Merrimack; Research grant/Funding (institution): Cascadian Therapeutics; Research grant/Funding (institution): Seattle Genetics; Research grant/Funding (institution): Daiichi Sankyo; Research grant/Funding (institution): Marcogenics; Research grant/Funding (institution): Ambryx; Research grant/Funding (institution): Immunomedics; Research grant/Funding (institution): Pieris; Research grant/Funding (institution): Radius; Research grant/Funding (institution): Arvinas."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Fabrice André", "first_name": "Fabrice", "last_name": "André", "second_name": "", "country": "France", "city": "Villejuif", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Juric", "first_name": "D.", "last_name": "Juric", "second_name": "", "title": " Research grant/Funding (self): Novartis; Advisory/Consultancy: Genentech; Advisory/Consultancy: Eisai; Advisory/Consultancy: Ipsen; Advisory/Consultancy: EMD Serono."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Campone", "first_name": "M.", "last_name": "Campone", "second_name": "", "title": " Research grant/Funding (institution), Non-remunerated activity/ies: Novartis; Honoraria (self), Research grant/Funding (institution): Roche; Honoraria (self): AstraZeneca; Honoraria (self): Pfizer; Advisory/Consultancy: Servier; Advisory/Consultancy: Sanofi; Advisory/Consultancy: Accord; Research grant/Funding (institution): Tesaro; Advisory/Consultancy: Eli Lilly."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "I. Mayer", "first_name": "I.", "last_name": "Mayer", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (institution): Novartis; Advisory/Consultancy, Research grant/Funding (institution): Genentech; Advisory/Consultancy: Eli Lilly; Advisory/Consultancy: AstraZeneca; Advisory/Consultancy: GlaxoSmithKline; Advisory/Consultancy: Immunomedics; Advisory/Consultancy: Macrogenics; Advisory/Consultancy: Seattle Genetics; Research grant/Funding (institution): Pfizer; Advisory/Consultancy: AbbVie; Advisory/Consultancy: Puma."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "G. Rubovszky", "first_name": "G.", "last_name": "Rubovszky", "second_name": "", "title": " Honoraria (self): Novartis."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "T. Yamashita", "first_name": "T.", "last_name": "Yamashita", "second_name": "", "title": " Honoraria (self), Research grant/Funding (institution): Chugai; Honoraria (self): Eisai; Honoraria (self): Novartis; Honoraria (self): Taiho; Honoraria (self), Research grant/Funding (institution): Nippon Kayaku; Honoraria (self): AstraZeneca; Honoraria (self), Research grant/Funding (institution): Kyowa Kirin; Honoraria (self): Pfizer Japan; Honoraria (self): Eli Lilly; Honoraria (self): Daiichi Sankyo."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "B. Kaufman", "first_name": "B.", "last_name": "Kaufman", "second_name": "", "title": " Honoraria (self): Novartis; Honoraria (self): Roche; Honoraria (self): AstraZeneca; Honoraria (self): Pfizer; Honoraria (self): AbbVie."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Lu", "first_name": "S.", "last_name": "Lu", "second_name": "", "title": " Advisory/Consultancy, Speaker Bureau/Expert testimony, Clinical study trial fee: Novartis; Advisory/Consultancy, Research grant/Funding (institution): Pfizer; Advisory/Consultancy: Boehringer Ingelheim; Research grant/Funding (institution): Roche; Research grant/Funding (institution): Merck Sharp & Dohme; Research grant/Funding (institution): GlaxoSmithKline."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "K. Inoue", "first_name": "K.", "last_name": "Inoue", "second_name": "", "title": " Research grant/Funding (institution): Novartis; Honoraria (self), Research grant/Funding (institution): Pfizer; Honoraria (self), Research grant/Funding (institution): Chugai; Honoraria (self), Research grant/Funding (institution): Eli Lilly; Research grant/Funding (institution): Daiichi-Sankyo; Research grant/Funding (institution): Parexel/Puma Biotechnology; Research grant/Funding (institution): MSD; Research grant/Funding (institution): AstraZeneca; Research grant/Funding (institution): Sanofi."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Takahashi", "first_name": "M.", "last_name": "Takahashi", "second_name": "", "title": " Honoraria (self): Novartis; Honoraria (self): AstraZeneca; Honoraria (self), Research grant/Funding (institution): Eisai; Honoraria (self): Eli Lilly; Honoraria (self): Pfizer; Research grant/Funding (institution): Chugai; Research grant/Funding (institution): Nippon Kayaku; Research grant/Funding (institution): Taiho."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "F. Ghaznawi", "first_name": "F.", "last_name": "Ghaznawi", "second_name": "", "title": " Full/Part-time employment: Novartis Pharmaceuticals Corporation."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Mills", "first_name": "D.", "last_name": "Mills", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Novartis Pharma AG."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Miller", "first_name": "M.", "last_name": "Miller", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Novartis Pharmaceuticals Corporation."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "F. Conte", "first_name": "F.", "last_name": "Conte", "second_name": "", "title": " Speaker Bureau/Expert testimony: Genenetech/Roche; Speaker Bureau/Expert testimony, Research grant/Funding (institution), Travel/Accommodation/Expenses: Novartis; Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: AstraZeneca; Research grant/Funding (institution): Roche; Research grant/Funding (institution): Merck Serono; Travel/Accommodation/Expenses: Celgene."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "K. Petrakova", "first_name": "K.", "last_name": "Petrakova", "second_name": "", "title": " Honoraria (self): Roche; Honoraria (self): Novartis; Honoraria (self): BMS."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "G. Jerusalem", "first_name": "G.", "last_name": "Jerusalem", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy: Amgen; Honoraria (self), Advisory/Consultancy: BMS; Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Lilly; Honoraria (self), Advisory/Consultancy, Research grant/Funding (self), Travel/Accommodation/Expenses: Novartis; Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Pfizer; Honoraria (self), Honoraria (institution), Research grant/Funding (self), Travel/Accommodation/Expenses: Roche; Advisory/Consultancy: AstraZeneca; Advisory/Consultancy: Celgene; Advisory/Consultancy: Daiichi Sankyo; Advisory/Consultancy: Puma Biotechnology."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Huober", "first_name": "J.", "last_name": "Huober", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy: Lilly; Honoraria (self), Advisory/Consultancy, Research grant/Funding (self), Travel/Accommodation/Expenses: Novartis; Honoraria (self), Advisory/Consultancy, Research grant/Funding (self): Roche; Honoraria (self), Advisory/Consultancy, Research grant/Funding (self): Pfizer; Honoraria (self), Advisory/Consultancy: AstraZeneca; Honoraria (self), Advisory/Consultancy: MSD; Honoraria (self), Advisory/Consultancy, Research grant/Funding (self), Travel/Accommodation/Expenses: Celgene; Advisory/Consultancy: Hexal; Travel/Accommodation/Expenses: Daiichi."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Núria López-Bigas", "first_name": "Núria", "last_name": "López-Bigas", "second_name": "", "country": "Spain", "city": "Barcelona", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Kevin R. Litchfield", "first_name": "Kevin", "last_name": "Litchfield", "second_name": "R.", "country": "United Kingdom", "city": "London", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Quezada", "first_name": "S.", "last_name": "Quezada", "second_name": "", "title": " Full/Part-time employment: Achilles Tx."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Swanton", "first_name": "C.", "last_name": "Swanton", "second_name": "", "title": " Advisory/Consultancy: Pfizer; Advisory/Consultancy: Novartis; Advisory/Consultancy: GlaxoSmithKline; Advisory/Consultancy: MSD; Advisory/Consultancy: BMS; Advisory/Consultancy: Celgene; Advisory/Consultancy: AstraZeneca; Advisory/Consultancy: Illumina; Advisory/Consultancy: Genentech; Advisory/Consultancy: Roche-Ventana; Advisory/Consultancy: GRAIL; Advisory/Consultancy: Medicxi; Advisory/Consultancy: Sarah Cannon Research Institute; Shareholder/Stockholder/Stock options: Apogen Biotechnologies; Shareholder/Stockholder/Stock options: Epic Bioscience; Shareholder/Stockholder/Stock options: GRAIL; Leadership role, Shareholder/Stockholder/Stock options: Achilles Therapeutics."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Giulia Mazzaschi", "first_name": "Giulia", "last_name": "Mazzaschi", "second_name": "", "country": "Italy", "city": "Parma", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Daniela S. Thommen", "first_name": "Daniela", "last_name": "Thommen", "second_name": "S.", "country": "Netherlands", "city": "Amsterdam", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Patricia Martin Romano", "first_name": "Patricia", "last_name": "Romano", "second_name": "Martin", "country": "France", "city": "Villejuif", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "L. Mezquita", "first_name": "L.", "last_name": "Mezquita", "second_name": "", "title": " Advisory/Consultancy, Speaker Bureau/Expert testimony: Bristol-Myers Squibb."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "L. Lacroix", "first_name": "L.", "last_name": "Lacroix", "second_name": "", "title": " Research grant/Funding (institution): AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Varga", "first_name": "A.", "last_name": "Varga", "second_name": "", "title": " Research grant/Funding (self), Research grant/Funding (institution): AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Baldini", "first_name": "C.", "last_name": "Baldini", "second_name": "", "title": " Advisory/Consultancy: Bristol-Myers Squibb."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "L. Friboulet", "first_name": "L.", "last_name": "Friboulet", "second_name": "", "title": " Travel/Accommodation/Expenses: AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Gazzah", "first_name": "A.", "last_name": "Gazzah", "second_name": "", "title": " Research grant/Funding (institution), Non-remunerated activity/ies, Principal/sub-Investigator: AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Soria", "first_name": "C.", "last_name": "Soria", "second_name": "", "title": " Shareholder/Stockholder/Stock options: AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Hollebecque", "first_name": "A.", "last_name": "Hollebecque", "second_name": "", "title": " Research grant/Funding (institution), Non-remunerated activity/ies: Bristol-Myers Squibb."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "B. Besse", "first_name": "B.", "last_name": "Besse", "second_name": "", "title": " Research grant/Funding (institution), Non-remunerated activity/ies: Boehringer Ingelheim."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Massard", "first_name": "C.", "last_name": "Massard", "second_name": "", "title": " Research grant/Funding (institution), Non-remunerated activity/ies: Principal/sub-Investigator; Research grant/Funding (institution): Research Grants; Non-remunerated activity/ies: Non-financial support (drug supplied)."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Italiano", "first_name": "A.", "last_name": "Italiano", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (institution): AstraZeneca; Advisory/Consultancy, Research grant/Funding (institution): Bayer; Advisory/Consultancy: Epizyme; Advisory/Consultancy, Research grant/Funding (institution): Roche; Advisory/Consultancy: Philips; Advisory/Consultancy, Research grant/Funding (institution): MSD; Advisory/Consultancy: Springworks; Research grant/Funding (institution): BMS; Research grant/Funding (institution): Merck; Research grant/Funding (institution): PharmaMar."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Joris Van De Haar", "first_name": "Joris", "last_name": "Van De Haar", "second_name": "", "country": "Netherlands", "city": "Amsterdam", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Kim Monkhorst", "first_name": "Kim", "last_name": "Monkhorst", "second_name": "", "country": "Netherlands", "city": "Amsterdam", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Chiara Cremolini", "first_name": "Chiara", "last_name": "Cremolini", "second_name": "", "country": "Italy", "city": "Pisa", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Norquist", "first_name": "J.", "last_name": "Norquist", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Merck & Co."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "K. Shiu", "first_name": "K.", "last_name": "Shiu", "second_name": "", "title": " Honoraria (self), Research grant/Funding (institution): BMS; Honoraria (self): Guardant Health; Honoraria (self): Innovent Biologics; Honoraria (self), Research grant/Funding (institution), Travel/Accommodation/Expenses: Merck KGaA; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution): Roche; Honoraria (self): Servier; Research grant/Funding (institution): Amgen; Research grant/Funding (institution): Gilead; Research grant/Funding (institution), Travel/Accommodation/Expenses: MSD; Travel/Accommodation/Expenses: Innovent Biologics."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "W. Kim", "first_name": "W.", "last_name": "Kim", "second_name": "", "title": " Research grant/Funding (institution): Merck Serono, AstraZeneca, Pfizer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "V. Jensen", "first_name": "V.", "last_name": "Jensen", "second_name": "", "title": " Research grant/Funding (institution): Merck Sharp & Dohme Corp."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "H. Jensen", "first_name": "H.", "last_name": "Jensen", "second_name": "", "title": " Research grant/Funding (institution): MSD; Research grant/Funding (institution): 2cureX; Research grant/Funding (institution): Incyte; Research grant/Funding (institution): BMS."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Punt", "first_name": "J.", "last_name": "Punt", "second_name": "", "title": " Advisory/Consultancy: Bayer; Advisory/Consultancy: Nordic Pharma; Advisory/Consultancy: Servier."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "I. Sevilla", "first_name": "I.", "last_name": "Sevilla", "second_name": "", "title": " Advisory/Consultancy: Ipsen, Pfizer, Syrtex, Amgen, Pharmamar; Speaker Bureau/Expert testimony: AAA, Sanofi, Novartis."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. de la Fouchardiere", "first_name": "C.", "last_name": "de la Fouchardiere", "second_name": "", "title": " Advisory/Consultancy: Roche, Pierre Fabre Oncologie, MSD, Eisai, Bayer; Travel/Accommodation/Expenses: Amgen, Eisai, BMS, Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "F. Rivera", "first_name": "F.", "last_name": "Rivera", "second_name": "", "title": " Advisory/Consultancy: MSD, Roche, Merck-Serono, Sanofi, BMS, Servier, Lilly, Amgen, Bayer, Celgene; Travel/Accommodation/Expenses: MSD, Roche, Merck-Serono, Sanofi, BMS, Servier, Lilly, Amgen, Bayer, Celgene."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "E. Elez", "first_name": "E.", "last_name": "Elez", "second_name": "", "title": " Honoraria (self), Research grant/Funding (self), Travel/Accommodation/Expenses: Hoffmann-La Roche, Servier, Amgen, Array Biopharma, Sanofi, Merck Sharp & Dohme Corp."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Diaz", "first_name": "A.", "last_name": "Diaz", "second_name": "", "title": " Advisory/Consultancy: Merck, Caris, Lyndra, Genocea Biociences, Illumina, Cell Design Labs, Neophore; Leadership role, Shareholder/Stockholder/Stock options, Officer/Board of Directors: PGDx; Shareholder/Stockholder/Stock options: Thrive, Neophore; Research grant/Funding (institution), Travel/Accommodation/Expenses: Merck; Licensing/Royalties: Multiple, managed by Johns Hopkins and MSKCC COI; Officer/Board of Directors: Jounce Therapeutics; Spouse/Financial dependant: Amgen (equity)."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "T. Yoshino", "first_name": "T.", "last_name": "Yoshino", "second_name": "", "title": " Research grant/Funding (institution): Novartis Pharma K."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "E. Van Cutsem", "first_name": "E.", "last_name": "Van Cutsem", "second_name": "", "title": " Advisory/Consultancy: Array, Astrazeneca, Bayer, Biocartis, Bristol-Myers Squibb, Celgene, Daiichi, Halozyme, GSK, Incyte, Ipsen, Lilly, Merck Sharp & Dohme, Merck KGaA, Novartis, Pierre-Fabre, Roche, Servier, Sirtex, Taiho; Research grant/Funding (institution): Bayer, Boehringer Ingelheim, Celgene, Ipsen, Lilly, Merck Sharp & Dohme, Merck KGaA, Novartis, Roche, Servier paid to the institution ."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "P. Yang", "first_name": "P.", "last_name": "Yang", "second_name": "", "title": " Full/Part-time employment: MSD China Holding Co."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "H. Farooqui", "first_name": "H.", "last_name": "Farooqui", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Merck & Co."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Le", "first_name": "D.", "last_name": "Le", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Research grant/Funding (self): Merck; Advisory/Consultancy, Research grant/Funding (self): BMS; Research grant/Funding (self): Aduro; Research grant/Funding (self): Medivir; Research grant/Funding (self): Curegenix; Research grant/Funding (self): Nouscom."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Erika Martinelli", "first_name": "Erika", "last_name": "Martinelli", "second_name": "", "country": "Italy", "city": "Napoli", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "T. Troiani", "first_name": "T.", "last_name": "Troiani", "second_name": "", "title": " Advisory/Consultancy: Roche, Merck, Sanofi, Servier, Novartis, Bayer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "F. Pietrantonio", "first_name": "F.", "last_name": "Pietrantonio", "second_name": "", "title": " Advisory/Consultancy: Amgen, Roche, Lilly, Sanofi, Merck-Serono, Bayer, Servier; Research grant/Funding (self): BMS."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Avallone", "first_name": "A.", "last_name": "Avallone", "second_name": "", "title": " Advisory/Consultancy: Amgen ; Speaker Bureau/Expert testimony: Servier ."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "N. Normanno", "first_name": "N.", "last_name": "Normanno", "second_name": "", "title": " Advisory/Consultancy: MSD, Qiagen, Biocartis, Incyte, Roche, BMS, MERCK, Thermofisher,Boehringer Ingelheim, Astrazeneca, Sanofi, Eli Lilly, Bayer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Falcone", "first_name": "A.", "last_name": "Falcone", "second_name": "", "title": " Advisory/Consultancy: Bayer, Bristol, Eli Lilly, Merck, Pierre-Fabre, Roche, Servier, and institutional support for clinical trials from Astra-Zeneca, Bayer, Bristol, Eli Lilly, Merck, MSD, Novartis, Roche, Sanofi, and Servier."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Pinto", "first_name": "C.", "last_name": "Pinto", "second_name": "", "title": " Advisory/Consultancy, Speaker Bureau/Expert testimony: BMS, MSD, Bayer, Astra-Zeneca, Roche, Merck, Lilly, Servier, Sanofi, Astellas."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "F. Ciardiello", "first_name": "F.", "last_name": "Ciardiello", "second_name": "", "title": " Advisory/Consultancy: Roche, Amgen, Merck, Pfizer, Sanofi, Bayer, Servier, BMS, Cellgene, Lilly; Research grant/Funding (self): Bayer, Roche, Merck, Amgen, AstraZeneca, Takeda."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Come Lepage", "first_name": "Come", "last_name": "Lepage", "second_name": "", "country": "Cede", "city": "Dijon", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Sara Lonardi", "first_name": "Sara", "last_name": "Lonardi", "second_name": "", "country": "Italy", "city": "Padova", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Lyudmila Bazhenova", "first_name": "Lyudmila", "last_name": "Bazhenova", "second_name": "", "country": "C", "city": "La Jolla", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Floriana Morgillo", "first_name": "Floriana", "last_name": "Morgillo", "second_name": "", "country": "Italy", "city": "Napoli", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Marie Wislez", "first_name": "Marie", "last_name": "Wislez", "second_name": "", "country": "Cedex 2", "city": "Paris", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Mazieres", "first_name": "J.", "last_name": "Mazieres", "second_name": "", "title": " Advisory/Consultancy: Roche; Research grant/Funding (institution): Roche; Advisory/Consultancy: AstraZeneca; Research grant/Funding (institution): AstraZeneca; Advisory/Consultancy: BMS; Research grant/Funding (institution): BMS; Advisory/Consultancy: MSD; Advisory/Consultancy: Pierre Fabre; Advisory/Consultancy: Hengruii; Advisory/Consultancy: Daiichi; Advisory/Consultancy: Boehringer; Advisory/Consultancy: Takeda."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Lavole", "first_name": "A.", "last_name": "Lavole", "second_name": "", "title": " Travel/Accommodation/Expenses: BMS."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "G. Zalcman", "first_name": "G.", "last_name": "Zalcman", "second_name": "", "title": " Honoraria (self): Pfizer; Research grant/Funding (institution): Roche; Advisory/Consultancy: BMS; Honoraria (self): BMS; Travel/Accommodation/Expenses: BMS; Honoraria (self): AstraZeneca; Travel/Accommodation/Expenses: AstraZeneca; Advisory/Consultancy: AstraZeneca; Advisory/Consultancy: MSD."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "O. Molinier", "first_name": "O.", "last_name": "Molinier", "second_name": "", "title": " Advisory/Consultancy: Bristol-Myers Squibb; Advisory/Consultancy: AstraZeneca; Advisory/Consultancy: Boehringer Ingelheim; Advisory/Consultancy: Tesaro; Travel/Accommodation/Expenses: Boehringer Ingelheim."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Massiani", "first_name": "A.", "last_name": "Massiani", "second_name": "", "title": " Travel/Accommodation/Expenses: Bristol-Myers Squibb; Travel/Accommodation/Expenses: Elivie; Travel/Accommodation/Expenses: Amgen; Travel/Accommodation/Expenses: Pfizer; Travel/Accommodation/Expenses: Boehringer Ingelheim; Travel/Accommodation/Expenses: AstraZeneca; Travel/Accommodation/Expenses: MSD."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Damotte", "first_name": "D.", "last_name": "Damotte", "second_name": "", "title": " Travel/Accommodation/Expenses: Roche; Travel/Accommodation/Expenses: AstraZeneca; Research grant/Funding (self): MedImmune; Honoraria (self): AbbVie; Travel/Accommodation/Expenses: AbbVie."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Antoine", "first_name": "M.", "last_name": "Antoine", "second_name": "", "title": " Honoraria (self): BMS; Honoraria (self): MSD; Honoraria (self): AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "V. Westeel", "first_name": "V.", "last_name": "Westeel", "second_name": "", "title": " Honoraria (self): Roche; Advisory/Consultancy: BMS; Advisory/Consultancy: AstraZeneca; Advisory/Consultancy: Roche; Advisory/Consultancy: Takeda; Speaker Bureau/Expert testimony: Roche; Speaker Bureau/Expert testimony: MSD; Speaker Bureau/Expert testimony: BMS; Travel/Accommodation/Expenses: Roche; Travel/Accommodation/Expenses: Pfizer; Travel/Accommodation/Expenses: Boehringer Ingelheim; Travel/Accommodation/Expenses: BMS; Research grant/Funding (institution): BMS; Research grant/Funding (institution): MSD; Research grant/Funding (institution): Roche; Research grant/Funding (institution): AbbVie; Research grant/Funding (institution): Lilly; Research grant/Funding (institution): Fresenius; Research grant/Funding (institution): Merck-Serono."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Adam", "first_name": "J.", "last_name": "Adam", "second_name": "", "title": " Honoraria (self), Research grant/Funding (institution): Roche; Honoraria (self): AstraZeneca; Honoraria (self), Research grant/Funding (institution): msd; Honoraria (self), Research grant/Funding (institution): Bayer; Honoraria (self): BMS."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Planchard", "first_name": "D.", "last_name": "Planchard", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: AstraZeneca; Honoraria (self), Advisory/Consultancy: BMS; Honoraria (self), Advisory/Consultancy: Boehringer Ingelheim; Honoraria (self), Advisory/Consultancy: Celgene; Advisory/Consultancy: Daiichi Sankyo; Honoraria (self), Advisory/Consultancy: Eli Lilly; Honoraria (self), Advisory/Consultancy: Merck KGaA; Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Pfizer; Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Roche-Genentech; Advisory/Consultancy: Samsung; Honoraria (self), Advisory/Consultancy: Per CME; Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Prime oncology; Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Novaris."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Remon Masip", "first_name": "J.", "last_name": "Masip", "second_name": "Remon", "title": " Travel/Accommodation/Expenses: Ose Pharma; Advisory/Consultancy: AstraZeneca; Travel/Accommodation/Expenses: MSD; Advisory/Consultancy: Pfizer; Travel/Accommodation/Expenses: Roche; Advisory/Consultancy: BMS."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "P. Lavaud", "first_name": "P.", "last_name": "Lavaud", "second_name": "", "title": " Travel/Accommodation/Expenses: Ipsen; Travel/Accommodation/Expenses: Janssen; Travel/Accommodation/Expenses: Mundi Pharma; Travel/Accommodation/Expenses: Astellas; Travel/Accommodation/Expenses: AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Naltet", "first_name": "C.", "last_name": "Naltet", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Roche; Honoraria (self), Travel/Accommodation/Expenses: BMS; Honoraria (self), Travel/Accommodation/Expenses: AstraZeneca; Travel/Accommodation/Expenses: pfizer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "B. Duchemann", "first_name": "B.", "last_name": "Duchemann", "second_name": "", "title": " Honoraria (self), Travel/Accommodation/Expenses: Roche; Honoraria (self): MSD; Travel/Accommodation/Expenses: Oxyvie; Travel/Accommodation/Expenses: Pfizer; Travel/Accommodation/Expenses: AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "F. Barlesi", "first_name": "F.", "last_name": "Barlesi", "second_name": "", "title": " Honoraria (self), Research grant/Funding (institution): Bristol-Myers Squibb; Honoraria (self), Research grant/Funding (institution): AstraZeneca; Honoraria (self), Research grant/Funding (institution): Pfizer; Honoraria (self), Research grant/Funding (institution): Novartis; Honoraria (self), Research grant/Funding (institution): Boehringer Ingelheim; Research grant/Funding (institution): AbbVie; Research grant/Funding (institution): ACEA; Research grant/Funding (institution): Eisai; Research grant/Funding (institution): Ipsen; Research grant/Funding (self): Ignyta; Honoraria (self), Research grant/Funding (institution): Eli Lilly; Research grant/Funding (institution): Innate Pharma; Research grant/Funding (institution): Loxo; Research grant/Funding (institution): MedImmune; Honoraria (self), Research grant/Funding (institution): Merck KGaA; Honoraria (self), Research grant/Funding (institution): MSD; Honoraria (self), Research grant/Funding (institution): Roche-Genentech; Research grant/Funding (institution): Sanofi; Honoraria (self), Research grant/Funding (institution): Bayer; Honoraria (self), Research grant/Funding (self): Takeda; Honoraria (self), Research grant/Funding (institution): Pierre Fabre."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Caramella", "first_name": "C.", "last_name": "Caramella", "second_name": "", "title": " Honoraria (self): pfizer; Honoraria (self): BMS; Honoraria (self): MSD; Honoraria (self): AstraZeneca; Honoraria (self): Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "U. Dafni", "first_name": "U.", "last_name": "Dafni", "second_name": "", "title": " Advisory/Consultancy: Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "K. Nackaerts", "first_name": "K.", "last_name": "Nackaerts", "second_name": "", "title": " Honoraria (institution): AbbVie; Honoraria (institution): Eli Lilly; Honoraria (institution): MSD; Honoraria (institution): Roche; Honoraria (institution): Takeda Millennium."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Madelaine", "first_name": "J.", "last_name": "Madelaine", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy: BMS; Honoraria (self), Advisory/Consultancy: Roche; Honoraria (self), Advisory/Consultancy: AstraZeneca; Honoraria (self), Advisory/Consultancy: Takeda; Honoraria (self), Advisory/Consultancy: Pfizer; Honoraria (self), Advisory/Consultancy: Novartis; Honoraria (self), Advisory/Consultancy: Boehringer-Ingelheim."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Popat", "first_name": "S.", "last_name": "Popat", "second_name": "", "title": " Honoraria (self): BMS; Honoraria (self): Roche; Honoraria (self): Takeda; Honoraria (self): AstraZeneca; Honoraria (self): Pfizer; Honoraria (self): MSD; Honoraria (self): EMD Serono; Honoraria (self): Guardant Health; Honoraria (self): AbbVie; Honoraria (self): Boehringer-Ingelheim; Honoraria (self): OncLive; Honoraria (self): Medscape; Honoraria (self): Incyte; Honoraria (self): Paradox Pharmaceuticals; Honoraria (self): Eli Lilly."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Reck", "first_name": "M.", "last_name": "Reck", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy: AbbVie; Honoraria (self), Advisory/Consultancy: Amgen; Honoraria (self), Advisory/Consultancy: AstraZeneca; Honoraria (self), Advisory/Consultancy: BMS; Honoraria (self), Advisory/Consultancy: Boehringer Ingelheim; Honoraria (self), Advisory/Consultancy: Lilly; Honoraria (self), Advisory/Consultancy: Merck; Honoraria (self), Advisory/Consultancy: MSD; Honoraria (self), Advisory/Consultancy: Novartis; Honoraria (self), Advisory/Consultancy: Pfizer; Honoraria (self), Advisory/Consultancy: Roche; Honoraria (self), Advisory/Consultancy: Samsung."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. De Ruysscher", "first_name": "D.", "last_name": "De Ruysscher", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (institution): BMS; Advisory/Consultancy: Celgene; Advisory/Consultancy: Merck/Pfizer; Advisory/Consultancy: Roche/Genentech; Advisory/Consultancy, Research grant/Funding (institution): AstraZeneca; Advisory/Consultancy: MSD; Advisory/Consultancy: Seattle Genetics; Research grant/Funding (institution): Boehringer-Ingelheim; Research grant/Funding (institution): Philips; Research grant/Funding (institution): Olink."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Le Pechoux", "first_name": "C.", "last_name": "Le Pechoux", "second_name": "", "title": " Honoraria (institution), Advisory/Consultancy: AstraZeneca; Advisory/Consultancy: Nanobiotix; Advisory/Consultancy: Roche; Honoraria (institution): Amgen; Honoraria (institution): Medscape; Honoraria (institution): Lilly; Honoraria (self): PriME Oncology."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. Stahel", "first_name": "R.", "last_name": "Stahel", "second_name": "", "title": " Honoraria (self): AbbVie; Honoraria (self), Research grant/Funding (self): AstraZeneca; Honoraria (self), Research grant/Funding (self): Boehringer Ingelheim; Honoraria (self), Research grant/Funding (self): MSD; Honoraria (self), Research grant/Funding (self): Pfizer; Honoraria (self), Research grant/Funding (self): Roche; Honoraria (self): Takeda; Research grant/Funding (self): BMS; Research grant/Funding (self): Genentech."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Bjorn H. Gronberg", "first_name": "Bjorn", "last_name": "Gronberg", "second_name": "H.", "country": "Norway", "city": "Trondheim", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Corinne Faivre-Finn", "first_name": "Corinne", "last_name": "Faivre-Finn", "second_name": "", "country": "United Kingdom", "city": "Manchester", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Teresa M. Amaral", "first_name": "Teresa", "last_name": "Amaral", "second_name": "M.", "country": "P", "city": "Tuebingen", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Matteo Lambertini", "first_name": "Matteo", "last_name": "Lambertini", "second_name": "", "country": "Italy", "city": "Genova", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Matthias Preusser", "first_name": "Matthias", "last_name": "Preusser", "second_name": "", "country": "Austria", "city": "Vienna", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "John B. Haanen", "first_name": "John", "last_name": "Haanen", "second_name": "B.", "country": "Netherlands", "city": "Amsterdam", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Jocalyn Clark", "first_name": "Jocalyn", "last_name": "Clark", "second_name": "", "country": "United Kingdom", "city": "London", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Domenica Lorusso", "first_name": "Domenica", "last_name": "Lorusso", "second_name": "", "country": "Italy", "city": "Rome", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Andreas Du Bois", "first_name": "Andreas", "last_name": "Du Bois", "second_name": "", "country": "Germany", "city": "Essen", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "David Cibula", "first_name": "David", "last_name": "Cibula", "second_name": "", "country": "Czech Republic", "city": "Prague", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Xiaohua Wu", "first_name": "Xiaohua", "last_name": "Wu", "second_name": "", "country": "China", "city": "Shanghai", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Sehouli", "first_name": "J.", "last_name": "Sehouli", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Roche; Advisory/Consultancy: Clovis; Advisory/Consultancy, Travel/Accommodation/Expenses: GSK/Tesaro; Honoraria (self), Advisory/Consultancy: AstraZeneca; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution): PharmaMar; Advisory/Consultancy: Pfizer; Advisory/Consultancy: Novocure; Advisory/Consultancy: Eisai; Advisory/Consultancy, Research grant/Funding (institution): Lilly; Advisory/Consultancy, Research grant/Funding (institution): Bayer; Research grant/Funding (institution): Roche Diagnostics; Leadership role: NOGGO; Leadership role: ESGO; Leadership role: PARSGO; Leadership role: AGO."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "E. Biagioli", "first_name": "E.", "last_name": "Biagioli", "second_name": "", "title": " Research grant/Funding (institution): Roche; Research grant/Funding (institution): GSK/Tesaro; Research grant/Funding (institution): AstraZeneca; Research grant/Funding (institution): PharmaMar."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "N. Ottevanger", "first_name": "N.", "last_name": "Ottevanger", "second_name": "", "title": " Research grant/Funding (institution): PharmaMar."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "G. Zeimet", "first_name": "G.", "last_name": "Zeimet", "second_name": "", "title": " Honoraria (self), Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: PharmaMar; Honoraria (self), Advisory/Consultancy, Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: Roche; Honoraria (self), Honoraria (institution), Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (institution), Travel/Accommodation/Expenses: AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "B. Vergote", "first_name": "B.", "last_name": "Vergote", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Amgen (Europe) GmBH; Advisory/Consultancy, Travel/Accommodation/Expenses: AstraZeneca; Advisory/Consultancy: Clovis; Advisory/Consultancy: Carrick Therapeutics; Advisory/Consultancy: Debiopharm International; Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Roche; Advisory/Consultancy, Contracted research: Genmab; Advisory/Consultancy: GSK; Advisory/Consultancy: Immunogen; Advisory/Consultancy: Medical University of Vienna; Advisory/Consultancy: Millenium Pharmaceuticals; Advisory/Consultancy, Travel/Accommodation/Expenses: MSD Belgium; Advisory/Consultancy: Octimet Oncology; Advisory/Consultancy, Contracted research: Oncoinvent AS; Advisory/Consultancy: PharmaMar; Advisory/Consultancy: Roche NV; Advisory/Consultancy: Sotio A."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Maenpaa", "first_name": "J.", "last_name": "Maenpaa", "second_name": "", "title": " Honoraria (self): Roche; Honoraria (self): GSK; Honoraria (self): AstraZeneca; Honoraria (self): Clovis; Honoraria (self): Orion Pharma."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. Fossati", "first_name": "R.", "last_name": "Fossati", "second_name": "", "title": " Research grant/Funding (institution): Roche; Research grant/Funding (institution): AstraZeneca; Research grant/Funding (institution): GSK/Tesaro; Research grant/Funding (institution): PharmaMar."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Poveda", "first_name": "A.", "last_name": "Poveda", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (self), Travel/Accommodation/Expenses: AstraZeneca; Advisory/Consultancy: Clovis; Advisory/Consultancy, Travel/Accommodation/Expenses: PharmaMar; Advisory/Consultancy: GSK."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Sara Colomer-Lahiguera", "first_name": "Sara", "last_name": "Colomer-Lahiguera", "second_name": "", "country": "Switzerland", "city": "Lausanne", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Valentina Biagioli", "first_name": "Valentina", "last_name": "Biagioli", "second_name": "", "country": "Italy", "city": "Rome", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Helena Ullgren", "first_name": "Helena", "last_name": "Ullgren", "second_name": "", "country": "Sweden", "city": "Solna", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "E.G. Elisabeth De Vries", "first_name": "E.G.", "last_name": "De Vries", "second_name": "Elisabeth", "country": "Netherlands", "city": "Groningen", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Andrew Bottomley", "first_name": "Andrew", "last_name": "Bottomley", "second_name": "", "country": "Belgium", "city": "Brussels", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Raya Leibowitz-Amit", "first_name": "Raya", "last_name": "Leibowitz-Amit", "second_name": "", "country": "Israel", "city": "Ramat Gan", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Bishal Gyawali", "first_name": "Bishal", "last_name": "Gyawali", "second_name": "", "country": "Aich", "city": "Kingston", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Ravindran Kanesvaran", "first_name": "Ravindran", "last_name": "Kanesvaran", "second_name": "", "country": "Singapore", "city": "Singapore", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Cécile Le Pechoux", "first_name": "Cécile", "last_name": "Le Pechoux", "second_name": "", "country": "CEDE", "city": "Villejuif", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Bardet", "first_name": "A.", "last_name": "Bardet", "second_name": "", "title": " Advisory/Consultancy: Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Rafal Dziadziuszko", "first_name": "Rafal", "last_name": "Dziadziuszko", "second_name": "", "country": "Poland", "city": "Gdansk", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Johann S. De Bono", "first_name": "Johann", "last_name": "De Bono", "second_name": "S.", "country": "United Kingdom", "city": "London", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Bracarda", "first_name": "S.", "last_name": "Bracarda", "second_name": "", "title": " Advisory/Consultancy: Bayer; Advisory/Consultancy: Astellas; Advisory/Consultancy: Janssen; Advisory/Consultancy: Pfizer; Advisory/Consultancy: BMS; Advisory/Consultancy: Roche; Advisory/Consultancy: Ipsen; Advisory/Consultancy: MSD; Advisory/Consultancy: Merck; Advisory/Consultancy: AstraZeneca; Advisory/Consultancy: AAA."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "N. Chi", "first_name": "N.", "last_name": "Chi", "second_name": "", "title": " Honoraria (self), Research grant/Funding (institution): AstraZeneca; Honoraria (self), Research grant/Funding (institution): Astellas; Honoraria (self), Research grant/Funding (institution): Janssen; Honoraria (self), Research grant/Funding (institution): Pfizer; Honoraria (self): Daiichi Sanyo; Honoraria (self), Research grant/Funding (institution): Bayer; Honoraria (self), Research grant/Funding (institution): Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Olmos", "first_name": "D.", "last_name": "Olmos", "second_name": "", "title": " Honoraria (institution), Travel/Accommodation/Expenses: Astellas Pharma ; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Bayer; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Janssen; Advisory/Consultancy, Research grant/Funding (institution): AstraZeneca; Advisory/Consultancy: Clovis Oncology; Research grant/Funding (institution): Astellas Medivation; Research grant/Funding (institution): Genentech/Roche; Research grant/Funding (institution): Pfizer; Travel/Accommodation/Expenses: Tokai Pharmaceuticals; Travel/Accommodation/Expenses: Ipsen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. Gafanov", "first_name": "R.", "last_name": "Gafanov", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (institution): Janssen; Advisory/Consultancy, Research grant/Funding (institution): MSD; Advisory/Consultancy, Research grant/Funding (institution): BMS; Advisory/Consultancy: Astellas; Advisory/Consultancy: Sanofi; Advisory/Consultancy: Pfizer; Advisory/Consultancy: Bayer; Advisory/Consultancy: Eisai; Advisory/Consultancy: Ipsen; Advisory/Consultancy: Pierre Fabre."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Borre", "first_name": "M.", "last_name": "Borre", "second_name": "", "title": " Advisory/Consultancy: Ferring; Advisory/Consultancy: MSD; Advisory/Consultancy: Bayer; Advisory/Consultancy: Astellas; Research grant/Funding (institution): AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "G. Vasconcelos Alves", "first_name": "G.", "last_name": "Alves", "second_name": "Vasconcelos", "title": " Research grant/Funding (institution): MSD; Research grant/Funding (institution): BMS; Advisory/Consultancy, Research grant/Funding (institution): Merck-Serono; Research grant/Funding (institution): Roche; Research grant/Funding (institution): Pfizer; Research grant/Funding (institution): AstraZeneca; Research grant/Funding (institution): Beigene; Research grant/Funding (institution): Ipsen; Advisory/Consultancy: Janssen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Garcia", "first_name": "J.", "last_name": "Garcia", "second_name": "", "title": " Full/Part-time employment: Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "G. Chen", "first_name": "G.", "last_name": "Chen", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Genentech."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Wongchenko", "first_name": "J.", "last_name": "Wongchenko", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Roche/Genentech."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Sweeney", "first_name": "C.", "last_name": "Sweeney", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (institution): Astellas; Advisory/Consultancy, Research grant/Funding (institution): Pfizer; Advisory/Consultancy, Research grant/Funding (institution): Janssen; Advisory/Consultancy, Research grant/Funding (institution): Dendreon; Advisory/Consultancy, Research grant/Funding (institution): Bayer; Research grant/Funding (institution): Sanofi; Advisory/Consultancy: Genentech; Advisory/Consultancy: GlaxoSmithKline."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Mateo", "first_name": "J.", "last_name": "Mateo", "second_name": "", "title": " Advisory/Consultancy: Amgen; Advisory/Consultancy: Clovis Oncology; Advisory/Consultancy: Janssen Pharmaceuticals; Speaker Bureau/Expert testimony: Astellas Pharma; Advisory/Consultancy, Research grant/Funding (self): AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "K. Fizazi", "first_name": "K.", "last_name": "Fizazi", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy: Amgen; Honoraria (self), Advisory/Consultancy: Astellas; Honoraria (self), Advisory/Consultancy: AstraZeneca; Honoraria (self), Advisory/Consultancy: AAA; Honoraria (self), Advisory/Consultancy: Bayer; Honoraria (self), Advisory/Consultancy: Curevac; Honoraria (self), Advisory/Consultancy: Essa; Honoraria (self), Advisory/Consultancy: Janssen Biotech; Honoraria (self), Advisory/Consultancy: MSD; Honoraria (self), Advisory/Consultancy: Novartis; Honoraria (self), Advisory/Consultancy: Orion Corporation; Honoraria (self), Advisory/Consultancy: Sanofi Aventis US."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "F. Saad", "first_name": "F.", "last_name": "Saad", "second_name": "", "title": " Advisory/Consultancy, Non-remunerated activity/ies: AstraZeneca; Advisory/Consultancy, Non-remunerated activity/ies: Bristol-Myers Squibb; Advisory/Consultancy, Non-remunerated activity/ies: Merck; Advisory/Consultancy, Non-remunerated activity/ies: Pfizer; Advisory/Consultancy, Non-remunerated activity/ies: Myovant; Honoraria (self), Advisory/Consultancy, Non-remunerated activity/ies: Sanofi; Honoraria (self), Advisory/Consultancy, Non-remunerated activity/ies: Janssen; Honoraria (self), Advisory/Consultancy, Non-remunerated activity/ies: Bayer; Honoraria (self), Advisory/Consultancy, Non-remunerated activity/ies: Astellas."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "N. Shore", "first_name": "N.", "last_name": "Shore", "second_name": "", "title": " Advisory/Consultancy: Amgen; Advisory/Consultancy: Astellas Pharma; Advisory/Consultancy: AstraZeneca; Advisory/Consultancy: Bayer; Advisory/Consultancy: Bristol-Myers Squibb; Advisory/Consultancy: Dendreon Pharmaceuticals; Advisory/Consultancy: Ferring; Advisory/Consultancy: Janssen Global Services; Advisory/Consultancy: Merck; Advisory/Consultancy: MDxHealth; Advisory/Consultancy: Pfizer; Advisory/Consultancy: Sanofi; Advisory/Consultancy: Tolmar Pharmaceuticals; Advisory/Consultancy: Clovis."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "O. Sartor", "first_name": "O.", "last_name": "Sartor", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (self): AstraZeneca; Advisory/Consultancy: Bayer; Advisory/Consultancy: Invitae; Advisory/Consultancy: Pfizer; Advisory/Consultancy: Clovis Oncology."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "P. Twardowski", "first_name": "P.", "last_name": "Twardowski", "second_name": "", "title": " Honoraria (self), Speaker Bureau/Expert testimony: Astellas Pharma; Honoraria (self), Speaker Bureau/Expert testimony: Janssen Biotech."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Kang", "first_name": "J.", "last_name": "Kang", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Burgents", "first_name": "J.", "last_name": "Burgents", "second_name": "", "title": " Full/Part-time employment, Within last 5 years: AstraZeneca; Shareholder/Stockholder/Stock options, Full/Part-time employment: Merck Sharp & Dohme Corporation."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Gresty", "first_name": "C.", "last_name": "Gresty", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Corcoran", "first_name": "C.", "last_name": "Corcoran", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Adelman", "first_name": "A.", "last_name": "Adelman", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Hussain", "first_name": "M.", "last_name": "Hussain", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy: AstraZeneca; Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Bayer; Honoraria (self): Daiichi Sankyo; Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Pfizer; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Genentech; Honoraria (self), Travel/Accommodation/Expenses: Astellas; Honoraria (self): Physicians' Education Resource; Honoraria (self): Projects in Knowledge; Honoraria (self): Sanofi/Genzyme; Honoraria (self): Phillips Gilmore Oncology; Honoraria (self): Research to Practice; Honoraria (self): MLI Peer Review; Research grant/Funding (institution): Prostate Cancer Clinical Trials Consortium."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Henrik Grönberg", "first_name": "Henrik", "last_name": "Grönberg", "second_name": "", "country": "Sweden", "city": "Stockholm", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Stephen R. Johnston", "first_name": "Stephen", "last_name": "Johnston", "second_name": "R.", "country": "United Kingdom", "city": "London", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "N. Harbeck", "first_name": "N.", "last_name": "Harbeck", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy: Eli Lilly and Company; Honoraria (self), Advisory/Consultancy: AstraZeneca; Honoraria (self), Advisory/Consultancy: Novartis; Honoraria (self), Advisory/Consultancy: Pfizer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Toi", "first_name": "M.", "last_name": "Toi", "second_name": "", "title": " Honoraria (self), Research grant/Funding (institution): Chugai; Honoraria (self), Research grant/Funding (institution): Takeda; Honoraria (self), Research grant/Funding (institution): Pfizer; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution): Kyowa-Hakko-Kirin; Honoraria (self), Research grant/Funding (institution): Taiho; Research grant/Funding (institution), Officer/Board of Directors: JBCRG Association; Honoraria (self), Research grant/Funding (institution): Eisai; Honoraria (self), Advisory/Consultancy, Research grant/Funding (self): Daiichi-Sankyo; Honoraria (self), Research grant/Funding (institution): AstraZeneca; Honoraria (self): Eli Lilly and Company; Honoraria (self): MSD; Honoraria (self): Genomic Health; Honoraria (self): Novartis; Honoraria (self), Honorarium for advisory meeting: Konica Minolta; Research grant/Funding (institution): Astellas; Honoraria (self), Honorarium for advisory meeting: BMS; Honoraria (self), Research grant/Funding (institution): Shimadzu; Honoraria (self): Yakult; Honoraria (self), Research grant/Funding (institution): Nippon Kayaku; Research grant/Funding (institution): AFI Technologies; Advisory/Consultancy: Athenex Oncology; Officer/Board of Directors: Organization for Oncology and Translational Research; Officer/Board of Directors: Kyoto Breast Cancer Research Network."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Martin", "first_name": "M.", "last_name": "Martin", "second_name": "", "title": " Honoraria (self), Research grant/Funding (self), Personal fees: Roche; Honoraria (self), Research grant/Funding (self), Personal fees: Novartis; Honoraria (self), Research grant/Funding (self), Personal fees: Puma; Honoraria (self), Travel/Accommodation/Expenses, Personal fees: Eli Lilly and Company; Honoraria (self), Personal fees: GSK; Honoraria (self), Personal fees: AstraZeneca; Honoraria (self), Personal fees: Amgen; Honoraria (self), Personal fees: Taiho Oncology; Honoraria (self), Personal fees: PharmaMar; Honoraria (self), Personal fees: Pfizer; Honoraria (self), Personal fees: Daiichi Sanyo."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "P. Hamilton", "first_name": "P.", "last_name": "Hamilton", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (institution), Advisory board (no Personal compensation accepted): Eli Lilly and Company; Advisory/Consultancy, Research grant/Funding (institution), Advisory board (no Personal compensation accepted): Pfizer; Speaker Bureau/Expert testimony, Research grant/Funding (institution), Speaker's bureau (no Personal compensation accepted): Genentech/Roche; Advisory/Consultancy: Flatiorn Health; Advisory/Consultancy, Research grant/Funding (institution), Consulting (no Personal compensation accepted): Cascadian Therapeutics; Research grant/Funding (institution): Hutchinson MediPharma; Research grant/Funding (institution): OncoMed; Research grant/Funding (institution): MedImmune; Research grant/Funding (institution): StemCentrx; Research grant/Funding (institution): AbbVie; Research grant/Funding (institution): Curis; Research grant/Funding (institution): Verastem; Research grant/Funding (institution): Zymeworks; Research grant/Funding (institution): Syndax; Research grant/Funding (institution): Lycera; Research grant/Funding (institution): Rgenix; Advisory/Consultancy, Research grant/Funding (institution), Consulting (no Personal compensation accepted): Novartis; Advisory/Consultancy, Research grant/Funding (institution), Consulting (no Personal compensation accepted): Mersana; Research grant/Funding (institution): Taplmmune; Research grant/Funding (institution): BerGenBio; Research grant/Funding (institution): Tesaro; Research grant/Funding (institution): Medivation; Research grant/Funding (institution): Kadmon; Research grant/Funding (institution): Boehringer Ingelheim; Research grant/Funding (institution): Eisai; Research grant/Funding (institution): H3 Biomedicine; Research grant/Funding (institution): Radius Health; Research grant/Funding (institution): Acerta; Research grant/Funding (institution): Takeda; Research grant/Funding (institution): Macrogenics; Research grant/Funding (institution): Immunomedics; Research grant/Funding (institution): FujiFilm; Research grant/Funding (institution): Effector; Research grant/Funding (institution): Syros; Research grant/Funding (institution): Unum; Research grant/Funding (institution): Sutro; Research grant/Funding (institution): Aravive; Research grant/Funding (institution): Deciphera; Research grant/Funding (institution): Clovis; Research grant/Funding (institution): Sermonix; Research grant/Funding (institution): Zenith; Research grant/Funding (institution): Arvinas; Research grant/Funding (institution): ArQule; Research grant/Funding (institution): Torque; Research grant/Funding (institution): Harpoon; Research grant/Funding (institution): Fachon; Research grant/Funding (institution): Orinove; Research grant/Funding (institution): Molecular Template; Research grant/Funding (institution): Seattle Genetics; Advisory/Consultancy, Research grant/Funding (institution), consulting (no Personal compensation accepted): Daiichi; Advisory/Consultancy, Research grant/Funding (institution), consulting (no Personal compensation accepted): AstraZeneca; Advisory/Consultancy, Research grant/Funding (institution), consulting (no Personal compensation accepted): Silverback Therapeutics; Advisory/Consultancy, Research grant/Funding (institution), consulting (no Personal compensation accepted): Black Diamond."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Sohn", "first_name": "J.", "last_name": "Sohn", "second_name": "", "title": " Research grant/Funding (institution): MSD; Research grant/Funding (institution): Roche; Research grant/Funding (institution): Novartis; Research grant/Funding (institution): AstraZeneca; Research grant/Funding (institution): Eli Lilly and Company; Research grant/Funding (institution): Pfizer; Research grant/Funding (institution): Bayer; Research grant/Funding (institution): GSK; Research grant/Funding (institution): CONTESSA; Research grant/Funding (institution): Daiichi Sankyo."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "V. Guarneri", "first_name": "V.", "last_name": "Guarneri", "second_name": "", "title": " Advisory/Consultancy, Speaker Bureau/Expert testimony: Eli Lilly and Compnay; Advisory/Consultancy, Speaker Bureau/Expert testimony: Novartis; Advisory/Consultancy, Research grant/Funding (institution): Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "P. Neven", "first_name": "P.", "last_name": "Neven", "second_name": "", "title": " Honoraria (self), Research grant/Funding (institution), Travel/Accommodation/Expenses: Eli Lilly and Company."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "F. Boyle", "first_name": "F.", "last_name": "Boyle", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy: Eli Lilly and Company; Honoraria (self), Advisory/Consultancy: Roche; Honoraria (self), Advisory/Consultancy: Pfizer; Honoraria (self), Advisory/Consultancy: Novartis."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "I. Smith", "first_name": "I.", "last_name": "Smith", "second_name": "", "title": " Full/Part-time employment, Former employee of Eli Lilly and Company: Eli Lilly and Compnay."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Headley", "first_name": "D.", "last_name": "Headley", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Eli Lilly and Company; Shareholder/Stockholder/Stock options: Novartis; Shareholder/Stockholder/Stock options: Takeda; Shareholder/Stockholder/Stock options: Varian Medical Systems; Shareholder/Stockholder/Stock options: Utah Medical Products; Shareholder/Stockholder/Stock options: Zoetis; Shareholder/Stockholder/Stock options: Bayer; Shareholder/Stockholder/Stock options: Merck; Shareholder/Stockholder/Stock options: Roche; Shareholder/Stockholder/Stock options: Evgen; Shareholder/Stockholder/Stock options: AstraZeneca; Shareholder/Stockholder/Stock options: Johnson & Johnson; Shareholder/Stockholder/Stock options: Pfizer; Shareholder/Stockholder/Stock options: Varex Imaging; Shareholder/Stockholder/Stock options: Zimmer BioMet; Shareholder/Stockholder/Stock options: Chugai Pharma."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. Wei", "first_name": "R.", "last_name": "Wei", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Eli Lilly and Company."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Frenzel", "first_name": "M.", "last_name": "Frenzel", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Eli Lilly and Company."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Cox", "first_name": "J.", "last_name": "Cox", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Eli Lilly and Company."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "P. Rastogi", "first_name": "P.", "last_name": "Rastogi", "second_name": "", "title": " Travel/Accommodation/Expenses: Eli Lilly and Company; Travel/Accommodation/Expenses: AstraZeneca; Travel/Accommodation/Expenses: Roche/Genentech."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "George Sledge", "first_name": "George", "last_name": "Sledge", "second_name": "", "country": "I", "city": "Stanford", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Andres Cervantes", "first_name": "Andres", "last_name": "Cervantes", "second_name": "", "country": "Valenci", "city": "Valencia", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Josep Tabernero", "first_name": "Josep", "last_name": "Tabernero", "second_name": "", "country": "Spain", "city": "Barcelona", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Markus Moehler", "first_name": "Markus", "last_name": "Moehler", "second_name": "", "country": "Germany", "city": "Mainz", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "K. Shitara", "first_name": "K.", "last_name": "Shitara", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (institution): Astellas Pharma; Advisory/Consultancy, Research grant/Funding (institution): Eli Lilly and Company; Advisory/Consultancy: Bristol Myers Squibb; Advisory/Consultancy: Takeda Pharmaceuticals; Advisory/Consultancy: Pfizer Inc; Advisory/Consultancy: Ono Pharmaceutical; Honoraria (self), Advisory/Consultancy: Novartis; Honoraria (self), Advisory/Consultancy: AbbVie Inc; Honoraria (self): Yakult; Research grant/Funding (institution): Dainippon Sumitomo Pharma; Research grant/Funding (institution): Daiichi Sankyo; Advisory/Consultancy, Research grant/Funding (institution): Taiho Pharmaceutical; Research grant/Funding (institution): Chugai Pharma; Advisory/Consultancy, Research grant/Funding (institution): Merck Pharmaceutical; Research grant/Funding (institution): Medi Science; Advisory/Consultancy: GlaxoSmithKline."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Garrido", "first_name": "M.", "last_name": "Garrido", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (institution): Bristol Myers Squibb; Advisory/Consultancy: MSD; Advisory/Consultancy, Research grant/Funding (institution): Novartis; Advisory/Consultancy: Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "K. Yamaguchi", "first_name": "K.", "last_name": "Yamaguchi", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (institution): Taiho; Advisory/Consultancy: Chugai; Research grant/Funding (institution): Sanofi; Advisory/Consultancy, Research grant/Funding (institution): Daiichi-Sankyo; Advisory/Consultancy: Lilly; Advisory/Consultancy, Research grant/Funding (institution): Ono; Advisory/Consultancy, Research grant/Funding (institution): Yakult Honsha; Advisory/Consultancy: Takeda; Advisory/Consultancy: Bristol Myers Squibb; Advisory/Consultancy: Merck Serono."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "V. Poulart", "first_name": "V.", "last_name": "Poulart", "second_name": "", "title": " Full/Part-time employment: Bristol Myers Squibb."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Cullen", "first_name": "D.", "last_name": "Cullen", "second_name": "", "title": " Travel/Accommodation/Expenses, Shareholder/Stockholder/Stock options, Full/Part-time employment: Bristol Myers Squibb."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Lei", "first_name": "M.", "last_name": "Lei", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Bristol Myers Squibb."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "K. Kondo", "first_name": "K.", "last_name": "Kondo", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Bristol Myers Squibb."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Li", "first_name": "M.", "last_name": "Li", "second_name": "", "title": " Full/Part-time employment: Bristol Myers Squibb."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Ajani", "first_name": "A.", "last_name": "Ajani", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (institution): Bristol Myers Squibb."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Y. Janjigian", "first_name": "Y.", "last_name": "Janjigian", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (institution): Eli Lilly; Speaker Bureau/Expert testimony: ASCO; Advisory/Consultancy: Michael J."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Narikazu Boku", "first_name": "Narikazu", "last_name": "Boku", "second_name": "", "country": "Japan", "city": "Tokyo", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "H. Ryu", "first_name": "H.", "last_name": "Ryu", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy: Ono; Honoraria (self), Advisory/Consultancy: BMS; Honoraria (self), Advisory/Consultancy: MSD; Honoraria (self), Advisory/Consultancy: Eli Lilly; Honoraria (self), Advisory/Consultancy: Taiho; Honoraria (self), Advisory/Consultancy: Novartis; Honoraria (self), Advisory/Consultancy: Daehwa."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Y. Oh", "first_name": "Y.", "last_name": "Oh", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (self): AstraZeneca; Advisory/Consultancy, Research grant/Funding (self): Novartis; Advisory/Consultancy: Genentech; Advisory/Consultancy: Merck Serono; Advisory/Consultancy: Bayer; Advisory/Consultancy: Taiho; Advisory/Consultancy: Aslan; Advisory/Consultancy: Halozyme; Advisory/Consultancy: Zymeworks; Advisory/Consultancy: Celgene; Research grant/Funding (self): Array; Research grant/Funding (self): Eli Lilly; Advisory/Consultancy: Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Chung", "first_name": "C.", "last_name": "Chung", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution): Merck-Serono; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution): Eli Lilly; Honoraria (self): Foundation Medicine; Advisory/Consultancy, Research grant/Funding (institution): Taiho; Advisory/Consultancy: Celltrion; Advisory/Consultancy, Research grant/Funding (institution): MSD; Advisory/Consultancy, Research grant/Funding (institution): BMS; Advisory/Consultancy: Gloria; Advisory/Consultancy, Research grant/Funding (institution): Beigene; Advisory/Consultancy, Research grant/Funding (institution): Amgen; Advisory/Consultancy: Zymework; Research grant/Funding (institution): GSK; Research grant/Funding (institution): Ono pharmaceutical."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "W. Lee", "first_name": "W.", "last_name": "Lee", "second_name": "", "title": " Honoraria (self): BMS; Honoraria (self): Eli Lilly; Honoraria (self): Genexine; Research grant/Funding (institution): Macrogenics; Research grant/Funding (institution): MSD; Research grant/Funding (institution): Ono pharmaceutical; Research grant/Funding (institution): Green Cross Corp."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Sakuramoto", "first_name": "S.", "last_name": "Sakuramoto", "second_name": "", "title": " Research grant/Funding (institution): Ono pharmaceutical; Research grant/Funding (institution): Taiho; Research grant/Funding (institution): Kaken pharmaceutical; Research grant/Funding (institution): Chugai."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "K. Kato", "first_name": "K.", "last_name": "Kato", "second_name": "", "title": " Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (institution): Ono Pharmaceutical; Advisory/Consultancy, Research grant/Funding (institution): Beigene; Advisory/Consultancy, Research grant/Funding (institution): MSD; Speaker Bureau/Expert testimony: Taiho; Speaker Bureau/Expert testimony: Eli Lilly; Speaker Bureau/Expert testimony, Research grant/Funding (institution): BMS; Research grant/Funding (institution): Shionogi; Research grant/Funding (institution): Merck Bio; Research grant/Funding (institution): Chugai."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Kadowaki", "first_name": "S.", "last_name": "Kadowaki", "second_name": "", "title": " Honoraria (self), Research grant/Funding (institution): Eli Lilly; Honoraria (self), Research grant/Funding (institution): Taiho; Honoraria (self), Research grant/Funding (institution): Ono Pharmaceutical; Honoraria (self), Research grant/Funding (institution): BMS; Honoraria (self): Yakult Honsya; Honoraria (self): Chugai; Honoraria (self): Bayer; Honoraria (self): Merck; Research grant/Funding (institution): MSD."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Chen", "first_name": "S.", "last_name": "Chen", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy: Ono Pharmaceutical; Honoraria (self): TTY Biopharma; Honoraria (self): MSD oncology; Honoraria (self): MedImmune; Honoraria (self): Merck KGaA; Honoraria (self): Roche; Honoraria (self): AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Y. Bai", "first_name": "Y.", "last_name": "Bai", "second_name": "", "title": " Honoraria (self): AbbVie; Honoraria (self): Bayer; Honoraria (self): BMS; Honoraria (self): Johnson & Johnson; Honoraria (self): GSK; Honoraria (self): Eli Lilly; Honoraria (self): MSD; Honoraria (self): Novartis; Honoraria (self): Ono Pharmaceutical; Honoraria (self): Pfizer; Honoraria (self): PharmaEngine; Honoraria (self): Roche; Honoraria (self): SynCore Biotechnology; Honoraria (self): Takeda; Honoraria (self): TTY Biopharm."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "T. Chen", "first_name": "T.", "last_name": "Chen", "second_name": "", "title": " Honoraria (self): Ono Pharmaceutical; Honoraria (self): Eli Lilly; Honoraria (self): MSD; Honoraria (self), Advisory/Consultancy: PharmaEngine; Honoraria (self), Research grant/Funding (institution): TTY Biopharm; Honoraria (self), Research grant/Funding (institution): SyncorePharm; Honoraria (self), Research grant/Funding (institution): Novartis; Honoraria (self): AstraZeneca; Honoraria (self): Ipsen; Leadership role: National Institute of Cancer Research, Taiwan; Research grant/Funding (institution): Merck Serono; Research grant/Funding (institution): Polaris; Research grant/Funding (institution): Pfizer; Research grant/Funding (institution): BMS; Licensing/Royalties: ENO-1 mAb from HuniLife; Full/Part-time employment: National Health Research Institutes, Taiwan; Officer/Board of Directors: SinoPharm Taiwan, Ltd."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "K. Kang", "first_name": "K.", "last_name": "Kang", "second_name": "", "title": " Advisory/Consultancy: ALX Oncology; Advisory/Consultancy: BMS; Advisory/Consultancy: Amgen; Advisory/Consultancy: Daehwa; Advisory/Consultancy: Macrogenics; Advisory/Consultancy: Novartis; Advisory/Consultancy: Surface Oncology; Advisory/Consultancy: Zymeworks."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Elizabeth C. Smyth", "first_name": "Elizabeth", "last_name": "Smyth", "second_name": "C.", "country": "United Kingdom", "city": "Cambridge", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Ken Kato", "first_name": "Ken", "last_name": "Kato", "second_name": "", "country": "Japan", "city": "Chuo-ku", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Sun", "first_name": "M.", "last_name": "Sun", "second_name": "", "title": " Research grant/Funding (institution): AstraZeneca; Research grant/Funding (institution): Ono; Research grant/Funding (institution): MSD."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Shah", "first_name": "A.", "last_name": "Shah", "second_name": "", "title": " Advisory/Consultancy: Daiichi; Advisory/Consultancy, Research grant/Funding (institution): Merck Sharp & Dohme Corp."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Enzinger", "first_name": "C.", "last_name": "Enzinger", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy: Astellas; Honoraria (self), Advisory/Consultancy: AstraZeneca; Honoraria (self), Advisory/Consultancy: Celgene; Honoraria (self), Advisory/Consultancy: Daiichi-Sankyo; Honoraria (self), Advisory/Consultancy: Five-Prime; Honoraria (self), Advisory/Consultancy: Lilly; Honoraria (self), Advisory/Consultancy: Loxo; Honoraria (self), Advisory/Consultancy: Merck Sharp & Dohme Corp."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Adenis", "first_name": "A.", "last_name": "Adenis", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Bayer; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Bristol Myers Squibb; Honoraria (self), Research grant/Funding (institution): Sanofi; Advisory/Consultancy: Servier; Research grant/Funding (institution), Travel/Accommodation/Expenses: Merck Sharp & Dohme Corp."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "T. Doi", "first_name": "T.", "last_name": "Doi", "second_name": "", "title": " Honoraria (self), Research grant/Funding (institution): Bristol Myers Squibb; Honoraria (self): Ono Pharmaceutical; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution): Abbvie; Honoraria (self): Astellas Pharma; Honoraria (self): Oncolys BioPharma; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution): Taiho Pharmaceutical; Honoraria (self): Otsuka; Advisory/Consultancy, Research grant/Funding (institution): MSD; Advisory/Consultancy, Research grant/Funding (institution): Daiichi Sankyo; Advisory/Consultancy: Amgen; Advisory/Consultancy, Research grant/Funding (institution): Sumitomo Dainippon; Advisory/Consultancy: Takeda; Advisory/Consultancy, Research grant/Funding (institution): Novartis; Advisory/Consultancy: Bayer; Advisory/Consultancy, Research grant/Funding (institution): Boehringer Ingelheim; Advisory/Consultancy: Rakuten Medical; Research grant/Funding (institution): Merck Serono; Research grant/Funding (institution): Pfizer; Research grant/Funding (institution): Lilly; Research grant/Funding (institution): Kyowa Hakko Kirin; Research grant/Funding (institution): Eisai; Research grant/Funding (institution): IQVIA."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "T. Kojima", "first_name": "T.", "last_name": "Kojima", "second_name": "", "title": " Honoraria (self), Research grant/Funding (institution): Ono Pharmaceutical; Honoraria (self): Oncolys BioPharma; Advisory/Consultancy: Astellas Pharma; Advisory/Consultancy: Bristol Myers Squibb; Advisory/Consultancy, Research grant/Funding (institution): MSD; Advisory/Consultancy, Research grant/Funding (institution): Ono Pharmaceutical; Advisory/Consultancy: Merck; Research grant/Funding (institution): Astellas Amgen BioPharma; Research grant/Funding (institution): Taiho Pharmaceutical; Research grant/Funding (institution): Shionogi."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "P. Metges", "first_name": "P.", "last_name": "Metges", "second_name": "", "title": " Honoraria (self): MSD; Honoraria (self): Bayer; Honoraria (self): Bristol Myers Squibb."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "B. Kim", "first_name": "B.", "last_name": "Kim", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (self): Novartis; Research grant/Funding (self): Sanofi-Aventis; Research grant/Funding (self): DongKook Pharma Co."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Chul Cho", "first_name": "C.", "last_name": "Cho", "second_name": "Chul", "title": " Advisory/Consultancy, Research grant/Funding (institution): Novartis; Advisory/Consultancy, Research grant/Funding (institution): AstraZeneca; Advisory/Consultancy: Boehringer Ingelheim; Advisory/Consultancy: Roche; Advisory/Consultancy: Bristol Myers Squibb; Advisory/Consultancy, Research grant/Funding (institution): Ono; Advisory/Consultancy, Research grant/Funding (institution): Yuhan; Advisory/Consultancy: Pfizer; Advisory/Consultancy, Research grant/Funding (institution): Eli Lilly; Advisory/Consultancy, Research grant/Funding (institution): Janssen; Advisory/Consultancy: Medpacto; Advisory/Consultancy, Research grant/Funding (institution): Blueprint Medicines; Advisory/Consultancy, Shareholder/Stockholder/Stock options: KANAPH Therapeutic Inc."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "H. Li", "first_name": "H.", "last_name": "Li", "second_name": "", "title": " Research grant/Funding (institution): MSD."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Maqueda", "first_name": "A.", "last_name": "Maqueda", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Servier; Honoraria (self), Advisory/Consultancy: Bristol Myers Squibb; Honoraria (self), Advisory/Consultancy: MSD; Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Lilly; Honoraria (self), Travel/Accommodation/Expenses: Roche; Honoraria (self), Travel/Accommodation/Expenses: Amgen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "E. Goekkurt", "first_name": "E.", "last_name": "Goekkurt", "second_name": "", "title": " Honoraria (self): MSD; Honoraria (self): Bristol Myers Squibb; Honoraria (self): Servier."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Q. Liu", "first_name": "Q.", "last_name": "Liu", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Merck Sharp & Dohme Corp."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Shah", "first_name": "S.", "last_name": "Shah", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Merck Sharp & Dohme Corp."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "P. Bhagia", "first_name": "P.", "last_name": "Bhagia", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Merck Sharp & Dohme Corp."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "L. Shen", "first_name": "L.", "last_name": "Shen", "second_name": "", "title": " Advisory/Consultancy: Merck Sharp & Dohme Corp."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Ronan J. Kelly", "first_name": "Ronan", "last_name": "Kelly", "second_name": "J.", "country": "T", "city": "Dallas", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Kuzdzal", "first_name": "J.", "last_name": "Kuzdzal", "second_name": "", "title": " Research grant/Funding (institution): Bristol Myers Squibb; Research grant/Funding (institution): Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "T. Zander", "first_name": "T.", "last_name": "Zander", "second_name": "", "title": " Advisory/Consultancy, advisory boards: Bristol Myers Squibb; Advisory/Consultancy, advisory boards: MSD; Advisory/Consultancy, advisory boards: Roche; Advisory/Consultancy, advisory boards: Lilly; Advisory/Consultancy, advisory boards: Novartis."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "G. Piessen", "first_name": "G.", "last_name": "Piessen", "second_name": "", "title": " Honoraria (self): MSD; Honoraria (self): Roche; Honoraria (self): Amgen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "L. Feliciano", "first_name": "L.", "last_name": "Feliciano", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (institution), consulting fees: AstraZeneca; Advisory/Consultancy, consulting fees: Genentech; Advisory/Consultancy, Research grant/Funding (institution), consulting fees: Bristol Myers Squibb; Advisory/Consultancy, consulting fees: Merck; Advisory/Consultancy, consulting fees: Eli Lilly."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "H. Uronis", "first_name": "H.", "last_name": "Uronis", "second_name": "", "title": " Research grant/Funding (institution): Macrogenics; Research grant/Funding (institution): Lycera; Research grant/Funding (institution): Merck; Research grant/Funding (institution): Advaxis; Research grant/Funding (institution): Bristol Myers Squibb."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "E. Elimova", "first_name": "E.", "last_name": "Elimova", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (institution): Bristol Myers Squibb; Advisory/Consultancy, Research grant/Funding (institution): Zymeworks; Spouse/Financial dependant: Merck Vaccines."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Grootscholten", "first_name": "C.", "last_name": "Grootscholten", "second_name": "", "title": " Research grant/Funding (institution): Bristol Myers Squibb."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Zhang", "first_name": "J.", "last_name": "Zhang", "second_name": "", "title": " Full/Part-time employment: Bristol Myers Squibb."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "L. Zhu", "first_name": "L.", "last_name": "Zhu", "second_name": "", "title": " Full/Part-time employment: Bristol Myers Squibb."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Cleary", "first_name": "M.", "last_name": "Cleary", "second_name": "", "title": " Advisory/Consultancy, Travel/Accommodation/Expenses: Bristol Myers Squibb; Research grant/Funding (institution): Merck; Research grant/Funding (institution): Tesaro; Research grant/Funding (institution): AstraZeneca; Research grant/Funding (institution): Esperas Pharma."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Moehler", "first_name": "M.", "last_name": "Moehler", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses, Adboards: Bristol Myers Squibb."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Masahiro Tsuboi", "first_name": "Masahiro", "last_name": "Tsuboi", "second_name": "", "country": "Chib", "city": "Kashiwa", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "L. Wu", "first_name": "L.", "last_name": "Wu", "second_name": "", "title": " Speaker Bureau/Expert testimony, Research grant/Funding (institution): AstraZeneca; Speaker Bureau/Expert testimony: Boehringer Ingelheim; Speaker Bureau/Expert testimony, Research grant/Funding (institution): BMS; Speaker Bureau/Expert testimony: Eli Lilly; Speaker Bureau/Expert testimony: MSD; Speaker Bureau/Expert testimony, Research grant/Funding (institution): Pfizer; Speaker Bureau/Expert testimony: Sanofi; Speaker Bureau/Expert testimony, Research grant/Funding (self): Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "T. John", "first_name": "T.", "last_name": "John", "second_name": "", "title": " Honoraria (self), Honoraria (institution), Advisory/Consultancy, Shareholder/Stockholder/Stock options: AstraZeneca; Honoraria (institution): Novartis; Advisory/Consultancy: Roche; Advisory/Consultancy: BMS; Advisory/Consultancy: Merck; Advisory/Consultancy: Ignyta; Advisory/Consultancy: Takeda; Advisory/Consultancy: MSD; Advisory/Consultancy: Specialised Therapeutics; Advisory/Consultancy: Pfizer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Grohe", "first_name": "C.", "last_name": "Grohe", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Speaker Bureau/Expert testimony: AstraZeneca; Honoraria (self), Advisory/Consultancy, Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: Boehringer Ingelheim; Honoraria (self), Advisory/Consultancy, Speaker Bureau/Expert testimony: MSD."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Majem", "first_name": "M.", "last_name": "Majem", "second_name": "", "title": " Honoraria (self), Research grant/Funding (self): BMS; Honoraria (self): MSD; Honoraria (self): Boehringer Ingelheim; Honoraria (self): AstraZeneca; Honoraria (self): Roche; Honoraria (self): Kyowa Kyrin; Honoraria (self): Pierre Fabre; Honoraria (self): Takeda; Honoraria (self): Bayer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "W. Goldman", "first_name": "W.", "last_name": "Goldman", "second_name": "", "title": " Speaker Bureau/Expert testimony: Merck; Honoraria (self), Research grant/Funding (self): AstraZeneca; Research grant/Funding (self): AbbVie; Research grant/Funding (self): Merck; Research grant/Funding (self): BMS."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "T. Kato", "first_name": "T.", "last_name": "Kato", "second_name": "", "title": " Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (self): AbbVie; Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (self): Amgen; Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (self): AstraZeneca; Advisory/Consultancy, Research grant/Funding (self): Chugai; Advisory/Consultancy, Research grant/Funding (self): Eli Lilly; Advisory/Consultancy, Research grant/Funding (self): Merck Biopharma; Advisory/Consultancy, Research grant/Funding (self): MSD; Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (self): Ono; Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (self): Pfizer; Advisory/Consultancy, Speaker Bureau/Expert testimony: Daiichi-Sankyo; Advisory/Consultancy: Nippon Kayaku; Advisory/Consultancy: Nitto Denko; Advisory/Consultancy: Sumitomo Dainippon; Advisory/Consultancy: Takeda; Speaker Bureau/Expert testimony, Research grant/Funding (self): Bristol Myers Squibb; Research grant/Funding (self): Novartis; Research grant/Funding (self): Taiho; Speaker Bureau/Expert testimony: Boehringer Ingelheim; Speaker Bureau/Expert testimony: F."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "F. de Marinis", "first_name": "F.", "last_name": "de Marinis", "second_name": "", "title": " Advisory/Consultancy: Roche; Advisory/Consultancy: BMS; Advisory/Consultancy: AstraZeneca; Advisory/Consultancy: MSD; Advisory/Consultancy: Pfizer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Domine", "first_name": "M.", "last_name": "Domine", "second_name": "", "title": " Advisory/Consultancy, Speaker Bureau/Expert testimony: AstraZeneca; Advisory/Consultancy, Speaker Bureau/Expert testimony: BMS; Advisory/Consultancy, Speaker Bureau/Expert testimony: Boehringer Ingelheim; Advisory/Consultancy, Speaker Bureau/Expert testimony: MSD; Advisory/Consultancy, Speaker Bureau/Expert testimony: Pfizer; Advisory/Consultancy, Speaker Bureau/Expert testimony: Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Shepherd", "first_name": "A.", "last_name": "Shepherd", "second_name": "", "title": " Honoraria (self), Shareholder/Stockholder/Stock options: AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Atasoy", "first_name": "A.", "last_name": "Atasoy", "second_name": "", "title": " Full/Part-time employment: AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. Herbst", "first_name": "R.", "last_name": "Herbst", "second_name": "", "title": " Honoraria (self): AbbVie; Honoraria (self): Armo Biosciences; Honoraria (self), Research grant/Funding (self): AstraZeneca; Honoraria (self): Biodesix; Honoraria (self): Bolt Biotherapeutics; Honoraria (self): Bristol-Myers Squibb; Honoraria (self), Research grant/Funding (self): Eli Lilly; Honoraria (self): Cybrexa; Honoraria (self): EMD Serrano; Honoraria (self), Research grant/Funding (self): Genentech/Roche; Honoraria (self): Genmab; Honoraria (self): Halozyme; Honoraria (self): Heat Biologics; Honoraria (self): IMAB Biopharma; Honoraria (self): Immunocore; Honoraria (self): Infinity Pharmaceuticals; Honoraria (self): Loxo Oncology; Honoraria (self), Research grant/Funding (self): Merck; Honoraria (self): Mirati Therapeutics; Honoraria (self): Nektar; Honoraria (self): Neon Therapeutics; Honoraria (self): NextCure; Honoraria (self): Novartis; Honoraria (self): Pfizer; Honoraria (self): Sanofi; Honoraria (self): Seattle Genetics; Honoraria (self): Shire PLC; Honoraria (self): Spectrum Pharmaceuticals; Honoraria (self): Symphogen; Honoraria (self): Takeda, Tesaro, Tocagen, WindMIL Therapeutics; Officer/Board of Directors: Junshi Pharmaceuticals."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Bauer", "first_name": "M.", "last_name": "Bauer", "second_name": "", "title": " Full/Part-time employment: Tennessee Oncology; Advisory/Consultancy: Guardant Health; Advisory/Consultancy: Loxo; Advisory/Consultancy: Pfizer; Advisory/Consultancy: Exelixis; Advisory/Consultancy: Blueprint Medicines; Advisory/Consultancy: Foundation Medicine; Advisory/Consultancy: Ignyta; Advisory/Consultancy: Moderna Therapeutics; Advisory/Consultancy: Pfizer; Speaker Bureau/Expert testimony: Bayer; Research grant/Funding (institution): Daiichi Sankyo; Medpacto, Inc."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "E. Felip", "first_name": "E.", "last_name": "Felip", "second_name": "", "title": " Advisory/Consultancy, Advisory Boards: AbbVie; AstraZeneca; Blue Print Medicines; Boehringer Ingelheim; Bristol-Myers Squibb, GSK; Eli Lilly; Guardant Health; Janssen; Medscape; Merck KGaA; Merck Sharp & Dohme; Novartis; Pfizer; Prime Oncology; Roche; Samsung; Springer; Takeda; Touchime; Speaker Bureau/Expert testimony, Board: Grífols Independent Member; Research grant/Funding (institution), Research Funding."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Y. Goto", "first_name": "Y.", "last_name": "Goto", "second_name": "", "title": " Advisory/Consultancy: Eli Lilly; Chugai; Taiho Pharmaceutical; Boehringer Ingelheim; Pfizer; Novartis; AstraZeneca; GlaxoSmithKline; MSD; Guardant Health; Daiichi Sankyo; Kyorin; Chugai; Speaker Bureau/Expert testimony: Illumina; AstraZeneca; Eli Lilly; Chugai; Taiho Pharmaceutical; Boehringer Ingelheim; Ono Pharmaceutical; Bristol-Myers Squibb; Pfizer; MSD; Shionogi Pharma; Novartis; Research grant/Funding (institution): AbbVie; Eli Lilly; Taiho Pharmaceutical; Bristol Myers Squibb; Ono Pharmaceutical; Daiichi Sankyo; Pfizer; Novartis; Kyorin; Chugai; Guardant Health; Daiichi-Sankyo."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "G. Liu", "first_name": "G.", "last_name": "Liu", "second_name": "", "title": " Advisory/Consultancy, Advisory board: Pfizer; Novartis; Merck; BMS; Roche; Advisory/Consultancy, Leadership role, Research grant/Funding (institution), Advisory board; educational rounds; research grants to institution: Takeda; AstraZeneca; Leadership role, Educational rounds: EMD Serono ."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "T. Mok", "first_name": "T.", "last_name": "Mok", "second_name": "", "title": " Research grant/Funding (institution): AstraZeneca, BMS, Clovis Oncology, G1 Therapeutics, MSD, Merck Serono, Novartis, Pfizer, Roche, SFJ, Takeda, XCovery ; Speaker Bureau/Expert testimony, Speaker's fees: ACEA Pharma; Alpha Biopharma Co."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Polli", "first_name": "A.", "last_name": "Polli", "second_name": "", "title": " Full/Part-time employment, Employee: Pfizer Inc."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Calella", "first_name": "M.", "last_name": "Calella", "second_name": "", "title": " Full/Part-time employment: Pfizer Inc."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "G. Peltz", "first_name": "G.", "last_name": "Peltz", "second_name": "", "title": " Full/Part-time employment: Pfizer Inc."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Shaw", "first_name": "A.", "last_name": "Shaw", "second_name": "", "title": " Honoraria (institution): Pfizer, Novartis, Genentech/Roche, Ariad/Takeda, Ignyta, Loxo, Bayer, Chugai, Blueprint Medicines, KSQ Therapeutics, Daiichi Sankyo, EMD Serono, Taiho Pharmaceutical, TP Therapeutics, Servier, Syros, Foundation Medicine, Guardant, Natera, Achilles, Archer; Travel/Accommodation/Expenses: Pfizer and Genentech; Full/Part-time employment: Novartis; Research grant/Funding (institution): Pfizer, Novartis, Roche/Genentech, Ariad, Ignyta, TP Therapeutics."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Christine Lovly", "first_name": "Christine", "last_name": "Lovly", "second_name": "", "country": "T", "city": "Nashville", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "T. Powles", "first_name": "T.", "last_name": "Powles", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy: AstraZeneca; Honoraria (self), Advisory/Consultancy: BMS; Honoraria (self), Advisory/Consultancy: Exelixis; Honoraria (self), Advisory/Consultancy: Incyte; Honoraria (self), Advisory/Consultancy: Ipsen; Honoraria (self), Advisory/Consultancy: Merck/MSD; Honoraria (self), Advisory/Consultancy: Novartis; Honoraria (self), Advisory/Consultancy: Pfizer; Honoraria (self), Advisory/Consultancy: Seattle Genetics; Research grant/Funding (institution): AstraZeneca; Research grant/Funding (institution): Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "T. Bourlon", "first_name": "T.", "last_name": "Bourlon", "second_name": "", "title": " Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (self), Travel/Accommodation/Expenses, Slide reviews: BMS; Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (self), Travel/Accommodation/Expenses: Ipsen; Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (self), Travel/Accommodation/Expenses: MSD; Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (self), Travel/Accommodation/Expenses: Pfizer; Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (self), Travel/Accommodation/Expenses: Bayer; Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (self), Travel/Accommodation/Expenses: Janssen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Hsieh", "first_name": "J.", "last_name": "Hsieh", "second_name": "", "title": " Research grant/Funding (self), Sponsered Clinical trial: BMS; Advisory/Consultancy, Research grant/Funding (self), Sponsored Clinical trial: Eisai; Research grant/Funding (self), Sponsored Clinical trial: Calithera; Research grant/Funding (self), Investigator initiated trial and correlate studies: AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "U. Basso", "first_name": "U.", "last_name": "Basso", "second_name": "", "title": " Speaker Bureau/Expert testimony, Research grant/Funding (self), Carry out activities of the study: BMS."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Suarez", "first_name": "C.", "last_name": "Suarez", "second_name": "", "title": " Honoraria (institution), Advisory/Consultancy, Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: BMS; Honoraria (self), Advisory/Consultancy, Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: Pfizer; Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Roche/Genentech; Honoraria (institution), Advisory/Consultancy, Speaker Bureau/Expert testimony: Astellas; Honoraria (self), Advisory/Consultancy: AtraZeneca; Honoraria (self), Advisory/Consultancy: Bayer; Honoraria (self), Advisory/Consultancy: Eusa; Honoraria (self), Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (self): Ipsen; Honoraria (institution), Advisory/Consultancy: Novartis; Honoraria (self), Advisory/Consultancy: Sanofi-Aventis; Honoraria (self), Advisory/Consultancy: Merck Sharp & Dohme Corp."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Pook", "first_name": "D.", "last_name": "Pook", "second_name": "", "title": " Advisory/Consultancy, Commercial Study Finding: BMS; Advisory/Consultancy, Research grant/Funding (self): Pfizer; Research grant/Funding (self): Ipsen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Y. Tomita", "first_name": "Y.", "last_name": "Tomita", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution): Ono pharmacetical; Honoraria (self): BMS; Honoraria (self), Research grant/Funding (self): Pfizer; Research grant/Funding (institution): Takeda."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "B. Escudier", "first_name": "B.", "last_name": "Escudier", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Novartis; Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Pfizer; Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Bristol-Myers Squibb; Honoraria (self), Advisory/Consultancy: Ipsen; Honoraria (self), Advisory/Consultancy: Eusa Pharma; Honoraria (self): Roche/Genentech."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "B. Simsek", "first_name": "B.", "last_name": "Simsek", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: BMS."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Motzer", "first_name": "J.", "last_name": "Motzer", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (institution): Bristol-Myers Squibb; Advisory/Consultancy, Research grant/Funding (institution): Pfizer; Advisory/Consultancy, Research grant/Funding (institution): Novartis; Advisory/Consultancy, Research grant/Funding (institution): Eisai; Advisory/Consultancy, Research grant/Funding (institution): Exelixis; Advisory/Consultancy, Research grant/Funding (institution): Genentech/Roche; Advisory/Consultancy: Merck; Advisory/Consultancy: Incyte; Advisory/Consultancy: Lilly."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Rosa Giuliani", "first_name": "Rosa", "last_name": "Giuliani", "second_name": "", "country": "United Kingdom", "city": "Liverpool", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Ryan John F.", "first_name": "Ryan", "last_name": "F.", "second_name": "John", "country": "Luxembourg", "city": "Luxembourg", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Paolo G. Casali", "first_name": "Paolo", "last_name": "Casali", "second_name": "G.", "country": "Italy", "city": "Milan", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Remy Nout", "first_name": "Remy", "last_name": "Nout", "second_name": "", "country": "Netherlands", "city": "Rotterdam", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Bookman", "first_name": "M.", "last_name": "Bookman", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy: Merck; Honoraria (self), Advisory/Consultancy: AstraZeneca; Non-remunerated activity/ies, Steering Committee: Roche; Honoraria (self): AbbVie; Honoraria (self): Aravive; Honoraria (self): Mateon; Honoraria (self): Immunogen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "G. Scambia", "first_name": "G.", "last_name": "Scambia", "second_name": "", "title": " Advisory/Consultancy: Tesaro Bio Italy S."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Willmott", "first_name": "J.", "last_name": "Willmott", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Speaker Bureau/Expert testimony: AstraZeneca; Honoraria (self), Advisory/Consultancy, Speaker Bureau/Expert testimony: Clovis; Honoraria (self), Advisory/Consultancy: Eisai; Honoraria (self), Advisory/Consultancy: Genentech; Honoraria (self), Advisory/Consultancy: GSK; Honoraria (self), Speaker Bureau/Expert testimony: Merck."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "N. Colombo", "first_name": "N.", "last_name": "Colombo", "second_name": "", "title": " Honoraria (self), Travel/Accommodation/Expenses: PharmaMar; Honoraria (self), Research grant/Funding (institution): AstraZeneca; Honoraria (self): GSK/Tesaro; Honoraria (self): Clovis; Honoraria (self): Immunogen; Honoraria (self): MSD; Honoraria (self): Pfizer; Honoraria (self): Biocad; Research grant/Funding (institution): Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Aghajanian", "first_name": "C.", "last_name": "Aghajanian", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy: Tesaro; Honoraria (self), Advisory/Consultancy: Immunogen; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution): Clovis; Honoraria (self), Advisory/Consultancy: Eisai/Merck; Honoraria (self), Advisory/Consultancy: Mersana Therapeutics; Honoraria (self), Advisory/Consultancy: Roche; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution): AbbVie; Research grant/Funding (institution): Genentech; Research grant/Funding (institution): AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "F. Wu", "first_name": "F.", "last_name": "Wu", "second_name": "", "title": " Full/Part-time employment: Genentech, Inc."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "V. Khor", "first_name": "V.", "last_name": "Khor", "second_name": "", "title": " Full/Part-time employment: Genentech, Inc."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "G. Lin", "first_name": "G.", "last_name": "Lin", "second_name": "", "title": " Full/Part-time employment: Genentech, Inc."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Pignata", "first_name": "S.", "last_name": "Pignata", "second_name": "", "title": " Honoraria (self), Research grant/Funding (institution): AstraZeneca; Honoraria (self), Research grant/Funding (institution): MSD; Honoraria (self): GSK; Honoraria (self): Clovis; Honoraria (self), Research grant/Funding (institution): Roche; Honoraria (self): PharmaMar; Research grant/Funding (institution): Pfizer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Andrew R. Clamp", "first_name": "Andrew", "last_name": "Clamp", "second_name": "R.", "country": "United Kingdom", "city": "Manchester", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "I. McNeish", "first_name": "I.", "last_name": "McNeish", "second_name": "", "title": " Advisory/Consultancy: Clovis Oncology; Advisory/Consultancy: Takeda; Advisory/Consultancy: Tesaro; Research grant/Funding (institution): AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Coyle", "first_name": "C.", "last_name": "Coyle", "second_name": "", "title": " Honoraria (self): Pfizer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Brenton", "first_name": "D.", "last_name": "Brenton", "second_name": "", "title": " Advisory/Consultancy, Leadership role: Inviata; Research grant/Funding (self): Aprea; Advisory/Consultancy: Clovis Oncology; Advisory/Consultancy: Bayer; Advisory/Consultancy: AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Perren", "first_name": "J.", "last_name": "Perren", "second_name": "", "title": " Advisory/Consultancy, Travel/Accommodation/Expenses: MSD; Travel/Accommodation/Expenses: Roche; Travel/Accommodation/Expenses: IGEA Medical."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Sundar", "first_name": "S.", "last_name": "Sundar", "second_name": "", "title": " Advisory/Consultancy: AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Ledermann", "first_name": "A.", "last_name": "Ledermann", "second_name": "", "title": " Advisory/Consultancy: Tesaro; Advisory/Consultancy, Research grant/Funding (self): AstraZeneca; Advisory/Consultancy, Research grant/Funding (self): MSD; Advisory/Consultancy, Research grant/Funding (self): MSD; Advisory/Consultancy: Roche; Advisory/Consultancy: Roche; Advisory/Consultancy: Clovis Oncology; Advisory/Consultancy: Clovis Oncology; Advisory/Consultancy: Tesaro."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Lorusso", "first_name": "D.", "last_name": "Lorusso", "second_name": "", "title": " Honoraria (self), Travel/Accommodation/Expenses: Amgen; Honoraria (self), Travel/Accommodation/Expenses: AstraZeneca; Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: PharmaMar; Honoraria (self), Research grant/Funding (institution), Travel/Accommodation/Expenses, Non-remunerated activity/ies: GSK; Honoraria (self), Travel/Accommodation/Expenses: Roche; Honoraria (self), Research grant/Funding (institution): Merck; Honoraria (self): Immunogen; Honoraria (self), Speaker Bureau/Expert testimony: Clovis; Honoraria (self): Genmab; Non-remunerated activity/ies: Abbott."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Gennigens", "first_name": "C.", "last_name": "Gennigens", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (institution): AstraZeneca; Advisory/Consultancy: BMS; Advisory/Consultancy: GSK; Advisory/Consultancy, Travel/Accommodation/Expenses: Ipsen; Advisory/Consultancy: Lilly; Advisory/Consultancy: MSD; Advisory/Consultancy, Travel/Accommodation/Expenses: Pfizer; Advisory/Consultancy, Travel/Accommodation/Expenses: PharmaMar; Advisory/Consultancy, Travel/Accommodation/Expenses: Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "L. Randall", "first_name": "L.", "last_name": "Randall", "second_name": "", "title": " Advisory/Consultancy, Travel/Accommodation/Expenses: Agenus; Advisory/Consultancy, Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: AstraZeneca; Advisory/Consultancy, Travel/Accommodation/Expenses: Clovis; Advisory/Consultancy, Travel/Accommodation/Expenses: Genentech; Advisory/Consultancy, Travel/Accommodation/Expenses: GSK; Advisory/Consultancy, Travel/Accommodation/Expenses: Intuitive; Advisory/Consultancy, Travel/Accommodation/Expenses: Mersana; Advisory/Consultancy, Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: Merck; Speaker Bureau/Expert testimony: GSK/Tesaro; Non-remunerated activity/ies: GOG Foundation."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "L. Woelber", "first_name": "L.", "last_name": "Woelber", "second_name": "", "title": " Honoraria (self): Tesaro, Medac Oncology, Roche, MSD, AstraZeneca, GSK, Jenapharm, Teva, OmniaMed; Research grant/Funding (institution): Medac Oncology, Tesaro, Roche, MSD, Genmab; Travel/Accommodation/Expenses: Medac Oncology, Tesaro."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Redondo", "first_name": "A.", "last_name": "Redondo", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Roche; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: PharmaMar; Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: AstraZeneca; Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: GSK; Honoraria (self): Novartis; Honoraria (self), Advisory/Consultancy: Amgen; Honoraria (self), Advisory/Consultancy: Clovis; Research grant/Funding (institution): Eisai."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. Rangwala", "first_name": "R.", "last_name": "Rangwala", "second_name": "", "title": " Full/Part-time employment: Genmab."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Chen", "first_name": "M.", "last_name": "Chen", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Genmab."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. Harris", "first_name": "R.", "last_name": "Harris", "second_name": "", "title": " Full/Part-time employment: Genmab."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "L. Nicacio", "first_name": "L.", "last_name": "Nicacio", "second_name": "", "title": " Full/Part-time employment: Seattle Genetics."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "L. Teng", "first_name": "L.", "last_name": "Teng", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Seattle Genetics."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Smith", "first_name": "M.", "last_name": "Smith", "second_name": "", "title": " Full/Part-time employment: Genmab."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Monk", "first_name": "J.", "last_name": "Monk", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy: AbbVie, Advaxis, Agenus, Amgen, Akeso Bio, Aravive; Honoraria (self), Advisory/Consultancy: AstraZeneca, Asymmetric Therapeutics, Boston Biomedical, ChemoCare, ChemoID, Circulogene, Clovis; Honoraria (self), Advisory/Consultancy: Conjupro, Dicepheria, Eisai, Geistlich, Genmab/Seattle Genetics, GOG Foundation; Honoraria (self), Advisory/Consultancy: Immunogen, Immunomedics, Incyte, Lovance, Janssen/J&J, Laekna Health Care; Honoraria (self), Advisory/Consultancy: Mateon, Merck, Mersana, Myriad, Nucana, Oncomed, Oncoquest, Perthera; Honoraria (self), Advisory/Consultancy: Pfizer, Precision Oncology, Puma, Regeneron, Roche/Genentech; Honoraria (self), Advisory/Consultancy: Samumed, Takeda, Tarveda, Tesaro/GSK, Vavotar Life Sciences, VBL, Vigeo; Full/Part-time employment: Arizona Oncology (US Oncology Network)."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Kohei Omatsu", "first_name": "Kohei", "last_name": "Omatsu", "second_name": "", "country": "Japan", "city": "Tokyo", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "N. Katsumata", "first_name": "N.", "last_name": "Katsumata", "second_name": "", "title": " Advisory/Consultancy: AbbVie."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Aoki", "first_name": "D.", "last_name": "Aoki", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution): AstraZeneca K."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "K. Fujiwara", "first_name": "K.", "last_name": "Fujiwara", "second_name": "", "title": " Honoraria (self): Bayer; Honoraria (self): Chugai Pharmaceutical; Honoraria (self): Daiichi Sankyo; Honoraria (self): Kyowa Hakko Kirin; Honoraria (self): Nippon Kayaku; Honoraria (self), Research grant/Funding (institution): Ono Pharmaceutical; Honoraria (self), Research grant/Funding (institution): Taiho Pharmaceutical; Honoraria (self), Research grant/Funding (institution): Zeria Pharmaceutical; Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Pfizer; Advisory/Consultancy, Research grant/Funding (institution): Eisai; Advisory/Consultancy, Research grant/Funding (institution): Merck Sharp & Dohme; Research grant/Funding (institution): AstraZeneca; Research grant/Funding (institution): Kaken Pharmaceutical; Research grant/Funding (institution): Oncotherapeutics; Research grant/Funding (institution): ImmunoGen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Panagiotis Kanavos", "first_name": "Panagiotis", "last_name": "Kanavos", "second_name": "", "country": "United Kingdom", "city": "London", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Colinda Scheele", "first_name": "Colinda", "last_name": "Scheele", "second_name": "", "country": "Belgium", "city": "Leuven", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Emmanuel Dornier", "first_name": "Emmanuel", "last_name": "Dornier", "second_name": "", "country": "France", "city": "Villejuif", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Saverio Alberti", "first_name": "Saverio", "last_name": "Alberti", "second_name": "", "country": "Italy", "city": "Messina", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Zhidan Wu", "first_name": "Zhidan", "last_name": "Wu", "second_name": "", "country": "United States of America", "city": "Cambridge", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Bennett", "first_name": "D.", "last_name": "Bennett", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Pfizer; Shareholder/Stockholder/Stock options: Gilead Sciences."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Brosnan", "first_name": "J.", "last_name": "Brosnan", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Pfizer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Calle", "first_name": "A.", "last_name": "Calle", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Pfizer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Collins", "first_name": "S.", "last_name": "Collins", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Pfizer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. Esquejo", "first_name": "R.", "last_name": "Esquejo", "second_name": "", "title": " Full/Part-time employment: Pfizer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Joaquim", "first_name": "S.", "last_name": "Joaquim", "second_name": "", "title": " Full/Part-time employment: Pfizer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Joyce", "first_name": "A.", "last_name": "Joyce", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Pfizer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "H. Kim", "first_name": "H.", "last_name": "Kim", "second_name": "", "title": " Full/Part-time employment: Pfizer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "B. LaCarubba", "first_name": "B.", "last_name": "LaCarubba", "second_name": "", "title": " Full/Part-time employment: Pfizer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "L. Lin", "first_name": "L.", "last_name": "Lin", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Pfizer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Peloquin", "first_name": "M.", "last_name": "Peloquin", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Pfizer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "B. Pettersen", "first_name": "B.", "last_name": "Pettersen", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Pfizer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Qiao", "first_name": "S.", "last_name": "Qiao", "second_name": "", "title": " Full/Part-time employment: Pfizer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Rossulek", "first_name": "M.", "last_name": "Rossulek", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Pfizer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "G. Weber", "first_name": "G.", "last_name": "Weber", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Pfizer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "B. Zhang", "first_name": "B.", "last_name": "Zhang", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Pfizer; Shareholder/Stockholder/Stock options: Lilly; Shareholder/Stockholder/Stock options: Merck; Officer/Board of Directors: Board of Director and SAB member for Keystone Symposium."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Birnbaum", "first_name": "M.", "last_name": "Birnbaum", "second_name": "", "title": " Leadership role, Shareholder/Stockholder/Stock options, Full/Part-time employment: Pfizer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Breen", "first_name": "D.", "last_name": "Breen", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Pfizer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Anna Diana", "first_name": "Anna", "last_name": "Diana", "second_name": "", "country": "Italy", "city": "Napoli", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Vincent Dezentje", "first_name": "Vincent", "last_name": "Dezentje", "second_name": "", "country": "Netherlands", "city": "Amsterdam", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Maxime Meylan", "first_name": "Maxime", "last_name": "Meylan", "second_name": "", "country": "France", "city": "Paris", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Y. Vano", "first_name": "Y.", "last_name": "Vano", "second_name": "", "title": " Honoraria (self), Travel/Accommodation/Expenses: Bristol-Myers Squibb; Honoraria (self), Travel/Accommodation/Expenses: Pfizer; Honoraria (self): Novartis; Honoraria (self): Ipsen; Honoraria (self): Merck; Honoraria (self), Travel/Accommodation/Expenses: MSD; Honoraria (self): Janssen; Honoraria (self): Sanofi; Honoraria (self): Astellas; Honoraria (self), Travel/Accommodation/Expenses: Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "N. Rioux Leclercq", "first_name": "N.", "last_name": "Leclercq", "second_name": "Rioux", "title": " Travel/Accommodation/Expenses, conference support: Pfizer; Travel/Accommodation/Expenses, conference support: Bristol-Myers squibb; Travel/Accommodation/Expenses, conference support: AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "N. Chaput", "first_name": "N.", "last_name": "Chaput", "second_name": "", "title": " Honoraria (self): Bristol-Myers Squibb; Honoraria (self): Roche; Honoraria (self): Sanofi; Honoraria (self): Cytune Pharma; Honoraria (self): AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Chevreau", "first_name": "C.", "last_name": "Chevreau", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Bristol-Myers Squibb; Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Ipsen; Honoraria (self), Advisory/Consultancy: Novartis."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Gross Goupil", "first_name": "M.", "last_name": "Goupil", "second_name": "Gross", "title": " Honoraria (self), Travel/Accommodation/Expenses: Bristo-Myers Squibb; Honoraria (self), Travel/Accommodation/Expenses: MSD; Honoraria (self), Travel/Accommodation/Expenses: Pfizer; Honoraria (self), Travel/Accommodation/Expenses: Roche; Honoraria (self), Travel/Accommodation/Expenses: AstraZeneca; Honoraria (self), Travel/Accommodation/Expenses: Novartis; Honoraria (self), Travel/Accommodation/Expenses: Ipsen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "B. Laguerre", "first_name": "B.", "last_name": "Laguerre", "second_name": "", "title": " Travel/Accommodation/Expenses: Pfizer; Honoraria (self): Bristol-Myers Squibb; Honoraria (self): Ipsen; Honoraria (self): Roche; Honoraria (self): MSD."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "L. Albiges", "first_name": "L.", "last_name": "Albiges", "second_name": "", "title": " Honoraria (institution): Pfizer; Honoraria (institution): Novartis; Honoraria (institution): Bristol-Myers Squibb; Honoraria (institution): Ipsen; Honoraria (institution): Roche; Honoraria (institution): AstraZeneca; Honoraria (institution): Amgen; Honoraria (institution): Astellas; Honoraria (institution): Exelixis; Honoraria (institution): Corvus Pharmaceuticals; Honoraria (institution): Peloton therapeutcis; Honoraria (institution): MSD; Honoraria (institution): Merck."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Zeynep B. Zengin", "first_name": "Zeynep", "last_name": "Zengin", "second_name": "B.", "country": "United States of America", "city": "Duarte", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Hsu", "first_name": "J.", "last_name": "Hsu", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Guardant Health."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Pal", "first_name": "S.", "last_name": "Pal", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (institution): Pfizer; Honoraria (self), Advisory/Consultancy: Novartis; Advisory/Consultancy, Research grant/Funding (institution): Aveo; Advisory/Consultancy: Genentech; Advisory/Consultancy, Research grant/Funding (institution): Exelis; Advisory/Consultancy, Research grant/Funding (institution): Bristol Myers Squibb; Advisory/Consultancy: Astellas Pharma; Advisory/Consultancy: GlaxoSmithKline; Advisory/Consultancy, Research grant/Funding (institution): Eisai; Advisory/Consultancy: Roche; Advisory/Consultancy: Ipsen; Honoraria (self): Medivation; Honoraria (institution): Astellas Pharma; Research grant/Funding (institution): Nektar Therapeutics; Research grant/Funding (institution): QED."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Walter Berger", "first_name": "Walter", "last_name": "Berger", "second_name": "", "country": "Austria", "city": "Vienna", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Sumanta Pal", "first_name": "Sumanta", "last_name": "Pal", "second_name": "", "country": "United States of America", "city": "Duarte", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "K. Tsao", "first_name": "K.", "last_name": "Tsao", "second_name": "", "title": " Shareholder/Stockholder/Stock options: Gilead; Advisory/Consultancy: Pfizer, Clovis, Eisai, Boehringer-Ingelheim."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "L. Pagliaro", "first_name": "L.", "last_name": "Pagliaro", "second_name": "", "title": " Research grant/Funding (institution): Pfizer, Exelixis, Inc."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "N. Vaishampayan", "first_name": "N.", "last_name": "Vaishampayan", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Speaker Bureau/Expert testimony: Exelixis, Inc."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Srinivas", "first_name": "S.", "last_name": "Srinivas", "second_name": "", "title": " Honoraria (self): Exelesis, Inc."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. McGregor", "first_name": "A.", "last_name": "McGregor", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy: Bayer, Astellas, AstraZeneca, Seattle Genetics, Exelixis, Nektar, Pfizer, Janssen, Genentech and EMD Serono; Research grant/Funding (institution): BMS, Exelixis, Genentech, Seattle Genetics, Calithera."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Panneerselvam", "first_name": "A.", "last_name": "Panneerselvam", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Exelixis, Inc."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Curran", "first_name": "D.", "last_name": "Curran", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Exelixis, Inc."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Yann Vano", "first_name": "Yann", "last_name": "Vano", "second_name": "", "country": "France", "city": "Paris", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Bennamoun", "first_name": "M.", "last_name": "Bennamoun", "second_name": "", "title": " Honoraria (institution), Advisory/Consultancy: Bristol Myers Squibb; Honoraria (institution), Advisory/Consultancy: Janssen; Honoraria (institution), Advisory/Consultancy: Sanofi; Honoraria (institution): Astellas."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Chevreau", "first_name": "M.", "last_name": "Chevreau", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Bristol Myers Squibb; Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Ipsen; Honoraria (self), Advisory/Consultancy: Novartis."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Borchiellini", "first_name": "D.", "last_name": "Borchiellini", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Bristol Myers Squibb; Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Pfizer; Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Novartis; Honoraria (self), Advisory/Consultancy: Ipsen; Travel/Accommodation/Expenses: Roche; Honoraria (self), Advisory/Consultancy: MSD."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Pannier", "first_name": "D.", "last_name": "Pannier", "second_name": "", "title": " Travel/Accommodation/Expenses: Bristol Myers Squibb; Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: AstraZeneca; Honoraria (self), Advisory/Consultancy: Bayer; Honoraria (self), Advisory/Consultancy: Janssen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Maillet", "first_name": "D.", "last_name": "Maillet", "second_name": "", "title": " Honoraria (institution), Advisory/Consultancy, Travel/Accommodation/Expenses: Janssen; Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Bristol Myers Squibb; Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Pfizer; Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: AstraZeneca; Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: MSD; Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Sanofi; Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Novartis; Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Ipsen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Tournigand", "first_name": "C.", "last_name": "Tournigand", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Bristol Myers Squibb; Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Sanofi; Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Novartis; Honoraria (self), Research grant/Funding (self): Roche; Honoraria (self), Research grant/Funding (self): MSD; Honoraria (self), Travel/Accommodation/Expenses: Bayer; Honoraria (self), Research grant/Funding (self): Amgen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "F. Joly", "first_name": "F.", "last_name": "Joly", "second_name": "", "title": " Honoraria (institution), Advisory/Consultancy, Travel/Accommodation/Expenses: Bristol Myers Squibb; Honoraria (institution), Advisory/Consultancy, Travel/Accommodation/Expenses: Pfizer; Honoraria (institution), Advisory/Consultancy, Travel/Accommodation/Expenses: MSD; Advisory/Consultancy, Travel/Accommodation/Expenses: Roche; Honoraria (institution), Advisory/Consultancy, Travel/Accommodation/Expenses: AstraZeneca; Honoraria (institution), Advisory/Consultancy: Astellas; Honoraria (institution), Advisory/Consultancy, Travel/Accommodation/Expenses: Janssen; Honoraria (institution), Advisory/Consultancy: Bayer; Advisory/Consultancy, Travel/Accommodation/Expenses: GSK; Advisory/Consultancy, Travel/Accommodation/Expenses: Sanofi; Advisory/Consultancy, Travel/Accommodation/Expenses: Ipsen; Advisory/Consultancy: Clovis."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "G. Gravis", "first_name": "G.", "last_name": "Gravis", "second_name": "", "title": " Honoraria (institution), Advisory/Consultancy, Travel/Accommodation/Expenses: Bristol Myers Squibb; Honoraria (institution), Advisory/Consultancy, Travel/Accommodation/Expenses: Pfizer; Honoraria (institution), Travel/Accommodation/Expenses: MSD; Advisory/Consultancy, Travel/Accommodation/Expenses: AstraZeneca; Honoraria (institution): Astellas; Honoraria (institution), Advisory/Consultancy, Travel/Accommodation/Expenses: Janssen; Honoraria (institution), Advisory/Consultancy: Bayer; Advisory/Consultancy, Travel/Accommodation/Expenses: Sanofi; Advisory/Consultancy, Travel/Accommodation/Expenses: Ipsen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Laurence Albiges", "first_name": "Laurence", "last_name": "Albiges", "second_name": "", "country": "France", "city": "Villejuif", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Rob H. Verhoeven", "first_name": "Rob", "last_name": "Verhoeven", "second_name": "H.", "country": "Netherlands", "city": "Utrecht", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Sabine Oertelt-Prigione", "first_name": "Sabine", "last_name": "Oertelt-Prigione", "second_name": "", "country": "Netherlands", "city": "Nijmegen", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Anna D. Wagner", "first_name": "Anna", "last_name": "Wagner", "second_name": "D.", "country": "Switzerland", "city": "Lausanne", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Andrew J. Davies", "first_name": "Andrew", "last_name": "Davies", "second_name": "J.", "country": "United Kingdom", "city": "Southampton", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Pier Luigi Zinzani", "first_name": "Pier", "last_name": "Zinzani", "second_name": "Luigi", "country": "Italy", "city": "Bologna", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. Ramchandren", "first_name": "R.", "last_name": "Ramchandren", "second_name": "", "title": " Advisory/Consultancy: Seattle Genetics, Sandoz-Novartis, Pharmacyclics/Janssen, Bristol-Myers Squibb; Research grant/Funding (self): Research Grant/Funding Merck, Seattle Genetics, Janssen, Genentech You."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Santoro", "first_name": "A.", "last_name": "Santoro", "second_name": "", "title": " Advisory/Consultancy, Speaker Bureau/Expert testimony: Bristol-Myers Squibb; Advisory/Consultancy, Speaker Bureau/Expert testimony: Servier; Advisory/Consultancy, Speaker Bureau/Expert testimony: Gilead Sciences; Advisory/Consultancy, Speaker Bureau/Expert testimony: Pfizer; Advisory/Consultancy, Speaker Bureau/Expert testimony: Eisai; Advisory/Consultancy, Speaker Bureau/Expert testimony: Bayer; Advisory/Consultancy, Speaker Bureau/Expert testimony: MSD; Advisory/Consultancy: Sanofi; Advisory/Consultancy, Speaker Bureau/Expert testimony: ArQule; Speaker Bureau/Expert testimony: Takeda; Speaker Bureau/Expert testimony: Roche; Speaker Bureau/Expert testimony: AbbVie; Speaker Bureau/Expert testimony: Amgen; Speaker Bureau/Expert testimony: Celgene; Speaker Bureau/Expert testimony: AstraZeneca; Speaker Bureau/Expert testimony: Lilly; Speaker Bureau/Expert testimony: Sandoz; Speaker Bureau/Expert testimony: Novartis."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. Gasiorowski", "first_name": "R.", "last_name": "Gasiorowski", "second_name": "", "title": " Honoraria (self): MSD; Honoraria (self): Takeda; Honoraria (self): Novartis; Honoraria (self): AbbVie."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Johnson", "first_name": "A.", "last_name": "Johnson", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy: Roche/Genentech; Honoraria (self), Advisory/Consultancy: Merck; Advisory/Consultancy: Bristol-Myers Squibb; Advisory/Consultancy, Research grant/Funding (self): AbbVie."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "V. Buccheri", "first_name": "V.", "last_name": "Buccheri", "second_name": "", "title": " Advisory/Consultancy, Advisory board: AstraZeneca; Research grant/Funding (institution): MSD; Research grant/Funding (institution): Roche; Research grant/Funding (institution): Seattle Genetics; Research grant/Funding (institution), Travel/Accommodation/Expenses: Takeda; Travel/Accommodation/Expenses: AbbVie."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "F. Perini", "first_name": "F.", "last_name": "Perini", "second_name": "", "title": " Honoraria (self), Speaker Bureau/Expert testimony: Janssen; Honoraria (self): Takeda; Honoraria (self): AbbVie."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Dickinson", "first_name": "M.", "last_name": "Dickinson", "second_name": "", "title": " Honoraria (self), Honoraria (institution), Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (institution): MSD; Honoraria (self), Honoraria (institution), Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (institution): Roche; Honoraria (self), Honoraria (institution), Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (institution): Takeda; Honoraria (self), Honoraria (institution), Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (institution): Celgene; Honoraria (self), Honoraria (institution), Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (institution): Novartis."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Ozcan", "first_name": "M.", "last_name": "Ozcan", "second_name": "", "title": " Research grant/Funding (institution): MSD; Research grant/Funding (institution): Bayer; Research grant/Funding (institution): Celgene; Honoraria (self), Research grant/Funding (institution): Roche; Research grant/Funding (institution): Janssen; Honoraria (self), Research grant/Funding (institution): Takeda; Research grant/Funding (institution): Archigen; Research grant/Funding (institution): Novartis; Honoraria (self), Research grant/Funding (institution): AbbVie; Honoraria (self): Amgen; Honoraria (self): BMS."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "N. Sekiguchi", "first_name": "N.", "last_name": "Sekiguchi", "second_name": "", "title": " Research grant/Funding (institution): Ono; Research grant/Funding (institution): A2 Healthcare; Research grant/Funding (institution): Bristol-Myers Squibb; Research grant/Funding (institution): Astellas; Research grant/Funding (institution): Daiichi Sankyo; Research grant/Funding (institution): Janssen; Research grant/Funding (institution): Merck Sharp & Dohme; Research grant/Funding (institution): Otsuka; Research grant/Funding (institution): Pfizer; Research grant/Funding (institution): PPD-SNBL,; Research grant/Funding (institution): Sumitomo Dainippon."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Nahar", "first_name": "A.", "last_name": "Nahar", "second_name": "", "title": " Full/Part-time employment: Merck & Co."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "P. Marinello", "first_name": "P.", "last_name": "Marinello", "second_name": "", "title": " Travel/Accommodation/Expenses, Shareholder/Stockholder/Stock options, Full/Part-time employment: Merck & Co."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Kuruvilla", "first_name": "J.", "last_name": "Kuruvilla", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy: AbbVie; Honoraria (self), Advisory/Consultancy: Bristol-Myers Squibb; Honoraria (self): Amgen; Honoraria (self): Celgene; Honoraria (self): AstraZeneca; Honoraria (self), Advisory/Consultancy: Gilead Sciences; Honoraria (self), Research grant/Funding (self): Janssen; Honoraria (self), Advisory/Consultancy: Karyopharm Therapeutics; Honoraria (self), Advisory/Consultancy: Merck; Honoraria (self): Novartis; Honoraria (self), Research grant/Funding (self): Roche; Honoraria (self), Advisory/Consultancy: Seattle Genetics; Advisory/Consultancy: Roche/Genentech."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Abraham Avigdor", "first_name": "Abraham", "last_name": "Avigdor", "second_name": "", "country": "Israel", "city": "Ramat Gan", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Zomas", "first_name": "A.", "last_name": "Zomas", "second_name": "", "title": " Full/Part-time employment: Takeda."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Dalal", "first_name": "M.", "last_name": "Dalal", "second_name": "", "title": " Full/Part-time employment, Stock ownership: Millennium Pharmaceuticals, Inc."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "G. Gini", "first_name": "G.", "last_name": "Gini", "second_name": "", "title": " Advisory/Consultancy: Takeda."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Bastian Von Tresckow", "first_name": "Bastian", "last_name": "Von Tresckow", "second_name": "", "country": "Germany", "city": "Essen", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Y. Moride", "first_name": "Y.", "last_name": "Moride", "second_name": "", "title": " Research grant/Funding (institution): Takeda Pharmaceuticals."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Plattel", "first_name": "J.", "last_name": "Plattel", "second_name": "", "title": " Advisory/Consultancy: Takeda Pharmaceuticals; Advisory/Consultancy: Bristol-Myers Squibb; Advisory/Consultancy: MSD."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Beatriz Nunez Garcia", "first_name": "Beatriz", "last_name": "Garcia", "second_name": "Nunez", "country": "Spain", "city": "Majadahonda", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Stefan Balabanov", "first_name": "Stefan", "last_name": "Balabanov", "second_name": "", "country": "Switzerland", "city": "Zurich", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Java Walladbegi", "first_name": "Java", "last_name": "Walladbegi", "second_name": "", "country": "Sweden", "city": "Göteborg", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Svanberg", "first_name": "A.", "last_name": "Svanberg", "second_name": "", "title": " Advisory/Consultancy: BrainCool AB."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Jontell", "first_name": "M.", "last_name": "Jontell", "second_name": "", "title": " Honoraria (self), Research grant/Funding (institution), Travel/Accommodation/Expenses, Shareholder/Stockholder/Stock options: BrainCool AB."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "K. Henriksson", "first_name": "K.", "last_name": "Henriksson", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Officer/Board of Directors: BrainCool AB; Advisory/Consultancy: Alivia."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "F. Schjesvold", "first_name": "F.", "last_name": "Schjesvold", "second_name": "", "title": " Advisory/Consultancy, Shareholder/Stockholder/Stock options: Oncopeptides; Honoraria (self): SkyliteDX; Honoraria (self), Advisory/Consultancy: Amgen; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution): Celgene; Honoraria (self): Takeda; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution): Janssen; Advisory/Consultancy: Novartis Pharma SAS; Research grant/Funding (institution): Braincool; Advisory/Consultancy: Sanofi ."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "G. Larfors", "first_name": "G.", "last_name": "Larfors", "second_name": "", "title": " Research grant/Funding (institution): BrainCool AB."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Eleni Tholouli", "first_name": "Eleni", "last_name": "Tholouli", "second_name": "", "country": "United Kingdom", "city": "Manchester", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "W. OSBORNE", "first_name": "W.", "last_name": "OSBORNE", "second_name": "", "title": " Advisory/Consultancy: Autolus Therapeutics; Advisory/Consultancy: Roche; Advisory/Consultancy: Takeda; Advisory/Consultancy: Pfizer; Advisory/Consultancy: Servier; Advisory/Consultancy: Kite; Advisory/Consultancy: MSD; Advisory/Consultancy: Novartis; Advisory/Consultancy: Beigene."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Ramakrishnan", "first_name": "A.", "last_name": "Ramakrishnan", "second_name": "", "title": " Advisory/Consultancy: Takeda; Advisory/Consultancy: Amgen; Honoraria (self): Cigna."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Y. Zhang", "first_name": "Y.", "last_name": "Zhang", "second_name": "", "title": " Full/Part-time employment: Autolus Therapeutics."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. Chen", "first_name": "R.", "last_name": "Chen", "second_name": "", "title": " Full/Part-time employment: Autolus Therapeutics."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Ayushi Chauhan", "first_name": "Ayushi", "last_name": "Chauhan", "second_name": "", "country": "United States of America", "city": "Washington", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Marina Popova", "first_name": "Marina", "last_name": "Popova", "second_name": "", "country": "Russian Federation", "city": "Saint Petersburg", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Yan Xie", "first_name": "Yan", "last_name": "Xie", "second_name": "", "country": "China", "city": "Beijing", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Charlie Gourley", "first_name": "Charlie", "last_name": "Gourley", "second_name": "", "country": "United Kingdom", "city": "Edinburgh", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Gantzer", "first_name": "J.", "last_name": "Gantzer", "second_name": "", "title": " Travel/Accommodation/Expenses: Ipsen; Travel/Accommodation/Expenses: PharmaMar; Travel/Accommodation/Expenses: Chugai."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "B. Ataseven", "first_name": "B.", "last_name": "Ataseven", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Roche; Advisory/Consultancy: Amgen; Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Tesaro; Honoraria (self): Celgene; Honoraria (self): Clovis Oncology; Honoraria (self): AstraZeneca; Travel/Accommodation/Expenses: PharmaMar."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Herrero", "first_name": "A.", "last_name": "Herrero", "second_name": "", "title": " Advisory/Consultancy: Roche; Advisory/Consultancy: Clovis Oncology; Advisory/Consultancy: AstraZeneca; Advisory/Consultancy: GSK/Tesaro."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "P. Sevelda", "first_name": "P.", "last_name": "Sevelda", "second_name": "", "title": " Advisory/Consultancy: Clovis Oncology; Advisory/Consultancy: Tesaro; Travel/Accommodation/Expenses: Pfizer; Travel/Accommodation/Expenses: Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "P. Vuylsteke", "first_name": "P.", "last_name": "Vuylsteke", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Roche; Advisory/Consultancy, Travel/Accommodation/Expenses: AstraZeneca; Travel/Accommodation/Expenses: PharmaMar."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "P. Buderath", "first_name": "P.", "last_name": "Buderath", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Roche; Honoraria (self): AstraZeneca; Travel/Accommodation/Expenses: Tesaro; Travel/Accommodation/Expenses: PharmaMar."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Pisano", "first_name": "C.", "last_name": "Pisano", "second_name": "", "title": " Advisory/Consultancy: Novartis; Advisory/Consultancy: Pfizer; Advisory/Consultancy: AstraZeneca; Advisory/Consultancy: GSK/Tesaro."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Yvette Drew", "first_name": "Yvette", "last_name": "Drew", "second_name": "", "country": "United Kingdom", "city": "Newcastle-upon-Tyne", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "T. Penson", "first_name": "T.", "last_name": "Penson", "second_name": "", "title": " Honoraria (institution), Advisory/Consultancy: AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Zimmermann", "first_name": "S.", "last_name": "Zimmermann", "second_name": "", "title": " Honoraria (self), Non-remunerated activity/ies: Roche; Honoraria (self), Non-remunerated activity/ies: Eli Lilly; Honoraria (self), Non-remunerated activity/ies: Bristol-Myers Squibb; Honoraria (self), Non-remunerated activity/ies: AstraZeneca; Honoraria (self), Non-remunerated activity/ies: MSD; Honoraria (self), Non-remunerated activity/ies: Novartis; Non-remunerated activity/ies: Amgen; Non-remunerated activity/ies: Astellas; Spouse/Financial dependant: Merck KGaA; Non-remunerated activity/ies: Vifor."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "P. Roxburgh", "first_name": "P.", "last_name": "Roxburgh", "second_name": "", "title": " Honoraria (institution), Advisory/Consultancy: AstraZeneca; Honoraria (self): GlaxoSmithKline; Honoraria (institution): Tesaro."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "B. You", "first_name": "B.", "last_name": "You", "second_name": "", "title": " Advisory/Consultancy, Travel/Accommodation/Expenses: AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Domchek", "first_name": "S.", "last_name": "Domchek", "second_name": "", "title": " Honoraria (self): AstraZeneca; Honoraria (self): Clovis; Honoraria (self): Bristol-Myers Squibb."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "H. Gao", "first_name": "H.", "last_name": "Gao", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "H. Angell", "first_name": "H.", "last_name": "Angell", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "K. Meyer", "first_name": "K.", "last_name": "Meyer", "second_name": "", "title": " Research grant/Funding (self), Travel/Accommodation/Expenses, Shareholder/Stockholder/Stock options, Full/Part-time employment: AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "L. Opincar", "first_name": "L.", "last_name": "Opincar", "second_name": "", "title": " Research grant/Funding (self), Shareholder/Stockholder/Stock options, Full/Part-time employment: AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "L. Ottesen", "first_name": "L.", "last_name": "Ottesen", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "O. Koralek", "first_name": "O.", "last_name": "Koralek", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Banerjee", "first_name": "S.", "last_name": "Banerjee", "second_name": "", "title": " Honoraria (self), Research grant/Funding (institution): AstraZeneca; Honoraria (self): Tesaro; Honoraria (self): Clovis Oncology; Honoraria (self): Merck; Honoraria (self): PharmaMar; Honoraria (self): Roche; Honoraria (self): Seattle Genetics; Honoraria (self): Nucana."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Benoit You", "first_name": "Benoit", "last_name": "You", "second_name": "", "country": "CEDE", "city": "Pierre Bénite", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. Kruitwagen", "first_name": "R.", "last_name": "Kruitwagen", "second_name": "", "title": " Research grant/Funding (institution): AstraZeneca; Research grant/Funding (institution): Merck; Research grant/Funding (institution): Novartis; Research grant/Funding (institution): Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. du Bois", "first_name": "A.", "last_name": "du Bois", "second_name": "", "title": " Advisory/Consultancy: Roche; Advisory/Consultancy: AstraZeneca; Advisory/Consultancy: GSK; Advisory/Consultancy: Clovis; Advisory/Consultancy: Pfizer; Advisory/Consultancy: Biocad; Advisory/Consultancy: Genmab/ Seattle Genetics; Advisory/Consultancy: MSD."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "F. Selle", "first_name": "F.", "last_name": "Selle", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: Roche; Honoraria (self), Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: AZ; Honoraria (self), Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: GSK; Honoraria (self), Speaker Bureau/Expert testimony: Clovis; Honoraria (self), Travel/Accommodation/Expenses: PharmaMar; Travel/Accommodation/Expenses: MSD."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Fabrice Lecuru", "first_name": "Fabrice", "last_name": "Lecuru", "second_name": "", "country": "France", "city": "Paris", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "G. Ferron", "first_name": "G.", "last_name": "Ferron", "second_name": "", "title": " Advisory/Consultancy: Olympus; Advisory/Consultancy, Travel/Accommodation/Expenses: AstraZeneca; Advisory/Consultancy: GlaxoSmithKline/Tesaro; Travel/Accommodation/Expenses: Roche Pharma AG; Travel/Accommodation/Expenses: PharmaMar."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "W. Meier", "first_name": "W.", "last_name": "Meier", "second_name": "", "title": " Honoraria (self): AstraZeneca; Honoraria (self): Tesaro; Honoraria (self): Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Greggi", "first_name": "S.", "last_name": "Greggi", "second_name": "", "title": " Advisory/Consultancy: AstraZeneca; Advisory/Consultancy, Travel/Accommodation/Expenses: Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Pomel", "first_name": "C.", "last_name": "Pomel", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy: AstraZeneca; Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Roche; Honoraria (self): GlaxoSmithKline; Honoraria (self), Advisory/Consultancy: Clovis Oncology."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Ponce", "first_name": "J.", "last_name": "Ponce", "second_name": "", "title": " Advisory/Consultancy: Medtronic; Advisory/Consultancy: Abex; Advisory/Consultancy: KCI."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "F. Raspagliesi", "first_name": "F.", "last_name": "Raspagliesi", "second_name": "", "title": " Advisory/Consultancy: Tesaro-GSK; Travel/Accommodation/Expenses: Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Sadaf", "first_name": "M.", "last_name": "Sadaf", "second_name": "", "title": " Travel/Accommodation/Expenses: AstraZeneca; Travel/Accommodation/Expenses: Johnson & Johnson."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Reinthaller", "first_name": "A.", "last_name": "Reinthaller", "second_name": "", "title": " Honoraria (self), Travel/Accommodation/Expenses: Roche; Honoraria (self), Travel/Accommodation/Expenses: PharmaMar; Honoraria (self), Travel/Accommodation/Expenses: AstraZeneca; Honoraria (self), Travel/Accommodation/Expenses: Tesaro; Honoraria (self): Novartis; Honoraria (self): GlaxoSmithKline; Honoraria (self): Amgen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "P. Harter", "first_name": "P.", "last_name": "Harter", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution): AstraZeneca; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution): Roche; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution): Tesaro; Advisory/Consultancy: Merck; Honoraria (self): Clovis Oncology; Honoraria (self): Stryker; Honoraria (self): MSD Oncology; Honoraria (self): Zai Lab; Honoraria (self): Lilly; Honoraria (self): Sotio; Research grant/Funding (institution): Genmab."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "David M. O'Malley", "first_name": "David", "last_name": "O'Malley", "second_name": "M.", "country": "United States of America", "city": "Columbus", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Panagiotis A. Konstantinopoulos", "first_name": "Panagiotis", "last_name": "Konstantinopoulos", "second_name": "A.", "country": "United States of America", "city": "Boston", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "F. Liu", "first_name": "F.", "last_name": "Liu", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (institution): Tesaro/GSK; Advisory/Consultancy, Research grant/Funding (institution): Clovis; Advisory/Consultancy, Research grant/Funding (institution): AstraZeneca; Advisory/Consultancy: Merck; Advisory/Consultancy: Genentech; Research grant/Funding (institution): 2X Oncology; Research grant/Funding (institution): Aravive; Research grant/Funding (institution): Arch Oncology; Research grant/Funding (institution): Bristol Myers Squibb; Research grant/Funding (institution): CytoMX Therapeutics; Research grant/Funding (institution): Regeneron; Research grant/Funding (institution): Surface Oncology; Research grant/Funding (institution): Vigeo Therapeutics."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "G. Fleming", "first_name": "G.", "last_name": "Fleming", "second_name": "", "title": " Honoraria (self): Curio Science; Advisory/Consultancy: GSK; Research grant/Funding (institution), Research IP Supply: Corcept; Research grant/Funding (institution): AbbVie; Research grant/Funding (institution): Roche; Research grant/Funding (institution): Tesaro/GSK; Research grant/Funding (institution): Syndax; Research grant/Funding (institution): 47inc; Research grant/Funding (institution): Iovance; Research grant/Funding (institution): Syros; Research grant/Funding (institution): Astex; Research grant/Funding (institution): Merck; Research grant/Funding (institution): Sanofi; Research grant/Funding (institution): Sermonix; Research grant/Funding (institution): Compugen; Research grant/Funding (institution): Incyte; Research grant/Funding (institution): Eisai."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Matulonis", "first_name": "A.", "last_name": "Matulonis", "second_name": "", "title": " Advisory/Consultancy: Novartis; Travel/Accommodation/Expenses: AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "L. Gilbert", "first_name": "L.", "last_name": "Gilbert", "second_name": "", "title": " Advisory/Consultancy: Merck; Advisory/Consultancy: AstraZeneca; Advisory/Consultancy: Pfizer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "V. Tinker", "first_name": "V.", "last_name": "Tinker", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (institution): AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. Sabatier", "first_name": "R.", "last_name": "Sabatier", "second_name": "", "title": " Research grant/Funding (institution): Eisai; Advisory/Consultancy, Non-remunerated activity/ies: Roche; Advisory/Consultancy, Non-remunerated activity/ies: Pfizer; Advisory/Consultancy: Tesaro; Advisory/Consultancy: Novartis; Advisory/Consultancy, Non-remunerated activity/ies: AstraZeneca; Non-remunerated activity/ies: Amgen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Ghamande", "first_name": "S.", "last_name": "Ghamande", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (institution): Seattle Genetics; Speaker Bureau/Expert testimony, Research grant/Funding (institution): Tesaro; Speaker Bureau/Expert testimony, Research grant/Funding (institution): GlaxoSmithKline; Research grant/Funding (institution): Merck; Research grant/Funding (institution): Roche; Research grant/Funding (institution): Genentech; Research grant/Funding (institution): Takeda; Research grant/Funding (institution): Advaxis; Research grant/Funding (institution): BMS; Research grant/Funding (institution): Clovis; Research grant/Funding (institution): AbbVie."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "L. Duska", "first_name": "L.", "last_name": "Duska", "second_name": "", "title": " Research grant/Funding (institution): Merck, Genentech/Roche, GlaxoSmithKline, Inovio; Advisory/Consultancy: AstraZeneca, Genentech/Roche, MorphoTek; Advisory/Consultancy: Merck, Cue Biopharma; Licensing/Royalties: Elsevier, JB Learning."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "W. Guo", "first_name": "W.", "last_name": "Guo", "second_name": "", "title": " Full/Part-time employment: GlaxoSmithKline."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "E. Im", "first_name": "E.", "last_name": "Im", "second_name": "", "title": " Full/Part-time employment: GlaxoSmithKline."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "B. Pothuri", "first_name": "B.", "last_name": "Pothuri", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (institution), Non-remunerated activity/ies: Tesaro; Advisory/Consultancy: AstraZeneca; Advisory/Consultancy: Clovis Oncology."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Mansoor R. Mirza", "first_name": "Mansoor", "last_name": "Mirza", "second_name": "R.", "country": "Denmark", "city": "Copenhagen", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Florian Lordick", "first_name": "Florian", "last_name": "Lordick", "second_name": "", "country": "Germany", "city": "Leipzig", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "John Reynolds", "first_name": "John", "last_name": "Reynolds", "second_name": "", "country": "Ireland", "city": "Dublin", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "K. Borchert", "first_name": "K.", "last_name": "Borchert", "second_name": "", "title": " Advisory/Consultancy, Travel/Accommodation/Expenses: Celgene; Advisory/Consultancy: Merck; Advisory/Consultancy, Travel/Accommodation/Expenses: Roche; Advisory/Consultancy: Sanofi; Advisory/Consultancy: Servier; Advisory/Consultancy, Travel/Accommodation/Expenses: Amgen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Kretzschmar", "first_name": "A.", "last_name": "Kretzschmar", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Mahlberg", "first_name": "C.", "last_name": "Mahlberg", "second_name": "", "title": " Honoraria (self): Roche; Honoraria (self), Travel/Accommodation/Expenses: Amgen; Honoraria (self): Novartis; Travel/Accommodation/Expenses: Merck; Travel/Accommodation/Expenses: Pfizer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "O. Bechstein", "first_name": "O.", "last_name": "Bechstein", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Astellas; Advisory/Consultancy, Travel/Accommodation/Expenses: Novartis; Honoraria (self), Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: Integra LifeSciences ; Honoraria (self), Travel/Accommodation/Expenses: Baxter; Honoraria (self), Travel/Accommodation/Expenses: Chiesi; Honoraria (self), Travel/Accommodation/Expenses: MCI Deutschland ; Honoraria (self), Travel/Accommodation/Expenses: Medupdate; Honoraria (self), Travel/Accommodation/Expenses: Merck Serono ; Honoraria (self), Travel/Accommodation/Expenses: Teva."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "P. Reichardt", "first_name": "P.", "last_name": "Reichardt", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy: Pfizer; Honoraria (self), Advisory/Consultancy: PharmaMar; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution): Novartis; Advisory/Consultancy: Clinigen Group ; Honoraria (self), Advisory/Consultancy: Lilly; Advisory/Consultancy: Roche; Honoraria (self), Advisory/Consultancy: Bayer; Advisory/Consultancy: Deciphera ; Honoraria (self): Amgen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "O. Goetze", "first_name": "O.", "last_name": "Goetze", "second_name": "", "title": " Advisory/Consultancy, Speaker Bureau/Expert testimony: Lilly; Advisory/Consultancy: MSD Oncology ; Advisory/Consultancy: Bayer; Advisory/Consultancy: Servier; Advisory/Consultancy: Roche; Research grant/Funding (self): Deutsche Forschungsgemeinschaft ; Research grant/Funding (self): Gemeinsamer Bundesausschuss ."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Hofheinz", "first_name": "D.", "last_name": "Hofheinz", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (self), Travel/Accommodation/Expenses: Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Kensei Yamaguchi", "first_name": "Kensei", "last_name": "Yamaguchi", "second_name": "", "country": "Japan", "city": "Koto-ku", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Bang", "first_name": "J.", "last_name": "Bang", "second_name": "", "title": " Advisory/Consultancy: Samyung; Advisory/Consultancy, Research grant/Funding (institution): BeiGene; Advisory/Consultancy, Research grant/Funding (institution): Green Cross; Advisory/Consultancy, Research grant/Funding (institution): Taiho Pharmaceutical; Advisory/Consultancy, Research grant/Funding (institution): Merck Serono; Advisory/Consultancy, Research grant/Funding (institution): AstraZeneca/MedImmune; Advisory/Consultancy, Research grant/Funding (institution): Novartis; Advisory/Consultancy, Research grant/Funding (institution): MSD Oncology; Advisory/Consultancy, Research grant/Funding (institution): Bayer; Advisory/Consultancy: Hanmi; Advisory/Consultancy, Research grant/Funding (institution): Genentech/Roche; Advisory/Consultancy, Research grant/Funding (institution): Lilly; Advisory/Consultancy, Research grant/Funding (institution): Daiichi Sankyo; Advisory/Consultancy, Research grant/Funding (institution): Astellas Pharma; Advisory/Consultancy, Research grant/Funding (institution): Bristol-Myers Squibb; Advisory/Consultancy, Research grant/Funding (institution): Genexine; Advisory/Consultancy, Research grant/Funding (institution): GlaxoSmithKline; Research grant/Funding (institution): Pfizer; Research grant/Funding (institution): Boehringer Ingelheim; Research grant/Funding (institution): Macrogenics; Research grant/Funding (institution): Boston Biomedical; Research grant/Funding (institution): Five Prime Therapeutics; Research grant/Funding (institution): Chong Kun Dang Pharmaceutical; Research grant/Funding (institution): Ono Pharmaceutical; Research grant/Funding (institution): Takeda; Research grant/Funding (institution): Curis."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Iwasa", "first_name": "S.", "last_name": "Iwasa", "second_name": "", "title": " Research grant/Funding (institution): Daiichi Sankyo ."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "N. Sugimoto", "first_name": "N.", "last_name": "Sugimoto", "second_name": "", "title": " Research grant/Funding (institution): Daiichi Sankyo ; Research grant/Funding (institution): MSD; Research grant/Funding (institution): Astellas; Research grant/Funding (institution): Solasia; Research grant/Funding (institution): ONO; Research grant/Funding (self): Lilly; Research grant/Funding (self): Taiho."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Sakai", "first_name": "D.", "last_name": "Sakai", "second_name": "", "title": " Speaker Bureau/Expert testimony, Research grant/Funding (institution): Chugai Pharma; Research grant/Funding (institution): Yakult Honsha; Research grant/Funding (institution): Ono Pharmaceutical; Research grant/Funding (self): Daiichi Sankyo; Research grant/Funding (self): Lilly Japan."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "H. Kawakami", "first_name": "H.", "last_name": "Kawakami", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution): Daiichi Sankyo; Honoraria (self), Advisory/Consultancy: Bristol and Myers Squibb; Honoraria (self), Advisory/Consultancy: Ono pharmaceutical ; Honoraria (self), Advisory/Consultancy: Eli Lilly Japan; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution): Taiho; Honoraria (self), Research grant/Funding (institution): Chugai; Honoraria (self): Takeda; Research grant/Funding (institution): Eisai; Honoraria (self), Advisory/Consultancy: MSD KK."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Lee", "first_name": "J.", "last_name": "Lee", "second_name": "", "title": " Advisory/Consultancy: Oncologie; Advisory/Consultancy: Seattle Genetics; Research grant/Funding (self): Astra Zeneca; Research grant/Funding (self): Merck Sharp and Dohme; Research grant/Funding (self): Eli Lilly and Company."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Sugihara", "first_name": "M.", "last_name": "Sugihara", "second_name": "", "title": " Full/Part-time employment: Daiichi Sankyo."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Y. Kawaguchi", "first_name": "Y.", "last_name": "Kawaguchi", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Daiichi Sankyo ."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Kojima", "first_name": "A.", "last_name": "Kojima", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Daiichi Sankyo ."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Hoff", "first_name": "M.", "last_name": "Hoff", "second_name": "", "title": " Non-remunerated activity/ies, F."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Ohtsu", "first_name": "A.", "last_name": "Ohtsu", "second_name": "", "title": " Research grant/Funding (self): BMS; Non-remunerated activity/ies, F."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Siddiqui", "first_name": "A.", "last_name": "Siddiqui", "second_name": "", "title": " Full/Part-time employment: Roche Products Limited; Non-remunerated activity/ies, F."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Heeson", "first_name": "S.", "last_name": "Heeson", "second_name": "", "title": " Shareholder/Stockholder/Stock options: F."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "H. Wu", "first_name": "H.", "last_name": "Wu", "second_name": "", "title": " Shareholder/Stockholder/Stock options: F."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Alexandra Leary", "first_name": "Alexandra", "last_name": "Leary", "second_name": "", "country": "France", "city": "Villejuif", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Florence Joly Lobbedez", "first_name": "Florence", "last_name": "Lobbedez", "second_name": "Joly", "country": "CEDEX ", "city": "Caen", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Fabbro", "first_name": "M.", "last_name": "Fabbro", "second_name": "", "title": " Advisory/Consultancy: AstraZeneca; Advisory/Consultancy: GSK."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Berton", "first_name": "D.", "last_name": "Berton", "second_name": "", "title": " Advisory/Consultancy: AstraZeneca; Advisory/Consultancy: Tesaro; Travel/Accommodation/Expenses, ESMO: Pfizer; Travel/Accommodation/Expenses, ESCO: PharmaMar."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Anota", "first_name": "A.", "last_name": "Anota", "second_name": "", "title": " Honoraria (self): Roche; Honoraria (self), Research grant/Funding (self), Travel/Accommodation/Expenses: BMS; Honoraria (self), Advisory/Consultancy: Sandoz; Advisory/Consultancy, Travel/Accommodation/Expenses: AstraZeneca; Travel/Accommodation/Expenses: Pfizer/Hospira; Travel/Accommodation/Expenses: Novartis."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Puszkiel", "first_name": "A.", "last_name": "Puszkiel", "second_name": "", "title": " Full/Part-time employment: Hospices Civils de Lyon, Groupement Hospitalier Sud."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Floquet", "first_name": "A.", "last_name": "Floquet", "second_name": "", "title": " Advisory/Consultancy, Travel/Accommodation/Expenses: Tesaro; Advisory/Consultancy: Clovis; Advisory/Consultancy, Travel/Accommodation/Expenses: AstraZeneca; Advisory/Consultancy: GSK; Advisory/Consultancy, Travel/Accommodation/Expenses, Non-remunerated activity/ies: MSD; Travel/Accommodation/Expenses, Non-remunerated activity/ies: Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "L. Bengrine Lefevre", "first_name": "L.", "last_name": "Lefevre", "second_name": "Bengrine", "title": " Honoraria (institution), Full/Part-time employment: Centre Georges Francois Leclerc (hospital); Advisory/Consultancy: AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Lortholary", "first_name": "A.", "last_name": "Lortholary", "second_name": "", "title": " Honoraria (self): GSK; Honoraria (self): Roche; Honoraria (self): Novartis."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Spaeth", "first_name": "D.", "last_name": "Spaeth", "second_name": "", "title": " Honoraria (self): Astra; Travel/Accommodation/Expenses: Pfizer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Abdeddaim", "first_name": "C.", "last_name": "Abdeddaim", "second_name": "", "title": " Advisory/Consultancy: GSK/Tesaro; Advisory/Consultancy: BMS; Advisory/Consultancy, Travel/Accommodation/Expenses: Merck."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Petran", "first_name": "D.", "last_name": "Petran", "second_name": "", "title": " Travel/Accommodation/Expenses, Congrès, Réunions: Amgen; Travel/Accommodation/Expenses, Congrès, Réunions: Sandoz; Travel/Accommodation/Expenses, Congrès, Réunions: Pfizer; Travel/Accommodation/Expenses, Congrès, Réunions: Ipsen; Travel/Accommodation/Expenses, Congrès, Réunions: Roche; Travel/Accommodation/Expenses, Congrès, Réunions: BMS."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "E. Brachet", "first_name": "E.", "last_name": "Brachet", "second_name": "", "title": " Advisory/Consultancy: BMS; Advisory/Consultancy: AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Jean-Sebastien Frenel", "first_name": "Jean-Sebastien", "last_name": "Frenel", "second_name": "", "country": "CEDE", "city": "Saint-Herblain", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "L. Vidal", "first_name": "L.", "last_name": "Vidal", "second_name": "", "title": " Full/Part-time employment: Syneos Health ( CRO)."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "P. Pautier", "first_name": "P.", "last_name": "Pautier", "second_name": "", "title": " Advisory/Consultancy, Travel/Accommodation/Expenses: AstraZeneca; Advisory/Consultancy, Travel/Accommodation/Expenses: Roche; Advisory/Consultancy, Travel/Accommodation/Expenses: Tesaro; Advisory/Consultancy: GSK."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Oza", "first_name": "M.", "last_name": "Oza", "second_name": "", "title": " Honoraria (self): Intas; Advisory/Consultancy: Immunogen; Advisory/Consultancy: Merck KGaA; Research grant/Funding (institution), Travel/Accommodation/Expenses: AstraZeneca; Research grant/Funding (institution): Immunovaccine; Non-remunerated activity/ies, Other Relationship: Clovis Oncology; Non-remunerated activity/ies, Other Relationship: Tesaro."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Korach", "first_name": "J.", "last_name": "Korach", "second_name": "", "title": " Advisory/Consultancy: AstraZeneca; Advisory/Consultancy: MSD Oncology."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "K. Tamura", "first_name": "K.", "last_name": "Tamura", "second_name": "", "title": " Research grant/Funding (self), Research grant/Funding (institution): Pfizer; Research grant/Funding (self): Daiichi Sankyo; Research grant/Funding (self): Eli Lilly; Research grant/Funding (self): MSD; Research grant/Funding (self): Chugai; Research grant/Funding (self): AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Sonke", "first_name": "S.", "last_name": "Sonke", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (institution): Novartis; Research grant/Funding (institution): AstraZeneca; Research grant/Funding (institution): Merck Sharp & Dohme; Research grant/Funding (institution): Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Freimund", "first_name": "A.", "last_name": "Freimund", "second_name": "", "title": " Licensing/Royalties, as CPI of the clinical trial, PRECISE, that is receiving study drug and part study funding: BeiGene Pharmaceuticals."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "K. Lee", "first_name": "K.", "last_name": "Lee", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: AstraZeneca; Honoraria (self), Advisory/Consultancy: Novartis; Honoraria (self), Advisory/Consultancy: Pfizer; Honoraria (self), Advisory/Consultancy: Roche; Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Boehringer Ingelheim; Honoraria (self), Advisory/Consultancy: Takeda."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "David Cella", "first_name": "David", "last_name": "Cella", "second_name": "", "country": "I", "city": "Chicago", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "K. Dahl Steffensen", "first_name": "K.", "last_name": "Steffensen", "second_name": "Dahl", "title": " Advisory/Consultancy, Research grant/Funding (institution): AbbVie; Research grant/Funding (institution): AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "L. Coleman", "first_name": "L.", "last_name": "Coleman", "second_name": "", "title": " Research grant/Funding (institution): NCI-SPORE; Leadership role, Research grant/Funding (institution), Scientific Steering Committee: AstraZeneca; Leadership role, Research grant/Funding (institution), Scientific Steering Committee: Clovis; Leadership role, Research grant/Funding (institution), Scientific Steering Committee: Roche/Genentech; Research grant/Funding (institution): V-Foundation; Leadership role, Research grant/Funding (institution), Scientific Steering Committee: Janssen; Leadership role, Research grant/Funding (institution), Scientific Steering Committee: Merck; Research grant/Funding (institution): Novartis; Leadership role, Scientific Steering Committee: AbbVie; Leadership role, Scientific Steering Committee: Biomarin; Leadership role, Scientific Steering Committee: GamaMab; Leadership role, Scientific Steering Committee: Genmab; Leadership role, Scientific Steering Committee: Immunogen; Leadership role, Scientific Steering Committee: Pfizer; Leadership role, Scientific Steering Committee: Tesaro/GSK."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Sullivan", "first_name": "D.", "last_name": "Sullivan", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: AbbVie."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Hudgens", "first_name": "S.", "last_name": "Hudgens", "second_name": "", "title": " Full/Part-time employment: Clinical Outcomes Solutions."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Bhavana Pothuri", "first_name": "Bhavana", "last_name": "Pothuri", "second_name": "", "country": "United States of America", "city": "New York", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Chase", "first_name": "D.", "last_name": "Chase", "second_name": "", "title": " Speaker Bureau/Expert testimony: Tesaro."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "E. Restuccia", "first_name": "E.", "last_name": "Restuccia", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: F."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Hiroya Takeuchi", "first_name": "Hiroya", "last_name": "Takeuchi", "second_name": "", "country": "Japan", "city": "Hamamatsu", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "H. Baba", "first_name": "H.", "last_name": "Baba", "second_name": "", "title": " Research grant/Funding (institution): Yakult Honsha Co."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Morita", "first_name": "S.", "last_name": "Morita", "second_name": "", "title": " Honoraria (self): Bristol-Myers Squibb Company."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Y. Kitagawa", "first_name": "Y.", "last_name": "Kitagawa", "second_name": "", "title": " Advisory/Consultancy: Ono Pharmaceutical Co."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "K. Yoshida", "first_name": "K.", "last_name": "Yoshida", "second_name": "", "title": " Research grant/Funding (self): Sanofi K."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "F. Heitz", "first_name": "F.", "last_name": "Heitz", "second_name": "", "title": " Non-remunerated activity/ies: NewOncology; Advisory/Consultancy: Roche; Advisory/Consultancy: AstraZeneca; Advisory/Consultancy: Clovis; Advisory/Consultancy: Tesaro; Advisory/Consultancy: PharmaMar."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. Burger", "first_name": "R.", "last_name": "Burger", "second_name": "", "title": " Advisory/Consultancy: Amgen; Advisory/Consultancy: AstraZeneca; Advisory/Consultancy: Tesaro; Advisory/Consultancy: Clovis Oncology; Advisory/Consultancy: Genentech; Advisory/Consultancy: Gradalis; Advisory/Consultancy: Janssen Research & Development; Advisory/Consultancy: Merck; Advisory/Consultancy: VBL Therapeutics."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "E. Guerra", "first_name": "E.", "last_name": "Guerra", "second_name": "", "title": " Advisory/Consultancy, Travel/Accommodation/Expenses: Roche; Advisory/Consultancy: Clovis Oncology; Advisory/Consultancy, Travel/Accommodation/Expenses: GlaxoSmithKline; Advisory/Consultancy: PharmaMar; Advisory/Consultancy: AstraZeneca; Advisory/Consultancy: Merck Sharp & Dohme; Travel/Accommodation/Expenses: Baxter."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Y. Li", "first_name": "Y.", "last_name": "Li", "second_name": "", "title": " Full/Part-time employment: GlaxoSmithKline."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "N. Moore", "first_name": "N.", "last_name": "Moore", "second_name": "", "title": " Advisory/Consultancy: AbbVie; Advisory/Consultancy: Aravive; Advisory/Consultancy: AstraZeneca; Advisory/Consultancy: Eisai; Advisory/Consultancy, Research grant/Funding (self): GSK/Tesaro; Advisory/Consultancy: Genentech/Roche; Advisory/Consultancy: Immunogen; Advisory/Consultancy: Mersana; Advisory/Consultancy, Research grant/Funding (self): Merck; Advisory/Consultancy: Myriad; Advisory/Consultancy: Terveda; Advisory/Consultancy: VBL Therapeutics; Research grant/Funding (self): PTC Therapeutics; Research grant/Funding (self): Lilly."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Oaknin", "first_name": "A.", "last_name": "Oaknin", "second_name": "", "title": " Advisory/Consultancy: Roche; Advisory/Consultancy: AstraZeneca; Advisory/Consultancy: PharmaMar; Advisory/Consultancy: Clovis Oncology; Advisory/Consultancy: Tesaro; Advisory/Consultancy: ImmunoGen; Advisory/Consultancy: Genmab."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Friedlander", "first_name": "M.", "last_name": "Friedlander", "second_name": "", "title": " Honoraria (institution), Advisory/Consultancy, Research grant/Funding (institution): AstraZeneca; Research grant/Funding (institution): Novartis; Research grant/Funding (institution): Beigene; Advisory/Consultancy: MSD; Advisory/Consultancy: Lilly; Advisory/Consultancy: Takeda; Non-remunerated activity/ies: AbbVie."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Leary", "first_name": "A.", "last_name": "Leary", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy: AstraZeneca; Advisory/Consultancy: Clovis Oncology; Advisory/Consultancy: Biocad; Advisory/Consultancy: Seattle Genetics."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Gourley", "first_name": "C.", "last_name": "Gourley", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution): AstraZeneca; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution): Tesaro; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution): Nucana; Honoraria (self), Advisory/Consultancy: Roche; Honoraria (self), Advisory/Consultancy: Clovis Oncology; Honoraria (self), Advisory/Consultancy: Foundation One; Honoraria (self), Advisory/Consultancy: MSD; Honoraria (self), Advisory/Consultancy: Sierra Oncology; Research grant/Funding (institution): Novartis; Research grant/Funding (institution): Aprea."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Oza", "first_name": "A.", "last_name": "Oza", "second_name": "", "title": " Non-remunerated activity/ies: AstraZeneca; Non-remunerated activity/ies: Clovis Oncology; Non-remunerated activity/ies: Tesaro."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "W. Bradley", "first_name": "W.", "last_name": "Bradley", "second_name": "", "title": " Advisory/Consultancy: Inovio."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "E. Holmes", "first_name": "E.", "last_name": "Holmes", "second_name": "", "title": " Full/Part-time employment: AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Lowe", "first_name": "S.", "last_name": "Lowe", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "P. DiSilvestro", "first_name": "P.", "last_name": "DiSilvestro", "second_name": "", "title": " Advisory/Consultancy: AstraZeneca; Advisory/Consultancy: Tesaro."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. Berger", "first_name": "R.", "last_name": "Berger", "second_name": "", "title": " Travel/Accommodation/Expenses: Roche; Travel/Accommodation/Expenses: Merck; Travel/Accommodation/Expenses: Biocad; Travel/Accommodation/Expenses: Clovis; Travel/Accommodation/Expenses: Advaxis; Honoraria (self): AstraZeneca; Advisory/Consultancy: PharmaMar."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "K. Yonemori", "first_name": "K.", "last_name": "Yonemori", "second_name": "", "title": " Honoraria (self): AstraZeneca; Honoraria (self): Pfizer; Honoraria (self): Taiho; Honoraria (self), Advisory/Consultancy: Eisai; Advisory/Consultancy: Takeda; Advisory/Consultancy: Novartis; Advisory/Consultancy: Ono."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "I. Vergote", "first_name": "I.", "last_name": "Vergote", "second_name": "", "title": " Honoraria (institution): Advaxis; Honoraria (institution): Eisai; Honoraria (institution): MSD Belgium; Honoraria (institution): F."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Costan", "first_name": "C.", "last_name": "Costan", "second_name": "", "title": " Advisory/Consultancy: AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "U. Canzler", "first_name": "U.", "last_name": "Canzler", "second_name": "", "title": " Honoraria (self): AstraZeneca; Honoraria (self): Roche; Honoraria (self): Lilly."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Zamagni", "first_name": "C.", "last_name": "Zamagni", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (self), Travel/Accommodation/Expenses: Roche; Advisory/Consultancy, Research grant/Funding (self), Travel/Accommodation/Expenses: Novartis; Advisory/Consultancy, Research grant/Funding (self), Travel/Accommodation/Expenses: Pfizer; Advisory/Consultancy, Research grant/Funding (self), Travel/Accommodation/Expenses: Tesaro; Advisory/Consultancy, Research grant/Funding (self): AstraZeneca; Advisory/Consultancy, Travel/Accommodation/Expenses: PharmaMar; Advisory/Consultancy, Travel/Accommodation/Expenses: Celgene; Research grant/Funding (self), Travel/Accommodation/Expenses: Pierre Fabre; Research grant/Funding (self), Travel/Accommodation/Expenses: Istituto Gentilli; Advisory/Consultancy: Eisai; Advisory/Consultancy: Lilly; Advisory/Consultancy: Amgen; Advisory/Consultancy: QuintilesIMS; Research grant/Funding (self): Takeda; Research grant/Funding (self): Teva; Research grant/Funding (self): Medivation; Research grant/Funding (self): AbbVie; Research grant/Funding (self): Array BioPharma; Research grant/Funding (self): Morphotek; Research grant/Funding (self): Synthon; Research grant/Funding (self): Seattle Genetics."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "E. Kalbacher", "first_name": "E.", "last_name": "Kalbacher", "second_name": "", "title": " Advisory/Consultancy, Travel/Accommodation/Expenses: AstraZeneca; Advisory/Consultancy, Travel/Accommodation/Expenses: Roche; Advisory/Consultancy, Travel/Accommodation/Expenses: Sanofi; Advisory/Consultancy, Travel/Accommodation/Expenses: Tesaro; Advisory/Consultancy, Travel/Accommodation/Expenses: GSK; Advisory/Consultancy, Travel/Accommodation/Expenses: Leopharma."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "N. De Gregorio", "first_name": "N.", "last_name": "De Gregorio", "second_name": "", "title": " Advisory/Consultancy: Roche; Advisory/Consultancy: PharmaMar; Advisory/Consultancy: Amgen; Advisory/Consultancy, Travel/Accommodation/Expenses: AstraZeneca; Advisory/Consultancy, Travel/Accommodation/Expenses: GSK."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "N. Dohollou", "first_name": "N.", "last_name": "Dohollou", "second_name": "", "title": " Advisory/Consultancy: AstraZeneca; Advisory/Consultancy: Pfizer; Advisory/Consultancy: Roche; Advisory/Consultancy: Lilly; Research grant/Funding (institution), serving as PI of a clinical trial: BMS; Research grant/Funding (institution), serving as PI of a clinical trial: Boehringer Ingelheim; Research grant/Funding (institution), serving as PI of a clinical trial: Genomic Health; Research grant/Funding (institution), serving as PI of a clinical trial: MSD; Research grant/Funding (institution), serving as PI of a clinical trial: Novartis."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Andrea Alimonti", "first_name": "Andrea", "last_name": "Alimonti", "second_name": "", "country": "Switzerland", "city": "Bellinzona", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Noel Clarke", "first_name": "Noel", "last_name": "Clarke", "second_name": "", "country": "United Kingdom", "city": "London", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Rebeca Lozano Mejorada", "first_name": "Rebeca", "last_name": "Mejorada", "second_name": "Lozano", "country": "Spain", "city": "Madrid", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "E. Castro Marcos", "first_name": "E.", "last_name": "Marcos", "second_name": "Castro", "title": " Honoraria (self): Astellas Pharma, AstraZeneca, Bayer, Janssen-Cilag, Pfizer; Advisory/Consultancy: AstraZeneca, Bayer, Janssen; Research grant/Funding (institution): AstraZeneca, Bayer, Janssen; Travel/Accommodation/Expenses: Bayer, Janssen-Cilag, Roche, Astellas Pharma."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "F. Lopez Campos", "first_name": "F.", "last_name": "Campos", "second_name": "Lopez", "title": " Advisory/Consultancy: Astellas Pharma; Speaker Bureau/Expert testimony: Janssen, Astellas Pharma; Travel/Accommodation/Expenses: Astellas Pharma, Janssen; Research grant/Funding (self): Astellas Pharma."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "U. Anido", "first_name": "U.", "last_name": "Anido", "second_name": "", "title": " Honoraria (self): Pfizer, Novartis, Bayer, Bristol-Myers-Squbb, EUSA Pharma, Eisai, Astellas Pharma, Jassen-Oncology, Sanofi; Advisory/Consultancy: Bayer, Pfizer, Novartis, Ipsen, Eisai, EUSA Pharma, Sanofi; Research grant/Funding (self): Pierre Fabre; Travel/Accommodation/Expenses: Astellas Pharma, Novartis, Roche, Pfizer, Ipsen, Sanofi."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Juan Fita", "first_name": "J.", "last_name": "Fita", "second_name": "Juan", "title": " Advisory/Consultancy: Janssen; Speaker Bureau/Expert testimony: Sanofi, Astellas, Janssen, BMS, Bayer; Travel/Accommodation/Expenses: Janssen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "N. Romero Laorden", "first_name": "N.", "last_name": "Laorden", "second_name": "Romero", "title": " Research grant/Funding (institution), Travel/Accommodation/Expenses: Janssen; Advisory/Consultancy, Research grant/Funding (institution): Pfizer; Advisory/Consultancy: Janssen, IPSEN, Astellas, Astra-Zeneca, MSD, Bayer, Tesaro, Sanofi."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Rubio Briones", "first_name": "J.", "last_name": "Briones", "second_name": "Rubio", "title": " Advisory/Consultancy: Janssen, Astellas, Bayer; Research grant/Funding (self): HealthMDx."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Pritchard", "first_name": "C.", "last_name": "Pritchard", "second_name": "", "title": " Advisory/Consultancy: AstraZeneca, Promega."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Olmos Hidalgo", "first_name": "D.", "last_name": "Hidalgo", "second_name": "Olmos", "title": " Honoraria (self): Bayer, Janssen, Sanofi; Advisory/Consultancy: AstraZeneca, Bayer, Clovis Oncology, Daiichi-Sankyo, Janssen, MSD, Roche ; Research grant/Funding (institution): Astellas, AstraZeneca, Bayer, Genentech, Janssen, Medication, MSD, Pfizer, Roche, Tokai Pahrmaceutics; Travel/Accommodation/Expenses: Bayer, Ipsen, Janssen, Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Mihaela Aldea", "first_name": "Mihaela", "last_name": "Aldea", "second_name": "", "country": "France", "city": "Villejuif", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "G. Gravis Mescam", "first_name": "G.", "last_name": "Mescam", "second_name": "Gravis", "title": " Honoraria (institution): Pfizer, BMS, MSD, AstraZeneca, Astellas, Janssen, Bayer; Advisory/Consultancy: BMS, Pfizer, AstraZeneca, Janssen, Sanofi, Ipsen, Bayer; Travel/Accommodation/Expenses: BMS, Pfizer, AstraZeneca, Janssen, Sanofi, Ipsen, MSD."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Helissey", "first_name": "C.", "last_name": "Helissey", "second_name": "", "title": " Advisory/Consultancy: Sanofi, Janssen, Astellas, Roche, AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Pobel", "first_name": "C.", "last_name": "Pobel", "second_name": "", "title": " Travel/Accommodation/Expenses: Sanofi, Ipsen, Sandoz."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "G. Baciarello", "first_name": "G.", "last_name": "Baciarello", "second_name": "", "title": " Honoraria (self): Janssen, Roche; Advisory/Consultancy: Amgen, Astellas Oncology, Janssen, Roche; Travel/Accommodation/Expenses: Astellas Oncology, Ipsen, Janssen, Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "E. Orillard", "first_name": "E.", "last_name": "Orillard", "second_name": "", "title": " Honoraria (self): Astellas, Janssen; Travel/Accommodation/Expenses: Pfizer, Amgen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "David Margel", "first_name": "David", "last_name": "Margel", "second_name": "", "country": "Israel", "city": "Petah Tikva", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Mark Markowski", "first_name": "Mark", "last_name": "Markowski", "second_name": "", "country": "M", "city": "Baltimore", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Eisenberger", "first_name": "A.", "last_name": "Eisenberger", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Officer/Board of Directors: Veru Inc."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. Tutrone", "first_name": "R.", "last_name": "Tutrone", "second_name": "", "title": " Research grant/Funding (institution): Veru Inc."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Pieczonka", "first_name": "C.", "last_name": "Pieczonka", "second_name": "", "title": " Research grant/Funding (institution): Veru Inc."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "H. Getzenberg", "first_name": "H.", "last_name": "Getzenberg", "second_name": "", "title": " Leadership role, Shareholder/Stockholder/Stock options, Full/Part-time employment: Veru Inc."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Rodriguez", "first_name": "D.", "last_name": "Rodriguez", "second_name": "", "title": " Leadership role, Shareholder/Stockholder/Stock options, Full/Part-time employment: Veru Inc."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "G. Barnette", "first_name": "G.", "last_name": "Barnette", "second_name": "", "title": " Leadership role, Shareholder/Stockholder/Stock options, Full/Part-time employment, Officer/Board of Directors: Veru Inc."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Steiner", "first_name": "S.", "last_name": "Steiner", "second_name": "", "title": " Leadership role, Shareholder/Stockholder/Stock options, Full/Part-time employment, Officer/Board of Directors: Veru Inc."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. Saltzstein", "first_name": "R.", "last_name": "Saltzstein", "second_name": "", "title": " Research grant/Funding (institution): Veru Inc."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Jason M. Redman", "first_name": "Jason", "last_name": "Redman", "second_name": "M.", "country": "United States of America", "city": "Bethesda", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Giulia Baciarello", "first_name": "Giulia", "last_name": "Baciarello", "second_name": "", "country": "CEDE", "city": "Villejuif", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Kilian M. Gust", "first_name": "Kilian", "last_name": "Gust", "second_name": "M.", "country": "Austria", "city": "Vienna", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Ramaprasad Srinivasan", "first_name": "Ramaprasad", "last_name": "Srinivasan", "second_name": "", "country": "United States of America", "city": "Bethesda", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "F. Donskov", "first_name": "F.", "last_name": "Donskov", "second_name": "", "title": " Honoraria (institution): Pfizer, Ipsen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "K. Rathmell", "first_name": "K.", "last_name": "Rathmell", "second_name": "", "title": " Research grant/Funding (self): Incyte."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "K. Narayan", "first_name": "K.", "last_name": "Narayan", "second_name": "", "title": " Research grant/Funding (self): Merck; Research grant/Funding (self): Janssen; Research grant/Funding (self): BMS; Research grant/Funding (self): Modra."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "L. Maughan", "first_name": "L.", "last_name": "Maughan", "second_name": "", "title": " Research grant/Funding (self): Exelixis, Bavarian-Nordic, Clovis, BMS; Travel/Accommodation/Expenses: Dava Oncology."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "T. Else", "first_name": "T.", "last_name": "Else", "second_name": "", "title": " Research grant/Funding (self): Corcept, Strongbridge; Advisory/Consultancy: Corcept, HRA."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "K. Maranchie", "first_name": "K.", "last_name": "Maranchie", "second_name": "", "title": " Research grant/Funding (self): Merck, Peleton, Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Welsh", "first_name": "J.", "last_name": "Welsh", "second_name": "", "title": " Travel/Accommodation/Expenses: Ipsen, MedImmune; Speaker Bureau/Expert testimony: Pfizer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Thamake", "first_name": "S.", "last_name": "Thamake", "second_name": "", "title": " Shareholder/Stockholder/Stock options: Peloton Therapeutics Inc."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "K. Park", "first_name": "K.", "last_name": "Park", "second_name": "", "title": " Full/Part-time employment: Merck & Co."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Yue Zhao", "first_name": "Yue", "last_name": "Zhao", "second_name": "", "country": "United Kingdom", "city": "London", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Turajlic", "first_name": "S.", "last_name": "Turajlic", "second_name": "", "title": " Research grant/Funding (institution): Roche Tissue Dianostics."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Begona Perez Valderrama", "first_name": "Begona", "last_name": "Valderrama", "second_name": "Perez", "country": "Spain", "city": "Seville", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Climent Duran", "first_name": "A.", "last_name": "Duran", "second_name": "Climent", "title": " Advisory/Consultancy, Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: Roche; Advisory/Consultancy, Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: Pfizer; Advisory/Consultancy, Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: MSD; Advisory/Consultancy, Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: Astra."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "L. Perez Gracia", "first_name": "L.", "last_name": "Gracia", "second_name": "Perez", "title": " Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (self), Travel/Accommodation/Expenses: Roche; Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (self), Travel/Accommodation/Expenses: BMS; Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (self), Travel/Accommodation/Expenses: MSD; Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (self): Ipsen; Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (self): Eisai; Research grant/Funding (self): Incyte; Research grant/Funding (self): Janssen; Advisory/Consultancy, Speaker Bureau/Expert testimony: Seattle Genetics."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "P. Maroto", "first_name": "P.", "last_name": "Maroto", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (self): Roche; Advisory/Consultancy: Pfizer; Advisory/Consultancy: Astellas; Advisory/Consultancy: Janssen; Advisory/Consultancy: Bristol-Myers Squib; Advisory/Consultancy: AstraZeneca; Advisory/Consultancy: Novartis."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Petros Grivas", "first_name": "Petros", "last_name": "Grivas", "second_name": "", "country": "United States of America", "city": "Seattle", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Caserta", "first_name": "C.", "last_name": "Caserta", "second_name": "", "title": " Advisory/Consultancy: Janssen; Advisory/Consultancy: Merck; Advisory/Consultancy: Bristol-Myers Squibb; Advisory/Consultancy: Novartis Pharma SAS; Advisory/Consultancy: Pfizer Pharmaceuticals Israel."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "B. Perez Valderrama", "first_name": "B.", "last_name": "Valderrama", "second_name": "Perez", "title": " Advisory/Consultancy, Non-remunerated activity/ies: Astellas Pharma; Advisory/Consultancy, Non-remunerated activity/ies: Bristol-Myers Squibb; Advisory/Consultancy, Non-remunerated activity/ies: Ipsen; Advisory/Consultancy: Pierr-Fabre; Advisory/Consultancy: Bayer; Advisory/Consultancy, Non-remunerated activity/ies: Roche; Advisory/Consultancy: Sanofi; Advisory/Consultancy: EUSA Pharma; Advisory/Consultancy: MSD Oncology; Advisory/Consultancy: Novartis Pharma SAS; Non-remunerated activity/ies: Pfizer Pharmaceuticals Israel."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "H. Gurney", "first_name": "H.", "last_name": "Gurney", "second_name": "", "title": " Advisory/Consultancy: BMS; Advisory/Consultancy: MSD; Advisory/Consultancy: Pfizer; Advisory/Consultancy: Roche; Advisory/Consultancy: Ipsen; Advisory/Consultancy: AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Reham Alghandour", "first_name": "Reham", "last_name": "Alghandour", "second_name": "", "country": "Egypt", "city": "Mansoura", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Bo Dai", "first_name": "Bo", "last_name": "Dai", "second_name": "", "country": "China", "city": "Shanghai", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "N. Tsuchiya", "first_name": "N.", "last_name": "Tsuchiya", "second_name": "", "title": " Honoraria (self): Astellas; Honoraria (self): AstraZeneca; Honoraria (self): Pfizer; Honoraria (self): Janssen; Honoraria (self): Novartis; Honoraria (self): Ono; Honoraria (self): Bayer; Honoraria (self): Sanofi; Honoraria (self): Takeda; Honoraria (self): Bristol-Myers Squibb; Honoraria (self): MDS."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Gupta", "first_name": "S.", "last_name": "Gupta", "second_name": "", "title": " Honoraria (self), Speaker Bureau/Expert testimony: Exelixis; Honoraria (self), Speaker Bureau/Expert testimony: Janssen; Honoraria (self), Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (institution): BMS; Honoraria (self), Advisory/Consultancy: Merck; Honoraria (self), Advisory/Consultancy: Seattle Genetics; Honoraria (self), Advisory/Consultancy: AstraZeneca; Research grant/Funding (institution): Astellas."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "B. Huang", "first_name": "B.", "last_name": "Huang", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Pfizer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "N. Costa", "first_name": "N.", "last_name": "Costa", "second_name": "", "title": " Full/Part-time employment: Pfizer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Pavlos Msaouel", "first_name": "Pavlos", "last_name": "Msaouel", "second_name": "", "country": "United States of America", "city": "Houston", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. Sweis", "first_name": "R.", "last_name": "Sweis", "second_name": "", "title": " Honoraria (self): Aduro; Honoraria (self): AstraZeneca; Honoraria (self): Bristol-Myers Squibb; Honoraria (self): Exelixis; Honoraria (self): Eisai; Honoraria (self): Mirati; Honoraria (self): Puma."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Mao", "first_name": "S.", "last_name": "Mao", "second_name": "", "title": " Speaker Bureau/Expert testimony: Bristol-Myers Squibb."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "E. Rosenberg", "first_name": "E.", "last_name": "Rosenberg", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (institution): Mirati Therapeutics; Advisory/Consultancy: Adicet Bio; Advisory/Consultancy: Agensys; Advisory/Consultancy, Research grant/Funding (institution): AstraZeneca; Advisory/Consultancy, Research grant/Funding (institution): Astellas; Advisory/Consultancy, Research grant/Funding (institution): Bayer; Advisory/Consultancy: BioClin Therapeutics; Advisory/Consultancy, Travel/Accommodation/Expenses: Bristol Myers Squibb; Advisory/Consultancy: EMD Serono; Advisory/Consultancy: Fortress Biotech; Advisory/Consultancy: GlaxoSmithKline; Advisory/Consultancy: Inovio Pharma; Advisory/Consultancy: Janssen; Advisory/Consultancy: Lilly; Advisory/Consultancy: Merck; Advisory/Consultancy: Pharmacyclics; Advisory/Consultancy, Research grant/Funding (institution): QED Therapeutics; Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Roche/Genentech; Advisory/Consultancy, Research grant/Funding (institution): Seattle Genetics; Advisory/Consultancy: Sensei Biotherapeutics; Advisory/Consultancy: Western Oncolytics; Advisory/Consultancy: Boerhinger Ingelheim; Advisory/Consultancy: Pfizer; Research grant/Funding (institution): Incyte; Research grant/Funding (institution): Jounce Therapeutics; Research grant/Funding (institution): Novartis; Travel/Accommodation/Expenses: Chugai."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Rezazadeh Kalebasty", "first_name": "A.", "last_name": "Kalebasty", "second_name": "Rezazadeh", "title": " Shareholder/Stockholder/Stock options: ECOM Medical; Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (institution), Travel/Accommodation/Expenses: Exelixis; Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (institution), Travel/Accommodation/Expenses: AstraZeneca; Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Bayer; Advisory/Consultancy, Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: Pfizer; Advisory/Consultancy, Speaker Bureau/Expert testimony: Novartis; Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (institution), Travel/Accommodation/Expenses: Genentech; Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (institution): Bristol-Myers Squibb; Advisory/Consultancy, Speaker Bureau/Expert testimony: EMD Serono; Speaker Bureau/Expert testimony, Research grant/Funding (institution), Travel/Accommodation/Expenses: Janssen; Speaker Bureau/Expert testimony, Research grant/Funding (institution): Astellas; Speaker Bureau/Expert testimony: Sanofi; Speaker Bureau/Expert testimony, Research grant/Funding (institution): Eisai; Speaker Bureau/Expert testimony: Amgen; Speaker Bureau/Expert testimony: Merck; Speaker Bureau/Expert testimony, Research grant/Funding (institution): Seattle Genetics; Research grant/Funding (institution): Macrogenics; Research grant/Funding (institution): Beyond Spring; Research grant/Funding (institution): BioClin Therapeutics; Research grant/Funding (institution): Clovis Oncology; Research grant/Funding (institution): Immunomedics; Research grant/Funding (institution): Epizy; Travel/Accommodation/Expenses: Prometheus Laboratories."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "N. Davis", "first_name": "N.", "last_name": "Davis", "second_name": "", "title": " Research grant/Funding (institution): Mirati Therapeutics."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "T. Zhang", "first_name": "T.", "last_name": "Zhang", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (institution): Pfizer; Advisory/Consultancy, Research grant/Funding (institution): Janssen; Research grant/Funding (institution): Acerta; Research grant/Funding (institution): Abbvie; Research grant/Funding (institution): Novartis; Research grant/Funding (institution): Merrimack; Research grant/Funding (institution): OmniSeq; Research grant/Funding (institution): PGDx; Advisory/Consultancy, Research grant/Funding (institution): Merck; Research grant/Funding (institution): Mirati Therapeutics; Research grant/Funding (institution): Astellas; Research grant/Funding (institution): Regeneron; Advisory/Consultancy, Speaker Bureau/Expert testimony: Genentech; Advisory/Consultancy, Speaker Bureau/Expert testimony: Exelixis; Advisory/Consultancy, Speaker Bureau/Expert testimony: Genomic Health; Advisory/Consultancy, Speaker Bureau/Expert testimony: Sanofi Aventis; Advisory/Consultancy: AstraZeneca; Advisory/Consultancy: Bayer; Advisory/Consultancy: Foundation Medicine; Advisory/Consultancy: Amgen; Advisory/Consultancy: MJH Associates; Advisory/Consultancy: Bristol-Myers Squibb; Advisory/Consultancy: Pharmacyclics; Advisory/Consultancy: Seattle Genetics."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Christensen", "first_name": "J.", "last_name": "Christensen", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Mirati Therapeutics."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. Shazer", "first_name": "R.", "last_name": "Shazer", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Mirati Therapeutics."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "X. Yan", "first_name": "X.", "last_name": "Yan", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Mirati Therapeutics."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Winter", "first_name": "M.", "last_name": "Winter", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Mirati Therapeutics."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "G. Vasudeva Iyer", "first_name": "G.", "last_name": "Iyer", "second_name": "Vasudeva", "title": " Honoraria (self), Research grant/Funding (institution): Mirati Therapeutics; Honoraria (self), Research grant/Funding (institution): Janssen; Research grant/Funding (institution): DeBioPharm; Research grant/Funding (institution): Novartis."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Wing Kin Liu", "first_name": "Kin", "last_name": "Liu", "second_name": "", "country": "United Kingdom", "city": "London", "title": "Wing"}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Ragnhild Hellesnes", "first_name": "Ragnhild", "last_name": "Hellesnes", "second_name": "", "country": "Norway", "city": "Tromso", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Pia J. Österlund", "first_name": "Pia", "last_name": "Österlund", "second_name": "J.", "country": "Finland", "city": "Tampere", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "David Sebag-Montefiore", "first_name": "David", "last_name": "Sebag-Montefiore", "second_name": "", "country": "United Kingdom", "city": "Leeds", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Christophe Borg", "first_name": "Christophe", "last_name": "Borg", "second_name": "", "country": "CEDE", "city": "Besancon", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "L. Etienne", "first_name": "L.", "last_name": "Etienne", "second_name": "", "title": " Research grant/Funding (institution): Bristol Meyers Squibb; Travel/Accommodation/Expenses: Sanofi; Travel/Accommodation/Expenses: Ipsen; Travel/Accommodation/Expenses: Novartis; Travel/Accommodation/Expenses: Roche; Travel/Accommodation/Expenses: Amgen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "V. Boige", "first_name": "V.", "last_name": "Boige", "second_name": "", "title": " Research grant/Funding (institution): Merck Serono; Advisory/Consultancy: Eisai; Advisory/Consultancy: Ipsen; Advisory/Consultancy: BMS; Advisory/Consultancy: Bayer; Advisory/Consultancy: Merck Serono; Travel/Accommodation/Expenses: Bayer; Travel/Accommodation/Expenses: Merck Serono; Travel/Accommodation/Expenses: Roche; Travel/Accommodation/Expenses: Sanofi."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Louvet", "first_name": "C.", "last_name": "Louvet", "second_name": "", "title": " Advisory/Consultancy: MSD; Advisory/Consultancy: Halozyme; Advisory/Consultancy: Roche; Advisory/Consultancy: Celgene; Travel/Accommodation/Expenses: MSD; Travel/Accommodation/Expenses: Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Lars Henrik Jensen", "first_name": "Lars", "last_name": "Jensen", "second_name": "Henrik", "country": "Denmark", "city": "Vejle", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Takayuki Yoshino", "first_name": "Takayuki", "last_name": "Yoshino", "second_name": "", "country": "Chib", "city": "Kashiwa", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Kotaka", "first_name": "M.", "last_name": "Kotaka", "second_name": "", "title": " Honoraria (self): Chugai Pharmaceutical; Honoraria (self): Yakult Honsha; Honoraria (self): Takeda Pharmaceutical."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Nakamura", "first_name": "M.", "last_name": "Nakamura", "second_name": "", "title": " Speaker Bureau/Expert testimony: Chugai Co."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "T. Mizushima", "first_name": "T.", "last_name": "Mizushima", "second_name": "", "title": " Speaker Bureau/Expert testimony: EA Pharma Co."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "T. Yamanaka", "first_name": "T.", "last_name": "Yamanaka", "second_name": "", "title": " Honoraria (self), Research grant/Funding (institution): Chugai; Honoraria (self), Research grant/Funding (institution): Takeda; Honoraria (self), Research grant/Funding (institution): Taiho; Honoraria (self), Research grant/Funding (institution): Boehringer-Ingelheim; Honoraria (self), Research grant/Funding (institution): Bayer; Honoraria (self): Pfizer; Advisory/Consultancy: Gilead Sciences; Advisory/Consultancy, Research grant/Funding (institution): Daiichi-Sankyo; Advisory/Consultancy: Huya Biosciences; Advisory/Consultancy: Sysmex; Research grant/Funding (institution): Ono; Research grant/Funding (institution): Merck Serono; Research grant/Funding (institution): Astellas; Research grant/Funding (institution): Eli Lilly."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "V. Formica", "first_name": "V.", "last_name": "Formica", "second_name": "", "title": " Honoraria (self): Amgen; Servier."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Scartozzi", "first_name": "M.", "last_name": "Scartozzi", "second_name": "", "title": " Advisory/Consultancy: Amgen; Bayer; Bristol-Myers Squibb; Celgene; Eisai; Merck Serono; Sanofi; Speaker Bureau/Expert testimony: Amgen; Bayer; Eisai; Merck Serono; Roche/Genentech; Servier; Research grant/Funding (self), Research grant/Funding (institution): Bayer; Celgene (Inst); Merck Serono (Inst); Merck Sharp & Dohme (Inst); Sanofi (Inst); Travel/Accommodation/Expenses: Celgene; Merck Serono; Servier."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "V. Zagonel", "first_name": "V.", "last_name": "Zagonel", "second_name": "", "title": " Advisory/Consultancy: Bristol-Myers Squibb; Merck; Speaker Bureau/Expert testimony: Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Lilly; Roche; Servier laboratories Ltd; Travel/Accommodation/Expenses: Bayer; Roche; Servier laboratories Ltd."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Van Morris", "first_name": "Van", "last_name": "Morris", "second_name": "", "country": "United States of America", "city": "Houston", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "I. Wistuba", "first_name": "I.", "last_name": "Wistuba", "second_name": "", "title": " Honoraria (self), Research grant/Funding (self): Genentech; Honoraria (self), Research grant/Funding (self): Bayer; Honoraria (self), Research grant/Funding (self): AstraZeneca/Medimmune; Honoraria (self), Research grant/Funding (self): Pfizer; Honoraria (self), Research grant/Funding (self): HTG Molecular; Honoraria (self): Asuragen; Honoraria (self), Research grant/Funding (self): Merck; Honoraria (self): GlaxoSmithKline; Honoraria (self): GuardantHealth; Honoraria (self): Oncocyte; Honoraria (self): MSD; Research grant/Funding (self): Oncoplex; Research grant/Funding (self): DepArray; Research grant/Funding (self): Bristol-Myers Squibb; Research grant/Funding (self): Adaptive; Research grant/Funding (self): Adaptimmune; Research grant/Funding (self): EMD Serono; Research grant/Funding (self): Takeda; Research grant/Funding (self): Amgen; Research grant/Funding (self): Karus; Research grant/Funding (self): Johnson & Johnson; Research grant/Funding (self): Iovance; Research grant/Funding (self): 4D; Research grant/Funding (self): Novartis; Research grant/Funding (self): Akoya."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "P. Hwu", "first_name": "P.", "last_name": "Hwu", "second_name": "", "title": " Research grant/Funding (institution): GlaxoSmithKline; Officer/Board of Directors: Immatics; Research grant/Funding (institution): Sanofi; Research grant/Funding (institution): Dragonfly."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Yao", "first_name": "C.", "last_name": "Yao", "second_name": "", "title": " Research grant/Funding (self): Ipsen; Research grant/Funding (self): Chiasma; Research grant/Funding (self): Hutchinson Medi Pharma; Research grant/Funding (self): Advanced Accelerator Applications; Research grant/Funding (self): Novartis; Research grant/Funding (self): Tarveda; Research grant/Funding (self): Crinetics."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Halperin", "first_name": "D.", "last_name": "Halperin", "second_name": "", "title": " Research grant/Funding (institution): Genentech; Research grant/Funding (self): Tarveda; Advisory/Consultancy, Research grant/Funding (self): Advanced Accelerator Applications; Advisory/Consultancy, Research grant/Funding (self): Lexicon; Research grant/Funding (self): Incyte; Research grant/Funding (self): ThermoFisher; Advisory/Consultancy: Ipsen; Advisory/Consultancy: Curium."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Marie-Christine Etienne-Grimaldi", "first_name": "Marie-Christine", "last_name": "Etienne-Grimaldi", "second_name": "", "country": "France", "city": "Nice", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Meulendijks", "first_name": "D.", "last_name": "Meulendijks", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Palles", "first_name": "C.", "last_name": "Palles", "second_name": "", "title": " Advisory/Consultancy: Oxford Cancer Biomarkers."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "U. Zanger", "first_name": "U.", "last_name": "Zanger", "second_name": "", "title": " Licensing/Royalties: Robert Bosch GmbH."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Taieb", "first_name": "J.", "last_name": "Taieb", "second_name": "", "title": " Advisory/Consultancy: Amgen; Honoraria (self): Lily; Advisory/Consultancy: Sanofi; Honoraria (self): Roche; Advisory/Consultancy: Merk; Honoraria (self), Advisory/Consultancy: MSD; Honoraria (self): Celgene; Advisory/Consultancy: Servier; Honoraria (self): Sirtex; Advisory/Consultancy: Pierre Fabre."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "E. Gross", "first_name": "E.", "last_name": "Gross", "second_name": "", "title": " Licensing/Royalties, Method for predicting treatment response in breast cancer: Patent pending."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Fotios Loupakis", "first_name": "Fotios", "last_name": "Loupakis", "second_name": "", "country": "Italy", "city": "Padova", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Aleshin", "first_name": "A.", "last_name": "Aleshin", "second_name": "", "title": " Full/Part-time employment: Natera."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Noelia Tarazona", "first_name": "Noelia", "last_name": "Tarazona", "second_name": "", "country": "Valenci", "city": "Valencia", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Ulrik N. Lassen", "first_name": "Ulrik", "last_name": "Lassen", "second_name": "N.", "country": "Denmark", "city": "Copenhagen", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Elena Garralda", "first_name": "Elena", "last_name": "Garralda", "second_name": "", "country": "Spain", "city": "Barcelona", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Mohamed A. Gouda", "first_name": "Mohamed", "last_name": "Gouda", "second_name": "A.", "country": "United States of America", "city": "Houston", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Parikh", "first_name": "A.", "last_name": "Parikh", "second_name": "", "title": " Advisory/Consultancy: Natera; Advisory/Consultancy, Research grant/Funding (institution): Eli Lilly; Advisory/Consultancy: Puretech; Research grant/Funding (institution): Plexxikon; Research grant/Funding (institution): Guardant Health; Research grant/Funding (institution): BMS; Research grant/Funding (institution): Novartis; Research grant/Funding (institution): Array; Research grant/Funding (institution): Tesaro."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Kummar", "first_name": "S.", "last_name": "Kummar", "second_name": "", "title": " Advisory/Consultancy: Bayer; Advisory/Consultancy: Boehringer Ingelheim; Advisory/Consultancy: HarbourBioMed; Advisory/Consultancy: Genome & Company; Advisory/Consultancy: Springworks Therapeutics; Advisory/Consultancy: Corvus Pharmaceuticals; Advisory/Consultancy: Varian; Leadership role, Co-Founder: PathomIQ ."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Zhang", "first_name": "C.", "last_name": "Zhang", "second_name": "", "title": " Leadership role, Full/Part-time employment: Plexxikon."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "P. Severson", "first_name": "P.", "last_name": "Severson", "second_name": "", "title": " Full/Part-time employment: Plexxikon."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "K. Inokuchi", "first_name": "K.", "last_name": "Inokuchi", "second_name": "", "title": " Full/Part-time employment: Plexxikon."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Silverman", "first_name": "M.", "last_name": "Silverman", "second_name": "", "title": " Advisory/Consultancy: Plexxikon."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "G. Bollag", "first_name": "G.", "last_name": "Bollag", "second_name": "", "title": " Leadership role, Full/Part-time employment: Plexxikon."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "F. Janku", "first_name": "F.", "last_name": "Janku", "second_name": "", "title": " Research grant/Funding (institution): Novartis; Research grant/Funding (institution): Genentech; Research grant/Funding (institution): BioMed Valley Discoveries; Research grant/Funding (institution): Plexxikon; Research grant/Funding (institution): Deciphera; Research grant/Funding (institution): Piqur; Research grant/Funding (institution): Symphogen; Research grant/Funding (institution): Bayer; Research grant/Funding (institution): FujiFilm Corporation; Research grant/Funding (institution): Astex; Research grant/Funding (institution): Asana; Research grant/Funding (institution): Astellas; Research grant/Funding (institution): Agios; Research grant/Funding (institution): Proximagen; Research grant/Funding (institution): Bristol-Myers Squibb; Advisory/Consultancy: Asana; Advisory/Consultancy: Deciphera; Advisory/Consultancy: IFM Therapeutics; Advisory/Consultancy: Synlogic; Advisory/Consultancy: Guardant Health; Advisory/Consultancy: Ideaya; Advisory/Consultancy: PureTech Health; Advisory/Consultancy, Shareholder/Stockholder/Stock options: Cardiff Oncology; Advisory/Consultancy: Immunomet; Advisory/Consultancy: Jazz Pharmaceuticals; Advisory/Consultancy: Sotio."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Goel", "first_name": "S.", "last_name": "Goel", "second_name": "", "title": " Non-remunerated activity/ies, - I have a patent with a co-inventor, John Mariadason, Ph."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. Chandana", "first_name": "R.", "last_name": "Chandana", "second_name": "", "title": " Research grant/Funding (institution): BeiGene, Ltd."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "E. Calvo", "first_name": "E.", "last_name": "Calvo", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (institution): Boehringer-Ingelheim, PsiOxus, Nanobiotix Janssen, AbbVie, Janseen-Cilag, Seattle Genetics, Pierre Fabre, Cerulean Pharma, EUSA, Celgene, AstraZeneca; Research grant/Funding (institution): Roche/Genentech, BMS, PharmaMar, PUMA, Sanofi, Lilly, Pfizer, Merck, Nektar, Amcure, Amgen, AstraZenca, Principia Bayer, CytomX, H3, Incyte, Kura, LOXO, Macrogenenics, Menarini, Merck Serono, Merus, Millenium, Rigontec, Tahio, Tesaro, BeiGene; Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (institution): Novartis; Leadership role, Full/Part-time employment, Officer/Board of Directors: START; Honoraria (self), Full/Part-time employment: HM Hospitals Group; Leadership role, Ownership: Oncoart Associated, International Cancer Consultants; Advisory/Consultancy: Nanobiotix, PsiOxus Therapeutics, AbbVie, Guidepoint Global, GLG, Pfizer, Servier, Amcure, ; Advisory/Consultancy, Speaker Bureau/Expert testimony: Novartis; Advisory/Consultancy, Travel/Accommodation/Expenses: Roche Genentech; Officer/Board of Directors, President and founder: NPO Foundation Intheos (Investigational Therapeutics in Oncological Sciences)."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "T. Arkenau", "first_name": "T.", "last_name": "Arkenau", "second_name": "", "title": " Research grant/Funding (institution): Beigene, Roche, Bayer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Cervantes", "first_name": "A.", "last_name": "Cervantes", "second_name": "", "title": " Research grant/Funding (institution): Beigene, Genentech, Fibrogen, Amcure, Sierra Oncology, AstraZenca, Medimmune, B L."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Fu", "first_name": "S.", "last_name": "Fu", "second_name": "", "title": " Research grant/Funding (institution): NIH/NCI, NeuPharma, Inc, Novartis, OncoMed Pharmaceuticals, Parexel International, LLC, Sellas Life Sciences Group, Soricimed Biopharma, Inc, Tolero Pharmaceuticals; Research grant/Funding (institution): AstraZenca, Anaeropharma Science, Arrien Pharmaceuticals, BeiGene, BioAtla, LCC; Research grant/Funding (institution): Abbisko, Boehringer Ingelheim, Eli Lilly & Co, Hookipa Biotech, Huya Bioscience International, IMV, Inc, Innovent Biologics, Co, Ltd, Macrogenics, Medivir AB, Millennium Pharmaceuticals, Inc, Nerviano Medical Sciences."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. Plummer", "first_name": "R.", "last_name": "Plummer", "second_name": "", "title": " Honoraria (self): BeiGene."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Evans", "first_name": "J.", "last_name": "Evans", "second_name": "", "title": " Research grant/Funding (institution): BeiGene, AstraZeneca, Basilea, MiNa Therapeutics, Pfizer, Sierra, Lilly, Novartis, Bicycle Therapeutics, Halozyme, Johnson & Johnson, Vrtex, CytomX, Plexxikon, Boehringer, Athenex, Adaptimmune, Verastem, Immunocore, Iovance, Berg, BiolinerX; Honoraria (institution), Research grant/Funding (institution): Bayer, Celgene, BMS, Clovis, Eisai, Genentech, GlaxoSmithKline, Immunova, Nucana, Karus Therapeutics, Otsuka, Roche, MSD, Medivir."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "L. Horvath", "first_name": "L.", "last_name": "Horvath", "second_name": "", "title": " Leadership role, Shareholder/Stockholder/Stock options, Full/Part-time employment: Connected Medical Solutions; Research grant/Funding (institution), Travel/Accommodation/Expenses: Astellas; Travel/Accommodation/Expenses: Janssen-Cilag; Honoraria (self), Shareholder/Stockholder/Stock options: Imagion Biosystems."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Prawira", "first_name": "A.", "last_name": "Prawira", "second_name": "", "title": " Research grant/Funding (institution): BeiGene, Arcusbio, Akesobio, Pfizer, Bayer, Mapkure, Roche/Genentech, BMS, Apollomics, CStone, Macrogenics, Five Prime, Henlius, Eli Lilly, Virogin, Janssen, AstraZenca, Bio Oncology, MSD, Eisai."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "K. Qu", "first_name": "K.", "last_name": "Qu", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: BeiGene, Ltd."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. Pelham", "first_name": "R.", "last_name": "Pelham", "second_name": "", "title": " Full/Part-time employment: BeiGene, Ltd."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Alberto Hernando-Calvo", "first_name": "Alberto", "last_name": "Hernando-Calvo", "second_name": "", "country": "Spain", "city": "Barcelona", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Vieito", "first_name": "M.", "last_name": "Vieito", "second_name": "", "title": " Advisory/Consultancy: Debio; Advisory/Consultancy: Roche; Advisory/Consultancy: TFS; Travel/Accommodation/Expenses: Roche; Travel/Accommodation/Expenses: Merck Serono."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "B. Azaro Pedrazzoli", "first_name": "B.", "last_name": "Pedrazzoli", "second_name": "Azaro", "title": " Advisory/Consultancy: Orion Pharma; Advisory/Consultancy: Ambcure GmbH; Research grant/Funding (self): Ambcure GmbH."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "I. Matos", "first_name": "I.", "last_name": "Matos", "second_name": "", "title": " Research grant/Funding (self), ESMO Research Fellowship: Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Saura", "first_name": "C.", "last_name": "Saura", "second_name": "", "title": " Advisory/Consultancy: AstraZenca; Advisory/Consultancy: Celgene; Advisory/Consultancy: Daiichi Sankyo; Advisory/Consultancy: F-Hoffmann La Roche Ltd; Advisory/Consultancy: Genomic Health; Advisory/Consultancy, Research grant/Funding (institution): Merck, Sharp and Dhome España S."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "G. Argiles Martinez", "first_name": "G.", "last_name": "Martinez", "second_name": "Argiles", "title": " Advisory/Consultancy, Research grant/Funding (institution): Hoffman La-Roche; Advisory/Consultancy: Bristol-Myers Squibb; Advisory/Consultancy: Bayer; Advisory/Consultancy, Research grant/Funding (institution): Servier; Advisory/Consultancy: Amgen; Advisory/Consultancy: Merck Serono; Advisory/Consultancy: Menarini; Research grant/Funding (institution): Bayer; Research grant/Funding (institution): Novartis; Research grant/Funding (institution): Boehringer Ingelheim; Research grant/Funding (institution): Boston Pharmaceuticals; Research grant/Funding (institution): Genentech."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "E. Munoz Couselo", "first_name": "E.", "last_name": "Couselo", "second_name": "Munoz", "title": " Honoraria (self), Advisory/Consultancy: Amgen; Honoraria (self), Advisory/Consultancy: Bristol-Myers Squibb; Honoraria (self), Advisory/Consultancy: Merck Sharp and Dohme; Honoraria (self), Advisory/Consultancy: Novartis; Honoraria (self), Advisory/Consultancy: Pierre Fabre; Honoraria (self), Advisory/Consultancy: Roche; Honoraria (self): Sanofi."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Seoane", "first_name": "J.", "last_name": "Seoane", "second_name": "", "title": " Leadership role, Research grant/Funding (institution): Mosaic Biomedical; Research grant/Funding (institution): Northern Biologics; Research grant/Funding (institution): Roche/Glycart; Research grant/Funding (institution): Hoffmann La Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Tabernero", "first_name": "J.", "last_name": "Tabernero", "second_name": "", "title": " Advisory/Consultancy: Array Biopharma ; Advisory/Consultancy: AstraZeneca; Advisory/Consultancy: Bayer; Advisory/Consultancy: BeiGene; Advisory/Consultancy: Boehringer Ingelheim; Advisory/Consultancy: Chugai; Advisory/Consultancy: Genentech; Advisory/Consultancy: Genmab A/S; Advisory/Consultancy: Halozyme; Advisory/Consultancy: Imugene Limited; Advisory/Consultancy: Inflection Biosciences Limited; Advisory/Consultancy: Ipsen; Advisory/Consultancy: Kura Oncology; Advisory/Consultancy: Lilly; Advisory/Consultancy: MSD; Advisory/Consultancy: Menarini; Advisory/Consultancy: Merck Serono; Advisory/Consultancy: Merrimack; Advisory/Consultancy: Merus; Advisory/Consultancy: Molecular Partners; Advisory/Consultancy: Novartis; Advisory/Consultancy: Pectomyc; Advisory/Consultancy: Pfizer; Advisory/Consultancy: Pharmacyclics; Advisory/Consultancy: ProteoDesign SL; Advisory/Consultancy: Rafael Pharmaceuticals; Advisory/Consultancy: F."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Vivancos", "first_name": "A.", "last_name": "Vivancos", "second_name": "", "title": " Advisory/Consultancy: Sysmex; Advisory/Consultancy, Research grant/Funding (institution): Novartis; Advisory/Consultancy: Merck; Advisory/Consultancy: Roche; Advisory/Consultancy, Research grant/Funding (institution): Bristol-Myers Squibb; Advisory/Consultancy: Guardant Health; Advisory/Consultancy: Bayer; Licensing/Royalties: Ferrer; Research grant/Funding (institution): Debio; Advisory/Consultancy: Sysmex; Research grant/Funding (institution): Cellestia Biotech; Research grant/Funding (institution): Roche; Research grant/Funding (institution): Chittern."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "E. Garralda", "first_name": "E.", "last_name": "Garralda", "second_name": "", "title": " Research grant/Funding (institution): Novartis; Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (institution): Roche; Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (institution): Thermo Fisher; Advisory/Consultancy: Hoffmann La Roche; Research grant/Funding (institution): Ellipses Pharma; Advisory/Consultancy: Neomed Therapeutics; Advisory/Consultancy: Boehringer Ingelheim; Advisory/Consultancy: Janssen Global Services; Advisory/Consultancy: SeaGen; Advisory/Consultancy: TFS; Research grant/Funding (institution): Alkermes; Advisory/Consultancy, Research grant/Funding (institution): Bristol Mayers Squibb; Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: Merck Sharp and Dohme; Travel/Accommodation/Expenses: Menarini; Travel/Accommodation/Expenses: Glycotope."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Ying Cheng", "first_name": "Ying", "last_name": "Cheng", "second_name": "", "country": "Jili", "city": "Changchun", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Nicolas Girard", "first_name": "Nicolas", "last_name": "Girard", "second_name": "", "country": "France", "city": "Paris", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Wermke", "first_name": "M.", "last_name": "Wermke", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: BMS; Honoraria (self): Merck; Honoraria (self), Advisory/Consultancy: Roche; Honoraria (self), Advisory/Consultancy: Novartis; Honoraria (self), Advisory/Consultancy: Kite Pharma; Honoraria (self), Advisory/Consultancy: Boehringer Ingelheim; Honoraria (self), Travel/Accommodation/Expenses: AstraZeneca; Advisory/Consultancy: Heidelberg Pharma; Travel/Accommodation/Expenses: Glenmark."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "F. Ghiringhelli", "first_name": "F.", "last_name": "Ghiringhelli", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Roche; Honoraria (self), Research grant/Funding (institution), Travel/Accommodation/Expenses: Astra; Honoraria (self): Merck Serono; Honoraria (self): BMS; Honoraria (self): MSD; Honoraria (self), Travel/Accommodation/Expenses: Amgen; Honoraria (self): Bayer; Honoraria (self), Travel/Accommodation/Expenses: Servier."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "T. Landsteiner", "first_name": "T.", "last_name": "Landsteiner", "second_name": "", "title": " Full/Part-time employment: Boehringer Ingelheim."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "G. Jayadeva", "first_name": "G.", "last_name": "Jayadeva", "second_name": "", "title": " Full/Part-time employment: Boehringer Ingelheim."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Alt", "first_name": "J.", "last_name": "Alt", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy: AstraZeneca; Honoraria (self), Advisory/Consultancy: BMS; Honoraria (self), Advisory/Consultancy: Boehringer Ingelheim; Honoraria (self), Advisory/Consultancy: MSD; Honoraria (self), Advisory/Consultancy: Novartis; Honoraria (self), Advisory/Consultancy: Pfizer; Honoraria (self), Advisory/Consultancy: Roche; Honoraria (self), Advisory/Consultancy: Takeda."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "B. Hackanson", "first_name": "B.", "last_name": "Hackanson", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy: BMS; Honoraria (self), Advisory/Consultancy: Boehringer Ingelheim; Honoraria (self), Advisory/Consultancy: MSD; Honoraria (self): Takeda; Honoraria (self): Pfizer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Noboru Yamamoto", "first_name": "Noboru", "last_name": "Yamamoto", "second_name": "", "country": "Japan", "city": "Chuo-ku", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "T. Koyama", "first_name": "T.", "last_name": "Koyama", "second_name": "", "title": " Honoraria (self): Sysmex; Honoraria (self): Chugai."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Nishino", "first_name": "M.", "last_name": "Nishino", "second_name": "", "title": " Honoraria (self): AstraZeneca; Honoraria (self): BMS; Honoraria (self): Boehringer Ingelheim Japan; Honoraria (self), Honoraria (institution): Chugai; Honoraria (self), Honoraria (institution): Eli Lilly; Honoraria (self): MSD; Honoraria (self): ONO; Honoraria (self): Taiho."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Kondo", "first_name": "S.", "last_name": "Kondo", "second_name": "", "title": " Research grant/Funding (institution): MSD; Research grant/Funding (institution): AbbVie; Research grant/Funding (institution): Eli Lilly; Research grant/Funding (institution): AZD; Research grant/Funding (institution): Pfizer; Research grant/Funding (institution): Takeda; Research grant/Funding (institution): Boehringer Ingelheim."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "T. Yoshida", "first_name": "T.", "last_name": "Yoshida", "second_name": "", "title": " Speaker Bureau/Expert testimony, Research grant/Funding (institution): AstraZeneca; Speaker Bureau/Expert testimony: BMS; Speaker Bureau/Expert testimony: Chugai; Speaker Bureau/Expert testimony: Novartis; Research grant/Funding (institution): Ono; Research grant/Funding (institution): Takeda; Research grant/Funding (institution): MSD; Research grant/Funding (institution): AbbVie."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "T. Ozaki", "first_name": "T.", "last_name": "Ozaki", "second_name": "", "title": " Full/Part-time employment: Ono pharmaceutical."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Kondo", "first_name": "M.", "last_name": "Kondo", "second_name": "", "title": " Full/Part-time employment: Ono pharmaceutical."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "T. Shimizu", "first_name": "T.", "last_name": "Shimizu", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (institution): Millenium-Takeda; Research grant/Funding (institution): Novartis; Research grant/Funding (institution): Eli Lilly; Research grant/Funding (institution): Daiichi-Sankyo; Research grant/Funding (institution): BMS; Research grant/Funding (institution): AstraZeneca; Research grant/Funding (institution): Eisai; Research grant/Funding (institution): AbbVie; Research grant/Funding (institution): Incyte; Research grant/Funding (institution): Astellas Pharma; Research grant/Funding (institution): Symbio Pharmaceuticals; Research grant/Funding (institution): 3D-Medicine; Research grant/Funding (institution): Chordia Therapeutics; Research grant/Funding (institution): Five Prime; Research grant/Funding (institution): PharmaMar."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Juan Martin Liberal", "first_name": "Juan", "last_name": "Liberal", "second_name": "Martin", "country": "Spain", "city": "Barcelona", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Fong", "first_name": "C.", "last_name": "Fong", "second_name": "", "title": " Honoraria (self): AstraZeneca, Merck Sharp & Dohme; Advisory/Consultancy: Merck Sharp & Dohme; Speaker Bureau/Expert testimony: Janssen; Travel/Accommodation/Expenses: Pfizer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "V. Moreno", "first_name": "V.", "last_name": "Moreno", "second_name": "", "title": " Travel/Accommodation/Expenses, Personal Fees: BMS; Travel/Accommodation/Expenses, Personal Fees: Bayer; Travel/Accommodation/Expenses, Personal Fees: Pieris."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Desai", "first_name": "J.", "last_name": "Desai", "second_name": "", "title": " Advisory/Consultancy: Amgen; Advisory/Consultancy: BeiGene; Advisory/Consultancy, Research grant/Funding (institution): Bionomics; Advisory/Consultancy: Eisai; Advisory/Consultancy: Lilly; Advisory/Consultancy, Research grant/Funding (institution): Novartis; Research grant/Funding (institution): Roche; Research grant/Funding (institution): GlaxoSmitKline."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "B. Markman", "first_name": "B.", "last_name": "Markman", "second_name": "", "title": " Advisory/Consultancy: Novartis; Advisory/Consultancy: Amgen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Voskoboynik", "first_name": "M.", "last_name": "Voskoboynik", "second_name": "", "title": " Travel/Accommodation/Expenses, personal fees: MSD; Travel/Accommodation/Expenses, personal fees: AstraZenca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "N. Budha", "first_name": "N.", "last_name": "Budha", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: BeiGene, Ltd."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Wu", "first_name": "J.", "last_name": "Wu", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: BeiGene, Ltd."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "W. Shen", "first_name": "W.", "last_name": "Shen", "second_name": "", "title": " Full/Part-time employment: BeiGene, Ltd."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Singh", "first_name": "M.", "last_name": "Singh", "second_name": "", "title": " Full/Part-time employment: BeiGene, Ltd."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "John Sarantopoulos", "first_name": "John", "last_name": "Sarantopoulos", "second_name": "", "country": "T", "city": "San Antonio", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Beg", "first_name": "M.", "last_name": "Beg", "second_name": "", "title": " Research grant/Funding (institution): Tolero Pharmaceuticals, Inc."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Melear", "first_name": "J.", "last_name": "Melear", "second_name": "", "title": " Research grant/Funding (institution): Tolero Pharmaceuticals, Inc; Speaker Bureau/Expert testimony: Janssen; Speaker Bureau/Expert testimony: AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Thompson", "first_name": "J.", "last_name": "Thompson", "second_name": "", "title": " Research grant/Funding (institution): Tolero Pharmaceuticals, Inc; Advisory/Consultancy: Pfizer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Tsai", "first_name": "C.", "last_name": "Tsai", "second_name": "", "title": " Advisory/Consultancy: Tempus Lab; Leadership role: Caremission LLC; Shareholder/Stockholder/Stock options: Salarius Pharmaceuticals; Research grant/Funding (institution): Tolero Pharmaceuticals, Inc."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Baranda", "first_name": "C.", "last_name": "Baranda", "second_name": "", "title": " Research grant/Funding (institution): Exelixis; Research grant/Funding (institution): Astellas; Research grant/Funding (institution): Tolero Pharmaceuticals; Research grant/Funding (institution): Xencor; Research grant/Funding (institution): Pfizer; Research grant/Funding (institution): Incyte; Research grant/Funding (institution): Eli Lilly; Research grant/Funding (institution), Travel/Accommodation/Expenses: Sanofi; Research grant/Funding (institution): Nektar; Research grant/Funding (institution): SQZ; Shareholder/Stockholder/Stock options: Forty-Seven Inc; Shareholder/Stockholder/Stock options: Moderna; Shareholder/Stockholder/Stock options: Zymeworks; Shareholder/Stockholder/Stock options: Morphosys AG."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "B. Bastos", "first_name": "B.", "last_name": "Bastos", "second_name": "", "title": " Research grant/Funding (institution): Tolero Pharmaceuticals, Inc; Speaker Bureau/Expert testimony: Regeneron; Speaker Bureau/Expert testimony: Sanofi Genzyme."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Spira", "first_name": "A.", "last_name": "Spira", "second_name": "", "title": " Honoraria (self), Research grant/Funding (self): Cytomx; Honoraria (self), Research grant/Funding (self): Amgen; Honoraria (self), Research grant/Funding (self): Novartis; Honoraria (self), Research grant/Funding (self): Merck; Honoraria (self), Research grant/Funding (self): AstraZeneca; Honoraria (self), Research grant/Funding (self): Bristol-Myers-Squibb; Research grant/Funding (self): EMD Serono; Research grant/Funding (self): Turning Point; Research grant/Funding (institution): Tolero Pharmaceuticals, Inc."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Y. Lou", "first_name": "Y.", "last_name": "Lou", "second_name": "", "title": " Advisory/Consultancy: Novocure; Research grant/Funding (institution): Tolero Pharmaceuticals, Inc; Research grant/Funding (institution): Tesaro; Research grant/Funding (institution): Merck Sharp & Dohme; Research grant/Funding (institution): Blueprint Medicines; Research grant/Funding (institution): Vaccinex; Advisory/Consultancy: AstraZeneca; Research grant/Funding (institution): Macrogenics; Advisory/Consultancy: Clarion Healthcare; Research grant/Funding (institution): Kyowa Hakko Kirin Pharma; Research grant/Funding (institution): Harpoon Therapeutics; Research grant/Funding (institution): Sun Pharma Advanced Research Company Limited."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Seetharam", "first_name": "M.", "last_name": "Seetharam", "second_name": "", "title": " Research grant/Funding (institution): Tolero Pharmaceuticals, Inc; Advisory/Consultancy: Daiichi-Sankyo; Honoraria (self): CME Horizon."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Uemura", "first_name": "M.", "last_name": "Uemura", "second_name": "", "title": " Shareholder/Stockholder/Stock options: Abbott Laboratories; Advisory/Consultancy: Seattle Genetics; Shareholder/Stockholder/Stock options, Spouse/Financial dependant: Regeneron Pharmaceuticals."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. Camidge", "first_name": "R.", "last_name": "Camidge", "second_name": "", "title": " Research grant/Funding (institution): Tolero Pharmaceuticals, Inc; Advisory/Consultancy: Anchiarno; Advisory/Consultancy: Amgen; Advisory/Consultancy, Research grant/Funding (institution): Takeda; Advisory/Consultancy, Research grant/Funding (institution): Roche / Genentech; Advisory/Consultancy: EMD Serono; Advisory/Consultancy: Sanofi; Advisory/Consultancy, Research grant/Funding (institution): Pfizer; Advisory/Consultancy: CBT Pharmaceuticals; Advisory/Consultancy: Daiichi-Sankyo; Advisory/Consultancy: G1 Therapeutics; Advisory/Consultancy, Research grant/Funding (institution): AbbVie; Advisory/Consultancy: Achilles; Advisory/Consultancy: BeyondSpring; Advisory/Consultancy: Apollomics; Advisory/Consultancy: 14ner / Elevation; Advisory/Consultancy: Archer; Advisory/Consultancy, Research grant/Funding (institution): Bristol-Myers Squibb; Advisory/Consultancy, Research grant/Funding (institution): AstraZeneca; Research grant/Funding (institution): Glaxo-Smith-Kline; Advisory/Consultancy, Research grant/Funding (institution): Hansoh; Research grant/Funding (institution): InhibRx; Research grant/Funding (institution): Lycera; Research grant/Funding (institution): MedImmune; Research grant/Funding (institution): Merck; Research grant/Funding (institution): Phosplatin; Research grant/Funding (institution): Psioxus; Research grant/Funding (institution): Rain; Research grant/Funding (institution): Seattle Genetics; Research grant/Funding (institution): Symphogen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "N. Yamamoto", "first_name": "N.", "last_name": "Yamamoto", "second_name": "", "title": " Research grant/Funding (institution): Tolero Pharmaceuticals, Inc; Research grant/Funding (institution): Astellas; Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (institution): Chugai; Advisory/Consultancy, Research grant/Funding (institution): Eisai; Research grant/Funding (institution): Taiho; Speaker Bureau/Expert testimony, Research grant/Funding (institution): Bristol-Myers-Squibb; Speaker Bureau/Expert testimony, Research grant/Funding (institution): Pfizer; Research grant/Funding (institution): Novartis; Speaker Bureau/Expert testimony, Research grant/Funding (institution): Eli Lilly; Research grant/Funding (institution): AbbVie; Research grant/Funding (institution): Daiichi-Sankyo; Research grant/Funding (institution): Bayer; Advisory/Consultancy, Research grant/Funding (institution): Boehringer-Ingelheim; Research grant/Funding (institution): Kyowa-Hakko Kirin; Advisory/Consultancy, Research grant/Funding (institution): Takeda; Speaker Bureau/Expert testimony, Research grant/Funding (institution): Ono; Research grant/Funding (institution): Janssen Pharma; Research grant/Funding (institution): Merck Sharp & Dohme; Research grant/Funding (institution): Merck; Research grant/Funding (institution): Glaxo-Smith-Kline; Research grant/Funding (institution): Sumitomo Dainippon; Advisory/Consultancy: Otsuka; Advisory/Consultancy: Cimic; Speaker Bureau/Expert testimony: AstraZeneca; Speaker Bureau/Expert testimony: Sysmex."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "P. Anthony", "first_name": "P.", "last_name": "Anthony", "second_name": "", "title": " Full/Part-time employment: Tolero Pharmaceuticals, Inc; Advisory/Consultancy: Paradigm."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Wade", "first_name": "M.", "last_name": "Wade", "second_name": "", "title": " Full/Part-time employment: Tolero Pharmaceuticals, Inc."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Bearss", "first_name": "J.", "last_name": "Bearss", "second_name": "", "title": " Officer/Board of Directors: Tolero Pharmaceuticals, Inc."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Sarantopoulos", "first_name": "J.", "last_name": "Sarantopoulos", "second_name": "", "title": " Research grant/Funding (institution): Tolero Pharmaceuticals, Inc."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Maria Vieito Villar", "first_name": "Maria", "last_name": "Villar", "second_name": "Vieito", "country": "La Coruñ", "city": "Barcelona", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Wang", "first_name": "S.", "last_name": "Wang", "second_name": "", "title": " Honoraria (self), Speaker Bureau/Expert testimony: AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Mehta", "first_name": "J.", "last_name": "Mehta", "second_name": "", "title": " Full/Part-time employment: Janssen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Maes", "first_name": "A.", "last_name": "Maes", "second_name": "", "title": " Full/Part-time employment: Janssen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Haslam", "first_name": "J.", "last_name": "Haslam", "second_name": "", "title": " Full/Part-time employment: Janssen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "P. Mistry", "first_name": "P.", "last_name": "Mistry", "second_name": "", "title": " Full/Part-time employment: Janssen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Kalota", "first_name": "A.", "last_name": "Kalota", "second_name": "", "title": " Full/Part-time employment: Janssen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "L. Lenox", "first_name": "L.", "last_name": "Lenox", "second_name": "", "title": " Full/Part-time employment: Janssen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. Infante", "first_name": "R.", "last_name": "Infante", "second_name": "", "title": " Full/Part-time employment: Janssen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "V. Lorenzi", "first_name": "V.", "last_name": "Lorenzi", "second_name": "", "title": " Full/Part-time employment: Janssen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "H. Xie", "first_name": "H.", "last_name": "Xie", "second_name": "", "title": " Full/Part-time employment: Janssen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Lauring", "first_name": "J.", "last_name": "Lauring", "second_name": "", "title": " Full/Part-time employment: Janssen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. Patel", "first_name": "R.", "last_name": "Patel", "second_name": "", "title": " Honoraria (self): Gilead; Honoraria (self): Exelixis; Honoraria (self): BMS; Honoraria (self): Genentech; Honoraria (self): Medivation."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Anastasios Stathis", "first_name": "Anastasios", "last_name": "Stathis", "second_name": "", "country": "Switzerland", "city": "Bellinzona", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Silke Gillessen", "first_name": "Silke", "last_name": "Gillessen", "second_name": "", "country": "Switzerland", "city": "Bellinzona", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Maria De Santis", "first_name": "Maria", "last_name": "De Santis", "second_name": "", "country": "Germany", "city": "Berlin", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Ben Tran", "first_name": "Ben", "last_name": "Tran", "second_name": "", "country": "Australia", "city": "Melbourne", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "T. Dorff", "first_name": "T.", "last_name": "Dorff", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (institution): Bayer; Advisory/Consultancy: Janssen Oncology; Advisory/Consultancy: AstraZeneca; Advisory/Consultancy: Roche; Advisory/Consultancy: Seattle Genetics; Advisory/Consultancy: Noxopharm; Advisory/Consultancy, Research grant/Funding (institution): Bristol-Myers Squibb; Speaker Bureau/Expert testimony: Exelixis; Speaker Bureau/Expert testimony: Prometheus Laboratories."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Rettig", "first_name": "M.", "last_name": "Rettig", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Johnson & Johnson; Advisory/Consultancy: Bayer; Research grant/Funding (institution), Travel/Accommodation/Expenses: Johnson and Johnson; Advisory/Consultancy: Ambrx ; Advisory/Consultancy: Amgen; Research grant/Funding (institution): Novartis; Research grant/Funding (institution): Medication/Astellas; Licensing/Royalties, Co-inventor on a patent for novel inhibitors of the N-terminal domain of the AR: No Commercial Partners."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "P. Lolkema", "first_name": "P.", "last_name": "Lolkema", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (institution): Johnson & Johnson; Advisory/Consultancy, Research grant/Funding (institution): Sanofi; Advisory/Consultancy: Bayer; Advisory/Consultancy: Pfizer; Advisory/Consultancy: Amgen; Advisory/Consultancy: Roche; Advisory/Consultancy, Research grant/Funding (institution): Astellas Pharma; Research grant/Funding (institution), Travel/Accommodation/Expenses: Merck Sharp & Dohme; Travel/Accommodation/Expenses: Ipsen; Advisory/Consultancy: Novartis; Advisory/Consultancy: Julius Clinical."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "P. Machiels", "first_name": "P.", "last_name": "Machiels", "second_name": "", "title": " Advisory/Consultancy: Boehringer Ingelheim; Advisory/Consultancy, Travel/Accommodation/Expenses: Pfizer; Advisory/Consultancy, Travel/Accommodation/Expenses: Merck Sharp & Dohme; Advisory/Consultancy: Debiopharm Group; Advisory/Consultancy: Nanobiotix; Advisory/Consultancy: Innate Pharma; Advisory/Consultancy: Roche; Advisory/Consultancy: AstraZeneca; Advisory/Consultancy, Research grant/Funding (self): Bayer; Advisory/Consultancy: Merck Serono; Advisory/Consultancy, Travel/Accommodation/Expenses: Bristol-Myers Squibb; Advisory/Consultancy, Research grant/Funding (self): Novartis; Advisory/Consultancy: Incyte; Advisory/Consultancy, Research grant/Funding (self): Janssen; Advisory/Consultancy: CUE Bioparma; Advisory/Consultancy: ALX Oncology; Travel/Accommodation/Expenses: Amgen; Research grant/Funding (self): Sanofi."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Rottey", "first_name": "S.", "last_name": "Rottey", "second_name": "", "title": " Advisory/Consultancy: Pfizer; Advisory/Consultancy, Research grant/Funding (self): Merck Sharp and Dohme; Advisory/Consultancy: Bristol Myers Squibb; Advisory/Consultancy, Research grant/Funding (self): Roche; Advisory/Consultancy: Novartis; Advisory/Consultancy: Johnson & Johnson)."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "K. Autio", "first_name": "K.", "last_name": "Autio", "second_name": "", "title": " Research grant/Funding (institution): CytomX Therapeutics; Research grant/Funding (institution): Pfizer; Research grant/Funding (institution): Merck; Research grant/Funding (institution): GlaxoSmithKline; Research grant/Funding (institution): ARMO BioSciences; Research grant/Funding (institution): Tizona Therapeutics, Inc; Research grant/Funding (institution): Amgen; Research grant/Funding (institution): AstraZeneca; Research grant/Funding (institution): Pfizer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. Greil", "first_name": "R.", "last_name": "Greil", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Celgene; Advisory/Consultancy: Novartis; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Roche; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Bristol-Myers Squibb; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution): Takeda; Honoraria (self), Advisory/Consultancy: Abbvie; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: AstraZeneca; Advisory/Consultancy: Janssen; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: MSD; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution): Merck; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Gilead Sciences; Honoraria (self), Advisory/Consultancy: Daiichi Sankyo; Honoraria (self), Research grant/Funding (institution), Travel/Accommodation/Expenses: Amgen; Travel/Accommodation/Expenses: Janssen-Cilag; Honoraria (self), Research grant/Funding (institution), Travel/Accommodation/Expenses: Novartis; Honoraria (self), Research grant/Funding (institution): Sandoz."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "N. Adra", "first_name": "N.", "last_name": "Adra", "second_name": "", "title": " Research grant/Funding (institution): Merck; Research grant/Funding (institution): Genentech."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Minocha", "first_name": "M.", "last_name": "Minocha", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Amgen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Cheng", "first_name": "C.", "last_name": "Cheng", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Amgen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "N. Clarke", "first_name": "N.", "last_name": "Clarke", "second_name": "", "title": " Advisory/Consultancy, Consultation and advisory fees: Janssen; Advisory/Consultancy, Consultation/ Lecture fees: Astellas; Advisory/Consultancy, Consultation / Advisory fees: Bayer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "G. Attard", "first_name": "G.", "last_name": "Attard", "second_name": "", "title": " Speaker Bureau/Expert testimony, Speakers' bureaus: Sanofi Aventis."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Dearnaley", "first_name": "D.", "last_name": "Dearnaley", "second_name": "", "title": " Research grant/Funding (institution), C46/A3976, C46/A10588 and C33589/A19727."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Gillessen", "first_name": "S.", "last_name": "Gillessen", "second_name": "", "title": " Honoraria (institution), Honorarium payments to hospital: Bayer; Honoraria (institution), Honorarium payments to hospital: Curevac; Honoraria (self), Honoraria (institution), Honorarium payments to hospital: Janssen; Honoraria (institution), Honorarium payments to hospital: Astellas; Honoraria (self), Honoraria (institution), Honorarium payments to hospital: Orion; Honoraria (institution), Honorarium payments to hospital: Max/Vax SA; Honoraria (institution), Honorarium payments to hospital: Ferring; Honoraria (institution), Honorarium payments to hospital: Roche; Honoraria (institution), Honorarium payments to hospital: Innocrin Pharmaceuticals; Honoraria (self), Honorarium payments to hospital: Sanofi; Honoraria (institution), Honorarium payments to hospital: Novartis; Non-remunerated activity/ies, Uncompensated advisory role: Nectar Therapeutics; Non-remunerated activity/ies, Uncompensated advisory role: ProteoMedix; Honoraria (institution), Honorarium payments to hospital: Cell Search; Honoraria (institution), Honorarium payments to hospital: Clovis; Honoraria (institution), Honorarium payments to hospital: Bristol-Myers Squibb; Honoraria (institution), Honorarium payments to hospital: MSD Merck Sharp & Dome."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Birtle", "first_name": "A.", "last_name": "Birtle", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Advisory Board Honoraria: Astellas; Advisory/Consultancy, Speaker Bureau/Expert testimony, Speaker Fee + Advisory Board Honoraria: Sanofi; Honoraria (self), Advisory/Consultancy, Advisory Board Honoraria: Janssen; Advisory/Consultancy, Advisory Board Honoraria: Bayer; Advisory/Consultancy, Advisory Board Honoraria: Astra Zeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Chowdhury", "first_name": "S.", "last_name": "Chowdhury", "second_name": "", "title": " Honoraria (self), Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses, Honoraria, Speakers fee, Travel Grant: Janssen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Z. Malik", "first_name": "Z.", "last_name": "Malik", "second_name": "", "title": " Advisory/Consultancy, Advisory boards: Sanofi; Advisory/Consultancy, Advisory boards: Janssen; Advisory/Consultancy, Advisory boards: Pfizer; Travel/Accommodation/Expenses, Assisted travel to Congress: Bayer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Pezaro", "first_name": "C.", "last_name": "Pezaro", "second_name": "", "title": " Honoraria (self), Honoraria (institution): Astellas; Honoraria (self), Honoraria (institution): AstraZeneca; Honoraria (self), Honoraria (institution): Janssen; Honoraria (self), Honoraria (institution): Mundipharma; Honoraria (self), Honoraria (institution): Pfizer; Travel/Accommodation/Expenses: Bayer; Travel/Accommodation/Expenses: Janssen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Sheehan", "first_name": "D.", "last_name": "Sheehan", "second_name": "", "title": " Travel/Accommodation/Expenses, Sponsorship for meeting attendance: Astellas; Travel/Accommodation/Expenses, Sponsorship for meeting attendance: Ipsen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Tanguay", "first_name": "J.", "last_name": "Tanguay", "second_name": "", "title": " Travel/Accommodation/Expenses, Conference attendance: Roche; Travel/Accommodation/Expenses, Conference attendance: Janssen; Advisory/Consultancy, Advisory board: Astellas; Advisory/Consultancy, Travel/Accommodation/Expenses, Advisory board & conference attendance: Bayer; Advisory/Consultancy, Advisory board: AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "K. Parmar", "first_name": "K.", "last_name": "Parmar", "second_name": "", "title": " Research grant/Funding (institution), Unrestricted grant to contribute to another comparison of STAMPEDE which supports the protocol overall, plus relevant drug and distribution."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. Sydes", "first_name": "R.", "last_name": "Sydes", "second_name": "", "title": " Research grant/Funding (institution): Astellas; Research grant/Funding (institution): Clovis; Honoraria (self), Research grant/Funding (institution), Travel/Accommodation/Expenses: Janssen; Research grant/Funding (institution): Novartis; Research grant/Funding (institution): Pfizer; Research grant/Funding (institution): Sanofi-Aventis; Honoraria (self): Eli-Lilly."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Roy Herbst", "first_name": "Roy", "last_name": "Herbst", "second_name": "", "country": "C", "city": "New Haven", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "G. Robinson", "first_name": "G.", "last_name": "Robinson", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (institution): Merck; Research grant/Funding (institution): AstraZeneca; Research grant/Funding (institution): Roche; Research grant/Funding (institution): Pfizer ."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. Hui", "first_name": "R.", "last_name": "Hui", "second_name": "", "title": " Advisory/Consultancy, Speaker Bureau/Expert testimony: Merck Sharp & Dohme Corp."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "N. Peled", "first_name": "N.", "last_name": "Peled", "second_name": "", "title": " Honoraria (self), Research grant/Funding (self): AstraZeneca; Honoraria (self), Research grant/Funding (self): Boehringer Ingelheim; Honoraria (self), Research grant/Funding (self): Bristol-Myers Squibb; Honoraria (self), Research grant/Funding (self): Eli Lilly; Honoraria (self), Research grant/Funding (self): Merck Sharp & Dohme Corp."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Cuffe", "first_name": "S.", "last_name": "Cuffe", "second_name": "", "title": " Travel/Accommodation/Expenses: Merck Sharp & Dohme Corp."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "K. Hotta", "first_name": "K.", "last_name": "Hotta", "second_name": "", "title": " Honoraria (self), Research grant/Funding (institution): Bristol-Myers Squibb; Honoraria (self), Research grant/Funding (institution): Eli Lilly; Honoraria (self), Research grant/Funding (institution): AstraZeneca; Honoraria (self): Merck Sharp & Dohme Corp."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Leal", "first_name": "A.", "last_name": "Leal", "second_name": "", "title": " Advisory/Consultancy: Takeda; Advisory/Consultancy: Novocure; Advisory/Consultancy: AstraZeneca; Advisory/Consultancy: Genentech; Advisory/Consultancy: Inivata; Advisory/Consultancy: Merck; Advisory/Consultancy: PharmaMar; Advisory/Consultancy: EMD Serono."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "W. Riess", "first_name": "W.", "last_name": "Riess", "second_name": "", "title": " Research grant/Funding (institution): Merck Sharp & Dohme Corp; Research grant/Funding (self): Spectrum; Research grant/Funding (institution): Revolution Medicines; Research grant/Funding (institution): AstraZeneca; Research grant/Funding (institution): GlaxoSmithKline; Advisory/Consultancy, Research grant/Funding (institution): Novartis; Honoraria (self): Blueprint Medicines; Honoraria (self): Medtronic; Advisory/Consultancy: Boehringer Ingelheim."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "E. Jensen", "first_name": "E.", "last_name": "Jensen", "second_name": "", "title": " Full/Part-time employment: Merck Sharp & Dohme Corp."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "B. Zhao", "first_name": "B.", "last_name": "Zhao", "second_name": "", "title": " Full/Part-time employment: Merck Sharp & Dohme Corp."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Pietanza", "first_name": "C.", "last_name": "Pietanza", "second_name": "", "title": " Full/Part-time employment: Merck Sharp & Dohme Corp."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Ahmet Sezer", "first_name": "Ahmet", "last_name": "Sezer", "second_name": "", "country": "Turkey", "city": "Adana", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "N. Rizvi", "first_name": "N.", "last_name": "Rizvi", "second_name": "", "title": " Advisory/Consultancy, outside the submitted work: AbbVie; Advisory/Consultancy, outside the submitted work: Apricity; Advisory/Consultancy, outside the submitted work: AstraZeneca; Advisory/Consultancy, outside the submitted work: Boehringer; Advisory/Consultancy, outside the submitted work: Calithera; Advisory/Consultancy, outside the submitted work: Dracen; Advisory/Consultancy, outside the submitted work: Editas; Advisory/Consultancy, outside the submitted work: EMD Sorono; Advisory/Consultancy, outside the submitted work: G1 Therapeutics; Advisory/Consultancy, outside the submitted work: Genentech; Advisory/Consultancy, outside the submitted work: Gilead; Advisory/Consultancy, outside the submitted work: GSK; Advisory/Consultancy, outside the submitted work: Illumina; Advisory/Consultancy, outside the submitted work: Lilly; Advisory/Consultancy, outside the submitted work: Merck; Advisory/Consultancy, outside the submitted work: Neogenomics; Advisory/Consultancy, outside the submitted work: Novartis; Advisory/Consultancy, Shareholder/Stockholder/Stock options, outside the submitted work: Brooklyn ImmunoTherapeutics; Advisory/Consultancy, outside the submitted work: Takeda; Advisory/Consultancy, Shareholder/Stockholder/Stock options, outside the submitted work: Bellicum; Licensing/Royalties, Patent (pending) filed by MSKCC, in the form of royalties, on “determinants of cancer response to immunotherapy, (PCT/US2015/062208)” licensed to Personal Genome Diagnostics: Personal Genome Diagnostics; Shareholder/Stockholder/Stock options, outside the submitted work: Gritstone."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "G. Gullo", "first_name": "G.", "last_name": "Gullo", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Regeneron Pharmaceuticals, Inc."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "P. Rietschel", "first_name": "P.", "last_name": "Rietschel", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Licensing/Royalties, Full/Part-time employment, Patents pending: Regeneron Pharmaceuticals, Inc."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "F. Monville", "first_name": "F.", "last_name": "Monville", "second_name": "", "title": " Full/Part-time employment: HalioDx."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. le treut", "first_name": "J.", "last_name": "le treut", "second_name": "", "title": " Advisory/Consultancy: AstraZeneca; Advisory/Consultancy: Boehringer; Honoraria (self): Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Garcia", "first_name": "S.", "last_name": "Garcia", "second_name": "", "title": " Travel/Accommodation/Expenses: MSD."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Ciccolini", "first_name": "J.", "last_name": "Ciccolini", "second_name": "", "title": " Research grant/Funding (institution), Travel/Accommodation/Expenses: AstraZeneca; Research grant/Funding (institution): Institut Roche; Honoraria (self): Pierre Fabre; Honoraria (self): BMS; Honoraria (self): Novartis; Honoraria (self): Lilly; Honoraria (self): Ipsen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "P. Outters", "first_name": "P.", "last_name": "Outters", "second_name": "", "title": " Full/Part-time employment: HalioDx."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "E. Vivier", "first_name": "E.", "last_name": "Vivier", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment, Officer/Board of Directors: Innate Pharma."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Fieschi", "first_name": "J.", "last_name": "Fieschi", "second_name": "", "title": " Officer/Board of Directors: HalioDx."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Roy S. Herbst", "first_name": "Roy", "last_name": "Herbst", "second_name": "S.", "country": "United States of America", "city": "New Haven", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Jong-Seok Lee", "first_name": "Jong-Seok", "last_name": "Lee", "second_name": "", "country": "Gyeonggi-d", "city": "Seongnam", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Sugawara", "first_name": "S.", "last_name": "Sugawara", "second_name": "", "title": " Honoraria (self), Research grant/Funding (institution): Ono Pharmaceutical; Honoraria (self): Bristol-Myers Squibb; Honoraria (self): MSD; Honoraria (self): Chugai Pharma; Honoraria (self): Nippon Boehringer Ingelheim; Honoraria (self): Taiho Pharmaceutical; Honoraria (self): Pfizer; Honoraria (self): Eli Lilly and Company; Honoraria (self): Novartis; Honoraria (self): Kyowa Hakko Kirin; Honoraria (self): AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "H. Kang", "first_name": "H.", "last_name": "Kang", "second_name": "", "title": " Research grant/Funding (institution): Ono Pharmaceutical."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. Kim", "first_name": "R.", "last_name": "Kim", "second_name": "", "title": " Research grant/Funding (institution): Ono Pharmaceutical."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "N. Inui", "first_name": "N.", "last_name": "Inui", "second_name": "", "title": " Honoraria (self): Ono Pharmaceutical; Honoraria (self), Research grant/Funding (institution): Taiho Pharmaceutical Co."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "T. Hida", "first_name": "T.", "last_name": "Hida", "second_name": "", "title": " Honoraria (self), Research grant/Funding (institution): Ono Pharmaceutical; Honoraria (self), Research grant/Funding (institution): Chugai Pharmaceutical Co."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "H. Lee", "first_name": "H.", "last_name": "Lee", "second_name": "", "title": " Research grant/Funding (institution): Ono Pharmaceutical."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "H. Tanaka", "first_name": "H.", "last_name": "Tanaka", "second_name": "", "title": " Honoraria (self), Research grant/Funding (institution): Ono Pharmaceutical; Honoraria (self), Research grant/Funding (institution): Bristol-Myers Squibb; Honoraria (self), Research grant/Funding (institution): Eli Lilly; Honoraria (self), Research grant/Funding (institution): MSD; Honoraria (self), Research grant/Funding (institution): Taiho Pharmaceutical; Honoraria (self): Pfizer; Honoraria (self): Novartis; Honoraria (self), Research grant/Funding (institution): Chugai pharmaceutical; Honoraria (self), Research grant/Funding (institution): AstraZeneca; Honoraria (self), Travel/Accommodation/Expenses: Boehringer Ingelheim."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "T. Yang", "first_name": "T.", "last_name": "Yang", "second_name": "", "title": " Honoraria (self): Ono Pharmaceutical; Honoraria (self): MSD; Honoraria (self): Pfizer; Honoraria (self): Boehringer Ingelheim; Honoraria (self): Roche; Honoraria (self): Chugai."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Nishio", "first_name": "M.", "last_name": "Nishio", "second_name": "", "title": " Honoraria (self), Research grant/Funding (institution): Ono Pharmaceutical; Honoraria (self), Research grant/Funding (institution): Bristol Myers Squibb; Honoraria (self), Research grant/Funding (institution): Pfizer; Honoraria (self), Research grant/Funding (institution): Chugai Pharmaceutical; Honoraria (self), Research grant/Funding (institution): Eli Lilly; Honoraria (self), Research grant/Funding (institution): Taiho Pharmaceutical; Honoraria (self), Research grant/Funding (institution): AstraZeneca; Honoraria (self): Boehringer-Ingelheim; Honoraria (self), Research grant/Funding (institution): MSD; Honoraria (self), Research grant/Funding (institution): Novartis; Honoraria (self): Merck Biopharma; Honoraria (self), Research grant/Funding (institution): Daiichi Sankyo; Honoraria (self), Research grant/Funding (institution): Takeda Pharmaceutical Company Limited; Honoraria (self): Teijin Pharma Limited."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Y. Ohe", "first_name": "Y.", "last_name": "Ohe", "second_name": "", "title": " Honoraria (self), Research grant/Funding (institution): Ono Pharmaceutical; Honoraria (self), Research grant/Funding (institution): AstraZeneca; Honoraria (self), Research grant/Funding (institution): Bristol-Myers Squibb; Honoraria (self), Research grant/Funding (institution): MSD; Honoraria (self): Boehringer Ingelheim; Honoraria (self), Research grant/Funding (institution): Chugai; Honoraria (self), Research grant/Funding (institution): Eli Lilly; Honoraria (self), Research grant/Funding (institution): Taiho; Honoraria (self), Research grant/Funding (institution): Takeda; Honoraria (self), Research grant/Funding (institution): Nippon Kayaku; Honoraria (self), Research grant/Funding (institution): Kyorin; Honoraria (self), Research grant/Funding (institution): Novartis; Honoraria (self), Research grant/Funding (institution): Janssen; Honoraria (self): Pfizer; Research grant/Funding (institution): Ignyta; Research grant/Funding (institution): Kyowa Hakko Kirin; Honoraria (self): Celtrion; Honoraria (self): Amgen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "T. Tamura", "first_name": "T.", "last_name": "Tamura", "second_name": "", "title": " Research grant/Funding (institution): Ono Pharmaceutical; Honoraria (self): Chugai Pharmaceutical; Honoraria (self): Lilly."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Yu", "first_name": "J.", "last_name": "Yu", "second_name": "", "title": " Research grant/Funding (institution): Ono Pharmaceutical."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "H. Akamatsu", "first_name": "H.", "last_name": "Akamatsu", "second_name": "", "title": " Honoraria (self): Ono Pharmaceutical; Honoraria (self), Research grant/Funding (institution): MSD; Honoraria (self), Research grant/Funding (institution): Chugai Pharmatheutical; Honoraria (self): Astrazeneca; Honoraria (self): Bristol-Myers Squibb."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Y. Namba", "first_name": "Y.", "last_name": "Namba", "second_name": "", "title": " Full/Part-time employment: Ono Pharmaceutical."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "N. Sumiyoshi", "first_name": "N.", "last_name": "Sumiyoshi", "second_name": "", "title": " Full/Part-time employment: Ono Pharmaceutical."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "K. Nakagawa", "first_name": "K.", "last_name": "Nakagawa", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution): Ono Pharmaceutical Co."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Takashi Seto", "first_name": "Takashi", "last_name": "Seto", "second_name": "", "country": "Fukuok", "city": "Fukuoka", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "K. Nosaki", "first_name": "K.", "last_name": "Nosaki", "second_name": "", "title": " Honoraria (self), Honoraria (institution), Research grant/Funding (self), Research grant/Funding (institution): Chugai Pharmaceutical Co."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. Toyozawa", "first_name": "R.", "last_name": "Toyozawa", "second_name": "", "title": " Honoraria (self): Kyowa Hakko Kirin; Honoraria (self): Nippon Kayaku; Honoraria (self): Novartis Pharma; Research grant/Funding (institution): AbbVie; Research grant/Funding (institution): Daiichi Sankyo; Research grant/Funding (institution): Pfizer Japan; Research grant/Funding (institution): Takeda Pharmaceutical."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "H. Hayashi", "first_name": "H.", "last_name": "Hayashi", "second_name": "", "title": " Honoraria (self), Research grant/Funding (self), Research grant/Funding (institution): AstraZeneca; Honoraria (self), Research grant/Funding (self), Research grant/Funding (institution): Boehringer Ingelheim Japan Inc; Honoraria (self), Research grant/Funding (institution): Bristol-Myers Squibb Co."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "H. Murakami", "first_name": "H.", "last_name": "Murakami", "second_name": "", "title": " Honoraria (self), Research grant/Funding (institution): AstraZeneca; Honoraria (self), Research grant/Funding (institution): Chugai pharma; Honoraria (self), Research grant/Funding (institution): Lilly Japan; Honoraria (self): Taiho Pharmaceutical; Honoraria (self), Research grant/Funding (institution): Takeda; Honoraria (self): Ono Pharmaceutical; Honoraria (self): Bristol-Myers Squibb Japan; Honoraria (self): MSD; Research grant/Funding (institution): Daiichi Sankyo; Research grant/Funding (institution): Taiho Pharmaceutical; Research grant/Funding (institution): AbbVie; Research grant/Funding (institution): IQVIA."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Niho", "first_name": "S.", "last_name": "Niho", "second_name": "", "title": " Honoraria (self), Research grant/Funding (institution): AstraZeneca; Honoraria (self), Research grant/Funding (institution): Pfizer; Honoraria (self), Research grant/Funding (institution): Eli Lilly; Honoraria (self): MSD; Honoraria (self): Boehringer Ingelheim; Research grant/Funding (institution): Merck Biopharma; Research grant/Funding (institution): Chugai."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "H. Saka", "first_name": "H.", "last_name": "Saka", "second_name": "", "title": " Honoraria (self): Chugai; Honoraria (self), Research grant/Funding (institution): AstraZeneca; Honoraria (self), Research grant/Funding (institution): Ono; Honoraria (self): Boehringer Ingelheim Japan; Research grant/Funding (institution): MSD; Research grant/Funding (institution): Taisho-Toyama."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "H. Yoshioka", "first_name": "H.", "last_name": "Yoshioka", "second_name": "", "title": " Honoraria (self), Lecture fee: Chugai pharmaceutical."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "I. Okamoto", "first_name": "I.", "last_name": "Okamoto", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Research grant/Funding (self), Research grant/Funding (institution): Chugai."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "H. Daga", "first_name": "H.", "last_name": "Daga", "second_name": "", "title": " Honoraria (self), Research grant/Funding (institution): Chugai; Honoraria (self): MSD; Honoraria (self), Research grant/Funding (institution): Astrazeneca; Honoraria (self): Ono."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "K. Azuma", "first_name": "K.", "last_name": "Azuma", "second_name": "", "title": " Speaker Bureau/Expert testimony: AstraZeneca; Speaker Bureau/Expert testimony: MSD; Speaker Bureau/Expert testimony: Chugai phrma; Speaker Bureau/Expert testimony: Bristol-meiers squib; Speaker Bureau/Expert testimony: Ono Pharma."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "K. Nishino", "first_name": "K.", "last_name": "Nishino", "second_name": "", "title": " Honoraria (self): AstraZeneca; Honoraria (self): Chugai; Honoraria (self): Eli Lilly Japan; Honoraria (self): Roche; Honoraria (self): Novartis; Honoraria (self): Pfizer; Honoraria (self): Ono; Honoraria (self): Nippon Boehringer Ingelheim."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Satouchi", "first_name": "M.", "last_name": "Satouchi", "second_name": "", "title": " Honoraria (self), Research grant/Funding (institution): AstraZeneca; Honoraria (self), Research grant/Funding (institution): MSD; Honoraria (self), Research grant/Funding (institution): Chugai; Honoraria (self): Taiho; Honoraria (self): Nippon kayaku; Honoraria (self), Research grant/Funding (institution): Boehringer Ingelheim; Honoraria (self), Research grant/Funding (institution): Bristol-Myers Squibb; Honoraria (self), Research grant/Funding (institution): Ono; Honoraria (self), Research grant/Funding (institution): Novartis; Honoraria (self), Research grant/Funding (institution): Eli Lilly; Honoraria (self), Research grant/Funding (institution): Pfizer; Research grant/Funding (institution): AbbVie; Research grant/Funding (institution): Ignyta; Research grant/Funding (institution): Takeda."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Adrian Sacher", "first_name": "Adrian", "last_name": "Sacher", "second_name": "", "country": "Canada", "city": "Toronto", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Hanna Maenpaa", "first_name": "Hanna", "last_name": "Maenpaa", "second_name": "", "country": "Finland", "city": "Helsinki", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Nicolaus Andratschke", "first_name": "Nicolaus", "last_name": "Andratschke", "second_name": "", "country": "Switzerland", "city": "Zurich", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Francesco Giusti", "first_name": "Francesco", "last_name": "Giusti", "second_name": "", "country": "Italy", "city": "Ispra", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Ka Man Cheung", "first_name": "Ka", "last_name": "Cheung", "second_name": "Man", "country": "Hong Kong PRC", "city": "Kowloon", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Lidia Gatto", "first_name": "Lidia", "last_name": "Gatto", "second_name": "", "country": "Italy", "city": "Bologna", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "William Kelly", "first_name": "William", "last_name": "Kelly", "second_name": "", "country": "T", "city": "San Antonio", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Marta Padovan", "first_name": "Marta", "last_name": "Padovan", "second_name": "", "country": "Italy", "city": "Padova", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Maxime Fontanilles", "first_name": "Maxime", "last_name": "Fontanilles", "second_name": "", "country": "France", "city": "Rouen", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "K. Seystahl", "first_name": "K.", "last_name": "Seystahl", "second_name": "", "title": " Advisory/Consultancy: Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. van den Bent", "first_name": "J.", "last_name": "van den Bent", "second_name": "", "title": " Advisory/Consultancy: Bayer; Advisory/Consultancy: Carthera; Advisory/Consultancy: Nerviano; Advisory/Consultancy: Agios; Advisory/Consultancy: AbbVie; Advisory/Consultancy: Amgen; Advisory/Consultancy: Karyopharm; Advisory/Consultancy: Genenta."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Preusser", "first_name": "M.", "last_name": "Preusser", "second_name": "", "title": " Advisory/Consultancy: Bayer; Advisory/Consultancy: Bristol-Myers Squibb; Advisory/Consultancy: Roche; Advisory/Consultancy: BMJ Journals; Advisory/Consultancy: MedMedia; Advisory/Consultancy: AstraZeneca; Advisory/Consultancy: AbbVie; Advisory/Consultancy: Lilly; Advisory/Consultancy: Medahead; Advisory/Consultancy, Research grant/Funding (institution): Daiichi Sankyo; Advisory/Consultancy: Sanofi; Advisory/Consultancy, Research grant/Funding (institution): Merck, Sharp & Dohme; Advisory/Consultancy: Tocagen; Advisory/Consultancy: Novartis; Advisory/Consultancy: Germon Lehrman Group; Advisory/Consultancy: GMC Contrast; Advisory/Consultancy: GlaxoSmithKline; Advisory/Consultancy: Mundipharma."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "F. Wolpert", "first_name": "F.", "last_name": "Wolpert", "second_name": "", "title": " Travel/Accommodation/Expenses: Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "U. Herrlinger", "first_name": "U.", "last_name": "Herrlinger", "second_name": "", "title": " Advisory/Consultancy: Medac; Advisory/Consultancy: Bristol-Myers Squibb; Advisory/Consultancy: Novocure; Advisory/Consultancy: Novartis; Advisory/Consultancy: Daiichi Sankyo; Advisory/Consultancy: Noxxon; Advisory/Consultancy: AbbVie; Advisory/Consultancy: Bayer; Advisory/Consultancy: Janssen; Advisory/Consultancy: Karyopharm."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "L. Mortier", "first_name": "L.", "last_name": "Mortier", "second_name": "", "title": " Travel/Accommodation/Expenses: Roche/Genentech; Travel/Accommodation/Expenses: Novartis; Advisory/Consultancy, Travel/Accommodation/Expenses: Bristol-Myers Squibb; Advisory/Consultancy, Research grant/Funding (institution): MSD Oncology; Research grant/Funding (institution): Pierre Fabre."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Weller", "first_name": "M.", "last_name": "Weller", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (institution): AbbVie; Research grant/Funding (institution): Adastra; Research grant/Funding (institution): Dracen; Advisory/Consultancy, Research grant/Funding (institution): Merck, Sharp & Dohme; Advisory/Consultancy, Research grant/Funding (institution): Merck (EMD); Advisory/Consultancy, Research grant/Funding (institution): Novocure; Advisory/Consultancy: Orbus; Advisory/Consultancy: Basilea; Advisory/Consultancy: Bristol-Myers Squibb; Advisory/Consultancy: Celgene; Advisory/Consultancy: Medac; Advisory/Consultancy: Roche; Advisory/Consultancy: Tocagen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Andrew J. Brenner", "first_name": "Andrew", "last_name": "Brenner", "second_name": "J.", "country": "United States of America", "city": "San Antonio", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Jose M. Martin-Moreno", "first_name": "Jose", "last_name": "Martin-Moreno", "second_name": "M.", "country": "Valenci", "city": "Valencia", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Tadeusz A. Dyba", "first_name": "Tadeusz", "last_name": "Dyba", "second_name": "A.", "country": "Italy", "city": "Ispra", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Ana Carneiro", "first_name": "Ana", "last_name": "Carneiro", "second_name": "", "country": "Sweden", "city": "Lund", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Brandao", "first_name": "M.", "last_name": "Brandao", "second_name": "", "title": " Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: Roche/GNE."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Scheffler", "first_name": "M.", "last_name": "Scheffler", "second_name": "", "title": " Advisory/Consultancy, Speaker Bureau/Expert testimony: Boehringer Ingelheim, Amgen, AstraZeneca, BMS, Roche, Pfizer, Takeda; Research grant/Funding (self): Amgen, Dracen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. Ferrara", "first_name": "R.", "last_name": "Ferrara", "second_name": "", "title": " Advisory/Consultancy: MSD."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Jalving", "first_name": "M.", "last_name": "Jalving", "second_name": "", "title": " Advisory/Consultancy: Merck, BMS, Novartis, Pierre Fabre, Tesaro, AstraZeneca; Research grant/Funding (self): BMS, AbbVie, Merck, Cristal Therapeutics."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "G. Lo Russo", "first_name": "G.", "last_name": "Russo", "second_name": "Lo", "title": " Advisory/Consultancy: MSD, BMS, Astrazeneca; Travel/Accommodation/Expenses: BMS, Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Pilotto", "first_name": "S.", "last_name": "Pilotto", "second_name": "", "title": " Advisory/Consultancy, Speaker Bureau/Expert testimony: AstraZeneca, Eli-Lilly, BMS, Boehringer Ingelheim, MSD and Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "E. Saloustros", "first_name": "E.", "last_name": "Saloustros", "second_name": "", "title": " Advisory/Consultancy: Pfizer, AstraZeneca, Roche; Speaker Bureau/Expert testimony: Pfizer, AstraZeneca, Roche, Amgen, BMS."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Jennifer Hinkel", "first_name": "Jennifer", "last_name": "Hinkel", "second_name": "", "country": "United Kingdom", "city": "Oxford", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Ray", "first_name": "A.", "last_name": "Ray", "second_name": "", "title": " Leadership role, Full/Part-time employment, Officer/Board of Directors: Lydion Research."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Brar", "first_name": "S.", "last_name": "Brar", "second_name": "", "title": " Full/Part-time employment: Lydion Research."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Hinkel", "first_name": "J.", "last_name": "Hinkel", "second_name": "", "title": " Officer/Board of Directors: Lydion Research; Full/Part-time employment: Caris Life Sciences; Officer/Board of Directors: Global Campaign for Cancer Survivorship."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Roman Adam", "first_name": "Roman", "last_name": "Adam", "second_name": "", "country": "Switzerland", "city": "St. Gallen", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Ramon Schaefer", "first_name": "Ramon", "last_name": "Schaefer", "second_name": "", "country": "Germany", "city": "Heidelberg", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Christophe Le Tourneau", "first_name": "Christophe", "last_name": "Le Tourneau", "second_name": "", "country": "France", "city": "Paris", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Francois-Clement Bidard", "first_name": "Francois-Clement", "last_name": "Bidard", "second_name": "", "country": "France", "city": "Paris", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Judith Bliss", "first_name": "Judith", "last_name": "Bliss", "second_name": "", "country": "United Kingdom", "city": "London", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Laura Biganzoli", "first_name": "Laura", "last_name": "Biganzoli", "second_name": "", "country": "Italy", "city": "Prato", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Sarat Chandarlapaty", "first_name": "Sarat", "last_name": "Chandarlapaty", "second_name": "", "country": "N", "city": "New York", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Bardia", "first_name": "A.", "last_name": "Bardia", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Research grant/Funding (self), Travel/Accommodation/Expenses: Novartis; Honoraria (self), Advisory/Consultancy, Research grant/Funding (self), Travel/Accommodation/Expenses: Pfizer; Honoraria (self), Advisory/Consultancy, Research grant/Funding (self), Travel/Accommodation/Expenses: Daiichi/AstraZeneca; Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: PUMA; Honoraria (self), Advisory/Consultancy, Research grant/Funding (self), Travel/Accommodation/Expenses: Sanofi; Honoraria (self), Advisory/Consultancy, Research grant/Funding (self), Travel/Accommodation/Expenses: Genentech/Roche; Honoraria (self), Advisory/Consultancy, Research grant/Funding (self), Travel/Accommodation/Expenses: Radius Health; Honoraria (self), Advisory/Consultancy, Research grant/Funding (self), Travel/Accommodation/Expenses: Merck; Honoraria (self), Advisory/Consultancy, Research grant/Funding (self), Travel/Accommodation/Expenses: Immunomedics; Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Eli Lilly; Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Phillips; Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Foundation Medicine; Licensing/Royalties: Up-To-Date."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Lord", "first_name": "S.", "last_name": "Lord", "second_name": "", "title": " Honoraria (self): Eisai; Honoraria (self): Prosigna; Advisory/Consultancy: Shionogi; Research grant/Funding (self): CRUK; Research grant/Funding (self): Against Breast Cancer; Travel/Accommodation/Expenses: Pfizer; Travel/Accommodation/Expenses: Roche; Travel/Accommodation/Expenses: Synthon; Travel/Accommodation/Expenses: Piqur Therapeutics; Shareholder/Stockholder/Stock options: Mitox."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "V. Pelekanou", "first_name": "V.", "last_name": "Pelekanou", "second_name": "", "title": " Full/Part-time employment: Sanofi."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "N. Ternes", "first_name": "N.", "last_name": "Ternes", "second_name": "", "title": " Full/Part-time employment: Sanofi R&D ."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Ming", "first_name": "J.", "last_name": "Ming", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Sanofi."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "V. Boutet", "first_name": "V.", "last_name": "Boutet", "second_name": "", "title": " Full/Part-time employment: Sanofi."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "E. Boitier", "first_name": "E.", "last_name": "Boitier", "second_name": "", "title": " Full/Part-time employment: Sanofi."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Gosselin", "first_name": "A.", "last_name": "Gosselin", "second_name": "", "title": " Full/Part-time employment: Sanofi."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Sang Lee", "first_name": "J.", "last_name": "Lee", "second_name": "Sang", "title": " Full/Part-time employment: Sanofi."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Protopopov", "first_name": "A.", "last_name": "Protopopov", "second_name": "", "title": " Full/Part-time employment: Sanofi."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Celanovic", "first_name": "M.", "last_name": "Celanovic", "second_name": "", "title": " Full/Part-time employment: Sanofi."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "L. Bauchet", "first_name": "L.", "last_name": "Bauchet", "second_name": "", "title": " Honoraria (self), Full/Part-time employment: Sanofi."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Boris Krastev", "first_name": "Boris", "last_name": "Krastev", "second_name": "", "country": "Bulgaria", "city": "Sofia", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. Rai", "first_name": "R.", "last_name": "Rai", "second_name": "", "title": " Full/Part-time employment: G1 Therapeutics."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Baird", "first_name": "D.", "last_name": "Baird", "second_name": "", "title": " Honoraria (institution), Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Molecular Partners; Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Shionogi; Advisory/Consultancy, Travel/Accommodation/Expenses: Daiichi Sankyo; Advisory/Consultancy: Roche/Genentech; Advisory/Consultancy: Novartis; Research grant/Funding (institution), Travel/Accommodation/Expenses: AstraZeneca; Research grant/Funding (institution): Genentech; Research grant/Funding (institution): Sanofi; Research grant/Funding (institution): Boehringer Ingelheim; Research grant/Funding (institution): Roche; Research grant/Funding (institution): Biomarin; Research grant/Funding (institution): G1 Therapeutics; Research grant/Funding (institution): Carrick Therapeutics."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. Roylance", "first_name": "R.", "last_name": "Roylance", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy: Novartis; Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Daiichi Sankyo; Advisory/Consultancy: Eli Lilly; Honoraria (self), Advisory/Consultancy: Pfizer; Advisory/Consultancy, Travel/Accommodation/Expenses: G1Therapeutics; Travel/Accommodation/Expenses: Roche; Travel/Accommodation/Expenses: AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "W. Tao", "first_name": "W.", "last_name": "Tao", "second_name": "", "title": " Full/Part-time employment: G1 Therapeutics."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "P. Beelen", "first_name": "P.", "last_name": "Beelen", "second_name": "", "title": " Full/Part-time employment: G1 Therapeutics."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Sorrentino", "first_name": "A.", "last_name": "Sorrentino", "second_name": "", "title": " Full/Part-time employment: G1 Therapeutics."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "W. Jacot", "first_name": "W.", "last_name": "Jacot", "second_name": "", "title": " Honoraria (self), Research grant/Funding (institution), Travel/Accommodation/Expenses: AstraZeneca; Honoraria (self), Travel/Accommodation/Expenses: Eisai; Honoraria (self), Travel/Accommodation/Expenses: Lilly; Honoraria (self): MSD; Honoraria (self), Travel/Accommodation/Expenses: Novartis; Honoraria (self), Travel/Accommodation/Expenses: Pfizer; Travel/Accommodation/Expenses: Sanofi; Honoraria (self), Travel/Accommodation/Expenses: Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "H. Cottu", "first_name": "H.", "last_name": "Cottu", "second_name": "", "title": " Honoraria (self), Research grant/Funding (institution), Travel/Accommodation/Expenses: Pfizer; Honoraria (self), Research grant/Funding (institution), Travel/Accommodation/Expenses: Roche; Honoraria (self): Lilly; Research grant/Funding (institution): Novartis."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "F. Dalenc", "first_name": "F.", "last_name": "Dalenc", "second_name": "", "title": " Travel/Accommodation/Expenses: Roche; Honoraria (institution), Travel/Accommodation/Expenses: Pfizer; Honoraria (institution): Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Patsouris", "first_name": "A.", "last_name": "Patsouris", "second_name": "", "title": " Honoraria (institution): Lilly; Honoraria (institution), Travel/Accommodation/Expenses: Eisai; Travel/Accommodation/Expenses: Roche; Travel/Accommodation/Expenses: Pfizer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Mailliez", "first_name": "A.", "last_name": "Mailliez", "second_name": "", "title": " Honoraria (institution): Pfizer; Travel/Accommodation/Expenses: AstraZeneca; Travel/Accommodation/Expenses: Pierre Fabre."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Levy", "first_name": "C.", "last_name": "Levy", "second_name": "", "title": " Honoraria (self): Pfizer; Honoraria (self), Travel/Accommodation/Expenses: Roche; Honoraria (self): MSD; Honoraria (self), Travel/Accommodation/Expenses: Lilly; Travel/Accommodation/Expenses: Daiichi."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Robain", "first_name": "M.", "last_name": "Robain", "second_name": "", "title": " Research grant/Funding (institution): Roche; Research grant/Funding (institution): Pfizer; Research grant/Funding (institution): AstraZeneca; Research grant/Funding (institution): MSD; Research grant/Funding (institution): BMS; Research grant/Funding (institution): Daiichi; Research grant/Funding (institution): GSK."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "T. Bachelot", "first_name": "T.", "last_name": "Bachelot", "second_name": "", "title": " Honoraria (self), Travel/Accommodation/Expenses: Roche; Honoraria (self), Research grant/Funding (institution), Travel/Accommodation/Expenses: Novartis; Honoraria (self), Research grant/Funding (institution), Travel/Accommodation/Expenses: AstraZeneca; Honoraria (self), Research grant/Funding (institution), Travel/Accommodation/Expenses: Pfizer; Honoraria (self): Seattle genetics."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "E. Brain", "first_name": "E.", "last_name": "Brain", "second_name": "", "title": " Honoraria (self), Travel/Accommodation/Expenses: AstraZeneca; Honoraria (self): BMS; Honoraria (self): Celgene; Honoraria (self): Clinigen; Honoraria (self): G1 therapeutics; Honoraria (self): Hospira; Honoraria (self): Jansen; Honoraria (self): Mylan; Honoraria (self): OBI pharma; Honoraria (self): Pfizer; Honoraria (self): Puma; Honoraria (self), Travel/Accommodation/Expenses: Roche; Honoraria (self): Samsung; Travel/Accommodation/Expenses: Novartis; Travel/Accommodation/Expenses: Pierre Fabre; Travel/Accommodation/Expenses: Sandoz."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Perol", "first_name": "D.", "last_name": "Perol", "second_name": "", "title": " Honoraria (self), Travel/Accommodation/Expenses: AstraZeneca; Honoraria (self): BMS; Honoraria (self): Lilly; Honoraria (self): Ipsen; Honoraria (self): Roche; Honoraria (self): Novartis; Honoraria (self): Pierre Fabre; Honoraria (self): MSD; Honoraria (self): Takeda."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Pauline Corbaux", "first_name": "Pauline", "last_name": "Corbaux", "second_name": "", "country": "France", "city": "Pierre Bénite", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "F. Le Du", "first_name": "F.", "last_name": "Le Du", "second_name": "", "title": " Advisory/Consultancy: Lilly; Advisory/Consultancy: SeaGen; Advisory/Consultancy, Travel/Accommodation/Expenses: Novartis; Advisory/Consultancy, Travel/Accommodation/Expenses: Pfizer; Travel/Accommodation/Expenses: AstraZeneca; Travel/Accommodation/Expenses: Eisai."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Frenel", "first_name": "S.", "last_name": "Frenel", "second_name": "", "title": " Advisory/Consultancy, Travel/Accommodation/Expenses: Roche; Advisory/Consultancy, Travel/Accommodation/Expenses: AstraZeneca; Advisory/Consultancy, Travel/Accommodation/Expenses: Lilly; Advisory/Consultancy, Travel/Accommodation/Expenses: Pfizer; Advisory/Consultancy: GSK; Advisory/Consultancy: Eisai; Advisory/Consultancy, Travel/Accommodation/Expenses: Novartis."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Marcela Carausu", "first_name": "Marcela", "last_name": "Carausu", "second_name": "", "country": "France", "city": "Saint-Cloud", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Xichun Hu", "first_name": "Xichun", "last_name": "Hu", "second_name": "", "country": "China", "city": "Shanghai", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Nicholas Turner", "first_name": "Nicholas", "last_name": "Turner", "second_name": "", "country": "United Kingdom", "city": "London", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. Dent", "first_name": "R.", "last_name": "Dent", "second_name": "", "title": " Honoraria (self), Travel/Accommodation/Expenses: Roche; Honoraria (self): Novartis; Honoraria (self): Lilly; Honoraria (self), Travel/Accommodation/Expenses: Pfizer; Honoraria (self): Eisai; Honoraria (self), Travel/Accommodation/Expenses: Merck; Honoraria (self), Travel/Accommodation/Expenses: AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Isakoff", "first_name": "S.", "last_name": "Isakoff", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (institution): Genentech; Advisory/Consultancy, Research grant/Funding (institution): AbbVie; Advisory/Consultancy: Hengrui; Advisory/Consultancy: Immunomedics; Advisory/Consultancy: Mylan; Advisory/Consultancy: Puma; Advisory/Consultancy, Research grant/Funding (institution): Oncopep Research ; Research grant/Funding (institution): AstraZeneca; Research grant/Funding (institution): Merck."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Saji", "first_name": "S.", "last_name": "Saji", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution): Chugai; Honoraria (self), Research grant/Funding (institution): Eisai; Honoraria (self): AstraZeneca; Honoraria (self), Research grant/Funding (institution): Takeda; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution): Novartis; Honoraria (self), Advisory/Consultancy: Kyowa-Kirin; Honoraria (self): Eli Lilly; Honoraria (self): MSD; Honoraria (self): Pfizer; Research grant/Funding (institution): Daiichi Sankyo; Research grant/Funding (institution): Taiho Pharmaceutical."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Z. Nowecki", "first_name": "Z.", "last_name": "Nowecki", "second_name": "", "title": " Travel/Accommodation/Expenses: Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Q. Lian", "first_name": "Q.", "last_name": "Lian", "second_name": "", "title": " Shareholder/Stockholder/Stock options: Roche; Shareholder/Stockholder/Stock options: AbbVie; Shareholder/Stockholder/Stock options: Gilead; Full/Part-time employment: GNE/Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Reilly", "first_name": "J.", "last_name": "Reilly", "second_name": "", "title": " Full/Part-time employment: Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "H. Hinton", "first_name": "H.", "last_name": "Hinton", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Wongchenko", "first_name": "M.", "last_name": "Wongchenko", "second_name": "", "title": " Full/Part-time employment: GNE/Roche; Shareholder/Stockholder/Stock options: Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Mani", "first_name": "A.", "last_name": "Mani", "second_name": "", "title": " Full/Part-time employment: GNE/Roche; Shareholder/Stockholder/Stock options: Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Robert Jones", "first_name": "Robert", "last_name": "Jones", "second_name": "", "country": "United Kingdom", "city": "Cardiff", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Wheatley", "first_name": "D.", "last_name": "Wheatley", "second_name": "", "title": " Honoraria (institution), Travel/Accommodation/Expenses: Roche; Honoraria (institution): Lilly; Honoraria (institution): Novartis; Honoraria (institution): Amgen; Honoraria (institution): Daiichi Sankyo."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Jayne E. Wood", "first_name": "Jayne", "last_name": "Wood", "second_name": "E.", "country": "United Kingdom", "city": "London", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Monika K. Krzyzanowska", "first_name": "Monika", "last_name": "Krzyzanowska", "second_name": "K.", "country": "Canada", "city": "Toronto", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Karolina Benesova", "first_name": "Karolina", "last_name": "Benesova", "second_name": "", "country": "Germany", "city": "Heidelberg", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Lorenz", "first_name": "M.", "last_name": "Lorenz", "second_name": "", "title": "Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Abbvie; BMS; MSD; Pfizer; Celgene; Roche; Chugai; Medac; GSK; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Novartis; UCB; Janssen-Cilag; Astra Zeneca; Lilly; Research grant/Funding (institution): Baxter; SOBI; Biogen; Actelion; Mundipharma; Bayer Vital; Octapharm; Sanofi; Hexal; Thermo Fischer; Shire."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Leipe", "first_name": "J.", "last_name": "Leipe", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Research grant/Funding (self): Pfizer; Novartis; Honoraria (self), Advisory/Consultancy: Abbvie; Astra Zeneca; BMS; Celgene; Hospira; Janssen-Cilag; Gilead; LEO Pharma; Lilly; MSD; Roche; Sanofi; UCB."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Hassel", "first_name": "C.", "last_name": "Hassel", "second_name": "", "title": " Honoraria (self), Research grant/Funding (institution), Travel/Accommodation/Expenses: BMS; Honoraria (self), Advisory/Consultancy: MDS; Honoraria (self): Roche; Novartis; Advisory/Consultancy, Travel/Accommodation/Expenses: Pierre Fabre."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "K. Jordan", "first_name": "K.", "last_name": "Jordan", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy: Amgen; Merck; MSD; Riemser; Helsinn; Tesaro; Kreussler; Voluntis; Pfizer; Pomme-med; Hexal."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Brian D. Gonzalez", "first_name": "Brian", "last_name": "Gonzalez", "second_name": "D.", "country": "United States of America", "city": "Tampa", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "P. Dicker", "first_name": "P.", "last_name": "Dicker", "second_name": "", "title": " Advisory/Consultancy: Roche, EMD Serono, Celldex, Janssen, Cybrexa, Self Care Catalysts, Oncohost, ThirdBridge, Noxopharm, Varian, Accordant, Moleculin."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "L. Jim", "first_name": "L.", "last_name": "Jim", "second_name": "", "title": " Advisory/Consultancy: RedHill BioPharma; Janssen Scientific Affairs, Merck."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Marianne J. Hjermstad", "first_name": "Marianne", "last_name": "Hjermstad", "second_name": "J.", "country": "Norway", "city": "Oslo", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Martin Nunez Abad", "first_name": "Martin", "last_name": "Abad", "second_name": "Nunez", "country": "Spain", "city": "Valencia", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Omer Dizdar", "first_name": "Omer", "last_name": "Dizdar", "second_name": "", "country": "Turkey", "city": "Ankara", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Lesley Fallowfield", "first_name": "Lesley", "last_name": "Fallowfield", "second_name": "", "country": "United Kingdom", "city": "Brighton", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Olivia Pagani", "first_name": "Olivia", "last_name": "Pagani", "second_name": "", "country": "Switzerland", "city": "Bellinzona", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Michael Friedlander", "first_name": "Michael", "last_name": "Friedlander", "second_name": "", "country": "NS", "city": "Sydney", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "B. Arun", "first_name": "B.", "last_name": "Arun", "second_name": "", "title": " Leadership role, Research grant/Funding (institution), Steering committee (non-paid): AbbVie; Research grant/Funding (institution): PharmaMar; Research grant/Funding (institution): AstraZeneca; Research grant/Funding (institution): Invitae."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Han", "first_name": "S.", "last_name": "Han", "second_name": "", "title": " Research grant/Funding (institution): AbbVie; Research grant/Funding (institution): Prescient; Research grant/Funding (institution): Horizon; Research grant/Funding (institution): Karyopharm; Research grant/Funding (institution): BMS; Research grant/Funding (institution): Novartis; Research grant/Funding (institution): Pfizer; Research grant/Funding (institution): Tesaro; Research grant/Funding (institution): TapImmune; Research grant/Funding (institution): Seattle Genetics; Research grant/Funding (institution): Department of Defense; Speaker Bureau/Expert testimony: Lilly."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "H. Wildiers", "first_name": "H.", "last_name": "Wildiers", "second_name": "", "title": " Honoraria (institution), Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Roche; Honoraria (institution), Advisory/Consultancy: AstraZeneca; Honoraria (institution), Advisory/Consultancy: Lilly; Honoraria (institution), Advisory/Consultancy: Novartis; Honoraria (institution), Advisory/Consultancy: AbbVie; Honoraria (institution), Advisory/Consultancy: Vifor Pharma; Honoraria (institution), Advisory/Consultancy, Travel/Accommodation/Expenses: Pfizer; Honoraria (institution), Advisory/Consultancy: Celldex Therapeutics; Honoraria (institution), Advisory/Consultancy: Janssen-Cilag; Honoraria (institution), Advisory/Consultancy: TRM Oncology; Honoraria (institution), Advisory/Consultancy: PUMA Biotechnology; Honoraria (institution), Advisory/Consultancy: Amgen; Honoraria (institution), Advisory/Consultancy: Orion Corporation."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "P. Ayoub", "first_name": "P.", "last_name": "Ayoub", "second_name": "", "title": " Research grant/Funding (institution): AbbVie; Research grant/Funding (institution): Boston Biomedical; Advisory/Consultancy: AstraZeneca; Advisory/Consultancy: Eisai; Advisory/Consultancy: Eli Lilly; Advisory/Consultancy: Novartis; Advisory/Consultancy, Speaker Bureau/Expert testimony: Pfizer; Advisory/Consultancy: Puma; Advisory/Consultancy: Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Puhalla", "first_name": "S.", "last_name": "Puhalla", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (institution): AbbVie; Advisory/Consultancy: MedImmune; Advisory/Consultancy: Celldex; Advisory/Consultancy: Puma; Advisory/Consultancy, Research grant/Funding (institution): Pfizer; Advisory/Consultancy, Research grant/Funding (institution): AstraZeneca; Advisory/Consultancy: Eisai; Advisory/Consultancy: NanoString; Research grant/Funding (institution): Lilly; Research grant/Funding (institution): Novartis; Research grant/Funding (institution): Incyte; Research grant/Funding (institution): Covance-Bayer; Research grant/Funding (institution): Genentech; Research grant/Funding (institution): Medivation."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "L. Floden", "first_name": "L.", "last_name": "Floden", "second_name": "", "title": " Full/Part-time employment: Clinical Outcomes Solutions."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "N. Khandelwal", "first_name": "N.", "last_name": "Khandelwal", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: AbbVie."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "K. Benjamin", "first_name": "K.", "last_name": "Benjamin", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: AbbVie."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. Kamalakar", "first_name": "R.", "last_name": "Kamalakar", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: AbbVie."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Maag", "first_name": "D.", "last_name": "Maag", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: AbbVie."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Volkmar Mueller", "first_name": "Volkmar", "last_name": "Mueller", "second_name": "", "country": "Germany", "city": "Hamburg", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "E. Paplomata", "first_name": "E.", "last_name": "Paplomata", "second_name": "", "title": " Honoraria (institution), Advisory/Consultancy: Mylan; Honoraria (institution), Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Novartis; Honoraria (institution), Advisory/Consultancy: Pfizer; Honoraria (institution), Advisory/Consultancy: R-Pharm; Research grant/Funding (institution): AbbVie; Research grant/Funding (institution): Cascadian Therapeutics; Research grant/Funding (institution): Corcept Therapeutics; Research grant/Funding (institution), Travel/Accommodation/Expenses: Genentech; Research grant/Funding (institution): Hoosier Cancer Research Network; Research grant/Funding (institution), Travel/Accommodation/Expenses: Merck; Research grant/Funding (institution): Seattle Genetics; Travel/Accommodation/Expenses: Amgen; Travel/Accommodation/Expenses: Tesaro."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Zelnak", "first_name": "A.", "last_name": "Zelnak", "second_name": "", "title": " Advisory/Consultancy: Novartis; Advisory/Consultancy: Pfizer; Travel/Accommodation/Expenses: Immunomedics."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "H. Jakobsen", "first_name": "H.", "last_name": "Jakobsen", "second_name": "", "title": " Advisory/Consultancy: Novartis; Advisory/Consultancy: Pfizer; Advisory/Consultancy: Roche; Advisory/Consultancy: Lilly."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "H. Brix", "first_name": "H.", "last_name": "Brix", "second_name": "", "title": " Travel/Accommodation/Expenses: Roche; Travel/Accommodation/Expenses: Pfizer; Travel/Accommodation/Expenses: Pierre Fabre."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Brenner", "first_name": "J.", "last_name": "Brenner", "second_name": "", "title": " Advisory/Consultancy, Leadership role, Shareholder/Stockholder/Stock options, intellectual property interest: NanoTX; Advisory/Consultancy, Shareholder/Stockholder/Stock options: Plus Therapeutics; Honoraria (self), Advisory/Consultancy, Research grant/Funding (self), Travel/Accommodation/Expenses: Vascular Biogenics; Advisory/Consultancy: Alamab Therapeutics; Research grant/Funding (self): Threshold Pharmaceuticals; Research grant/Funding (institution): miRNA Therapeutics; Research grant/Funding (institution): Boston Biomedical; Research grant/Funding (institution): Upshaw Smith; Research grant/Funding (institution): Immunomedics; Research grant/Funding (institution): Medicenna."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Gelmon", "first_name": "A.", "last_name": "Gelmon", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (institution): AstraZeneca; Advisory/Consultancy, Research grant/Funding (institution): Bristol-Myers Squibb; Advisory/Consultancy: Genentech; Advisory/Consultancy: Genomic Health; Advisory/Consultancy: Janssen Oncology; Advisory/Consultancy: Lilly; Advisory/Consultancy: Merck; Advisory/Consultancy: Mylan; Advisory/Consultancy: NanoString Technologies; Advisory/Consultancy: Novartis; Advisory/Consultancy, Research grant/Funding (institution): Pfizer; Advisory/Consultancy, Research grant/Funding (institution): Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "G. Curigliano", "first_name": "G.", "last_name": "Curigliano", "second_name": "", "title": " Advisory/Consultancy: Bristol-Myers Squibb; Advisory/Consultancy, Speaker Bureau/Expert testimony: Lilly; Advisory/Consultancy: Novartis; Advisory/Consultancy, Speaker Bureau/Expert testimony: Pfizer; Advisory/Consultancy, Speaker Bureau/Expert testimony: Roche; Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (institution): Seattle Genetics; Research grant/Funding (institution): Ellipsis; Full/Part-time employment: University of Milano, Istituto Europeo di Oncologia, IRCCS, Milan, Italy."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "K. DeBusk", "first_name": "K.", "last_name": "DeBusk", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Seattle Genetics; Shareholder/Stockholder/Stock options: Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Ramos", "first_name": "J.", "last_name": "Ramos", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Seattle Genetics."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "X. An", "first_name": "X.", "last_name": "An", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Seattle Genetics; Full/Part-time employment: Novartis."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Peter A. Fasching", "first_name": "Peter", "last_name": "Fasching", "second_name": "A.", "country": "Germany", "city": "Erlangen", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Nusch", "first_name": "A.", "last_name": "Nusch", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses, Advisory Board/Consulting; Travel support; Research Funding: Novartis; Honoraria (self), Advisory/Consultancy, Advisory Board/Consulting: Amgen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "N. El Saghir", "first_name": "N.", "last_name": "Saghir", "second_name": "El", "title": " Honoraria (self), Advisory/Consultancy, Advisory Board; Lectures: Novartis; Honoraria (self), Advisory/Consultancy, Advisory Board; Lectures: Pfizer; Honoraria (self), Advisory/Consultancy, Advisory Board; Lectures: Eli Lilly; Honoraria (self), Advisory/Consultancy, Advisory Board; Lectures: Roche; Honoraria (self), Advisory/Consultancy, Advisory Board; Lectures: AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "E. Alba", "first_name": "E.", "last_name": "Alba", "second_name": "", "title": " Honoraria (self), Research grant/Funding (institution), Advisory Board; Research Funding: Roche; Honoraria (self), Advisory/Consultancy, Advisory Board: Novartis; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Advisory Board; Research Funding: Pfizer; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Advisory Board: Eli Lilly; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Advisory Board; Research Funding: Bristol-Myers Squibb; Honoraria (self), Advisory/Consultancy, Advisory Board: Genomic Health; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Advisory Board; Research Funding: Nanostring; Travel/Accommodation/Expenses, Travel Support: Celgene; Research grant/Funding (institution), Research Funding: Sysmex."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Im", "first_name": "A.", "last_name": "Im", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Research Grant; Advisory Board: AstraZeneca; Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses, Advisory Board; Travel Support: Novartis; Honoraria (self), Advisory/Consultancy, Advisory Board: Hanmi; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Advisory Board: Pfizer; Honoraria (self), Advisory/Consultancy, Advisory Board: Eisai; Honoraria (self), Advisory/Consultancy, Advisory Board: Amgen; Honoraria (self), Advisory/Consultancy, Advisory Board: MediPacto; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Advisory Board: Roche; Honoraria (self), Advisory/Consultancy, Advisory Board: Lilly."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "W. Janni", "first_name": "W.", "last_name": "Janni", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (institution), Travel/Accommodation/Expenses, Advisory Board/Consulting; Research Funding; Travel Support; Expert Testimony: Novartis."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Chandiwana", "first_name": "D.", "last_name": "Chandiwana", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment, Employment and stock ownership: Novartis."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "B. Lanoue", "first_name": "B.", "last_name": "Lanoue", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment, Employment and stock ownership: Novartis."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Thuerigen", "first_name": "A.", "last_name": "Thuerigen", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment, Employment and stock ownership: Novartis."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Gaur", "first_name": "A.", "last_name": "Gaur", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment, Employment and stock ownership: Novartis."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Joan Albanell", "first_name": "Joan", "last_name": "Albanell", "second_name": "", "country": "Spain", "city": "Barcelona", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Ramos", "first_name": "M.", "last_name": "Ramos", "second_name": "", "title": " Speaker Bureau/Expert testimony: Roche; Speaker Bureau/Expert testimony: Novartis; Speaker Bureau/Expert testimony: Pfizer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Santaballa Bertran", "first_name": "A.", "last_name": "Bertran", "second_name": "Santaballa", "title": " Advisory/Consultancy, Speaker Bureau/Expert testimony: MSD; Advisory/Consultancy: AstraZeneca; Advisory/Consultancy, Speaker Bureau/Expert testimony: Pfizer; Advisory/Consultancy, Speaker Bureau/Expert testimony: GSK; Advisory/Consultancy: Clovis; Advisory/Consultancy: Roche; Advisory/Consultancy: Pierre Fabre."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "F. Moreno", "first_name": "F.", "last_name": "Moreno", "second_name": "", "title": " Honoraria (self), Travel/Accommodation/Expenses: Pfizer; Honoraria (self), Travel/Accommodation/Expenses: Novartis; Honoraria (self), Travel/Accommodation/Expenses: Roche; Honoraria (self): MSD; Honoraria (self): AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Margeli Vila", "first_name": "M.", "last_name": "Vila", "second_name": "Margeli", "title": " Advisory/Consultancy: Pfizer; Advisory/Consultancy: Novartis; Advisory/Consultancy: AstraZeneca; Advisory/Consultancy: Kern-Pharma."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "F. Rojo Todo", "first_name": "F.", "last_name": "Todo", "second_name": "Rojo", "title": " Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (institution), Travel/Accommodation/Expenses: Roche; Advisory/Consultancy, Speaker Bureau/Expert testimony: AstraZeneca; Advisory/Consultancy, Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: Novartis; Advisory/Consultancy, Speaker Bureau/Expert testimony: BMS; Advisory/Consultancy, Speaker Bureau/Expert testimony: MSD; Advisory/Consultancy, Speaker Bureau/Expert testimony: Lilly; Advisory/Consultancy, Speaker Bureau/Expert testimony: Pfizer; Advisory/Consultancy: Genomic Health; Advisory/Consultancy: Guardant Health; Advisory/Consultancy: Archer; Advisory/Consultancy, Speaker Bureau/Expert testimony: Pierre Fabre."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Joseph Gligorov", "first_name": "Joseph", "last_name": "Gligorov", "second_name": "", "country": "France", "city": "Paris", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Giulio Draetta", "first_name": "Giulio", "last_name": "Draetta", "second_name": "", "country": "United States of America", "city": "Houston", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Lillian L. Siu", "first_name": "Lillian", "last_name": "Siu", "second_name": "L.", "country": "Ontari", "city": "Toronto", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. Geva", "first_name": "R.", "last_name": "Geva", "second_name": "", "title": " Honoraria (self), Travel/Accommodation/Expenses: BMS; Honoraria (self): Lilly; Honoraria (self), Travel/Accommodation/Expenses: Medison; Honoraria (self): Roche; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution): Novartis; Honoraria (self): Janssen; Honoraria (self): Takeda; Honoraria (self), Advisory/Consultancy: MSD; Honoraria (self): Pfizer; Advisory/Consultancy, Travel/Accommodation/Expenses: Bayer; Advisory/Consultancy: Boehringer Ingelheim; Advisory/Consultancy: BOL Pharma; Travel/Accommodation/Expenses: Merck."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Rasco", "first_name": "D.", "last_name": "Rasco", "second_name": "", "title": " Research grant/Funding (institution): Merck."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "K. Abraham", "first_name": "K.", "last_name": "Abraham", "second_name": "", "title": " Full/Part-time employment: Merck Sharp & Dohme Corp."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "F. Markensohn", "first_name": "F.", "last_name": "Markensohn", "second_name": "", "title": " Full/Part-time employment: Merck Sharp & Dohme Corp."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "L. Suttner", "first_name": "L.", "last_name": "Suttner", "second_name": "", "title": " Full/Part-time employment: Merck; Research grant/Funding (self): GlaxoSmithKline."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Siddiqi", "first_name": "S.", "last_name": "Siddiqi", "second_name": "", "title": " Full/Part-time employment: Merck."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Altura", "first_name": "A.", "last_name": "Altura", "second_name": "", "title": " Full/Part-time employment: Merck Sharp & Dohme Corp."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Geoffrey Ku", "first_name": "Geoffrey", "last_name": "Ku", "second_name": "", "country": "N", "city": "New York", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "K. Aviano", "first_name": "K.", "last_name": "Aviano", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Pieris Pharmaceuticals."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "L. Mar", "first_name": "L.", "last_name": "Mar", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Pieris Pharmaceuticals."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "P. Jolicoeur", "first_name": "P.", "last_name": "Jolicoeur", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Pieris Pharmaceuticals."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Olwill", "first_name": "S.", "last_name": "Olwill", "second_name": "", "title": " Leadership role, Shareholder/Stockholder/Stock options, Full/Part-time employment, Officer/Board of Directors: Pieris Pharmaceuticals."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "I. Bruns", "first_name": "I.", "last_name": "Bruns", "second_name": "", "title": " Leadership role, Shareholder/Stockholder/Stock options, Full/Part-time employment, Officer/Board of Directors: Pieris Pharmaceuticals."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Benoit J. Rousseau", "first_name": "Benoit", "last_name": "Rousseau", "second_name": "J.", "country": "CEDE", "city": "Créteil", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "V. Simmet", "first_name": "V.", "last_name": "Simmet", "second_name": "", "title": " Honoraria (self): Lilly; Honoraria (self): Servier; Travel/Accommodation/Expenses: Amgen; Travel/Accommodation/Expenses: Novartis."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Bruyas", "first_name": "A.", "last_name": "Bruyas", "second_name": "", "title": " Speaker Bureau/Expert testimony: BMS."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. Cohen", "first_name": "R.", "last_name": "Cohen", "second_name": "", "title": " Honoraria (self): Servier; Honoraria (self): Amgen; Honoraria (self): Sanofi."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "O. Bouche", "first_name": "O.", "last_name": "Bouche", "second_name": "", "title": " Honoraria (self), Travel/Accommodation/Expenses: Roche; Honoraria (self): Merck; Honoraria (self), Speaker Bureau/Expert testimony: Amgen; Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: Bayer; Speaker Bureau/Expert testimony: Pierre Fabre; Speaker Bureau/Expert testimony: Servier; Travel/Accommodation/Expenses: Lilly."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Marabelle", "first_name": "A.", "last_name": "Marabelle", "second_name": "", "title": " Speaker Bureau/Expert testimony, Research grant/Funding (self), Travel/Accommodation/Expenses: Roche/Genentech; Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: BMS; Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: MSD; Research grant/Funding (institution): Pfizer; Advisory/Consultancy, Research grant/Funding (institution): Lytix pharma; Research grant/Funding (institution): Eisai; Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: AstraZeneca/Medimmune; Research grant/Funding (institution): Tesaro; Research grant/Funding (institution): Chugai; Advisory/Consultancy: GSK; Advisory/Consultancy: Innate pharma; Advisory/Consultancy: Novartis; Advisory/Consultancy: Bayer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Antoine Italiano", "first_name": "Antoine", "last_name": "Italiano", "second_name": "", "country": "CEDE", "city": "Bordeaux", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Sepulveda Sanchez", "first_name": "M.", "last_name": "Sanchez", "second_name": "Sepulveda", "title": " Advisory/Consultancy, Research grant/Funding (self): Pfizer; Advisory/Consultancy, Travel/Accommodation/Expenses: AbbVie; Advisory/Consultancy: Celgene, A Bristol-Myers Squibb Company; Advisory/Consultancy: GW Pharma; Speaker Bureau/Expert testimony: Astellas; Travel/Accommodation/Expenses: Ipsen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "O. Saavedra", "first_name": "O.", "last_name": "Saavedra", "second_name": "", "title": " Travel/Accommodation/Expenses: MSD; Travel/Accommodation/Expenses: Kyowakirin."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Michot", "first_name": "M.", "last_name": "Michot", "second_name": "", "title": " Honoraria (self): Celgene, A Bristol-Myers Squibb Company; Honoraria (self): Bristol-Myers Squibb; Honoraria (self): AstraZeneca; Honoraria (self): Janssen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "G. Musuraca", "first_name": "G.", "last_name": "Musuraca", "second_name": "", "title": " Advisory/Consultancy: Servier."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. Sarmiento", "first_name": "R.", "last_name": "Sarmiento", "second_name": "", "title": " Travel/Accommodation/Expenses, Shareholder/Stockholder/Stock options, Full/Part-time employment: Celgene, A Bristol-Myers Squibb Company."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "B. Amoroso", "first_name": "B.", "last_name": "Amoroso", "second_name": "", "title": " Advisory/Consultancy, Shareholder/Stockholder/Stock options, Full/Part-time employment: Celgene, A Bristol-Myers Squibb Company; Advisory/Consultancy: NordicNanovector; Advisory/Consultancy: ArgenX."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "I. Aronchik", "first_name": "I.", "last_name": "Aronchik", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Bristol-Myers Squibb."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "E. Filvaroff", "first_name": "E.", "last_name": "Filvaroff", "second_name": "", "title": " Travel/Accommodation/Expenses, Shareholder/Stockholder/Stock options, Licensing/Royalties, Full/Part-time employment: Bristol-Myers Squibb; Shareholder/Stockholder/Stock options: Amgen; Shareholder/Stockholder/Stock options: Gilead; Shareholder/Stockholder/Stock options: Genentech/Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "B. Hanna", "first_name": "B.", "last_name": "Hanna", "second_name": "", "title": " Research grant/Funding (self), Shareholder/Stockholder/Stock options, Full/Part-time employment: Bristol-Myers Squibb."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Z. Nikolova", "first_name": "Z.", "last_name": "Nikolova", "second_name": "", "title": " Travel/Accommodation/Expenses, Shareholder/Stockholder/Stock options, Full/Part-time employment: Celgene, A Bristol-Myers Squibb Company."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Pinto", "first_name": "A.", "last_name": "Pinto", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Roche; Honoraria (self): Celgene, A Bristol Myers Squibb Company; Honoraria (self): Servier; Honoraria (self): Bristol-Myers Squibb; Honoraria (self): MSD; Advisory/Consultancy: Novartis; Travel/Accommodation/Expenses: Takeda."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Antoine Hollebecque", "first_name": "Antoine", "last_name": "Hollebecque", "second_name": "", "country": "France", "city": "Villejuif", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. de Bono", "first_name": "S.", "last_name": "de Bono", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Sierra Oncology; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Daiichi; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: AstraZeneca; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Astellas; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Bayer; Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Boehringer Ingelheim; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Genentech/Roche; Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Genmab; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: GSK; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Janssen; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Merck Serono; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: MSD; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Menarini Silicon Biosystems; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Orion; Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Pfizer; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Sanofi; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Taiho; Research grant/Funding (institution): Cellcentric; Research grant/Funding (institution): Celgene, a Bristol-Myers Squibb Company."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "F. de Braud", "first_name": "F.", "last_name": "de Braud", "second_name": "", "title": " Advisory/Consultancy: TizianaLife Sciences; Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (institution): Bristol Myers Squibb; Advisory/Consultancy, Research grant/Funding (institution): Celgene, A Bristol-Myers Squibb Company; Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (institution): Novartis; Advisory/Consultancy: Servier; Advisory/Consultancy: Pharm Research Associated; Advisory/Consultancy: Daiichi Sankyo; Advisory/Consultancy, Speaker Bureau/Expert testimony: Ignyta; Advisory/Consultancy, Speaker Bureau/Expert testimony: Amgen; Advisory/Consultancy, Speaker Bureau/Expert testimony: Pfizer; Advisory/Consultancy: Octimet Oncology; Advisory/Consultancy: Incyte; Advisory/Consultancy: Teofarma; Advisory/Consultancy: Pierre Fabre; Advisory/Consultancy, Speaker Bureau/Expert testimony: Roche; Advisory/Consultancy: EMD Serono; Speaker Bureau/Expert testimony, Research grant/Funding (institution): Bayer; Speaker Bureau/Expert testimony, Research grant/Funding (institution): Lilly; Research grant/Funding (institution): Nektar; Research grant/Funding (institution): Loxo Oncology; Research grant/Funding (institution): Tesaro; Speaker Bureau/Expert testimony: AstraZeneca; Speaker Bureau/Expert testimony: Gentili; Speaker Bureau/Expert testimony: Fondazione Menarini; Speaker Bureau/Expert testimony: Menarini; Speaker Bureau/Expert testimony: MSD; Speaker Bureau/Expert testimony: Noema S."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "E. Baudin", "first_name": "E.", "last_name": "Baudin", "second_name": "", "title": " Speaker Bureau/Expert testimony, Research grant/Funding (institution): Novartis; Speaker Bureau/Expert testimony, Research grant/Funding (institution): Ipsen; Speaker Bureau/Expert testimony: AAA; Speaker Bureau/Expert testimony: Pfizer; Speaker Bureau/Expert testimony: Hutchinson Pharma."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Lamba", "first_name": "M.", "last_name": "Lamba", "second_name": "", "title": " Research grant/Funding (self), Shareholder/Stockholder/Stock options, Full/Part-time employment: Pfizer; Research grant/Funding (self), Shareholder/Stockholder/Stock options, Full/Part-time employment: Celgene, A Bristol-Myers Squibb Company; Research grant/Funding (self), Shareholder/Stockholder/Stock options: Bristol-Myers Squibb."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Maud Toulmonde", "first_name": "Maud", "last_name": "Toulmonde", "second_name": "", "country": "CEDE", "city": "Bordeaux", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Bessede", "first_name": "A.", "last_name": "Bessede", "second_name": "", "title": " Officer/Board of Directors: Immusmol."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Y. Blay", "first_name": "Y.", "last_name": "Blay", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (institution): PharmaMar."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Javier Martin Broto", "first_name": "Javier", "last_name": "Broto", "second_name": "Martin", "country": "Spain", "city": "Seville", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Florence Duffaud", "first_name": "Florence", "last_name": "Duffaud", "second_name": "", "country": "CEDEX ", "city": "Marseille", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "O. Mir", "first_name": "O.", "last_name": "Mir", "second_name": "", "title": " Honoraria (self): Amgen; Honoraria (self), Honoraria (institution): Astra-Zeneca; Honoraria (self), Research grant/Funding (institution): Bayer; Honoraria (self): Bristol Myers-Squibb; Honoraria (self), Speaker Bureau/Expert testimony, Research grant/Funding (institution): Eli-Lilly; Honoraria (self), Honoraria (institution), Advisory/Consultancy, Shareholder/Stockholder/Stock options: Ipsen; Honoraria (self): Lundbeck; Honoraria (self): MSD; Honoraria (self), Honoraria (institution): Novartis; Honoraria (self), Honoraria (institution), Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: Pfizer; Honoraria (self), Honoraria (institution), Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: Roche; Honoraria (self), Speaker Bureau/Expert testimony: Servier; Honoraria (self): Vifor pharma; Honoraria (institution), Advisory/Consultancy, Research grant/Funding (institution): Blueprint Medicines; Honoraria (institution): PharmaMar; Research grant/Funding (institution): Agios pharmaceutical; Research grant/Funding (institution): Epizyme; Travel/Accommodation/Expenses: Amgen; Shareholder/Stockholder/Stock options: Amplitude surgical; Shareholder/Stockholder/Stock options: Transgene."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "P. Boudou Rouquette", "first_name": "P.", "last_name": "Rouquette", "second_name": "Boudou", "title": " Advisory/Consultancy, Travel/Accommodation/Expenses: Takeda; Advisory/Consultancy: BMS; Travel/Accommodation/Expenses: PharmaMar."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "N. Penel", "first_name": "N.", "last_name": "Penel", "second_name": "", "title": " Research grant/Funding (institution): Bayer HealthCare."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Perrin", "first_name": "C.", "last_name": "Perrin", "second_name": "", "title": " Advisory/Consultancy, Travel/Accommodation/Expenses: Pfizer; Advisory/Consultancy, Travel/Accommodation/Expenses: Eisai; Travel/Accommodation/Expenses: Roche; Travel/Accommodation/Expenses: Daiichi; Travel/Accommodation/Expenses: Novartis."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "N. Gaspar", "first_name": "N.", "last_name": "Gaspar", "second_name": "", "title": " Advisory/Consultancy: Eisai; Advisory/Consultancy: Ipsen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Joseph A. Ludwig", "first_name": "Joseph", "last_name": "Ludwig", "second_name": "A.", "country": "A", "city": "Houston", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "F. Riedel", "first_name": "F.", "last_name": "Riedel", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (institution): Oncternal."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Toretsky", "first_name": "J.", "last_name": "Toretsky", "second_name": "", "title": " Shareholder/Stockholder/Stock options: Oncternal Therapeutics."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "B. Breitmeyer", "first_name": "B.", "last_name": "Breitmeyer", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Officer/Board of Directors: Oncternal Therapeutics."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Sandra Strauss", "first_name": "Sandra", "last_name": "Strauss", "second_name": "", "country": "United Kingdom", "city": "London", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Ruth Palmer", "first_name": "Ruth", "last_name": "Palmer", "second_name": "", "country": "Sweden", "city": "Göteborg", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Stefano Trebeschi", "first_name": "Stefano", "last_name": "Trebeschi", "second_name": "", "country": "Netherlands", "city": "Amsterdam", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Akshayaa Vaidyanathan", "first_name": "Akshayaa", "last_name": "Vaidyanathan", "second_name": "", "country": "Netherlands", "city": "Maastricht", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "F. Zerka", "first_name": "F.", "last_name": "Zerka", "second_name": "", "title": " Research grant/Funding (institution), PREDICT: Oncoradiomics."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Woodruff", "first_name": "C.", "last_name": "Woodruff", "second_name": "", "title": " Shareholder/Stockholder/Stock options: Oncoradiomics."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. Leijenaar", "first_name": "R.", "last_name": "Leijenaar", "second_name": "", "title": " Shareholder/Stockholder/Stock options: Oncoradiomics."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "W. Vos", "first_name": "W.", "last_name": "Vos", "second_name": "", "title": " Shareholder/Stockholder/Stock options: Oncoradiomics."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Walsh", "first_name": "S.", "last_name": "Walsh", "second_name": "", "title": " Research grant/Funding (self), Research grant/Funding (institution), Shareholder/Stockholder/Stock options: Oncoradiomics."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "P. Lambin", "first_name": "P.", "last_name": "Lambin", "second_name": "", "title": " Research grant/Funding (self), Research grant/Funding (institution), Shareholder/Stockholder/Stock options: Oncoradiomics."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Ralph Leijenaar", "first_name": "Ralph", "last_name": "Leijenaar", "second_name": "", "country": "Belgium", "city": "Liège", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Vaidyanathan", "first_name": "A.", "last_name": "Vaidyanathan", "second_name": "", "title": " Full/Part-time employment: Oncoradiomics."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "B. Miraglio", "first_name": "B.", "last_name": "Miraglio", "second_name": "", "title": " Full/Part-time employment: Oncoradiomics."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "N. Tsoutzidis", "first_name": "N.", "last_name": "Tsoutzidis", "second_name": "", "title": " Full/Part-time employment: Oncoradiomics."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Sauli Vuoti", "first_name": "Sauli", "last_name": "Vuoti", "second_name": "", "country": "Finland", "city": "Jyvaskyla", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Claudia Maletzki", "first_name": "Claudia", "last_name": "Maletzki", "second_name": "", "country": "Germany", "city": "Rostock", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Pieter Demetter", "first_name": "Pieter", "last_name": "Demetter", "second_name": "", "country": "Belgium", "city": "Brussels", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Emma Polonio", "first_name": "Emma", "last_name": "Polonio", "second_name": "", "country": "Spain", "city": "Girona", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Alexandra Tsidulko", "first_name": "Alexandra", "last_name": "Tsidulko", "second_name": "", "country": "Russian Federation", "city": "Novosibirsk", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "HONG CHENG", "first_name": "HONG", "last_name": "CHENG", "second_name": "", "country": "China", "city": "Beijing", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Hugo Arasanz", "first_name": "Hugo", "last_name": "Arasanz", "second_name": "", "country": "Spain", "city": "Pamplona", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Prudence Francis", "first_name": "Prudence", "last_name": "Francis", "second_name": "", "country": "VI", "city": "Melbourne", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Shaheenah Dawood", "first_name": "Shaheenah", "last_name": "Dawood", "second_name": "", "country": "United Arab Emirates", "city": "Dubai", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Giampaolo Bianchini", "first_name": "Giampaolo", "last_name": "Bianchini", "second_name": "", "country": "Italy", "city": "Milan", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Huang", "first_name": "S.", "last_name": "Huang", "second_name": "", "title": " Advisory/Consultancy, Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: Amgen; Research grant/Funding (institution): AstraZeneca; Research grant/Funding (institution): MSD; Speaker Bureau/Expert testimony, Research grant/Funding (institution): Novartis; Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (institution), Travel/Accommodation/Expenses: Pfizer; Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: F."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Egle", "first_name": "D.", "last_name": "Egle", "second_name": "", "title": " Honoraria (self), Research grant/Funding (institution), Travel/Accommodation/Expenses: Roche; Honoraria (self), Travel/Accommodation/Expenses: Pfizer; Honoraria (self), Travel/Accommodation/Expenses: Novartis; Honoraria (self), Travel/Accommodation/Expenses: AstraZeneca; Honoraria (self), Travel/Accommodation/Expenses: Lilly; Honoraria (self), Travel/Accommodation/Expenses: MSD."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Thill", "first_name": "M.", "last_name": "Thill", "second_name": "", "title": " Honoraria (self), Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: Amgen; Honoraria (self), Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: Celgene; Honoraria (self), Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: Roche; Honoraria (self), Speaker Bureau/Expert testimony: MSD."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Ciruelos", "first_name": "M.", "last_name": "Ciruelos", "second_name": "", "title": " Advisory/Consultancy, Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: Roche; Advisory/Consultancy, Speaker Bureau/Expert testimony: Lilly; Advisory/Consultancy, Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: Pfizer; Advisory/Consultancy, Speaker Bureau/Expert testimony: Novartis."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Colleoni", "first_name": "A.", "last_name": "Colleoni", "second_name": "", "title": " Honoraria (self): Novartis; Advisory/Consultancy: PierreFabre; Advisory/Consultancy: Pfizer; Advisory/Consultancy: Puma Biotechnology; Advisory/Consultancy: OBI Pharma; Advisory/Consultancy: Celldex; Advisory/Consultancy: AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "L. Del Mastro", "first_name": "L.", "last_name": "Del Mastro", "second_name": "", "title": " Honoraria (self): Roche; Honoraria (self): Pfizer; Honoraria (self): Ipsen; Honoraria (self): Eli Lilly; Honoraria (self): Novartis; Honoraria (self): Takeda; Honoraria (self): MSD; Honoraria (self): Genomic Health; Travel/Accommodation/Expenses: Celgene."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "G. Viale", "first_name": "G.", "last_name": "Viale", "second_name": "", "title": " Advisory/Consultancy, Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: Roche Genentech; Advisory/Consultancy: BMS; Advisory/Consultancy: MSD; Advisory/Consultancy: AstraZeneca; Travel/Accommodation/Expenses: Celgene."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Maria Vittoria Dieci", "first_name": "Maria", "last_name": "Dieci", "second_name": "Vittoria", "country": "Italy", "city": "Padova", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Musolino", "first_name": "A.", "last_name": "Musolino", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Roche; Advisory/Consultancy, Travel/Accommodation/Expenses: Eli Lilly; Advisory/Consultancy: Pfizer; Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Eisai; Advisory/Consultancy: Macrogenics; Research grant/Funding (institution): AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Spazzapan", "first_name": "S.", "last_name": "Spazzapan", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Roche; Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Novartis; Advisory/Consultancy, Travel/Accommodation/Expenses: Pfizer; Advisory/Consultancy, Travel/Accommodation/Expenses: Gentili; Advisory/Consultancy: Takeda; Advisory/Consultancy: AstraZeneca; Advisory/Consultancy, Travel/Accommodation/Expenses: Celgene; Research grant/Funding (institution): AbbVie; Research grant/Funding (institution): Cell-dex therapeutics; Travel/Accommodation/Expenses: Tesaro; Travel/Accommodation/Expenses: Teva."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Hiroko Bando", "first_name": "Hiroko", "last_name": "Bando", "second_name": "", "country": "Ibarak", "city": "Tsukuba", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "N. Masuda", "first_name": "N.", "last_name": "Masuda", "second_name": "", "title": " Honoraria (self), Research grant/Funding (institution), Outside the submitted work: Chugai; Honoraria (self), Research grant/Funding (institution), Outside the submitted work: AstraZeneca; Honoraria (self), Research grant/Funding (institution), Outside the submitted work: Pfizer; Honoraria (self), Research grant/Funding (institution), Outside the submitted work: Eli Lilly; Honoraria (self), Research grant/Funding (institution), Outside the submitted work: Eisai; Honoraria (self), Research grant/Funding (institution), Outside the submitted work: Takeda; Honoraria (self), Research grant/Funding (institution), Outside the submitted work: Kyowa Kirin; Research grant/Funding (institution), Outside the submitted work: MSD; Honoraria (self), Research grant/Funding (institution), Outside the submitted work: Novartis; Honoraria (self), Research grant/Funding (institution), Outside the submitted work: Daiichi Sankyo; Advisory/Consultancy, Board of directors: Japan Breast Cancer Research Group Association."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Nagai", "first_name": "S.", "last_name": "Nagai", "second_name": "", "title": " Honoraria (self), Outside the submitted work: Chugai; Honoraria (self), Outside the submitted work: Taiho ; Honoraria (self), Outside the submitted work: Pfizer; Honoraria (self), Outside the submitted work: Eli Lilly; Honoraria (self), Outside the submitted work: Novartis; Honoraria (self), Outside the submitted work: Eisai."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Ohtani", "first_name": "S.", "last_name": "Ohtani", "second_name": "", "title": " Honoraria (self), Outside the submitted work: Chugai; Honoraria (self), Outside the submitted work: AstraZeneca; Honoraria (self), Outside the submitted work: Pfizer; Honoraria (self), Outside the submitted work: Eli Lilly; Honoraria (self), Outside the submitted work: Eisai."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "T. Aruga", "first_name": "T.", "last_name": "Aruga", "second_name": "", "title": " Honoraria (self), Outside the submitted work: Eisai."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Y. Kikawa", "first_name": "Y.", "last_name": "Kikawa", "second_name": "", "title": " Honoraria (self), Outside the submitted work: Eisai; Honoraria (self), Outside the submitted work: Novartis; Honoraria (self), Outside the submitted work: Pfizer; Honoraria (self), Outside the submitted work: Eli Lilly; Honoraria (self), Outside the submitted work: Taiho; Honoraria (self), Outside the submitted work: Chugai."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "H. Kasai", "first_name": "H.", "last_name": "Kasai", "second_name": "", "title": " Research grant/Funding (institution): Eisai; Honoraria (self), Outside the submitted work: Chugai."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "H. Kawabata", "first_name": "H.", "last_name": "Kawabata", "second_name": "", "title": " Research grant/Funding (institution): Chugai; Research grant/Funding (institution): MSD; Research grant/Funding (institution): Novartis; Research grant/Funding (institution): Daiichi Sankyo."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. Uozumi", "first_name": "R.", "last_name": "Uozumi", "second_name": "", "title": " Honoraria (self), Outside the submitted work: Eisai; Honoraria (self), Outside the submitted work: Sawai; Honoraria (self), Outside the submitted work: CAC Croit."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Ohno", "first_name": "S.", "last_name": "Ohno", "second_name": "", "title": " Honoraria (self), Outside the submitted work: Chugai; Honoraria (self), Research grant/Funding (institution), Outside the submitted work: Eisai; Honoraria (self), Research grant/Funding (institution), Outside the submitted work: Taiho; Honoraria (self), Outside the submitted work: AstraZeneca; Honoraria (self), Outside the submitted work: Pfizer; Honoraria (self), Outside the submitted work: Eli Lilly; Honoraria (self), Outside the submitted work: Kyowa Kirin; Honoraria (self), Outside the submitted work: Nihon Kayaku."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Isabel Grote", "first_name": "Isabel", "last_name": "Grote", "second_name": "", "country": "Germany", "city": "Hannover", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. Wuerstlein", "first_name": "R.", "last_name": "Wuerstlein", "second_name": "", "title": " Honoraria (self): Agendia; Honoraria (self): Amgen; Honoraria (self): Aristo; Honoraria (self): AstraZeneca; Honoraria (self): Boehringer Ingelheim; Honoraria (self): Carl Zeiss; Honoraria (self): Celgene; Honoraria (self): Clinsol; Honoraria (self): Daiichi Sankyo; Honoraria (self): Eisai; Honoraria (self): Genomic Health; Honoraria (self): Glaxo Smith Kline; Honoraria (self): Hexal; Honoraria (self): Lilly; Honoraria (self): Medstrom Medical; Honoraria (self): MSD; Honoraria (self): Mundipharma; Honoraria (self): Nanostring; Honoraria (self): Novartis; Honoraria (self): Odonate; Honoraria (self): Paxman; Honoraria (self): Palleos; Honoraria (self): Pfizer; Honoraria (self): Pierre Fabre; Honoraria (self): PumaBiotechnology; Honoraria (self): Riemser; Honoraria (self): Roche; Honoraria (self): Sandoz/Hexal; Honoraria (self): Seattle Genetics; Honoraria (self): Tesaro Bio."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "U. Nitz", "first_name": "U.", "last_name": "Nitz", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy: Amgen; AstraZeneca; Genomic Health; Novartis; Pfizer; Pierre Fabre; Roche; Zodiac Pharma."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Kuemmel", "first_name": "S.", "last_name": "Kuemmel", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Roche, Genomic Health, Novartis, AstraZeneca, Amgen, Celgene, Somatex Medical Technologies, Daiichi Sankyo, pfm medical, Pfizer, MSD, Lilly, SonoscapeRoche, Genomic Health, Novartis, AstraZeneca, Amgen, Celgene, Somatex Medical Technologies, Daiichi Sanky."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Braun", "first_name": "M.", "last_name": "Braun", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: AstraZeneca, Celgene, Eisai, Genomic Health, GalaxoSmithKline, Medac, Novatis, Pfizer, Roche, RTI Surgical, Teva."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Tio", "first_name": "J.", "last_name": "Tio", "second_name": "", "title": " Travel/Accommodation/Expenses: Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "B. Aktas", "first_name": "B.", "last_name": "Aktas", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Pfizer, Roche Pharma, Novartis Pharma, AstraZeneca, Amgen, Tesaro Bio Germany, PharmaMar, Eisai."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "W. Malter", "first_name": "W.", "last_name": "Malter", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy: Nanostring, Celgene, Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "H. Kreipe", "first_name": "H.", "last_name": "Kreipe", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy: Roche, Novartis, AstraZeneca, Genomic Health."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Cruz", "first_name": "J.", "last_name": "Cruz", "second_name": "", "title": " Honoraria (self), Speaker: GSK, AstraZeneca, F."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "L. Fallowfield", "first_name": "L.", "last_name": "Fallowfield", "second_name": "", "title": " Honoraria (self): Pfizer, AstraZeneca, BMS, Lilly, Novartis, Genomic Health and Nanostring; Non-remunerated activity/ies, Third-party writing assistance: F."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "P. Auvinen", "first_name": "P.", "last_name": "Auvinen", "second_name": "", "title": " Non-remunerated activity/ies, Third-party writing assistance."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Pulido", "first_name": "C.", "last_name": "Pulido", "second_name": "", "title": " Speaker Bureau/Expert testimony, Public speaking: AstraZeneca, Grunenthal and Novartis; Non-remunerated activity/ies, Third-party writing assistance: F."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Cvetanovic", "first_name": "A.", "last_name": "Cvetanovic", "second_name": "", "title": " Non-remunerated activity/ies, Third-party writing assistance: F."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Wilks", "first_name": "S.", "last_name": "Wilks", "second_name": "", "title": " Advisory/Consultancy: Seattle Genetics; Non-remunerated activity/ies, Third-party writing assistance: F."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "L. Ribeiro", "first_name": "L.", "last_name": "Ribeiro", "second_name": "", "title": " Advisory/Consultancy, Speaker Bureau/Expert testimony: Roche Pharmaceuticals, Merck Serono, MSD, BMS, AstraZeneca and Pfizer; Non-remunerated activity/ies, Personal medical education and participation in congresses: BMS, Roche Pharmaceuticals, Merck Serono, Pfizer, Amgen and Pierre Fabre; Non-remunerated activity/ies, Third-party writing assistance: F."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Burotto", "first_name": "M.", "last_name": "Burotto", "second_name": "", "title": " Advisory/Consultancy, Speaker Bureau/Expert testimony, Speaking at industry symposiums: F."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Klingbiel", "first_name": "D.", "last_name": "Klingbiel", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment, Non-remunerated activity/ies, Third-party writing assistance: F."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Messeri", "first_name": "D.", "last_name": "Messeri", "second_name": "", "title": " Full/Part-time employment, Non-remunerated activity/ies, Third-party writing assistance: F."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Alexandrou", "first_name": "A.", "last_name": "Alexandrou", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Non-remunerated activity/ies, Third-party writing assistance: F."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "P. Trask", "first_name": "P.", "last_name": "Trask", "second_name": "", "title": " Non-remunerated activity/ies, Third-party writing assistance: F."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Fredriksson", "first_name": "J.", "last_name": "Fredriksson", "second_name": "", "title": " Full/Part-time employment, Non-remunerated activity/ies, Third-party writing assistance: F."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Z. Machackova", "first_name": "Z.", "last_name": "Machackova", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment, Non-remunerated activity/ies, Third-party writing assistance: F."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "L. Stamatovic", "first_name": "L.", "last_name": "Stamatovic", "second_name": "", "title": " Honoraria (self), Speaker: AstraZeneca, Novartis, Pfizer and F."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Pivot Xavier", "first_name": "Pivot", "last_name": "Xavier", "second_name": "", "country": "France", "city": "Strasbourg", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Barbara Pistilli", "first_name": "Barbara", "last_name": "Pistilli", "second_name": "", "country": "France", "city": "Villejuif", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. Ferreira", "first_name": "R.", "last_name": "Ferreira", "second_name": "", "title": " Advisory/Consultancy, Travel/Accommodation/Expenses: Roche; Advisory/Consultancy, Travel/Accommodation/Expenses: Novartis."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Michiels", "first_name": "S.", "last_name": "Michiels", "second_name": "", "title": " Advisory/Consultancy: IDDI; Advisory/Consultancy: Janssen Cilag; Speaker Bureau/Expert testimony: Hexal; Speaker Bureau/Expert testimony: Steba; Speaker Bureau/Expert testimony: IQVIA; Speaker Bureau/Expert testimony: Roche; Speaker Bureau/Expert testimony: Sensorion; Speaker Bureau/Expert testimony: Biophytis; Speaker Bureau/Expert testimony: Servier; Speaker Bureau/Expert testimony: Yuhan."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "I. Vaz Luis", "first_name": "I.", "last_name": "Luis", "second_name": "Vaz", "title": " Speaker Bureau/Expert testimony: Novartis; Speaker Bureau/Expert testimony: Amgen; Speaker Bureau/Expert testimony: AstraZeneca; Advisory/Consultancy: Kephren."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Antonio Passaro", "first_name": "Antonio", "last_name": "Passaro", "second_name": "", "country": "Italy", "city": "Milan", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Emanuela Romano", "first_name": "Emanuela", "last_name": "Romano", "second_name": "", "country": "CEDEX ", "city": "Paris", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Y. Shyr", "first_name": "Y.", "last_name": "Shyr", "second_name": "", "title": " Advisory/Consultancy: Roche; Advisory/Consultancy: Novartis; Advisory/Consultancy: Pfizer; Advisory/Consultancy: Johnson & Johnson; Advisory/Consultancy: GlaxoSmithKline; Advisory/Consultancy, Speaker Bureau/Expert testimony: AstraZeneca; Speaker Bureau/Expert testimony: Boehringer Ingelheim; Speaker Bureau/Expert testimony: Eisai."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Shah", "first_name": "D.", "last_name": "Shah", "second_name": "", "title": " Research grant/Funding (institution), American Cancer Society and the Hope Foundation for Cancer Research (Mentored Research Scholar Grants in Applied and Clinical Research, MRSG-16-152-01-CCE; PI: Shah DP), and grants from the National Cancer Institute (P30 CA054174; PI: Mesa R): American Cancer Society; Research grant/Funding (institution): National Cancer Institute; Research grant/Funding (institution): Hope Foundation for Cancer Research."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Painter", "first_name": "C.", "last_name": "Painter", "second_name": "", "title": " Shareholder/Stockholder/Stock options: Pfizer; Shareholder/Stockholder/Stock options: Epizyme; Shareholder/Stockholder/Stock options: Inovio; Shareholder/Stockholder/Stock options: OPKO Health Inc."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. Khaki", "first_name": "R.", "last_name": "Khaki", "second_name": "", "title": " Shareholder/Stockholder/Stock options: Pfizer; Shareholder/Stockholder/Stock options: Merck."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Pennell", "first_name": "A.", "last_name": "Pennell", "second_name": "", "title": " Advisory/Consultancy: Astrazeneca; Advisory/Consultancy: Merck; Advisory/Consultancy: Eli Lilly; Advisory/Consultancy: Genentech; Advisory/Consultancy: BMS; Advisory/Consultancy: Amgen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "B. Halmos", "first_name": "B.", "last_name": "Halmos", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (institution): AstraZeneca; Advisory/Consultancy, Research grant/Funding (institution): Bristol Myers Squibb; Advisory/Consultancy, Research grant/Funding (institution): Merck; Advisory/Consultancy, Research grant/Funding (institution): Boehringer-Ingelheim; Advisory/Consultancy, Research grant/Funding (institution): Novartis; Advisory/Consultancy: Pfizer; Advisory/Consultancy, Research grant/Funding (institution): Amgen; Advisory/Consultancy: Spectrum; Advisory/Consultancy: Takeda; Advisory/Consultancy, Research grant/Funding (institution): Guardant Health; Advisory/Consultancy: Foundation One; Advisory/Consultancy, Research grant/Funding (institution): Genentech; Research grant/Funding (institution): AbbVie; Research grant/Funding (institution): Advaxis; Research grant/Funding (institution): GSK; Research grant/Funding (institution): Eli-Lilly; Research grant/Funding (institution): Mirati."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "H. Lyman", "first_name": "H.", "last_name": "Lyman", "second_name": "", "title": " Advisory/Consultancy: G1 Therapeutics; Advisory/Consultancy: Spectrum; Advisory/Consultancy: Invitae; Advisory/Consultancy: Sandoz; Advisory/Consultancy: Samsung; Advisory/Consultancy: Beyond Spring; Advisory/Consultancy, Travel/Accommodation/Expenses: Bayer; Advisory/Consultancy: Mylan; Research grant/Funding (institution): Amgen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Pia Kvistborg", "first_name": "Pia", "last_name": "Kvistborg", "second_name": "", "country": "Netherlands", "city": "Amsterdam", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Deborah Doroshow", "first_name": "Deborah", "last_name": "Doroshow", "second_name": "", "country": "United States of America", "city": "New York", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "L. Schmidt", "first_name": "L.", "last_name": "Schmidt", "second_name": "", "title": " Travel/Accommodation/Expenses: Pfizer; Travel/Accommodation/Expenses: Astellas."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Z. Bakouny", "first_name": "Z.", "last_name": "Bakouny", "second_name": "", "title": " Non-remunerated activity/ies: Bristol Myers Squibb; Research grant/Funding (self): Genentech/ImCore."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Awad", "first_name": "M.", "last_name": "Awad", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (self): Bristol Myers Squibb; Advisory/Consultancy, Research grant/Funding (self): Lilly; Advisory/Consultancy, Research grant/Funding (self): AstraZeneca; Advisory/Consultancy, Research grant/Funding (self): Genentech; Advisory/Consultancy: Merck; Advisory/Consultancy: Achilles; Advisory/Consultancy: AbbVie."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Javier Baena Espinar", "first_name": "Javier", "last_name": "Espinar", "second_name": "Baena", "country": "Spain", "city": "Madrid", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. Hirsch", "first_name": "R.", "last_name": "Hirsch", "second_name": "", "title": " Advisory/Consultancy: AstraZeneca; Advisory/Consultancy: BMS; Advisory/Consultancy: Merck; Advisory/Consultancy: Daiichi; Advisory/Consultancy: Genentech/Roche; Advisory/Consultancy: Lilly/Loxo; Advisory/Consultancy: Boehringer-Ingelheim."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Tiseo", "first_name": "M.", "last_name": "Tiseo", "second_name": "", "title": " Honoraria (self), Speaker Bureau/Expert testimony, Research grant/Funding (institution): AstraZeneca; Advisory/Consultancy, Research grant/Funding (institution): Boehringer Ingelheim; Advisory/Consultancy: Novartis; Advisory/Consultancy: MSD; Advisory/Consultancy: BMS; Advisory/Consultancy: Takeda."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Wakelee", "first_name": "A.", "last_name": "Wakelee", "second_name": "", "title": " Research grant/Funding (institution), Clinical Research grant: Gilead; Honoraria (self), Advisory/ Consultancy, advisor or consultant honoraria: AstraZeneca; Advisory/Consultancy, Research grant/Funding (institution), advisor or consultant, research: Xcovery; Advisory/Consultancy, advisor or consultant: Jassen; Advisory/Consultancy, advisor or consultant: Daiichi Sankyo, INC; Advisory/Consultancy, advisor or consultant: Helsinn; Advisory/Consultancy, advisor or consultant: Mirati; Advisory/Consultancy, advisor or consultant (not: Takeda; Advisory/Consultancy, advisor or consultant (not: Cellworks; Advisory/Consultancy, Research grant/Funding (institution), advisor or consultant (not: Genentech/Roche; Advisory/Consultancy, Research grant/Funding (institution), advisor or consultant (not: Merck; Travel/Accommodation/Expenses, CME presentation (travel funding): Clinical care options oncology, LLC; Travel/Accommodation/Expenses, CME presentation (travel funding): Fishawack facilitate LTD; Travel/Accommodation/Expenses, CME presentation (travel funding): Medscape; Travel/Accommodation/Expenses, CME presentation (travel funding): Onclive/intellisphere LLC; Travel/Accommodation/Expenses, CME presentation (travel funding): Philips Gillmore Oncology 2018; Travel/Accommodation/Expenses, CME presentation (travel funding): Physician education resource, LLC/MJH; Travel/Accommodation/Expenses, CME presentation (travel funding): Potomac center for medical education; Travel/Accommodation/Expenses, CME presentation (travel funding): Prime Oncology LLC (2018); Travel/Accommodation/Expenses, CME presentation (travel funding): Primo (2018); Travel/Accommodation/Expenses, CME presentation (travel funding): Research to practice; Travel/Accommodation/Expenses, CME presentation (travel funding): UpToDate; Travel/Accommodation/Expenses, CME presentation (travel funding): WebMdHealth; Honoraria (self), Research grant/Funding (institution), honoraria, research funding to: Novartis; Travel/Accommodation/Expenses, International professional society: RGCON- Rajiv gand conference; Travel/Accommodation/Expenses, International professional society: JLCS - japanese lung cancer society; Travel/Accommodation/Expenses, International professional society: KSMO - korean society of medical oncology; Full/Part-time employment, professor of medicine: Stanford university; Travel/Accommodation/Expenses, Scientific advisory committe - travel: ITMIG; Research grant/Funding (institution), research funding to institution: ACEA biosciences."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Garassino", "first_name": "C.", "last_name": "Garassino", "second_name": "", "title": " Honoraria (self): Boehringer Ingelheim; Honoraria (self), Local PI, Enrollment in clinical Trials in: Otsuka Pharma; Honoraria (self), Research grant/Funding (institution), PI, Enrollment and Steering: AstraZeneca; Honoraria (self), Research grant/Funding (institution), PI, Enrollment in clinical Trials in: Novartis; Honoraria (self), Research grant/Funding (institution), PI, Enrollment in clinical Trials in: BMS; Honoraria (self), Research grant/Funding (institution), PI, Enrollment in clinical Trials in: Roche; Honoraria (self), Research grant/Funding (institution), PI, MISP in Thimic malignancies: Pfizer; Honoraria (self), Research grant/Funding (institution), PI, Enrollment in clinical Trials in: Celgene; Research grant/Funding (institution): Incyte; Research grant/Funding (institution): Inivata; Research grant/Funding (self): Takeda; Honoraria (self), PI, Enrollment in clinical Trials Thimic: Tiziana Sciences; Honoraria (self), PI, Enrollment in clinical Trials in: Clovis; Honoraria (self), PI, Enrollment in clinical Trials in: Merck Serono; Honoraria (self), Research grant/Funding (self), PI, Enrollment in clinical Trials in: Bayer; Honoraria (self), Research grant/Funding (institution), PI, Enrollment in clinical Trials in: MSD; Honoraria (self), Local PI, Enrollment and Steering: GlaxoSmithKline S."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "L. Horn", "first_name": "L.", "last_name": "Horn", "second_name": "", "title": " Advisory/Consultancy, Consulting: AstraZeneca; Advisory/Consultancy, Consulting: Genentech-Roche; Advisory/Consultancy, Consulting: Incyte; Advisory/Consultancy, Consulting: Merck; Advisory/Consultancy, Consulting: Pfizer; Advisory/Consultancy, Research grant/Funding (self), Travel/Accommodation/Expenses, Consulting and travel to meeting: Xcovery; Advisory/Consultancy, Consulting: EMD Serono; Advisory/Consultancy, Consulting: Tesaro; Advisory/Consultancy, Consulting: AbbVie; Research grant/Funding (self): Boehringer Ingelheim; Research grant/Funding (self), Travel/Accommodation/Expenses, Honorarium: BMS; Honoraria (self), Honorarium: Medscape; Honoraria (self), Honorarium: PER; Honoraria (self), Honorarium: Research to Practice; Honoraria (self), Honorarium: OncLive; Advisory/Consultancy, Consulting: Amgen; Advisory/Consultancy, Consulting: Bayer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Eva Segelov", "first_name": "Eva", "last_name": "Segelov", "second_name": "", "country": "NS", "city": "Clayton", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Jianming Xu", "first_name": "Jianming", "last_name": "Xu", "second_name": "", "country": "China", "city": "Beijing", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "W. Su", "first_name": "W.", "last_name": "Su", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Hutchison MediPharma Limited."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Guillaume P. Nicolas", "first_name": "Guillaume", "last_name": "Nicolas", "second_name": "P.", "country": "Switzerland", "city": "Basel", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. McEwan", "first_name": "S.", "last_name": "McEwan", "second_name": "", "title": " Full/Part-time employment: Ipsen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Wild", "first_name": "D.", "last_name": "Wild", "second_name": "", "title": " Advisory/Consultancy: Ipsen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Hicks", "first_name": "J.", "last_name": "Hicks", "second_name": "", "title": " Advisory/Consultancy, Shareholder/Stockholder/Stock options, with proceeds donated to my institution: Telix Pharmaceuticals."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Jaume Capdevila", "first_name": "Jaume", "last_name": "Capdevila", "second_name": "", "country": "Spain", "city": "Barcelona", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Teule", "first_name": "A.", "last_name": "Teule", "second_name": "", "title": " Advisory/Consultancy, Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: Novartis; Advisory/Consultancy, Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: Ipsen; Advisory/Consultancy, Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: AAA; Advisory/Consultancy, Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: Pfizer; Advisory/Consultancy, Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Benavent", "first_name": "M.", "last_name": "Benavent", "second_name": "", "title": " Speaker Bureau/Expert testimony: Pfizer; Speaker Bureau/Expert testimony: Ipsen; Speaker Bureau/Expert testimony: Novartis."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Custodio", "first_name": "A.", "last_name": "Custodio", "second_name": "", "title": " Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (institution): Ipsen; Advisory/Consultancy, Speaker Bureau/Expert testimony: Novartis; Advisory/Consultancy, Speaker Bureau/Expert testimony: AAA; Advisory/Consultancy, Speaker Bureau/Expert testimony: MSD; Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (institution): Bristol-Myers Squibb; Non-remunerated activity/ies, Senior leadership role: Grupo Español de Tumores Neuroendocrinos (GETNE); Non-remunerated activity/ies, Senior leadership role: European Society of Neuroendocrine Tumours (ENETS)."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "V. Alonso", "first_name": "V.", "last_name": "Alonso", "second_name": "", "title": " Advisory/Consultancy: Amgen; Speaker Bureau/Expert testimony: Merck Serono; Advisory/Consultancy: Roche; Speaker Bureau/Expert testimony: Sanofi Genzyme; Advisory/Consultancy: Servier; Advisory/Consultancy: Bayer; Advisory/Consultancy: Ipsen; Advisory/Consultancy: Novartis."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "T. Alonso Gordoa", "first_name": "T.", "last_name": "Gordoa", "second_name": "Alonso", "title": " Advisory/Consultancy, Speaker Bureau/Expert testimony, Leadership role, Research grant/Funding (institution), Project lead in neuroendocrine tumours: Ipsen; Advisory/Consultancy, Speaker Bureau/Expert testimony, Leadership role, Research grant/Funding (institution), Project lead in kidney cancer: Pfizer; Advisory/Consultancy, Research grant/Funding (institution): Roche; Advisory/Consultancy: Sanofi; Advisory/Consultancy, Research grant/Funding (institution): Bayer; Advisory/Consultancy, Research grant/Funding (institution): Astellas; Advisory/Consultancy, Research grant/Funding (institution): Janssen-Cilag; Advisory/Consultancy, Research grant/Funding (institution): MSD; Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (institution): Bristol-Myers Squibb; Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (institution): Eisai; Research grant/Funding (institution): AstraZeneca; Research grant/Funding (institution): GSK-Novartis; Research grant/Funding (institution): Clovis; Research grant/Funding (institution): Nektar Therapeutics; Non-remunerated activity/ies, Member of the Spanish Germ Cell Tumors Board: Spanish Germ Cell Tumors; Non-remunerated activity/ies, Scientific advisor: Spanish Society of Medical Oncology (SEOM)."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "G. Crespo", "first_name": "G.", "last_name": "Crespo", "second_name": "", "title": " Advisory/Consultancy, Speaker Bureau/Expert testimony: Bristol-Myers Squibb; Advisory/Consultancy, Speaker Bureau/Expert testimony: Ipsen; Advisory/Consultancy, Speaker Bureau/Expert testimony: Roche; Advisory/Consultancy, Speaker Bureau/Expert testimony: Eisai; Advisory/Consultancy, Speaker Bureau/Expert testimony: Sanofi; Speaker Bureau/Expert testimony: Janssen; Advisory/Consultancy, Speaker Bureau/Expert testimony: Eusa Pharma."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Llanos", "first_name": "M.", "last_name": "Llanos", "second_name": "", "title": " Advisory/Consultancy: Amgen; Speaker Bureau/Expert testimony: Merck; Speaker Bureau/Expert testimony: Roche; Speaker Bureau/Expert testimony: Eisai; Speaker Bureau/Expert testimony: Servier; Speaker Bureau/Expert testimony: Ipsen; Speaker Bureau/Expert testimony: Lilly; Speaker Bureau/Expert testimony: Bristol-Myers Squibb; Speaker Bureau/Expert testimony: Sanofi; Speaker Bureau/Expert testimony: Pfizer; Advisory/Consultancy, Writing: Shire."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "L. Manzano", "first_name": "L.", "last_name": "Manzano", "second_name": "", "title": " Advisory/Consultancy, Melanoma and Colo-Rectal Cancer (Advisory Role): Bristol-Myers Squibb; Advisory/Consultancy, Melanoma: Novartis; Advisory/Consultancy, Melanoma (Advisory Role): Pierre Fabre; Advisory/Consultancy, Melanoma: Roche; Advisory/Consultancy, Melanoma (Consultancy): MSD; Advisory/Consultancy, Colo-Rectal Cancer (Advisory Role): Amgen; Advisory/Consultancy, Colo-Rectal Cancer (Advisory Role): Merck."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Mimi Hu", "first_name": "Mimi", "last_name": "Hu", "second_name": "", "country": "United States of America", "city": "Houston", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "V. Subbiah", "first_name": "V.", "last_name": "Subbiah", "second_name": "", "title": " Research grant/Funding (self): Roche/Genentech; Research grant/Funding (self): Novartis; Research grant/Funding (self): Bayer; Research grant/Funding (self): GSK; Research grant/Funding (self): Nanocarrier; Research grant/Funding (self): Vegenics; Research grant/Funding (self): Celgene; Research grant/Funding (self): Northwest Biotherapeutics; Research grant/Funding (self): Berghealth; Research grant/Funding (self): Incyte; Research grant/Funding (self): Fujifilm; Research grant/Funding (self): PharmaMar; Research grant/Funding (self): D3; Research grant/Funding (self): Pfizer; Research grant/Funding (self): Multivir; Research grant/Funding (self): Amgen; Research grant/Funding (self): AbbVie; Research grant/Funding (self): Alfa-sigma; Research grant/Funding (self): Agensys; Research grant/Funding (self): Boston Biomedical; Research grant/Funding (self): Idera Pharma; Research grant/Funding (self): Inhibrx; Research grant/Funding (self): Exelixis; Research grant/Funding (self): Blueprint Medicines Corporation; Research grant/Funding (self): Loxo Oncology; Research grant/Funding (self): MedImmune; Research grant/Funding (self): Altum; Research grant/Funding (self): Dragonfly Therapeutics; Research grant/Funding (self): Takeda; Research grant/Funding (self): National Comprehensive Cancer Network."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Wirth", "first_name": "J.", "last_name": "Wirth", "second_name": "", "title": " Advisory/Consultancy: Bayer; Advisory/Consultancy: Blueprint Medicines Corporation; Advisory/Consultancy: Cue Biopharma; Advisory/Consultancy: Eisai; Advisory/Consultancy: Exelixis; Advisory/Consultancy: Genentech; Advisory/Consultancy: Lilly; Advisory/Consultancy: Loxo Oncology; Advisory/Consultancy: Merck; Advisory/Consultancy: Rakuten Medical."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Schuler", "first_name": "M.", "last_name": "Schuler", "second_name": "", "title": " Advisory/Consultancy: AstraZeneca; Advisory/Consultancy: Boehringer Ingelheim; Advisory/Consultancy: Bristol-Myers Squibb; Advisory/Consultancy: Novartis; Advisory/Consultancy: Roche; Advisory/Consultancy: Takeda; Advisory/Consultancy: MorphoSys."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Mansfield", "first_name": "S.", "last_name": "Mansfield", "second_name": "", "title": " Honoraria (institution): AbbVie; Honoraria (institution): AstraZeneca; Honoraria (institution): BMS; Honoraria (institution): Roche/Genentech; Travel/Accommodation/Expenses: Novartis; Research grant/Funding (institution): Verily Research; Non-remunerated activity/ies: Mesothelioma Applied Research Foundation."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Brose", "first_name": "S.", "last_name": "Brose", "second_name": "", "title": " Honoraria (self), Research grant/Funding (institution): Exelixis; Advisory/Consultancy, Research grant/Funding (institution): Blueprint Medicines Corporation; Advisory/Consultancy, Research grant/Funding (institution): Lilly; Honoraria (self), Advisory/Consultancy: Bayer; Honoraria (self), Advisory/Consultancy: Eisai; Honoraria (self): Raffo; Advisory/Consultancy: Loxo."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Leboulleux", "first_name": "S.", "last_name": "Leboulleux", "second_name": "", "title": " Advisory/Consultancy: Lilly; Advisory/Consultancy: Bayer; Speaker Bureau/Expert testimony: Eisai."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Theresa Link", "first_name": "Theresa", "last_name": "Link", "second_name": "", "country": "Germany", "city": "Dresden", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "U. Blohmer", "first_name": "U.", "last_name": "Blohmer", "second_name": "", "title": " Honoraria (self): Amgen; Honoraria (self): AstraZeneca; Honoraria (self): Novartis; Honoraria (self): Pfizer; Honoraria (self): Roche; Honoraria (self): SonoScape."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Untch", "first_name": "M.", "last_name": "Untch", "second_name": "", "title": " Honoraria (institution), Non-remunerated activity/ies, All fees to the institution/employer: AbbVie; Honoraria (institution), Non-remunerated activity/ies, All fees to the institution/employer: Amgen GmbH ; Honoraria (institution), Non-remunerated activity/ies, All fees to the institution/employer: AstraZeneca; Honoraria (institution), All fees to the institution/employer: BMS; Honoraria (institution), Non-remunerated activity/ies, All fees to the institution/employer: Celgene GmbH ; Honoraria (institution), Non-remunerated activity/ies, All fees to the institution/employer: Daiichi Sankyo ; Honoraria (institution), Non-remunerated activity/ies, All fees to the institution/employer: Eisai GmbH ; Honoraria (institution), All fees to the institution/employer: Lilly Deutschland; Honoraria (institution), Non-remunerated activity/ies, All fees to the institution/employer: Lilly Int."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Fasching", "first_name": "A.", "last_name": "Fasching", "second_name": "", "title": " Speaker Bureau/Expert testimony, Lectures: Amgen; Advisory/Consultancy, Advisory Board: Roche; Research grant/Funding (institution): BionTech; Honoraria (self), Advisory/Consultancy, Advisory Board: Roche; Advisory/Consultancy, Advisory Board: Pfizer; Advisory/Consultancy, Advisory Board: Celgene; Speaker Bureau/Expert testimony, Lectures: Daiichi Sankyo; Advisory/Consultancy, Speaker Bureau/Expert testimony, Advisory Board, Lectures: Merck Sharp & Dohme; Advisory/Consultancy, Advisory Board: Macrogenics; Advisory/Consultancy, Advisory Board: Eisai; Advisory/Consultancy, Advisory Board: Puma; Research grant/Funding (institution), Research Support: Cepheid; Honoraria (self), Advisory Board; Lectures: Lilly; Advisory/Consultancy, Research grant/Funding (institution), Research Support; Advisory Board: Novartis; Advisory/Consultancy, Advisory Board: AstraZeneca; Speaker Bureau/Expert testimony, Lectures: Amgen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "P. Wimberger", "first_name": "P.", "last_name": "Wimberger", "second_name": "", "title": " Honoraria (self): Amgen; Honoraria (self): AstraZeneca; Honoraria (self): MSD; Honoraria (self): Novartis; Honoraria (self): Pfizer; Honoraria (self): Roche; Honoraria (self): PharmaMar; Honoraria (self): Eisai; Honoraria (self): Teva; Honoraria (self): Clovis; Honoraria (self): Tesaro."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Seiler", "first_name": "S.", "last_name": "Seiler", "second_name": "", "title": " Research grant/Funding (institution), GeparOla study was supported by AstraZeneca: AstraZeneca; Advisory/Consultancy, Advisory Boards: Amgen; Advisory/Consultancy, Advisory Boards: Hexal; Speaker Bureau/Expert testimony, Presentations: Roche; Honoraria (self), Advisory Boards: Mundipharma; Travel/Accommodation/Expenses, Travel costs: Novartis."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Schmitt", "first_name": "D.", "last_name": "Schmitt", "second_name": "", "title": " Research grant/Funding (institution): German Breast Group; Honoraria (self): AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Jackisch", "first_name": "C.", "last_name": "Jackisch", "second_name": "", "title": " Honoraria (self): AstraZeneca; Honoraria (self): Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "E. Rhiem", "first_name": "E.", "last_name": "Rhiem", "second_name": "", "title": " Honoraria (self): AstraZeneca; Honoraria (self): Tesaro; Honoraria (self): Pfizer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Hanusch", "first_name": "C.", "last_name": "Hanusch", "second_name": "", "title": " Honoraria (self): Roche; Honoraria (self): Novartis; Honoraria (self): Pfizer; Honoraria (self): AstraZeneca; Honoraria (self): Lilly; Honoraria (self): Celgene."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Denkert", "first_name": "C.", "last_name": "Denkert", "second_name": "", "title": " Honoraria (self): Novartis; Honoraria (self): Roche; Honoraria (self): MSD Oncology; Honoraria (self): Daiichi Sankyo; Research grant/Funding (institution): Myriad Genetics; Shareholder/Stockholder/Stock options, Cofounder and shareholder: Sividon Diagnostics / Myriad; Licensing/Royalties, cancer immunotherapy: EP18209672; Licensing/Royalties, therapy response: EP20150702464; Licensing/Royalties, Ki67 evaluator: Software (VMscope digital pathology)."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Herui Yao", "first_name": "Herui", "last_name": "Yao", "second_name": "", "country": "China", "city": "Guangzhou", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "W. Zhu", "first_name": "W.", "last_name": "Zhu", "second_name": "", "title": " Honoraria (self): AstraZeneca; Honoraria (self): Roche/Foundation Medicine; Honoraria (self): Roche/Genentech; Honoraria (self): Takeda; Shareholder/Stockholder/Stock options: TP Therapeutics."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "B. Keam", "first_name": "B.", "last_name": "Keam", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (self): AstraZeneca; Advisory/Consultancy, Research grant/Funding (self): MSD Oncology; Advisory/Consultancy: ABL Bio; Advisory/Consultancy: Genexine; Advisory/Consultancy: Cellid; Advisory/Consultancy: Ono Pharmaceutical."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Adkins", "first_name": "D.", "last_name": "Adkins", "second_name": "", "title": " Advisory/Consultancy: Lilly; Advisory/Consultancy: Pfizer; Advisory/Consultancy: Celgene; Advisory/Consultancy: Merck; Advisory/Consultancy: CUE; Advisory/Consultancy: Aduro; Advisory/Consultancy: KURA; Advisory/Consultancy: Oncolys; Advisory/Consultancy: Enzychyme; Advisory/Consultancy: Matrix; Advisory/Consultancy: Celldex."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Baik", "first_name": "S.", "last_name": "Baik", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (self): AstraZeneca; Research grant/Funding (self): Celgene; Research grant/Funding (self): Novartis; Research grant/Funding (self): MedImmune; Research grant/Funding (self): SWOG; Research grant/Funding (self): Genentech; Research grant/Funding (self): Loxo Oncology; Research grant/Funding (self): Pfizer; Research grant/Funding (self): Spectrum Pharmaceuticals; Research grant/Funding (self): Blueprint Medicines Corporation; Research grant/Funding (self): Daiichi Sankyo; Research grant/Funding (self): Rain Therapeutics; Research grant/Funding (self): AbbVie; Research grant/Funding (self): TP Therapeutics; Research grant/Funding (self): Lilly Oncology."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Sarker", "first_name": "D.", "last_name": "Sarker", "second_name": "", "title": " Honoraria (self): Pfizer; Honoraria (self): Bayer; Advisory/Consultancy: Ipsen; Honoraria (self): Novartis; Advisory/Consultancy: Eisai; Advisory/Consultancy: Surface Oncology; Advisory/Consultancy: MSD Oncology."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Turner", "first_name": "C.", "last_name": "Turner", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Blueprint Medicines Corporation."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Taylor", "first_name": "M.", "last_name": "Taylor", "second_name": "", "title": " Advisory/Consultancy, Speaker Bureau/Expert testimony: BMS; Advisory/Consultancy, Speaker Bureau/Expert testimony: Eisai; Advisory/Consultancy: Array BioPharma; Advisory/Consultancy: Loxo Oncology; Advisory/Consultancy: Bayer; Advisory/Consultancy: ArQule; Advisory/Consultancy: Blueprint Medicines Corporation; Advisory/Consultancy: Novartis; Advisory/Consultancy: Sanofi/Genzyme; Speaker Bureau/Expert testimony: Merck."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Silvia Formenti", "first_name": "Silvia", "last_name": "Formenti", "second_name": "", "country": "United States of America", "city": "New York", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Zarnie Lwin", "first_name": "Zarnie", "last_name": "Lwin", "second_name": "", "country": "QL", "city": "Herston", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "E. Yanez", "first_name": "E.", "last_name": "Yanez", "second_name": "", "title": " Research grant: Amgen, Pfizer, Astellas, BMS, Roche, AbbVie, MSD F."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "E. Castanon", "first_name": "E.", "last_name": "Castanon", "second_name": "", "title": " Travel/Accommodation/Expenses: AstraZeneca, MSD, BMS, and Roche; Advisory/Consultancy: BMS, Roche, and BeiGene."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Graham", "first_name": "D.", "last_name": "Graham", "second_name": "", "title": " Research grant/Funding (institution): Pfizer; Honoraria (self): Clinigen Group and McCann Health."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Doherty", "first_name": "M.", "last_name": "Doherty", "second_name": "", "title": " Research grant/Funding (self): Merck and AstraZeneca; Advisory/Consultancy, Consulting fees: AstraZeneca, Merck, Eisai, Boehringer Ingelheim, Takeda, Pfizer, and Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Lopez", "first_name": "J.", "last_name": "Lopez", "second_name": "", "title": " Advisory/Consultancy: Eisai, Novartis, and Genmab; Speaker Bureau/Expert testimony, Research grant/Funding (self): Roche, Basilea Pharmaceutica, Genmab."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "K. Norwood", "first_name": "K.", "last_name": "Norwood", "second_name": "", "title": " Full/Part-time employment:  Merck Sharp & Dohme Corp."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "P. Kubiak", "first_name": "P.", "last_name": "Kubiak", "second_name": "", "title": " Full/Part-time employment: Eisai Inc."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Nehal Lakhani", "first_name": "Nehal", "last_name": "Lakhani", "second_name": "", "country": "United States of America", "city": "Grand Rapids", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "W. Tolcher", "first_name": "W.", "last_name": "Tolcher", "second_name": "", "title": " Advisory/Consultancy: Nanobiotix, Pierre Fabre, Ascentage Pharma, AbbVie, EMD Serono, BioInvent, Adagene, ADC Therapeutics, Agenus, Aximmune, Bayer, Boston Biomedical, Forbius (formerly Formation Biologics), HBM Partners, Mekanistic, NBE Therapeutics, Nuvalent, Pelican, Pfizer; Research grant/Funding (institution): AbbVie, Pfizer, Syndax, Asana Biosciences, ADC Therapeutics, Adagene, Aminex, Ascentage Pharma, Arrys, CStone Pharmaceuticals, Deciphera, GlaxoSmithKline, Inhibrx, Innate Pharma, Kiromic, Mersana, Naturewise, NextCure, Nitto BioPharma, Pieris Pharmaceutic."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Rodon", "first_name": "J.", "last_name": "Rodon", "second_name": "", "title": " Travel/Accommodation/Expenses: European Journal of Cancer, Vall d'Hebron Institut of Oncology, Chinese University of Hong Kong, SOLTI, Elsevier, GlaxoSmithKline; Advisory/Consultancy: Novartis, Eli Lilly, Orion Pharmaceuticals, Servier Pharmaceuticals, Peptomyc, Merck Sharp & Dohme, Kelun Pharmaceutical/Klus Pharma, Spectrum Pharmaceuticals Inc, Pfizer, Roche Pharmaceuticals, Ellipses Pharma, NovellusDx, Ionctura and Molecular Partners; Research grant/Funding (self): Blueprint Pharmaceuticals, Bayer and Novartis; Honoraria (institution): Spectrum Pharmaceuticals, Tocagen, Symphogen, BioAtla, Pfizer, GenMab, CytomX, Kelun-Biotech, Takeda-Millenium, GlaxoSmithKline, Ipsen; Travel/Accommodation/Expenses: from ESMO, US Department of Defense, Louissiana State University, Hunstman Cancer Institute, Cancer Core Europe, Karolinska Cancer Institute and King Abdullah International Medical Research Center (KAIMRC), Molecular Partners."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Oliva", "first_name": "M.", "last_name": "Oliva", "second_name": "", "title": " Advisory/Consultancy: BMS; Advisory/Consultancy, Research grant/Funding (self): Mirati Therapeutics; Research grant/Funding (self): Nubyota; Research grant/Funding (institution): Symphogen; Travel/Accommodation/Expenses: MSD Oncology; Travel/Accommodation/Expenses: Merck."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Sharma", "first_name": "M.", "last_name": "Sharma", "second_name": "", "title": " Honoraria (institution): Alexo, Amgen, Apexian, Asana, Ascentage, Astellas, AstraZeneca, Beigene, Bolt Biotherapeutics, Bristol-Myers Squibb, Compugen, Coordination, Constellation, CytomX, Effector Therapeutics, Exelixis, Formation Biologics, Forty Seven, Ikena, Innovent Biologi."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "T. Poulsen", "first_name": "T.", "last_name": "Poulsen", "second_name": "", "title": " Full/Part-time employment: Symphogen R."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "P. Nadal", "first_name": "P.", "last_name": "Nadal", "second_name": "", "title": " Advisory/Consultancy, Full/Part-time employment: Symphogen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Lantto", "first_name": "J.", "last_name": "Lantto", "second_name": "", "title": " Full/Part-time employment: Symphogen A/S."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "L. Wood", "first_name": "L.", "last_name": "Wood", "second_name": "", "title": " Advisory/Consultancy: Symphogen; Advisory/Consultancy: Forbius; Advisory/Consultancy: Tessa Therapeutics; Spouse/Financial dependant: Karyopharm."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "I. Nadler", "first_name": "I.", "last_name": "Nadler", "second_name": "", "title": " Advisory/Consultancy, Leadership role: Forbius; Advisory/Consultancy: Symphogen; Advisory/Consultancy: Karyopharm; Advisory/Consultancy: Tessa Therapeutics."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "L. Siu", "first_name": "L.", "last_name": "Siu", "second_name": "", "title": " Research grant/Funding (institution): Novartis, Bristol-Myers Squibb, Pfizer, Boerhinger-Ingelheim, GlaxoSmithKline, Roche/Genentech, Karyopharm, AstraZeneca/MedImmune, Merck, Celgene, Astellas, Bayer, AbbVie, Amgen, Symphogen, Intensity Therapeutics, Mirati, Shattucks, Avid; Advisory/Consultancy: Merck, Pfizer, Celgene, AstraZeneca/MedImmune, Morphosys, Roche, Loxo, Oncorus, Symphogen, Seattle Genetics, GSK, Voronoi, Treadwell Therapeutics, Tessa, Navire, Relay Therapeutics, Rubius Therapeutics; Honoraria (institution): Arvinas; Leadership role: Treadwell therapeutics; Officer/Board of Directors: AACR."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Manish Sharma", "first_name": "Manish", "last_name": "Sharma", "second_name": "", "country": "M", "city": "Grand Rapids", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "E. Sanborn", "first_name": "E.", "last_name": "Sanborn", "second_name": "", "title": " Advisory/Consultancy, Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: AstraZeneca; Speaker Bureau/Expert testimony: Amgen; Advisory/Consultancy: Seattle Genetics; Advisory/Consultancy: Peregrine Pharmaceuticals; Advisory/Consultancy: ARIAD/Takeda; Advisory/Consultancy: Genentech/Roche; Advisory/Consultancy: Celldex; Advisory/Consultancy: AbbVie; Research grant/Funding (self): Merck; Research grant/Funding (institution): Bristol-Myers Squibb; Research grant/Funding (institution): MedImmune."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Cote", "first_name": "M.", "last_name": "Cote", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (institution): Agios; Advisory/Consultancy, Research grant/Funding (institution): PharmaMar; Advisory/Consultancy, Research grant/Funding (institution): Epizyme; Research grant/Funding (institution): Eisai; Research grant/Funding (institution): MacroGenics; Research grant/Funding (institution): Plexxicon; Research grant/Funding (institution): Merck KGaA; Research grant/Funding (institution): CBA; Research grant/Funding (institution): Springworks; Research grant/Funding (institution): Bayer; Research grant/Funding (institution): Boston Biomedical; Research grant/Funding (institution): Bavarian Nordic; Advisory/Consultancy, Medical Advisory Board: Chordoma Foundation; Advisory/Consultancy, Scientific Advisory Committee: Angiosarcoma AwarenessFoundation."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Bendell", "first_name": "C.", "last_name": "Bendell", "second_name": "", "title": " Research grant/Funding (institution): AbbVie; Research grant/Funding (institution): Stemcentrx; Research grant/Funding (institution): ADC Therapeutics; Research grant/Funding (institution): Agios; Research grant/Funding (institution): Arcus Biosciences; Research grant/Funding (institution): ARMO Biosciences; Research grant/Funding (institution): Array BioPharma; Research grant/Funding (institution): Arrys Therapeutics; Research grant/Funding (institution): AstraZeneca; Research grant/Funding (institution): Bayer; Research grant/Funding (institution): BeiGene; Research grant/Funding (institution): Bellicum Pharmaceuticals; Research grant/Funding (institution): Bicycle Therapeutics; Research grant/Funding (institution): Blueprint Medicine; Research grant/Funding (institution): Boehringer Ingelheim; Research grant/Funding (institution): Boston Biomedical; Research grant/Funding (institution): BMS; Research grant/Funding (institution): CALGB; Research grant/Funding (institution): Calithera Biosciences; Research grant/Funding (institution): Celgene; Research grant/Funding (institution): Cyteir Therapeutics; Research grant/Funding (institution): CytomX; Research grant/Funding (institution): eFFECTOR Therapeutics; Research grant/Funding (institution): Eisai; Research grant/Funding (institution): Lilly; Research grant/Funding (institution): EMD Serono; Research grant/Funding (institution): Evelo Biosciences; Research grant/Funding (institution): Genentech/Roche; Research grant/Funding (institution): Five Prime Therapeutics; Research grant/Funding (institution): Forty Seven."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Kaul", "first_name": "S.", "last_name": "Kaul", "second_name": "", "title": " Shareholder/Stockholder/Stock options: AbbVie; Shareholder/Stockholder/Stock options: Bristol-Myers Squibb; Shareholder/Stockholder/Stock options: Johnson & Johnson; Shareholder/Stockholder/Stock options: Merck; Shareholder/Stockholder/Stock options: CVS; Shareholder/Stockholder/Stock options: Walgreens; Shareholder/Stockholder/Stock options: Abbott; Shareholder/Stockholder/Stock options: Baxter; Shareholder/Stockholder/Stock options: Boston Scientific; Shareholder/Stockholder/Stock options: Medtronics; Shareholder/Stockholder/Stock options: United Healthcare; Advisory/Consultancy: MacroGenics; Advisory/Consultancy, Travel/Accommodation/Expenses: PharmaEssentia; Advisory/Consultancy: Bristol-Myers Squibb."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "F. Chen", "first_name": "F.", "last_name": "Chen", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: MacroGenics, Inc."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Berezhnoy", "first_name": "A.", "last_name": "Berezhnoy", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: MacroGenics, Inc."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "E. Bonvini", "first_name": "E.", "last_name": "Bonvini", "second_name": "", "title": " Leadership role, Shareholder/Stockholder/Stock options, Full/Part-time employment: MacroGenics, Inc."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Sumrow", "first_name": "J.", "last_name": "Sumrow", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: MacroGenics, Inc."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Luke", "first_name": "J.", "last_name": "Luke", "second_name": "", "title": " Advisory/Consultancy: TTC Oncology; Advisory/Consultancy: 7 Hills; Advisory/Consultancy, Shareholder/Stockholder/Stock options: Alphamab Oncology; Advisory/Consultancy, Shareholder/Stockholder/Stock options: Pyxis; Advisory/Consultancy, Research grant/Funding (institution): Spring bank; Advisory/Consultancy: Tempest; Advisory/Consultancy, Research grant/Funding (institution): AbbVie; Advisory/Consultancy, Travel/Accommodation/Expenses: Akrevia; Advisory/Consultancy, Research grant/Funding (institution): Algios; Advisory/Consultancy, Research grant/Funding (institution): Array; Advisory/Consultancy, Research grant/Funding (institution): Astellas; Advisory/Consultancy, Travel/Accommodation/Expenses: Bayer; Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Bristol-Myers Squibb; Advisory/Consultancy: Eisai; Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: EMD Serono; Advisory/Consultancy: Ideava; Advisory/Consultancy, Research grant/Funding (institution): Incyte; Advisory/Consultancy, Travel/Accommodation/Expenses: Janssen; Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Merck; Advisory/Consultancy, Travel/Accommodation/Expenses: Mersana; Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Novartis; Advisory/Consultancy: PTx; Advisory/Consultancy, Travel/Accommodation/Expenses: RefleXion; Advisory/Consultancy: Regeneron; Advisory/Consultancy: Rubius; Advisory/Consultancy: Silicon; Advisory/Consultancy, Research grant/Funding (institution): Tesaro; Advisory/Consultancy: Vividion; Research grant/Funding (institution): MacroGenics; Advisory/Consultancy: Arch Oncology."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Michael Millward", "first_name": "Michael", "last_name": "Millward", "second_name": "", "country": "W", "city": "Nedlands", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "B. Tran", "first_name": "B.", "last_name": "Tran", "second_name": "", "title": " Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (self), Research grant/Funding (institution), Travel/Accommodation/Expenses: Amgen; Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (self), Travel/Accommodation/Expenses: Astellas; Advisory/Consultancy, Research grant/Funding (self), Travel/Accommodation/Expenses: Bayer; Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (self): BMS; Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (self), Research grant/Funding (institution), National Coordinator for THOR study: Janssen-Cilag; Advisory/Consultancy, Research grant/Funding (self), Research grant/Funding (institution): MSD; Advisory/Consultancy, Research grant/Funding (institution): Novartis; Advisory/Consultancy, Travel/Accommodation/Expenses: Sanofi; Advisory/Consultancy: Tolmar; Advisory/Consultancy, Research grant/Funding (self): Ipsen; Advisory/Consultancy: IQVIA; Research grant/Funding (self), Research grant/Funding (institution): AstraZeneca; Research grant/Funding (self): Pfizer; Research grant/Funding (self), Research grant/Funding (institution): Servier; Research grant/Funding (institution): Aslan; Research grant/Funding (institution): GSK; Research grant/Funding (institution): Taiho; Research grant/Funding (institution): Akeso Biopharma; Research grant/Funding (institution): MedImmune; Research grant/Funding (institution): Aptevo."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Y. Kwek", "first_name": "Y.", "last_name": "Kwek", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Akeso Biopharma."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Y. Xia", "first_name": "Y.", "last_name": "Xia", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment, Officer/Board of Directors: Akeso Biopharma."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Maria Rescigno", "first_name": "Maria", "last_name": "Rescigno", "second_name": "", "country": "Italy", "city": "Milan", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "David S. Hong", "first_name": "David", "last_name": "Hong", "second_name": "S.", "country": "United States of America", "city": "Houston", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Durm", "first_name": "A.", "last_name": "Durm", "second_name": "", "title": " Research grant/Funding (institution): Merck; Research grant/Funding (institution): AstraZeneca; Research grant/Funding (institution): Bristol-Myers Squibb; Non-remunerated activity/ies: Amgen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Falchook", "first_name": "S.", "last_name": "Falchook", "second_name": "", "title": " Honoraria (self): Wolters Kluwer; Advisory/Consultancy, Travel/Accommodation/Expenses: FujiFilm; Travel/Accommodation/Expenses: Bristol-Myers Squibb; Travel/Accommodation/Expenses: Sarah Cannon Research Institute; Speaker Bureau/Expert testimony: Total Health Conferencing; Research grant/Funding (institution): 3-V Biosciences; Research grant/Funding (institution): AbbVie; Research grant/Funding (institution): ADC Therapeutics; Research grant/Funding (institution): Aileron; Research grant/Funding (institution): American Society of Clinical Oncology; Research grant/Funding (institution): Amgen; Research grant/Funding (institution): ARMO; Research grant/Funding (institution): AstraZeneca; Research grant/Funding (institution): BeiGene; Research grant/Funding (institution): Bioatla; Research grant/Funding (institution): Biothera; Research grant/Funding (institution): Celldex; Research grant/Funding (institution): Celgene; Research grant/Funding (institution): Ciclomed; Speaker Bureau/Expert testimony: Rocky Mountain Oncology Society ; Research grant/Funding (institution): Curegenix; Research grant/Funding (institution): Curis; Research grant/Funding (institution): Cyteir; Research grant/Funding (institution): Daiichi; Research grant/Funding (institution): DelMar; Research grant/Funding (institution): eFFECTOR; Research grant/Funding (institution): Eli Lilly; Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: EMD Serono; Research grant/Funding (institution): Epizyme, Exelixis, Fujifilm, Genmab, GlaxoSmithKline, Hutchison MediPharma, Ignyta, Incyte, Jacobio, Jounce, Kolltan, Loxo, MedImmune, Millennium, Merck, miRNA Therapeutics, National Institutes of Health, Novartis, OncoMed, Oncorus; Research grant/Funding (institution): Oncothyreon, Poseida, Precision Oncology, Prelude, Regeneron, Rgenix, Ribon, Strategia, Syndax, Taiho, Takeda, Tarveda, Tesaro, Tocagen, Turning Point Therapeutics, U."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "H. Strickler", "first_name": "H.", "last_name": "Strickler", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (institution): Amgen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "F. Burns", "first_name": "F.", "last_name": "Burns", "second_name": "", "title": " Advisory/Consultancy: Novartis; Advisory/Consultancy: Blueprint Medicine; Advisory/Consultancy: Thermo Fisher Scientific."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Kim", "first_name": "J.", "last_name": "Kim", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Amgen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Ang", "first_name": "A.", "last_name": "Ang", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Amgen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. Lipford", "first_name": "R.", "last_name": "Lipford", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Amgen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "G. Ngarmchamnanrith", "first_name": "G.", "last_name": "Ngarmchamnanrith", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Amgen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Anderson", "first_name": "A.", "last_name": "Anderson", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Amgen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "T. Li", "first_name": "T.", "last_name": "Li", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (institution): Genentech/Roche; Advisory/Consultancy: Thermo Fisher Scientific; Advisory/Consultancy, Research grant/Funding (institution): Guardant Health; Advisory/Consultancy, Research grant/Funding (institution): Hengrui Therapeutics; Advisory/Consultancy: Mersana Therapeutics; Advisory/Consultancy, Research grant/Funding (institution): Eli Lilly; Travel/Accommodation/Expenses: Resolution Bioscience; Research grant/Funding (institution), Travel/Accommodation/Expenses: MORE Health; Research grant/Funding (institution): Amgen; Research grant/Funding (institution): Daiichi Sankyo; Research grant/Funding (institution): AstraZeneca; Research grant/Funding (institution): BioMedValley Discoveries; Research grant/Funding (institution): Illumina; Research grant/Funding (institution): GRAIL."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Byoung Chul Cho", "first_name": "Byoung", "last_name": "Cho", "second_name": "Chul", "country": "Kore", "city": "Seoul", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Y. Han", "first_name": "Y.", "last_name": "Han", "second_name": "", "title": " Advisory/Consultancy: MSD Oncology, AstraZeneca, Bristol-Myers Squibb, Lilly, Novartis, Takeda, Pfizer; Honoraria (self): Roche, AstraZeneca, Bristol-Myers Squibb, MSD, Takeda; Research grant/Funding (self): Roche, Pfizer, Ono Pharmaceutical, Takeda."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "B. Haura", "first_name": "B.", "last_name": "Haura", "second_name": "", "title": " Advisory/Consultancy: Janssen; Travel/Accommodation/Expenses: Bristol-Myers Squibb, Roche, Janssen; Research grant/Funding (institution): Janssen, Novartis, Revolution Medicines, AstraZeneca, Genentech; Research grant/Funding (self): FORMA Therapeutics, Incyte."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "K. Sabari", "first_name": "K.", "last_name": "Sabari", "second_name": "", "title": " Advisory/Consultancy: AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Bauml", "first_name": "M.", "last_name": "Bauml", "second_name": "", "title": " Advisory/Consultancy: Bristol-Myers Squibb, Merck, AstraZeneca, Genentech, Celgene, Boehringer Ingelheim, Guardant Health, Takeda, Novartis, Janssen, Ayala Pharmaceuticals, Regeneron; Research grant/Funding (institution): Merck, Carevive Systems, Novartis, Incyte, Bayer, Janssen, AstraZeneca, Takeda, Amgen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "E. Gomez", "first_name": "E.", "last_name": "Gomez", "second_name": "", "title": " Speaker Bureau/Expert testimony: Bristol-Myers Squibb, Atara, AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "E. Knoblauch", "first_name": "E.", "last_name": "Knoblauch", "second_name": "", "title": " Full/Part-time employment: Janssen; Shareholder/Stockholder/Stock options: Johnson & Johnson."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Colin Lindsay", "first_name": "Colin", "last_name": "Lindsay", "second_name": "", "country": "United Kingdom", "city": "Manchester", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Li Zhang", "first_name": "Li", "last_name": "Zhang", "second_name": "", "country": "China", "city": "Guangzhou", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Yukihiro Toi", "first_name": "Yukihiro", "last_name": "Toi", "second_name": "", "country": "Japan", "city": "Sendai", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Fujimoto", "first_name": "D.", "last_name": "Fujimoto", "second_name": "", "title": " Honoraria (self), Research grant/Funding (self): AstraZeneca; Honoraria (self): Boehringer Ingelheim; Honoraria (self): Bristol-Myers Squibb; Honoraria (self): Chugai Pharmaceutical; Honoraria (self): Eli Lilly; Honoraria (self): MSD; Honoraria (self): Novartis; Honoraria (self): Ono Pharmaceutical; Honoraria (self): Taiho Pharmaceutical."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Tachihara", "first_name": "M.", "last_name": "Tachihara", "second_name": "", "title": " Honoraria (self), Research grant/Funding (self): AstraZeneca; Honoraria (self): Boehringer Ingelheim,; Honoraria (self): Chugai Pharmaceutical; Honoraria (self): Eli Lilly; Honoraria (self): MSD; Honoraria (self): Olympus; Honoraria (self): Ono Pharmaceutical; Honoraria (self): Taiho Pharmaceutical."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "N. Furuya", "first_name": "N.", "last_name": "Furuya", "second_name": "", "title": " Honoraria (self): AstraZeneca; Honoraria (self): Boehringer Ingelheim; Honoraria (self): Bristol-Myers Squibb; Honoraria (self): Chugai Pharmaceutical; Honoraria (self): Eli Lilly; Honoraria (self): Kyowa Kirin; Honoraria (self): MSD; Honoraria (self): Novartis; Honoraria (self): Ono Pharmaceutical; Honoraria (self): Taiho Pharmaceutical."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Shimizu", "first_name": "J.", "last_name": "Shimizu", "second_name": "", "title": " Honoraria (self): AstraZeneca; Honoraria (self): MSD; Honoraria (self): Ono Pharmaceutical; Honoraria (self): Taiho Pharmaceutical; Honoraria (self): Chugai Pharmaceutical."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "N. Katakami", "first_name": "N.", "last_name": "Katakami", "second_name": "", "title": " Honoraria (self): AstraZeneca; Honoraria (self): Boehringer Ingelheim; Honoraria (self): Bristol-Myers Squibb; Honoraria (self): Chugai Pharmaceutical; Honoraria (self): Eli Lilly; Honoraria (self): MSD; Honoraria (self): Novartis; Honoraria (self): Ono Pharmaceutical; Honoraria (self): Taiho Pharmaceutical; Honoraria (self): Japan Pharmaceutical Association."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "N. Miura", "first_name": "N.", "last_name": "Miura", "second_name": "", "title": " Honoraria (self): Nippon Boehringer Ingelheim Co."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Teraoka", "first_name": "S.", "last_name": "Teraoka", "second_name": "", "title": " Honoraria (self): AstraZeneca; Honoraria (self): Chugai Pharmaceutical; Honoraria (self): Novartis; Honoraria (self): Boehringer Ingelheim; Honoraria (self): Taiho Pharmaceutical; Honoraria (self): Ono Pharmaceutical Co."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Simone P. Niclou", "first_name": "Simone", "last_name": "Niclou", "second_name": "P.", "country": "Luxembourg", "city": "Luxembourg", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Michael Weller", "first_name": "Michael", "last_name": "Weller", "second_name": "", "country": "Switzerland", "city": "Zurich", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "P. Roth", "first_name": "P.", "last_name": "Roth", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy: Bristol-Myers Squibb; Honoraria (self), Advisory/Consultancy: Debiopharm; Honoraria (self), Advisory/Consultancy: Medac, Merck; Honoraria (self), Advisory/Consultancy: MSD; Honoraria (self), Advisory/Consultancy: Novocure; Honoraria (self), Advisory/Consultancy: QED; Honoraria (self), Advisory/Consultancy: Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "T. Pietsch", "first_name": "T.", "last_name": "Pietsch", "second_name": "", "title": " Honoraria (self): Chugai; Honoraria (self): Mayo Clinic."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Sabel", "first_name": "M.", "last_name": "Sabel", "second_name": "", "title": " Honoraria (self): Novocure; Honoraria (self): Integra."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "G. Reifenberger", "first_name": "G.", "last_name": "Reifenberger", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy: AbbVie."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Mario Caccese", "first_name": "Mario", "last_name": "Caccese", "second_name": "", "country": "Italy", "city": "Padova", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Maximilian J. Mair", "first_name": "Maximilian", "last_name": "Mair", "second_name": "J.", "country": "Austria", "city": "Vienna", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Berghoff", "first_name": "S.", "last_name": "Berghoff", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Research grant/Funding (self): Daiichi Sankyo; Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Roche; Honoraria (self), Advisory/Consultancy: Bristol-Myers Squibb; Honoraria (self), Advisory/Consultancy: Merck; Travel/Accommodation/Expenses: Amgen; Travel/Accommodation/Expenses: AbbVie."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Ariane Steindl", "first_name": "Ariane", "last_name": "Steindl", "second_name": "", "country": "Austria", "city": "Vienna", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Thomas John", "first_name": "Thomas", "last_name": "John", "second_name": "", "country": "Australia", "city": "Melbourne", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "H. Chiu", "first_name": "H.", "last_name": "Chiu", "second_name": "", "title": " Honoraria (self): Pfizer, AstraZeneca/MedImmune, Boehringer Ingelheim, Bristol-Myers Squibb, Chugai Pharmaceutical, Eli Lilly, MSD, Novartis, Ono Pharmaceutical, and Roche; Advisory/Consultancy: AstraZeneca/MedImmune, Boehringer Ingelheim, Bristol-Myers Squibb, Chugai Pharmaceutical, MSD, Novartis, Ono Pharmaceutical, and Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Cho", "first_name": "C.", "last_name": "Cho", "second_name": "", "title": " Advisory/Consultancy: Novartis, AstraZeneca, Boehringer Ingelheim, Roche, BMS, Ono, Yuhan, Pfizer, Eli Lilly, Janssen, Takeda, MSD, Janssen, Medpacto, Blueprint med-icines, Kanaph Therapeutic Inc; Research grant/Funding (institution): Novartis, Bayer, AstraZeneca, Mogam Institute, Dong-A ST, Champions Oncology, Janssen, Yuhan, Ono, Dizal Pharma, MSD, AbbVie, Medpacto, GI-Innovation, Eli Lilly, Blueprint medicines; Shareholder/Stockholder/Stock options: TheraCanVac Inc, Gencurix Inc, Bridgebio Therapeutics, Kanaph Therapeutic Inc; Licensing/Royalties: Champions Oncology; Officer/Board of Directors: Daan biotherapeutics."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Fakih", "first_name": "M.", "last_name": "Fakih", "second_name": "", "title": " Honoraria (self): Amgen; Advisory/Consultancy: Array, Amgen, Pfizer, and Bayer Pharmaceuticals; Speaker Bureau/Expert testimony: Amgen, Guardant360; Research grant/Funding (institution): Amgen, AstraZeneca, Novartis."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "F. Farago", "first_name": "F.", "last_name": "Farago", "second_name": "", "title": " Honoraria (self): Dava Oncology, Clinical Care Options, Medical Learning Institute, Medscape, PeerView, Research to Practice; Advisory/Consultancy: Bayer, Loxo Oncology, Inc."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Demetri", "first_name": "D.", "last_name": "Demetri", "second_name": "", "title": " Honoraria (self): M."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "K. Goto", "first_name": "K.", "last_name": "Goto", "second_name": "", "title": " Honoraria (self): Astellas Pharma Inc."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Doebele", "first_name": "C.", "last_name": "Doebele", "second_name": "", "title": " Advisory/Consultancy: Ignyta, Genentech/Roche, Loxo Oncology, Bayer, Eli Lilly, AstraZeneca, Pfizer, Blueprint Medicines, Anchiano, and Rain Therapeutics; Research grant/Funding (institution): Ignyta, Loxo, Mirati, Pfizer, Eli Lilly, and Strategia; Travel/Accommodation/Expenses: Ignyta, Genentech/Roche, Eli Lilly, Pfizer, Blueprint Medicines, and Rain Therapeutics; Shareholder/Stockholder/Stock options: Rain Therapeutics; Licensing/Royalties, Patent and biologic material licensing fees: Ignyta, Loxo, Abbott Molecular, Genentech/Roche, Chugai, Foundation Medicine, Black Diamond, and Rain Therapeutics, Voronoi, Pearl River, Ariad."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Siena", "first_name": "S.", "last_name": "Siena", "second_name": "", "title": " Advisory/Consultancy: Amgen, Bayer, BMS, CheckMab, Celgene, Daiichi Sankyo, Incyte, Merck, Novartis, Roche, and Seattle Genetics."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Drilon", "first_name": "A.", "last_name": "Drilon", "second_name": "", "title": " Honoraria (institution): Ignyta/Roche/Genentech, Loxo, Bayer, lilly, TP Therapeutics, AstraZeneca, Pfizer, Blueprint, Takeda, Ariad, Millennium, Helsinn, BeiGene, BerGenBio, Hengrui, Exelixis, Tyra, Verastem, MORE Health, AbbVie, 14ner/Elevation Oncology, Axis, Peerview Institute,; Research grant/Funding (self): Foundation Medicine; Research grant/Funding (institution): Pfizer, Exelixis, Taiho, Teva, GlaxoSmithKline and PharmaMar; Licensing/Royalties: Wolters Kluwer; Honoraria (institution): OncLive, Paradigm Medical Communications, Remedica Ltd, ArcherDX, Foundation Medicine, PeerVoice, Research to Practice, Medscapem, WebMD."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "V. Liu", "first_name": "V.", "last_name": "Liu", "second_name": "", "title": " Advisory/Consultancy: AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Catalyst, Celgene, G1 Therapeutics, Genentech/Roche, Guardant Health, Inivata, Janssen, Lilly, Loxo, MSD, Pfizer, PharmaMar, Regeneron, Takeda; Research grant/Funding (institution): Alkermes, AstraZeneca, Bayer, Blueprint, Bristol-Myers Squibb, Corvus, Genentech, Lilly, Lycera, Merck, Merus, Molecular Partners, Pfizer, Rain, RAPT, Spectrum, Turning Point Therapeutics; Travel/Accommodation/Expenses: AstraZeneca, Genentech/Roche, MSD."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Ahn", "first_name": "J.", "last_name": "Ahn", "second_name": "", "title": " Honoraria (self): AstraZeneca, Lilly, Takeda, Roche, MSD; Advisory/Consultancy: AstraZeneca, Lilly, Takeda, Roche, MSD, Merck, Boehringer Ingelheim, Ono Pharmaceutical, Bristol-Myers Squibb, Alpha Pharmaceutical, and Progeneer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "L. Bazhenova", "first_name": "L.", "last_name": "Bazhenova", "second_name": "", "title": " Advisory/Consultancy: Genentech, BeyondSpring Pharma, AstraZeneca, BI, Takeda, Blueprint, Novartis; Research grant/Funding (self): BeyondSpring Pharma; Shareholder/Stockholder/Stock options: Epic Sciences."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. Overbeck", "first_name": "R.", "last_name": "Overbeck", "second_name": "", "title": " Advisory/Consultancy: AstraZeneca, BMS, Boehringer Ingelheim, Eli Lilly, Medac, MSD, Novartis, Roche/Genentech, Sanofi-Aventis, Tesaro/GSK; Travel/Accommodation/Expenses: AstraZeneca, Roche/Genentech."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Nieva", "first_name": "J.", "last_name": "Nieva", "second_name": "", "title": " Honoraria (self): AstraZeneca, Fujirebio, Western Oncolytics; Research grant/Funding (institution): Merck; Shareholder/Stockholder/Stock options: Epic Sciences, Cansera, Quantgene; Licensing/Royalties: Cansera."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "L. Veronese", "first_name": "L.", "last_name": "Veronese", "second_name": "", "title": " Full/Part-time employment: F."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Day", "first_name": "M.", "last_name": "Day", "second_name": "", "title": " Full/Part-time employment: Genentech."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "F. De Braud", "first_name": "F.", "last_name": "De Braud", "second_name": "", "title": " Advisory/Consultancy: Bristol-Myers Squibb, Eli Lilly, Roche, Amgen, AstraZeneca, Istituto Gentili, Fondazione Internazionale Menarini, Octomet Oncology, Novartis, Merck Sharp & Dohme, Ignyta, Bayer, Noema, ACCMED, Dephaforum, Nadirex, Biotechspert, Pfizer, Speaker Bureau/Expert testimony: Bristol-Myers Squibb, Roche, Merck Sharp & Dohme, Ignyta,Dephaforum, prIME Oncology, Pfizer, Biotechespert; Research grant/Funding (institution): Roche, Novartis, Merck Sharp & Dohme, Bristol-Myers Squibb, Pfizer, Kymab, Celgene, Tesaro; Travel/Accommodation/Expenses: Bristol-Myers Squibb, Roche, Celgene, Amgen; Advisory/Consultancy: Tiziana Life Sciences, Pierre Fabre."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Sherko Kümmel", "first_name": "Sherko", "last_name": "Kümmel", "second_name": "", "country": "Germany", "city": "Essen", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "H. Zhang", "first_name": "H.", "last_name": "Zhang", "second_name": "", "title": " Research grant/Funding (institution), Non-financial support: F."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "H. Jung", "first_name": "H.", "last_name": "Jung", "second_name": "", "title": " Honoraria (self), Research grant/Funding (institution), Personal fees, Non-financial support: F."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. Hegg", "first_name": "R.", "last_name": "Hegg", "second_name": "", "title": " Research grant/Funding (institution), Non-financial support: F."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Koehler", "first_name": "A.", "last_name": "Koehler", "second_name": "", "title": " Research grant/Funding (institution), Travel/Accommodation/Expenses, Non-financial support: F."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "L. Telli", "first_name": "L.", "last_name": "Telli", "second_name": "", "title": " Research grant/Funding (institution), Non-financial support: F."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Ferrario", "first_name": "C.", "last_name": "Ferrario", "second_name": "", "title": " Research grant/Funding (institution), Non-financial support, Other: F."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Nguyen Duc", "first_name": "A.", "last_name": "Duc", "second_name": "Nguyen", "title": " Research grant/Funding (institution), Full/Part-time employment, Non-financial support: F."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "V. Maiya", "first_name": "V.", "last_name": "Maiya", "second_name": "", "title": " Full/Part-time employment: F."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "E. Mittendorf", "first_name": "E.", "last_name": "Mittendorf", "second_name": "", "title": " Advisory/Consultancy: Merck; Advisory/Consultancy: Genomic Health; Advisory/Consultancy: Sellas Life Sciences; Research grant/Funding (institution): GlaxoSmithKline."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Vincent M. De Jong", "first_name": "Vincent", "last_name": "De Jong", "second_name": "M.", "country": "Netherlands", "city": "Amsterdam", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Kok", "first_name": "M.", "last_name": "Kok", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (institution): Bristol-Meyers Squibb; Research grant/Funding (institution): Roche-Genentech; Research grant/Funding (institution): AstraZeneca; Advisory/Consultancy: Daiichi Sankyo."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Linn", "first_name": "S.", "last_name": "Linn", "second_name": "", "title": " Research grant/Funding (self): ZonMw; Research grant/Funding (self): A Sister's Hope ; Advisory/Consultancy, Research grant/Funding (institution), Non-remunerated activity/ies, institutional non-financial support: AstraZeneca; Advisory/Consultancy, Non-remunerated activity/ies, institutional non-financial support: Cergentis; Advisory/Consultancy, Non-remunerated activity/ies, institutional non-financial support: IBM; Advisory/Consultancy, Research grant/Funding (institution): Pfizer; Advisory/Consultancy, Research grant/Funding (institution), Non-remunerated activity/ies, institutional non-financial support: Roche-Genentech; Research grant/Funding (institution), Non-remunerated activity/ies, institutional non-financial support: Tesaro; Research grant/Funding (institution), Non-remunerated activity/ies, institutional non-financial support: immunomedics; Non-remunerated activity/ies: Bayer; Research grant/Funding (institution), institutional non-financial support: Agendia; Research grant/Funding (institution): Eurocept-pharmaceuticals; Research grant/Funding (institution): Novartis."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "F. Salgado", "first_name": "F.", "last_name": "Salgado", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (self), Travel/Accommodation/Expenses: Roche; Advisory/Consultancy: Bristol-Myers Squibb; Research grant/Funding (self), Travel/Accommodation/Expenses: Merck; Research grant/Funding (self): Puma Biotechnology; Travel/Accommodation/Expenses: AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Andreas Schneeweiss", "first_name": "Andreas", "last_name": "Schneeweiss", "second_name": "", "country": "Germany", "city": "Heidelberg", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "H. Tesch", "first_name": "H.", "last_name": "Tesch", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Roche; Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Novartis."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "T. Link", "first_name": "T.", "last_name": "Link", "second_name": "", "title": " Non-remunerated activity/ies: Pharma Mar; Non-remunerated activity/ies: Daiichi Sankyo; Honoraria (self), Non-remunerated activity/ies: MSD; Honoraria (self): Amgen; Honoraria (self), Non-remunerated activity/ies: Pfizer; Honoraria (self): Novartis; Honoraria (self): Teva; Honoraria (self): Tesaro; Honoraria (self), Non-remunerated activity/ies: Roche; Honoraria (self), Non-remunerated activity/ies: Clovis; Non-remunerated activity/ies: Celgene."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Erica L. Mayer", "first_name": "Erica", "last_name": "Mayer", "second_name": "L.", "country": "United States of America", "city": "Boston", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "I. Gnant", "first_name": "I.", "last_name": "Gnant", "second_name": "", "title": " Travel/Accommodation/Expenses: Amgen; Travel/Accommodation/Expenses: AstraZeneca; Travel/Accommodation/Expenses: Celgene; Travel/Accommodation/Expenses: Lilly; Travel/Accommodation/Expenses: Invectys; Travel/Accommodation/Expenses: Pfizer; Travel/Accommodation/Expenses: Novartis; Travel/Accommodation/Expenses: Puma; Travel/Accommodation/Expenses: NanoString; Travel/Accommodation/Expenses: Roche; Travel/Accommodation/Expenses: Medison; Travel/Accommodation/Expenses: Lifebrain; Spouse/Financial dependant: Sandoz."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. DeMichele", "first_name": "A.", "last_name": "DeMichele", "second_name": "", "title": " Honoraria (self), Research grant/Funding (institution): Pfizer; Research grant/Funding (institution): Genentech; Research grant/Funding (institution): Menarini; Advisory/Consultancy: Context Therapeutics; Research grant/Funding (institution): Novartis; Research grant/Funding (institution): Calithera."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Prat", "first_name": "A.", "last_name": "Prat", "second_name": "", "title": " Honoraria (self), Research grant/Funding (institution): Roche; Advisory/Consultancy, Research grant/Funding (institution): Pfizer; Advisory/Consultancy, Research grant/Funding (institution): Novartis; Advisory/Consultancy, Research grant/Funding (institution): Amgen; Honoraria (self): BMS; Honoraria (self), Research grant/Funding (institution): Daiichi-Sankyo; Advisory/Consultancy: Puma; Advisory/Consultancy: Oncolytics Biotech; Advisory/Consultancy: MSD; Advisory/Consultancy, Research grant/Funding (institution): Lilly; Honoraria (self), Research grant/Funding (institution): Nanostring Technologies; Research grant/Funding (institution): Boehringer; Research grant/Funding (institution): Sysmex Europa GmbH; Research grant/Funding (institution): Medica Scientia Inno Research; Research grant/Funding (institution): Celgene; Research grant/Funding (institution): Astellas Pharma."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "G. Pfeiler", "first_name": "G.", "last_name": "Pfeiler", "second_name": "", "title": " Advisory/Consultancy: Amgen; Advisory/Consultancy: Roche; Advisory/Consultancy: Novartis; Advisory/Consultancy: Lilly; Advisory/Consultancy: Pfizer; Advisory/Consultancy: AstraZeneca; Advisory/Consultancy: MSD."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "O. Metzger", "first_name": "O.", "last_name": "Metzger", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (institution): AbbVie; Research grant/Funding (institution): Breast Cancer Research Foundation; Research grant/Funding (institution): Cascadian Therapeutics; Research grant/Funding (institution): Eisai; Research grant/Funding (institution): Pfizer; Honoraria (self), Research grant/Funding (institution): Roche/Genentech; Research grant/Funding (institution): Komen for the Cure; Advisory/Consultancy: G1 Therapeutics; Advisory/Consultancy, Travel/Accommodation/Expenses: Group Oncoclinicas."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Fumagalli", "first_name": "D.", "last_name": "Fumagalli", "second_name": "", "title": " Research grant/Funding (institution): Pfizer; Research grant/Funding (institution): AstraZeneca; Research grant/Funding (institution): Novartis; Research grant/Funding (institution): Roche/Genentech; Research grant/Funding (institution): Servier; Research grant/Funding (institution): Tesaro."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "K. Puyana Theall", "first_name": "K.", "last_name": "Theall", "second_name": "Puyana", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Pfizer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Serena Di Cosimo", "first_name": "Serena", "last_name": "Di Cosimo", "second_name": "", "country": "Italy", "city": "Milan", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Donna Rivera", "first_name": "Donna", "last_name": "Rivera", "second_name": "", "country": "United States of America", "city": "Washington", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Lewis Au", "first_name": "Lewis", "last_name": "Au", "second_name": "", "country": "United Kingdom", "city": "Sutton", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Riyue Bao", "first_name": "Riyue", "last_name": "Bao", "second_name": "", "country": "United States of America", "city": "Pittsburgh", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Pierre T. Van Mol", "first_name": "Pierre", "last_name": "Van Mol", "second_name": "T.", "country": "Belgium", "city": "Leuven", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Melissa Bersanelli", "first_name": "Melissa", "last_name": "Bersanelli", "second_name": "", "country": "P", "city": "Parma", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Buti", "first_name": "S.", "last_name": "Buti", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (institution): Bristol-Myers Squibb (BMS), Pfizer; MSD, Ipsen, Roche, Eli-Lilly, AstraZeneca and Novartis."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "P. Bonomo", "first_name": "P.", "last_name": "Bonomo", "second_name": "", "title": " Honoraria (self): Merck Serono, Angelini Pharma,."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Roger Sun", "first_name": "Roger", "last_name": "Sun", "second_name": "", "country": "France", "city": "Villejuif", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "E. Deutsch", "first_name": "E.", "last_name": "Deutsch", "second_name": "", "title": " Advisory/Consultancy: Roche, BMS, Boehringer, Astrazeneca, Lilly Amgen and Merck-Serono."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Alberto Zambelli", "first_name": "Alberto", "last_name": "Zambelli", "second_name": "", "country": "Italy", "city": "Bergamo", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Nalinie Nalinie Joharatnam-Hogan", "first_name": "Nalinie", "last_name": "Joharatnam-Hogan", "second_name": "Nalinie", "country": "United Kingdom", "city": "London", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Lennard Lee", "first_name": "Lennard", "last_name": "Lee", "second_name": "", "country": "United Kingdom", "city": "Birmingham", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Gudrun M. Kreye", "first_name": "Gudrun", "last_name": "Kreye", "second_name": "M.", "country": "Austria", "city": "Krems an der Donau", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Anton Snegovoy", "first_name": "Anton", "last_name": "Snegovoy", "second_name": "", "country": "Russian Federation", "city": "Moscow", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Atul Batra", "first_name": "Atul", "last_name": "Batra", "second_name": "", "country": "Delh", "city": "New Delhi", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Harm L. Ormel", "first_name": "Harm", "last_name": "Ormel", "second_name": "L.", "country": "Netherlands", "city": "Groningen", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Deniz Can Guven", "first_name": "Deniz", "last_name": "Guven", "second_name": "Can", "country": "Turkey", "city": "Ankara", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Gilberto De Castro Jr.", "first_name": "Gilberto", "last_name": "De Castro", "second_name": "", "country": "S", "city": "Sao Paulo", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Atul Sharma", "first_name": "Atul", "last_name": "Sharma", "second_name": "", "country": "India", "city": "New Delhi", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Luigi Celio", "first_name": "Luigi", "last_name": "Celio", "second_name": "", "country": "Italy", "city": "Milan", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Cortinovis", "first_name": "D.", "last_name": "Cortinovis", "second_name": "", "title": " Advisory/Consultancy: Helsinn Healthcare SA."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "L. Cavanna", "first_name": "L.", "last_name": "Cavanna", "second_name": "", "title": " Advisory/Consultancy: AstraZeneca, Merck; Travel/Accommodation/Expenses: Celgene, Pfizer, Ipsen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. Chiari", "first_name": "R.", "last_name": "Chiari", "second_name": "", "title": " Speaker Bureau/Expert testimony, Conventions speaker: Roche, MSD, BMS, Astrazeneca, Pfizer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "E. Bonizzoni", "first_name": "E.", "last_name": "Bonizzoni", "second_name": "", "title": " Advisory/Consultancy, Spot consultancy assignments by Italfarmaco and statistical consultant at Helsinn: Italfarmaco, Helsinn."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. De Placido", "first_name": "S.", "last_name": "De Placido", "second_name": "", "title": " Advisory/Consultancy: GSK, Novartis, Roche, Celgene, Astrazeneca, Amgen, Eisai, Italfarmaco, Pfizer, Eli Lilly; Speaker Bureau/Expert testimony, Invited speech: GSK, Novartis, Roche, Celgene, Astrazeneca, Amgen, Pfizer, Eli Lilly."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "E. Bria", "first_name": "E.", "last_name": "Bria", "second_name": "", "title": " Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses, E."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "B. received institutional research grants", "first_name": "B.", "last_name": "grants", "second_name": "received institutional research", "title": " Astra-Zeneca, Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Teresa Smit", "first_name": "Teresa", "last_name": "Smit", "second_name": "", "country": "South Africa", "city": "Johannesburg", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Pietro Lapidari", "first_name": "Pietro", "last_name": "Lapidari", "second_name": "", "country": "France", "city": "Villejuif", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Spyros Xynogalos", "first_name": "Spyros", "last_name": "Xynogalos", "second_name": "", "country": "Greece", "city": "Athens", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Michael Speicher", "first_name": "Michael", "last_name": "Speicher", "second_name": "", "country": "Austria", "city": "Graz", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Teresa Davoli", "first_name": "Teresa", "last_name": "Davoli", "second_name": "", "country": "United States of America", "city": "New York", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Tao Fu", "first_name": "Tao", "last_name": "Fu", "second_name": "", "country": "China", "city": "Beijing", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Yan Asmann", "first_name": "Yan", "last_name": "Asmann", "second_name": "", "country": "United States of America", "city": "Jacksonville", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Christoph Benedikt Westphalen", "first_name": "Christoph", "last_name": "Westphalen", "second_name": "Benedikt", "country": "Germany", "city": "Munich", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Ganesan", "first_name": "S.", "last_name": "Ganesan", "second_name": "", "title": " Advisory/Consultancy: Merck, Novartis, Foundation Medicine, Roche, Foghorn Therapeutics, Inspirata; Shareholder/Stockholder/Stock options, Has equity in Inspirata: Inspirata; Spouse/Financial dependant, Spouse is an employee of Merck and has equity in Merck: Merck; Non-remunerated activity/ies, Third-party editorial assistance: F."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "V. Heinemann", "first_name": "V.", "last_name": "Heinemann", "second_name": "", "title": " Honoraria (self): Merck, Roche, Celgene, Amgen, Sanofi, Lilly, Sirtex, Boehringer-Ingelheim, Taiho, Servier; Advisory/Consultancy: Merck, Roche, Amgen, Sanofi, Sirtex, Servier, Celgene, Boehringer-Ingelheim, Halozyme, MSD, BMS; Research grant/Funding (institution): Merck, Roche, Amgen, Sirtex, Servier, Celgene, Boehringer-Ingelheim, Shire; Travel/Accommodation/Expenses: Merck, Roche, Amgen, Sirtex, Servier, Shire, MSD, BMS; Non-remunerated activity/ies, Third-party editorial assistance: F."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "E. Rouleau", "first_name": "E.", "last_name": "Rouleau", "second_name": "", "title": " Advisory/Consultancy: AstraZeneca, Roche Diagnostic, BMS; Travel/Accommodation/Expenses: AstraZeneca, BMS; Non-remunerated activity/ies, Third-party editorial assistance: F."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Fine", "first_name": "A.", "last_name": "Fine", "second_name": "", "title": " Full/Part-time employment: Foundation Medicine; Shareholder/Stockholder/Stock options, Non-remunerated activity/ies, Third-party editorial assistance: F."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "L. Garcia Palacios", "first_name": "L.", "last_name": "Palacios", "second_name": "Garcia", "title": " Full/Part-time employment, Non-remunerated activity/ies, Third-party editorial assistance: F."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Sokol", "first_name": "S.", "last_name": "Sokol", "second_name": "", "title": " Full/Part-time employment: Foundation Medicine ; Shareholder/Stockholder/Stock options, Non-remunerated activity/ies, Third-party editorial assistance: F."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Thomas", "first_name": "M.", "last_name": "Thomas", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment, Non-remunerated activity/ies, Third-party editorial assistance: F."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Jacob J. Adashek", "first_name": "Jacob", "last_name": "Adashek", "second_name": "J.", "country": "United States of America", "city": "Tampa", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Sicklick", "first_name": "J.", "last_name": "Sicklick", "second_name": "", "title": " Research grant/Funding (institution): Novartis Pharmaceuticals; Research grant/Funding (institution): Amgen Pharmaceuticals; Research grant/Funding (institution): Foundation Medicine; Advisory/Consultancy: Grand Rounds; Advisory/Consultancy: Loxo Oncology; Advisory/Consultancy: Deciphera; Advisory/Consultancy: Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. Kurzrock", "first_name": "R.", "last_name": "Kurzrock", "second_name": "", "title": " Research grant/Funding (institution): Genentech; Research grant/Funding (institution): Incyte; Research grant/Funding (institution): Merck; Research grant/Funding (institution): Serono; Research grant/Funding (institution): Pfizer; Research grant/Funding (institution): Sequenom; Research grant/Funding (institution): Foundation Medicine; Research grant/Funding (institution): Grifols; Research grant/Funding (institution): Guardant; Advisory/Consultancy: Loxo; Advisory/Consultancy: X Biotech; Advisory/Consultancy: NeoMed; Advisory/Consultancy: Actuate Therapeutics; Speaker Bureau/Expert testimony: Roche; Leadership role, Shareholder/Stockholder/Stock options: IDby DNA; Leadership role, Shareholder/Stockholder/Stock options: Curematch Inc."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Amanda Fitzpatrick", "first_name": "Amanda", "last_name": "Fitzpatrick", "second_name": "", "country": "United Kingdom", "city": "London", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Leonie Voorwerk", "first_name": "Leonie", "last_name": "Voorwerk", "second_name": "", "country": "Netherlands", "city": "Amsterdam", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "E. Theelen", "first_name": "E.", "last_name": "Theelen", "second_name": "", "title": " Research grant/Funding (institution): MSD; Research grant/Funding (institution): AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "E. Voest", "first_name": "E.", "last_name": "Voest", "second_name": "", "title": " Research grant/Funding (institution): Bristol-Myers-Squib."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "E. de Visser", "first_name": "E.", "last_name": "de Visser", "second_name": "", "title": " Research grant/Funding (institution): Roche; Advisory/Consultancy: Third Rock Ventures."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Marcus Schmidt", "first_name": "Marcus", "last_name": "Schmidt", "second_name": "", "country": "Germany", "city": "Mainz", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "I. Vogler", "first_name": "I.", "last_name": "Vogler", "second_name": "", "title": " Full/Part-time employment: BioNTech RNA Pharmaceuticals GmbH."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "E. Derhovanessian", "first_name": "E.", "last_name": "Derhovanessian", "second_name": "", "title": " Full/Part-time employment: BioNTech SE."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "T. Omokoko", "first_name": "T.", "last_name": "Omokoko", "second_name": "", "title": " Full/Part-time employment: BioNTech Cell & Gene Therapies GmbH."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "E. Godehardt", "first_name": "E.", "last_name": "Godehardt", "second_name": "", "title": " Full/Part-time employment: BioNTech RNA Pharmaceuticals GmbH."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Cortini", "first_name": "A.", "last_name": "Cortini", "second_name": "", "title": " Full/Part-time employment: BioNTech Cell & Gene Therapies GmbH."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Newrzela", "first_name": "S.", "last_name": "Newrzela", "second_name": "", "title": " Full/Part-time employment: BioNTech Cell & Gene Therapies GmbH."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Bolte", "first_name": "S.", "last_name": "Bolte", "second_name": "", "title": " Full/Part-time employment: BioNTech SE."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Langer", "first_name": "D.", "last_name": "Langer", "second_name": "", "title": " Full/Part-time employment: BioNTech SE."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "U. Sahin", "first_name": "U.", "last_name": "Sahin", "second_name": "", "title": " Leadership role, Officer/Board of Directors: BioNTech SE."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Majid Momeny", "first_name": "Majid", "last_name": "Momeny", "second_name": "", "country": "Finland", "city": "Turku", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Marzia Del Re", "first_name": "Marzia", "last_name": "Del Re", "second_name": "", "country": "Italy", "city": "Pisa", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Marta Palafox", "first_name": "Marta", "last_name": "Palafox", "second_name": "", "country": "Spain", "city": "Barcelona", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Llombart Cussac", "first_name": "A.", "last_name": "Cussac", "second_name": "Llombart", "title": " Leadership role: Eisai, Celgene, Lilly, Pfizer, Roche, Novartis, MSD; Shareholder/Stockholder/Stock options: MedSIR, Initia-Research; Advisory/Consultancy: Lilly, Roche, Pfizer, Novartis, Pierre-Fabre, GenomicHealth, GSK; Speaker Bureau/Expert testimony: Lilly, AstraZeneca, MSD; Research grant/Funding (self): Roche, Foundation Medicine, Pierre-Fabre, Agendia; Travel/Accommodation/Expenses: Roche, Lilly, Novartis, Pfizer, AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Perez Garcia", "first_name": "M.", "last_name": "Garcia", "second_name": "Perez", "title": " Advisory/Consultancy: Roche, Lilly; Travel/Accommodation/Expenses: Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Del Campo", "first_name": "M.", "last_name": "Del Campo", "second_name": "", "title": " Advisory/Consultancy: Pfizer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Bellet Ezquerra", "first_name": "M.", "last_name": "Ezquerra", "second_name": "Bellet", "title": " Advisory/Consultancy: Novartis, Pfizer, Lilly; Speaker Bureau/Expert testimony, Non-remunerated activity/ies: Novartis, Pfizer, Lilly; Non-remunerated activity/ies, Contracted Research."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "V. Serra", "first_name": "V.", "last_name": "Serra", "second_name": "", "title": " Non-remunerated activity/ies, Support for non-commercial research: Novartis, Genetech and AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Barry Laird", "first_name": "Barry", "last_name": "Laird", "second_name": "", "country": "United Kingdom", "city": "Edinburgh", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Guy Jerusalem", "first_name": "Guy", "last_name": "Jerusalem", "second_name": "", "country": "Belgium", "city": "Liège", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Cristofanilli", "first_name": "M.", "last_name": "Cristofanilli", "second_name": "", "title": " Advisory/Consultancy: CytoDyn; Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (institution): Pfizer; Advisory/Consultancy: Lilly; Advisory/Consultancy: Novartis; Advisory/Consultancy, Speaker Bureau/Expert testimony: Foundation Medicine; Advisory/Consultancy: G1 Therapeutics; Advisory/Consultancy: Sermionexx; Advisory/Consultancy: Genentch."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "L. Pusztai", "first_name": "L.", "last_name": "Pusztai", "second_name": "", "title": " Honoraria (self), Research grant/Funding (institution), Clinical trial support: Merck; Honoraria (self), Research grant/Funding (institution), Clinical trial support: AstraZeneca; Honoraria (self), Research grant/Funding (institution), Clinical trial support: Seattle Genetics; Honoraria (self): Novartis; Honoraria (self), Research grant/Funding (institution), Clinical trial support: Roche Genentech; Honoraria (self): Eisai; Honoraria (self): Daiichi; Honoraria (self): Syndax; Honoraria (self): Immunomedics."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. Bartsch", "first_name": "R.", "last_name": "Bartsch", "second_name": "", "title": " Advisory/Consultancy: Accord; Honoraria (self): AstraZeneca; Advisory/Consultancy, Research grant/Funding (institution): Daiichi; Advisory/Consultancy, Travel/Accommodation/Expenses: Eli-Lilly; Advisory/Consultancy, Travel/Accommodation/Expenses: MSD; Advisory/Consultancy, Research grant/Funding (institution): Novartis; Advisory/Consultancy, Research grant/Funding (institution): Roche; Advisory/Consultancy: Puma; Advisory/Consultancy: Pierre-Favre; Advisory/Consultancy: Sandoz; Advisory/Consultancy: Eisai."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Tagliamento", "first_name": "M.", "last_name": "Tagliamento", "second_name": "", "title": " Travel/Accommodation/Expenses: Roche; Travel/Accommodation/Expenses: Bristol-Myers Squibb; Travel/Accommodation/Expenses: AstraZeneca; Travel/Accommodation/Expenses: Takeda; Travel/Accommodation/Expenses: Novartis; Travel/Accommodation/Expenses: Amgen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Antonio Marra", "first_name": "Antonio", "last_name": "Marra", "second_name": "", "country": "Italy", "city": "Milan", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Gehan B. Soosaipillai", "first_name": "Gehan", "last_name": "Soosaipillai", "second_name": "B.", "country": "United Kingdom", "city": "London", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Pinato", "first_name": "J.", "last_name": "Pinato", "second_name": "", "title": " Honoraria (self), Lecture fees: ViiV Healthcare; Honoraria (self), Lecture fees: Bayer Healthcare; Research grant/Funding (institution), Travel/Accommodation/Expenses: Bristol-Myers Squibb, Bayer Healthcare; Advisory/Consultancy: Mina Therapeutics, EISAI, Roche, Astra Zeneca; Research grant/Funding (institution): MSD."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Margherita Ratti", "first_name": "Margherita", "last_name": "Ratti", "second_name": "", "country": "Italy", "city": "Cremona", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Aurelie Bardet", "first_name": "Aurelie", "last_name": "Bardet", "second_name": "", "country": "France", "city": "Villejuif", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Faron", "first_name": "M.", "last_name": "Faron", "second_name": "", "title": " Travel/Accommodation/Expenses: Ipsen; Travel/Accommodation/Expenses: Novartis; Travel/Accommodation/Expenses: Pfizer; Honoraria (self): HRA Pharma; Honoraria (self): Ipsen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "I. Borget", "first_name": "I.", "last_name": "Borget", "second_name": "", "title": " Honoraria (self): Merck; Honoraria (self): CSL Berhing; Honoraria (self): Allergan; Honoraria (self): Novartis; Research grant/Funding (institution): BMS."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Bonastre", "first_name": "J.", "last_name": "Bonastre", "second_name": "", "title": " Honoraria (self): Bristol-Myers Squibb; Advisory/Consultancy: Bristol-Myers Squibb; Advisory/Consultancy: MSD; Advisory/Consultancy: PharmaMar (Inst); Advisory/Consultancy: Bristol-Myers Squibb (Inst); Advisory/Consultancy: Merck Serono; Travel/Accommodation/Expenses: Bristol-Myers Squibb."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Karlijn De Joode", "first_name": "Karlijn", "last_name": "De Joode", "second_name": "", "country": "Netherlands", "city": "Rotterdam", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Westgeest", "first_name": "M.", "last_name": "Westgeest", "second_name": "", "title": " Honoraria (self): Astellas; Honoraria (self): Roche; Travel/Accommodation/Expenses: Ipsen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "L. Hendriks", "first_name": "L.", "last_name": "Hendriks", "second_name": "", "title": " Advisory/Consultancy, Mentorship program with key opinion leaders: funded by AstraZeneca: AstraZeneca; Honoraria (self), Educational webinars: Quadia; Research grant/Funding (institution): AstraZeneca; Advisory/Consultancy, Paid to institution: Eli Lilly; Advisory/Consultancy, Paid to institution: Roche Genentech; Advisory/Consultancy, Paid to institution: Pfizer; Advisory/Consultancy, Advisory board and speakers fee all paid to institution: MSD; Advisory/Consultancy, Paid to institution: Takeda; Leadership role, Local PI of pharma initiated research: AstraZeneca; Leadership role, Local PI of pharma initiated research: Novartis; Leadership role, Local PI of pharma initiated research: BMS; Leadership role, Local PI of pharma initiated research: MSD / Merck; Leadership role, Local PI of pharma initiated research: GSK; Leadership role, Local PI of pharma initiated research: Takeda; Leadership role, Local PI of pharma initiated research: Blueprint Medicines; Leadership role, Local PI of pharma initiated research: Roche Genentech; Advisory/Consultancy, Paid to institution: Amgen; Advisory/Consultancy, Paid to institution: Boehringer Ingelheim; Advisory/Consultancy, Paid to institution: BMS; Advisory/Consultancy, Travel/Accommodation/Expenses, Advisory board paid to institution: Roche Genentech; Travel/Accommodation/Expenses: BMS; Research grant/Funding (institution): Roche Genentech; Research grant/Funding (institution): Boehringer Ingelheim."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Dingemans", "first_name": "C.", "last_name": "Dingemans", "second_name": "", "title": " Honoraria (self): Roche; Honoraria (self): Eli Lilly; Honoraria (self): Boehringer Ingelheim; Honoraria (self): Pfizer; Honoraria (self): BMS; Honoraria (self): Novartis; Honoraria (self): Takeda; Honoraria (self): PharmaMar; Advisory/Consultancy, non financial support: AbbVie; Research grant/Funding (institution): BMS; Research grant/Funding (institution): Amgen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Van der Veldt", "first_name": "M.", "last_name": "Van der Veldt", "second_name": "", "title": " Honoraria (institution), Advisory/Consultancy: BMS; Honoraria (institution), Advisory/Consultancy: MSD; Honoraria (institution), Advisory/Consultancy: Pfizer; Honoraria (institution), Advisory/Consultancy: Sanofi; Honoraria (institution), Advisory/Consultancy: Eisai; Honoraria (institution), Advisory/Consultancy: Ipsen; Honoraria (institution), Advisory/Consultancy: Roche; Honoraria (institution), Advisory/Consultancy: Novartis; Honoraria (institution), Advisory/Consultancy: Merck; Honoraria (institution), Advisory/Consultancy: Pierre Fabre."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Markus Joerger", "first_name": "Markus", "last_name": "Joerger", "second_name": "", "country": "Switzerland", "city": "St. Gallen", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Astrid LIÈVRE", "first_name": "Astrid", "last_name": "LIÈVRE", "second_name": "", "country": "France", "city": "Rennes", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Thariat", "first_name": "J.", "last_name": "Thariat", "second_name": "", "title": " Honoraria (self): BMS; Honoraria (institution), Travel/Accommodation/Expenses, Full/Part-time employment: Centre François Baclesse; Leadership role: President of the French Head and Neck Intergroup, GORTEC secretary; Non-remunerated activity/ies: Director of Easy-CRF society; Research grant/Funding (institution): Nanobiotix."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "G. Ahle", "first_name": "G.", "last_name": "Ahle", "second_name": "", "title": " Travel/Accommodation/Expenses: Abbvie; Biogen; Novartis; Roche; Sanofi; Non-remunerated activity/ies: ANOCEF; NENO; AlSacEP."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. Mathieu", "first_name": "R.", "last_name": "Mathieu", "second_name": "", "title": " Honoraria (self), Research grant/Funding (self): Astellas; Honoraria (self): AstraZeneca; Ferring; Ipsen; Janssen; MSD; Pfizer; Sanofi; Takeda."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Debieuvre", "first_name": "D.", "last_name": "Debieuvre", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Pfizer; Roche; Novartis; BMS; MSD; Honoraria (self), Research grant/Funding (institution), Travel/Accommodation/Expenses: AstraZeneca; Honoraria (self), Research grant/Funding (institution): Chugaï; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Boerhinger-Ingelheim; Research grant/Funding (institution): Chiesi; Sandoz; Takeda; GSK; Research grant/Funding (self): Lilly."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Canellas", "first_name": "A.", "last_name": "Canellas", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy: BMS; Honoraria (self), Travel/Accommodation/Expenses: AstraZeneca; Travel/Accommodation/Expenses: Oxyvie; LVL Medical; Boerhinger Ingelheim."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "L. Mansi", "first_name": "L.", "last_name": "Mansi", "second_name": "", "title": " Honoraria (institution), Advisory/Consultancy: Sandoz; Advisory/Consultancy: Roche; Eisai; Pfizer; Novartis; Speaker Bureau/Expert testimony: Exact Sciences; Travel/Accommodation/Expenses: Lilly."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "P. Gorphe", "first_name": "P.", "last_name": "Gorphe", "second_name": "", "title": " Honoraria (self): Intuitive Surgical; Non-remunerated activity/ies: Chair, scientific board, French Head and Neck Intergroup; Research grant/Funding (institution): MSD."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. IDBAIH Ahmed", "first_name": "A.", "last_name": "Ahmed", "second_name": "IDBAIH", "title": " Research grant/Funding (institution): Transgene; Sanofi; Air Liquide; Travel/Accommodation/Expenses: Carthera; Leo Pharma."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Herbert H. Loong", "first_name": "Herbert", "last_name": "Loong", "second_name": "H.", "country": "Hong Kong PRC", "city": "Shatin", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Robin L. Jones", "first_name": "Robin", "last_name": "Jones", "second_name": "L.", "country": "W", "city": "London", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Serrano", "first_name": "C.", "last_name": "Serrano", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (self): Deciphera Pharmaceuticals; Honoraria (self), Research grant/Funding (self), Travel/Accommodation/Expenses: Bayer AG; Research grant/Funding (self), Travel/Accommodation/Expenses: Pfizer, Inc; Honoraria (self), Advisory/Consultancy: Blueprint Medicines Corporation; Travel/Accommodation/Expenses: PharmaMar; Travel/Accommodation/Expenses: Novartis; Travel/Accommodation/Expenses: Lilly."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. von Mehren", "first_name": "M.", "last_name": "von Mehren", "second_name": "", "title": " Advisory/Consultancy: Blueprint Medicines Corporation; Advisory/Consultancy: Arog Pharmaceuticals."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. George", "first_name": "S.", "last_name": "George", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (institution): Blueprint Medicines Corporation; Advisory/Consultancy, Research grant/Funding (self): Deciphera Pharmaceuticals; Research grant/Funding (self): Pfizer; Research grant/Funding (self): Bayer; Research grant/Funding (self): Ariad; Research grant/Funding (self): Novartis; Advisory/Consultancy: Daiichi Sankyo; Advisory/Consultancy: Eli Lilly; Advisory/Consultancy: AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Heinrich", "first_name": "M.", "last_name": "Heinrich", "second_name": "", "title": " Honoraria (self), Research grant/Funding (self): Blueprint Medicines Corporation; Honoraria (self): Molecular MD; Honoraria (self): Novartis; Honoraria (self), Research grant/Funding (self): Deciphera Pharmaceuticals."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "P. Schoeffski", "first_name": "P.", "last_name": "Schoeffski", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy: Deciphera Pharmaceuticals; Honoraria (self): Exelixis; Advisory/Consultancy: Plexxikon; Advisory/Consultancy: Eisai; Advisory/Consultancy: Loxo; Advisory/Consultancy: Lilly; Advisory/Consultancy: Blueprint Medicines Corporation; Advisory/Consultancy: Ellipses Pharma; Advisory/Consultancy: Merck; Advisory/Consultancy: Servier; Advisory/Consultancy: Genmab; Advisory/Consultancy: Adaptimmune; Advisory/Consultancy: Intellisphere; Advisory/Consultancy: Transgene; Research grant/Funding (self): MSD; Research grant/Funding (self): Ipsen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "P. Cassier", "first_name": "P.", "last_name": "Cassier", "second_name": "", "title": " Honoraria (self): Blueprint Medicines Corporation; Advisory/Consultancy: Abbvie; Advisory/Consultancy: Bayer; Advisory/Consultancy: BMS; Advisory/Consultancy: Merck Serono; Advisory/Consultancy: MSD; Advisory/Consultancy: Novartis; Advisory/Consultancy: Roche/Genentech; Advisory/Consultancy: GSK; Advisory/Consultancy: Janssen; Advisory/Consultancy: Lilly; Advisory/Consultancy: Amgen; Advisory/Consultancy, Research grant/Funding (self): Novartis."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "P. Chawla", "first_name": "P.", "last_name": "Chawla", "second_name": "", "title": " Research grant/Funding (self): Amgen; Research grant/Funding (self): Roche; Research grant/Funding (self): Threshold Pharmaceuticals; Research grant/Funding (self): GSK; Research grant/Funding (self): CytRx Corporation; Research grant/Funding (self): Ignyta; Research grant/Funding (self): Immune Design; Research grant/Funding (self): Tracon Pharma; Research grant/Funding (self): SARC; Research grant/Funding (self): Karyopharm Therapeutics; Research grant/Funding (self): Jansen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Tap", "first_name": "D.", "last_name": "Tap", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy: Blueprint Medicines Corporation; Honoraria (self): Eli Lilly; Honoraria (self): EMD Serono; Honoraria (self): Eisai; Honoraria (self): Janssen; Honoraria (self): Immune Design; Honoraria (self): Daiichi Sankyo; Honoraria (self): Loxo; Honoraria (self): GSK; Honoraria (self): Agios Pharmaceuticals; Honoraria (self): NanoCarrier; Honoraria (self): Deciphera Pharmaceuticals; Advisory/Consultancy: Certis Oncology Solutions; Advisory/Consultancy, Shareholder/Stockholder/Stock options: Atropos Therapeutics; Advisory/Consultancy, Shareholder/Stockholder/Stock options: Daiichi Sankyo."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "T. Zhou", "first_name": "T.", "last_name": "Zhou", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Blueprint Medicines Corporation."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Roche", "first_name": "M.", "last_name": "Roche", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Blueprint Medicines Corporation."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Bauer", "first_name": "S.", "last_name": "Bauer", "second_name": "", "title": " Honoraria (self), Research grant/Funding (self): Blueprint Medicines Corporation; Research grant/Funding (self): Incyte; Research grant/Funding (self): Novartis; Honoraria (self): Deciphera Pharmaceuticals; Honoraria (self): Bayer; Honoraria (self): Exelixis; Honoraria (self): Novartis."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "John R. Zalcberg", "first_name": "John", "last_name": "Zalcberg", "second_name": "R.", "country": "VI", "city": "Melbourne", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "H. Gelderblom", "first_name": "H.", "last_name": "Gelderblom", "second_name": "", "title": " Research grant/Funding (institution): Daiichi; Research grant/Funding (institution): Five Prime; Research grant/Funding (institution): Novartis; Research grant/Funding (institution): Deciphera; Research grant/Funding (institution): Lilly; Research grant/Funding (institution): Roche; Research grant/Funding (institution): Eisai; Research grant/Funding (institution): Debio; Research grant/Funding (institution): Boehringer; Research grant/Funding (institution): Pfizer; Research grant/Funding (institution): Amgen; Research grant/Funding (institution): TEVA."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "L. Jones", "first_name": "L.", "last_name": "Jones", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy: Adaptimmune; Honoraria (self), Advisory/Consultancy: Athenex; Honoraria (self), Advisory/Consultancy: Blueprint; Honoraria (self), Advisory/Consultancy: Clinigen; Honoraria (self), Advisory/Consultancy: Eisai; Honoraria (self), Advisory/Consultancy: Epizyme; Honoraria (self), Advisory/Consultancy: Daiichi; Honoraria (self), Advisory/Consultancy: Deciphera; Honoraria (self), Advisory/Consultancy: Immunedesign; Honoraria (self), Advisory/Consultancy: Lilly; Honoraria (self), Advisory/Consultancy: Merck; Honoraria (self), Advisory/Consultancy: Pharmamar; Honoraria (self), Advisory/Consultancy: Upto Date; Advisory/Consultancy: Tracon; Research grant/Funding (institution), Clinical trial: MSD."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Attia", "first_name": "S.", "last_name": "Attia", "second_name": "", "title": " Research grant/Funding (self): Desmoid Tumor Research Foundation; Research grant/Funding (institution): AB Science; Research grant/Funding (institution): Tracon Pharma; Research grant/Funding (institution): CytRx Corporation; Research grant/Funding (institution): Bayer; Research grant/Funding (institution): Novartis; Research grant/Funding (institution): Daiichi Sankyo; Research grant/Funding (institution): Lilly; Research grant/Funding (institution), Travel/Accommodation/Expenses: Immune Design; Research grant/Funding (institution): Karyopharm Therapeutics; Research grant/Funding (institution): Epizyme; Research grant/Funding (institution): Blueprint Medicines; Research grant/Funding (institution): Genmab; Research grant/Funding (institution): CBA Pharma; Research grant/Funding (institution): Merck; Research grant/Funding (institution): Philogen; Research grant/Funding (institution): Gradalis; Research grant/Funding (institution): Deciphera; Research grant/Funding (institution): Takeda; Research grant/Funding (institution): Incyte; Research grant/Funding (institution): Springworks; Research grant/Funding (institution): Adaptimmune; Research grant/Funding (institution): Advenchen Laboratories; Research grant/Funding (institution): Bavarian Nordic; Research grant/Funding (institution): BTG; Research grant/Funding (institution): PTC Therapeutics; Research grant/Funding (institution): GlaxoSmithKline; Research grant/Funding (institution): FORMA Therapeutics."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "P. Chi", "first_name": "P.", "last_name": "Chi", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (institution), Clinical Research Support: Deciphera; Advisory/Consultancy: Exelixis; Research grant/Funding (institution), Clinical Research Support: Novartis; Research grant/Funding (institution), Clinical Research Support: Array."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "N. Meade", "first_name": "N.", "last_name": "Meade", "second_name": "", "title": " Travel/Accommodation/Expenses, Shareholder/Stockholder/Stock options, Full/Part-time employment, Sponser (of study) full time employee; granted stock options as a full time employee and sponser of study: Deciphera."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "V. Reichert", "first_name": "V.", "last_name": "Reichert", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Deciphera."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "K. Shi", "first_name": "K.", "last_name": "Shi", "second_name": "", "title": " Shareholder/Stockholder/Stock options: Alnylam; Shareholder/Stockholder/Stock options: Immunogen; Shareholder/Stockholder/Stock options: Karyopharm; Full/Part-time employment: Deciphera."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Filip Janku", "first_name": "Filip", "last_name": "Janku", "second_name": "", "country": "T", "city": "Houston", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "K. Ganjoo", "first_name": "K.", "last_name": "Ganjoo", "second_name": "", "title": " Advisory/Consultancy: Daiichi Sankyo; Advisory/Consultancy: Foundation Medicine; Research grant/Funding (institution): Deciphera."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Trent", "first_name": "J.", "last_name": "Trent", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (institution): Blueprint Medicines; Advisory/Consultancy, Research grant/Funding (institution): Deciphera ; Advisory/Consultancy: Daiichi-Sankyo; Advisory/Consultancy: Epizyme; Advisory/Consultancy, Research grant/Funding (institution): Agios; Research grant/Funding (institution): Plexxicon; Research grant/Funding (institution): Advanchen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Abdul Razak", "first_name": "A.", "last_name": "Razak", "second_name": "Abdul", "title": " Research grant/Funding (institution): Deciphera."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Gordon", "first_name": "M.", "last_name": "Gordon", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (institution): Deciphera; Advisory/Consultancy, Research grant/Funding (institution): Tracon; Advisory/Consultancy, Research grant/Funding (institution): ImaginAB; Advisory/Consultancy: Imaging Endpoints; Advisory/Consultancy, Research grant/Funding (institution): Daiichi Sankyo; Advisory/Consultancy, Research grant/Funding (institution): Agenus; Advisory/Consultancy, Research grant/Funding (institution): Salarius; Advisory/Consultancy, Research grant/Funding (institution): RedHill Bipharma; Leadership role, Officer/Board of Directors: CareMission; Research grant/Funding (institution): Medimmune; Research grant/Funding (institution): Merck; Research grant/Funding (institution): BMS; Research grant/Funding (institution): Amgen; Research grant/Funding (institution): Tesaro; Research grant/Funding (institution): Beigene; Research grant/Funding (institution): ABBVIE; Research grant/Funding (institution): Aeglea; Research grant/Funding (institution): Arcus; Research grant/Funding (institution): Astex; Research grant/Funding (institution): Blueprint; Research grant/Funding (institution): Calithera; Research grant/Funding (institution): CellDex; Research grant/Funding (institution): Corcept; Research grant/Funding (institution): Clovis; Research grant/Funding (institution): Eli Lilly; Research grant/Funding (institution): Endocyte; Research grant/Funding (institution): Five Prime; Research grant/Funding (institution): Genocea; Research grant/Funding (institution): Neon; Research grant/Funding (institution): Plexxicon; Research grant/Funding (institution): Revolution Medicine; Research grant/Funding (institution): Seattle Genetics; Research grant/Funding (institution): Serono; Research grant/Funding (institution): SynDevRx; Research grant/Funding (institution): Tolero; Research grant/Funding (institution): Roche/Genentech; Research grant/Funding (institution): Syndax; Research grant/Funding (institution): FujiFilm; Research grant/Funding (institution): Veru; Shareholder/Stockholder/Stock options: Medelis."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "N. Somaiah", "first_name": "N.", "last_name": "Somaiah", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy: Deciphera; Advisory/Consultancy: Blueprint."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Jennings", "first_name": "J.", "last_name": "Jennings", "second_name": "", "title": " Full/Part-time employment: Deciphera."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "N. Hindi", "first_name": "N.", "last_name": "Hindi", "second_name": "", "title": " Honoraria (self), Research grant/Funding (institution), Travel/Accommodation/Expenses: PharmaMar; Research grant/Funding (institution): Novartis; Research grant/Funding (institution): Eisai; Honoraria (self), Research grant/Funding (institution): Lilly; Research grant/Funding (institution): Deciphera; Research grant/Funding (institution): Blueprint; Research grant/Funding (institution): Amgem; Research grant/Funding (institution): GSK; Research grant/Funding (institution): Adaptimmune; Research grant/Funding (institution): Celgene; Research grant/Funding (institution): Daychii; Research grant/Funding (institution): Karyopharm; Research grant/Funding (institution): Forma; Research grant/Funding (institution): Nektar; Research grant/Funding (institution): Bayer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Marcilla", "first_name": "D.", "last_name": "Marcilla", "second_name": "", "title": " Travel/Accommodation/Expenses: PharmaMar."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Valverde", "first_name": "C.", "last_name": "Valverde", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (institution): PharmaMar; Advisory/Consultancy, Research grant/Funding (institution): Lilly; Advisory/Consultancy, Research grant/Funding (institution): Pfizer; Advisory/Consultancy, Research grant/Funding (institution): Bayer; Advisory/Consultancy, Research grant/Funding (institution): Novartis; Research grant/Funding (institution): Incyte; Research grant/Funding (institution): Eisai."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "P. Luna", "first_name": "P.", "last_name": "Luna", "second_name": "", "title": " Advisory/Consultancy, Travel/Accommodation/Expenses: PharmaMar; Advisory/Consultancy: Lilly."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Emanuela Palmerini", "first_name": "Emanuela", "last_name": "Palmerini", "second_name": "", "country": "Italy", "city": "Bologna", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Gambarotti", "first_name": "M.", "last_name": "Gambarotti", "second_name": "", "title": " Honoraria (self), Honoraria (institution): Amgen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "G. Casali", "first_name": "G.", "last_name": "Casali", "second_name": "", "title": " Honoraria (self): Bayer; Honoraria (self): Deciphera; Honoraria (self): Eisai; Honoraria (self): Eli Lilly; Honoraria (self): Nektar Therapeutics ; Honoraria (self): Pfizer; Honoraria (institution): Advencen Laboratories; Honoraria (institution): Amgen Dompé; Honoraria (institution): AROG Phaermaceuticals; Honoraria (institution): Bayer; Honoraria (institution): Blueprint medicines; Honoraria (institution): Daiichi Sankyo; Honoraria (institution): Deciphera; Honoraria (institution): Eisai; Honoraria (institution): Eli Lilly; Honoraria (institution): Epizyme Inc; Honoraria (institution): Glaxo; Honoraria (institution): Karyopharm Pharmaceuticals; Honoraria (institution): Novartis; Honoraria (institution): Pfizer; Honoraria (institution): PharmaMar."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "P. Picci", "first_name": "P.", "last_name": "Picci", "second_name": "", "title": " Honoraria (self), Travel/Accommodation/Expenses: Takeda; Honoraria (self), Honoraria (institution): Amgen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Ferrari", "first_name": "S.", "last_name": "Ferrari", "second_name": "", "title": " Honoraria (self): Takeda."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Eugenie Younger", "first_name": "Eugenie", "last_name": "Younger", "second_name": "", "country": "United Kingdom", "city": "London", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Herbert Ho Fung H. Loong", "first_name": "Herbert", "last_name": "Loong", "second_name": "Ho Fung H.", "country": "Hong Kong PRC", "city": "Shatin", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Anna Maria Frezza", "first_name": "Anna", "last_name": "Frezza", "second_name": "Maria", "country": "Italy", "city": "Milan", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "G. Baldi", "first_name": "G.", "last_name": "Baldi", "second_name": "", "title": " Honoraria (self), Travel/Accommodation/Expenses: Pharmamar; Honoraria (self), Travel/Accommodation/Expenses: Eli Lilly; Honoraria (self): Eisai."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "F. Duffaud", "first_name": "F.", "last_name": "Duffaud", "second_name": "", "title": " Honoraria (self): Bayer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "W. Van Der Graaf", "first_name": "W.", "last_name": "Van Der Graaf", "second_name": "", "title": " Research grant/Funding (institution): Novartis; Honoraria (institution): Bayer; Honoraria (institution): Springworks."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Stacchiotti", "first_name": "S.", "last_name": "Stacchiotti", "second_name": "", "title": " Advisory/Consultancy: Adaptimmune; Advisory/Consultancy, Research grant/Funding (institution): Bayer; Advisory/Consultancy, Research grant/Funding (institution): Daiichi Sankyo; Advisory/Consultancy, Research grant/Funding (institution): Eli Lilly; Advisory/Consultancy, Research grant/Funding (institution): Epizyme; Advisory/Consultancy: Immunodesign; Advisory/Consultancy: Karyopharm; Advisory/Consultancy: Maxivax; Advisory/Consultancy, Research grant/Funding (institution): Pharmamar; Research grant/Funding (institution): Amgen Dompè; Advisory/Consultancy: Takeda; Research grant/Funding (institution): Novartis; Research grant/Funding (institution): Pfizer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Georgios Kantidakis", "first_name": "Georgios", "last_name": "Kantidakis", "second_name": "", "country": "Belgium", "city": "Brussels", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Silvia Stacchiotti", "first_name": "Silvia", "last_name": "Stacchiotti", "second_name": "", "country": "Italy", "city": "Milan", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. Sanfilippo", "first_name": "R.", "last_name": "Sanfilippo", "second_name": "", "title": " Research grant/Funding (institution), Travel/Accommodation/Expenses: Pharmamar."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Anastasia Constantinidou", "first_name": "Anastasia", "last_name": "Constantinidou", "second_name": "", "country": "Cyprus", "city": "Nicosia", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "William K. Evans", "first_name": "William", "last_name": "Evans", "second_name": "K.", "country": "Ontari", "city": "Hamilton", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Aris Angelis", "first_name": "Aris", "last_name": "Angelis", "second_name": "", "country": "United Kingdom", "city": "London", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Tit Albreht", "first_name": "Tit", "last_name": "Albreht", "second_name": "", "country": "Slovenia", "city": "Ljubljana", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Aida Bujosa Rodríguez", "first_name": "Aida", "last_name": "Rodríguez", "second_name": "Bujosa", "country": "Spain", "city": "Barcelona", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Barnadas", "first_name": "A.", "last_name": "Barnadas", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: Pfizer; Advisory/Consultancy, Speaker Bureau/Expert testimony: Novartis; Advisory/Consultancy: Lilly; Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: Roche; Speaker Bureau/Expert testimony: Genomic Health International."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "E. Amir", "first_name": "E.", "last_name": "Amir", "second_name": "", "title": " Speaker Bureau/Expert testimony: Genentech/Roche; Honoraria (self): Apobiologix; Honoraria (self): Agendia; Honoraria (self): Myriad Genetics; Honoraria (self): Sandoz."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Tibau", "first_name": "A.", "last_name": "Tibau", "second_name": "", "title": " Travel/Accommodation/Expenses: Lilly; Travel/Accommodation/Expenses: Pfizer; Travel/Accommodation/Expenses: Genentech/Roche; Travel/Accommodation/Expenses: Ipsen; Honoraria (self): Eisai."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Kerstin N. Vokinger", "first_name": "Kerstin", "last_name": "Vokinger", "second_name": "N.", "country": "Switzerland", "city": "Zurich", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Karla Hernandez Villafuerte", "first_name": "Karla", "last_name": "Villafuerte", "second_name": "Hernandez", "country": "Germany", "city": "Heidelberg", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Svedman", "first_name": "C.", "last_name": "Svedman", "second_name": "", "title": " Advisory/Consultancy, IHE conducts research and evaluations for a large number of for-profit health care companies: IHE and EFPIA (unrestricted grant)."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "T. Hofmarcher", "first_name": "T.", "last_name": "Hofmarcher", "second_name": "", "title": " Advisory/Consultancy, IHE conducts research and evaluations for a large number of for-profit health care companies: IHE and EFPIA (unrestricted grant)."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Juliana Veras", "first_name": "Juliana", "last_name": "Veras", "second_name": "", "country": "France", "city": "Paris", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Diego Hernandez", "first_name": "Diego", "last_name": "Hernandez", "second_name": "", "country": "Germany", "city": "Heidelberg", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Suresh Senan", "first_name": "Suresh", "last_name": "Senan", "second_name": "", "country": "Netherlands", "city": "Amsterdam", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Caicun Zhou", "first_name": "Caicun", "last_name": "Zhou", "second_name": "", "country": "China", "city": "Shanghai", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Yunpeng Yang", "first_name": "Yunpeng", "last_name": "Yang", "second_name": "", "country": "China", "city": "Guangzhou", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "L. Zhang", "first_name": "L.", "last_name": "Zhang", "second_name": "", "title": " Research grant/Funding (self): Eli Lilly and Company; Research grant/Funding (self): Pfizer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Giuseppe Giaccone", "first_name": "Giuseppe", "last_name": "Giaccone", "second_name": "", "country": "A", "city": "New York", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. Garcia Campelo", "first_name": "R.", "last_name": "Campelo", "second_name": "Garcia", "title": " Honoraria (self), Advisory/Consultancy, Speaker Bureau/Expert testimony: Pfizer; Honoraria (self), Advisory/Consultancy, Speaker Bureau/Expert testimony: Novartis; Honoraria (self), Advisory/Consultancy, Speaker Bureau/Expert testimony: Roche; Honoraria (self), Advisory/Consultancy, Speaker Bureau/Expert testimony: Lilly; Honoraria (self), Advisory/Consultancy, Speaker Bureau/Expert testimony: AstraZeneca; Honoraria (self), Advisory/Consultancy, Speaker Bureau/Expert testimony: Takeda; Honoraria (self), Advisory/Consultancy, Speaker Bureau/Expert testimony: MSD."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "F. DENIS", "first_name": "F.", "last_name": "DENIS", "second_name": "", "title": " Advisory/Consultancy, Travel/Accommodation/Expenses: Roche; Advisory/Consultancy: Shugai; Advisory/Consultancy: AstraZeneca; Advisory/Consultancy: Bayer; Advisory/Consultancy: MSD; Advisory/Consultancy, Licensing/Royalties: Sivan."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "E. Quoix", "first_name": "E.", "last_name": "Quoix", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: BMS; Speaker Bureau/Expert testimony: Shugai; Travel/Accommodation/Expenses: Roche; Travel/Accommodation/Expenses: Takeda; Honoraria (self), interview at ASCO 2019: Medscape."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Madroszyk", "first_name": "A.", "last_name": "Madroszyk", "second_name": "", "title": " Advisory/Consultancy, Speaker Bureau/Expert testimony: AstraZeneca; Advisory/Consultancy, Speaker Bureau/Expert testimony: Roche; Travel/Accommodation/Expenses: Pfizer; Travel/Accommodation/Expenses: MSD."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "W. Hilgers", "first_name": "W.", "last_name": "Hilgers", "second_name": "", "title": " Advisory/Consultancy, Travel/Accommodation/Expenses: BMS; Honoraria (self): MSD; Advisory/Consultancy, Travel/Accommodation/Expenses: Janssen; Advisory/Consultancy, Travel/Accommodation/Expenses: Astellas; Advisory/Consultancy, Travel/Accommodation/Expenses: Roche; Advisory/Consultancy: AstraZeneca; Advisory/Consultancy: Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "T. Moran", "first_name": "T.", "last_name": "Moran", "second_name": "", "title": " Advisory/Consultancy: Roche; Advisory/Consultancy: Boehringer Ingelheim."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Galetta", "first_name": "D.", "last_name": "Galetta", "second_name": "", "title": " Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: Roche; Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: Boehringer Ingelheim; Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: MSD; Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: BMS; Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "F. Cappuzzo", "first_name": "F.", "last_name": "Cappuzzo", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Speaker Bureau/Expert testimony: Roche; Honoraria (self), Advisory/Consultancy, Speaker Bureau/Expert testimony: AstraZeneca; Honoraria (self), Advisory/Consultancy, Speaker Bureau/Expert testimony: BMS; Honoraria (self), Advisory/Consultancy, Speaker Bureau/Expert testimony: Bayer; Honoraria (self), Advisory/Consultancy, Speaker Bureau/Expert testimony: Pfizer; Honoraria (self), Advisory/Consultancy, Speaker Bureau/Expert testimony: Lilly; Honoraria (self), Advisory/Consultancy, Speaker Bureau/Expert testimony: Takeda; Honoraria (self), Advisory/Consultancy, Speaker Bureau/Expert testimony: MSD."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "G. Robinet", "first_name": "G.", "last_name": "Robinet", "second_name": "", "title": " Honoraria (self), Research grant/Funding (institution), Travel/Accommodation/Expenses: Roche; Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: MSD; Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: AstraZenaca; Advisory/Consultancy: BMS."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Viteri", "first_name": "S.", "last_name": "Viteri", "second_name": "", "title": " Full/Part-time employment: Pangaea Oncology; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Roche; Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: BMS; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution): AbbVie; Honoraria (self), Travel/Accommodation/Expenses: MSD; Research grant/Funding (institution), Travel/Accommodation/Expenses: Ose Immunotherapeutics; Research grant/Funding (institution), Travel/Accommodation/Expenses: Merck KgaA; Research grant/Funding (institution): Janssen; Research grant/Funding (institution): Boehringer Ingelheim; Research grant/Funding (institution): Boston Pharmaceuticals; Research grant/Funding (institution): Exelexis; Research grant/Funding (institution): Novocure; Research grant/Funding (institution): MedImmune."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Costantini", "first_name": "D.", "last_name": "Costantini", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Licensing/Royalties, Full/Part-time employment, Officer/Board of Directors: OSE Immunotherapeutics."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. Dziadziuszko", "first_name": "R.", "last_name": "Dziadziuszko", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Roche; Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: AstraZeneca; Honoraria (self): Pfizer; Honoraria (self): Novartis; Honoraria (self): MSD; Honoraria (self): Foundation Medicine; Honoraria (self), Advisory/Consultancy: Takeda; Advisory/Consultancy: Seattle Genetics."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Farastuk Bozorgmehr", "first_name": "Farastuk", "last_name": "Bozorgmehr", "second_name": "", "country": "Germany", "city": "Heidelberg", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Atmaca", "first_name": "A.", "last_name": "Atmaca", "second_name": "", "title": " Advisory/Consultancy: BMS; Advisory/Consultancy: Roche; Advisory/Consultancy: MSD; Advisory/Consultancy: AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Faehling", "first_name": "M.", "last_name": "Faehling", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy: BMS; Honoraria (self), Advisory/Consultancy: MSD; Honoraria (self), Advisory/Consultancy: Roche; Honoraria (self), Advisory/Consultancy: AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "N. Reinmuth", "first_name": "N.", "last_name": "Reinmuth", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy: BMS."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Stenzinger", "first_name": "A.", "last_name": "Stenzinger", "second_name": "", "title": " Advisory/Consultancy, Speaker Bureau/Expert testimony: AstraZeneca; Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (institution): Bayer; Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (self): BMS; Advisory/Consultancy, Speaker Bureau/Expert testimony: Eli Lilly; Advisory/Consultancy, Speaker Bureau/Expert testimony: Illumina; Advisory/Consultancy, Speaker Bureau/Expert testimony: Janssen; Advisory/Consultancy, Speaker Bureau/Expert testimony: MSD; Advisory/Consultancy, Speaker Bureau/Expert testimony: Novartis; Advisory/Consultancy, Speaker Bureau/Expert testimony: Pfizer; Advisory/Consultancy, Speaker Bureau/Expert testimony: Roche; Advisory/Consultancy, Speaker Bureau/Expert testimony: Seattle Genetics; Advisory/Consultancy, Speaker Bureau/Expert testimony: Takeda; Advisory/Consultancy, Speaker Bureau/Expert testimony: ThermoFischer; Research grant/Funding (institution): Chugai."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "E. Ciuleanu", "first_name": "E.", "last_name": "Ciuleanu", "second_name": "", "title": " Advisory/Consultancy, Travel/Accommodation/Expenses: Astella Pharma; Advisory/Consultancy, Travel/Accommodation/Expenses: Janssen; Advisory/Consultancy, Travel/Accommodation/Expenses: Bristol Myers Squibb; Advisory/Consultancy, Travel/Accommodation/Expenses: Merck Serono; Advisory/Consultancy, Travel/Accommodation/Expenses: Amgen; Advisory/Consultancy, Travel/Accommodation/Expenses: Roche; Advisory/Consultancy, Travel/Accommodation/Expenses: Pfizer; Advisory/Consultancy, Travel/Accommodation/Expenses: MSD; Advisory/Consultancy, Travel/Accommodation/Expenses: Servier; Advisory/Consultancy, Travel/Accommodation/Expenses: Ipsen; Advisory/Consultancy, Travel/Accommodation/Expenses: AD Pharma; Advisory/Consultancy, Travel/Accommodation/Expenses: AstraZeneca; Advisory/Consultancy, Travel/Accommodation/Expenses: Lilly; Advisory/Consultancy, Travel/Accommodation/Expenses: Novartis."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "B. Zurawski", "first_name": "B.", "last_name": "Zurawski", "second_name": "", "title": " Honoraria (self), Speaker Bureau/Expert testimony: Bayer; Honoraria (self), Speaker Bureau/Expert testimony: Astellas; Honoraria (self), Speaker Bureau/Expert testimony: MSD; Honoraria (self), Speaker Bureau/Expert testimony: Bristol Myers Squibb; Honoraria (self): Janssen Cilag; Honoraria (self): AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Bennouna", "first_name": "J.", "last_name": "Bennouna", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: AstraZeneca; Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Roche; Honoraria (self), Advisory/Consultancy: Bristol Myers Squibb; Honoraria (self), Advisory/Consultancy: Boehringer Ingelheim; Honoraria (self), Advisory/Consultancy: MSD; Honoraria (self), Advisory/Consultancy: Servier; Honoraria (self), Advisory/Consultancy: Bayer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Moisei", "first_name": "A.", "last_name": "Moisei", "second_name": "", "title": " Full-time employment: Adelphi Values."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Y. Yuan", "first_name": "Y.", "last_name": "Yuan", "second_name": "", "title": " Full-time employment: Bristol Myers Squibb."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "I. Blum", "first_name": "I.", "last_name": "Blum", "second_name": "", "title": " Full-time employment, Stockholder: Bristol Myers Squibb."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "P. Carbone", "first_name": "P.", "last_name": "Carbone", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Travel/Accommodation/ Expenses: AstraZeneca; Honoraria (self): Nexus Oncology; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Bristol-Myers Squibb; Honoraria (institution), Advisory/Consultancy,  Travel/Accommodation/Expenses: Merck; Advisory/ Consultancy, Travel/Accommodation/Expenses: AbbVie; Leadership role: The Ohio State University; Leadership role: ASCO and AACR; Leadership role: NCI; Leadership role: Eastern Cooperative Oncology Group and the Thoracic Core committees for both the Alliance and ECOG/ACRIN; Leadership role, Past president: International Association for the Study of Lung Cancer (IASLC); Leadership role: Damon Runyon, K08, ASCO, AACR, CDA, LIFE and IDEA; Leadership role, Leader: Vanderbilt CCC’s Host-Tumor Interactions and Thoracic/Head and Neck Programs; Leadership role: Vanderbilt Lung Cancer SPORE, and an NCI U01 consortium; Officer/ Board of Directors: IASLC, LCFA, LUNGevity, ALCMI, Joan’s Legacy Foundation, Lance Armstrong Foundation, Wendy Wyrick Foundation, Wendy Will Case Foundation, Jack Roth Foundation; Full/ Part-time employment, Professor of Medicine: The Ohio State University Comprehensive Cancer Center; Advisory/Consultancy, Travel/Accommodation/Expenses: EMD Serono; Advisory/Consultancy, Travel/Accommodation/Expenses: Inviata; Advisory/Consultancy, Travel/Accommodation/Expenses: Inovio; Advisory/Consultancy, Travel/Accommodation/Expenses: Janssen; Advisory/Consultancy, Travel/Accommodation/Expenses: Loxo Oncology; Advisory/Consultancy, Travel/Accommodation/ Expenses: Merck, Sharp & Dohme; Honoraria (self), Advisory/Consultancy, Travel/ Accommodation/Expenses: Pfizer; Advisory/Consultancy, Travel/Accommodation/Expenses: Roche/ Genentech; Advisory/Consultancy, Travel/Accommodation/Expenses: Takeda Oncology; Advisory/ Consultancy, Travel/Accommodation/Expenses: Trinity; Advisory/Consultancy, Travel/Accommodation/ Expenses: Incyte; Advisory/Consultancy, Travel/Accommodation/Expenses: Kyowa Kirin; Advisory/ Consultancy, Travel/Accommodation/Expenses: Novartis; Advisory/Consultancy, Travel/ Accommodation/Expenses: Gritstone Oncology; Advisory/Consultancy, Travel/Accommodation/Expenses: GlaxoSmithKline; Advisory/Consultancy, Travel/Accommodation/Expenses: Roche China; Advisory/Consultancy, Travel/Accommodation/Expenses: GenePlus; Advisory/Consultancy, Travel/ Accommodation/Expenses: Daiichi Sankyo Inc; Advisory/Consultancy: Seattle Genetics, GI Therapeutics (Intellisphere), Gloria Biosciences."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Mark A. Socinski", "first_name": "Mark", "last_name": "Socinski", "second_name": "A.", "country": "P", "city": "Orlando", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. Cornelissen", "first_name": "R.", "last_name": "Cornelissen", "second_name": "", "title": " Research grant/Funding (institution): Spectrum Pharmaceuticals."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Clarke", "first_name": "J.", "last_name": "Clarke", "second_name": "", "title": " Research grant/Funding (institution): Spectrum Pharmaceuticals."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "N. Tchekmedyian", "first_name": "N.", "last_name": "Tchekmedyian", "second_name": "", "title": " Research grant/Funding (institution): Spectrum Pharmaceuticals."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Molina", "first_name": "J.", "last_name": "Molina", "second_name": "", "title": " Research grant/Funding (institution): Spectrum Pharmaceuticals."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "G. Bhat", "first_name": "G.", "last_name": "Bhat", "second_name": "", "title": " Full/Part-time employment: Spectrum Pharmaceuticals."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "F. Lebel", "first_name": "F.", "last_name": "Lebel", "second_name": "", "title": " Full/Part-time employment: Spectrum Pharmaceuticals."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "X. Le", "first_name": "X.", "last_name": "Le", "second_name": "", "title": " Research grant/Funding (institution): Spectrum Pharmaceuticals."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Stephen V. Liu", "first_name": "Stephen", "last_name": "Liu", "second_name": "V.", "country": "United States of America", "city": "Washington", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Villaruz", "first_name": "C.", "last_name": "Villaruz", "second_name": "", "title": " Advisory/Consultancy: Achilles; Research grant/Funding (institution): Genentech; Research grant/Funding (institution): AstraZeneca; Research grant/Funding (institution): Exelixis; Research grant/Funding (institution): Incyte; Research grant/Funding (institution): Merck; Research grant/Funding (institution): Rain Therapeutics; Research grant/Funding (institution): GSK."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "F. Lee", "first_name": "F.", "last_name": "Lee", "second_name": "", "title": " Honoraria (self): AstraZeneca; Advisory/Consultancy: AstraZeneca; Research grant/Funding (self): BMS; Research grant/Funding (self): Merck Sharp & Dohme; Travel/Accommodation/Expenses: AstraZeneca; Travel/Accommodation/Expenses: Novartis."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Sacher", "first_name": "A.", "last_name": "Sacher", "second_name": "", "title": " Honoraria (self): AstraZeneca; Honoraria (self): Merck; Honoraria (self): Genentech-Roche; Honoraria (self): Kisoli; Honoraria (self): BMS; Honoraria (self): Bayer; Honoraria (self): Tesaro; Honoraria (self): Pfizer; Advisory/Consultancy: AstraZeneca; Advisory/Consultancy: Merck; Advisory/Consultancy: Genentech-Roche; Advisory/Consultancy: Kisoli; Advisory/Consultancy: BMS; Advisory/Consultancy: Bayer; Advisory/Consultancy: Pfizer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "E. McCoach", "first_name": "E.", "last_name": "McCoach", "second_name": "", "title": " Honoraria (self): Novartis; Honoraria (self): Guardant health; Advisory/Consultancy: Genentech; Research grant/Funding (institution): Novartis; Research grant/Funding (institution): Revolution Medicines; Travel/Accommodation/Expenses: Lilly; Travel/Accommodation/Expenses: Takeda."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Nguyen", "first_name": "D.", "last_name": "Nguyen", "second_name": "", "title": " Full/Part-time employment: Pacific Shores Medical Group."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Li", "first_name": "C.", "last_name": "Li", "second_name": "", "title": " Advisory/Consultancy: Roche Hong Kong; Advisory/Consultancy: AstraZeneca; Advisory/Consultancy: Foundation Medicine; Advisory/Consultancy: Boehringer Ingelheim; Advisory/Consultancy: Lilly Oncology; Advisory/Consultancy: Merck; Advisory/Consultancy: Pfizer; Advisory/Consultancy: Novartis; Advisory/Consultancy: Takeda; Advisory/Consultancy: MSD; Research grant/Funding (self): Roche Hong Kong; Travel/Accommodation/Expenses: Roche Hng Kong; Travel/Accommodation/Expenses: Taiho; Travel/Accommodation/Expenses: Eisai; Travel/Accommodation/Expenses: Sanomic & xcelom; Travel/Accommodation/Expenses: Takeda; Travel/Accommodation/Expenses: AstraZeneca; Travel/Accommodation/Expenses: MSD; Travel/Accommodation/Expenses: Boehringer Ingelheim; Travel/Accommodation/Expenses: Pfizer; Travel/Accommodation/Expenses: Mundipharma."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Pacheco", "first_name": "M.", "last_name": "Pacheco", "second_name": "", "title": " Honoraria (self): Takeda; Honoraria (self): Genentech; Advisory/Consultancy: AstraZeneca; Advisory/Consultancy: Gerson Lehrman Group; Advisory/Consultancy: Hengrui Pharmaceuticals; Advisory/Consultancy: Jazz Pharmaceuticals; Advisory/Consultancy: Novartis; Advisory/Consultancy: Pfizer; Advisory/Consultancy: Takeda; Research grant/Funding (institution): Pfizer; Travel/Accommodation/Expenses: AstraZeneca; Travel/Accommodation/Expenses: Novartis; Travel/Accommodation/Expenses: Pfizer; Travel/Accommodation/Expenses: Takeda."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Kim", "first_name": "C.", "last_name": "Kim", "second_name": "", "title": " Advisory/Consultancy: Novartis; Research grant/Funding (institution): AstraZeneca; Research grant/Funding (institution): BMS; Research grant/Funding (institution): Novartis; Research grant/Funding (institution): Regeneron; Research grant/Funding (institution): Tesaro; Research grant/Funding (institution): Karyopharm; Research grant/Funding (institution): Debiopharm; Research grant/Funding (institution): Altor Bioscience."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "L. Schenk", "first_name": "L.", "last_name": "Schenk", "second_name": "", "title": " Honoraria (self): Medscape; Honoraria (self): Physician’s Education Resource; Advisory/Consultancy: AbbVie; Speaker Bureau/Expert testimony: Takeda; Speaker Bureau/Expert testimony: Roche; Full/Part-time employment: Practice Update."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "N. Leighl", "first_name": "N.", "last_name": "Leighl", "second_name": "", "title": " Honoraria (self): MSD; Honoraria (self): BMS; Research grant/Funding (institution): Guardant Health; Research grant/Funding (institution): Roche; Research grant/Funding (institution): Array; Research grant/Funding (institution): Pfizer; Research grant/Funding (institution): MSD."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "L. Tozzi", "first_name": "L.", "last_name": "Tozzi", "second_name": "", "title": " Shareholder/Stockholder/Stock options: Rain Therapeutics; Full/Part-time employment: Rain Therapeutics."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Gregory J. Riely", "first_name": "Gregory", "last_name": "Riely", "second_name": "J.", "country": "N", "city": "New York", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "W. Neal", "first_name": "W.", "last_name": "Neal", "second_name": "", "title": " Advisory/Consultancy: AstraZeneca; Advisory/Consultancy, Research grant/Funding (institution): Genentech/Roche; Advisory/Consultancy, Research grant/Funding (institution): Exelixis; Advisory/Consultancy: Jounce Therapeutics; Advisory/Consultancy, Research grant/Funding (institution): Takeda; Advisory/Consultancy: Lilly; Honoraria (self): Calithera Biosciences; Honoraria (self): Research to Practice; Honoraria (self): MLI Peerview; Honoraria (self): Medscape; Honoraria (self): Biomedical Learning Institute; Honoraria (self): Prime Oncology; Honoraria (self): Rockpointe; Honoraria (self): CME Matters; Honoraria (self): MJH CME; Research grant/Funding (institution): Merck; Research grant/Funding (institution): Novartis; Research grant/Funding (institution): Boehringer Ingelheim; Research grant/Funding (self): Nektar; Research grant/Funding (institution): Adaptimmune; Research grant/Funding (institution): GSK."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Z. Piotrowska", "first_name": "Z.", "last_name": "Piotrowska", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (self), Travel/Accommodation/Expenses: AstraZeneca; Advisory/Consultancy, Research grant/Funding (self), Travel/Accommodation/Expenses: ARIAD; Advisory/Consultancy, Research grant/Funding (self), Travel/Accommodation/Expenses: Takeda; Advisory/Consultancy: AbbVie; Advisory/Consultancy, Research grant/Funding (self): Novartis; Advisory/Consultancy, Research grant/Funding (self): Guardant Health; Advisory/Consultancy, Research grant/Funding (self): Spectrum; Advisory/Consultancy: ImmunoGen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "B. Costa", "first_name": "B.", "last_name": "Costa", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution): Takeda/Millennium Pharmaceuticals; Honoraria (self), Research grant/Funding (institution): Pfizer; Advisory/Consultancy, Research grant/Funding (institution): AstraZeneca; Research grant/Funding (institution): Genentech; Research grant/Funding (institution): Merck; Research grant/Funding (institution): Merrimack; Research grant/Funding (institution): Bristol-Myers Squibb; Research grant/Funding (institution): Clovis Oncology; Research grant/Funding (institution): Spectrum."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Tsao", "first_name": "A.", "last_name": "Tsao", "second_name": "", "title": " Advisory/Consultancy: Novartis; Advisory/Consultancy, Research grant/Funding (institution): Boehringer Ingelheim; Advisory/Consultancy, Research grant/Funding (institution): Genentech/Roche; Advisory/Consultancy, Research grant/Funding (institution): MedImmune; Advisory/Consultancy: Imedex; Advisory/Consultancy: Lilly; Advisory/Consultancy, Research grant/Funding (self), Research grant/Funding (institution): BMS; Advisory/Consultancy: Epizyme; Advisory/Consultancy: AstraZeneca/MedImmune; Advisory/Consultancy: ARIAD; Advisory/Consultancy: EMD Serono; Advisory/Consultancy: Takeda; Advisory/Consultancy: HERON; Licensing/Royalties: UptoDate; Research grant/Funding (self): Seattle Genetics; Research grant/Funding (self): Millennium; Research grant/Funding (self): Polaris; Research grant/Funding (institution): Merck."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Patel", "first_name": "J.", "last_name": "Patel", "second_name": "", "title": " Advisory/Consultancy: AbbVie; Advisory/Consultancy: AstraZeneca; Advisory/Consultancy: Takeda."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Gadgeel", "first_name": "S.", "last_name": "Gadgeel", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (institution): Pfizer; Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Genentech/Roche; Advisory/Consultancy: ARIAD; Advisory/Consultancy, Speaker Bureau/Expert testimony: AstraZeneca; Advisory/Consultancy: BMS; Advisory/Consultancy: AbbVie; Research grant/Funding (institution), Travel/Accommodation/Expenses: ARIAD/Takeda; Research grant/Funding (self), Research grant/Funding (institution): Merck; Research grant/Funding (institution): Blueprint Medicines."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "H. West", "first_name": "H.", "last_name": "West", "second_name": "", "title": " Advisory/Consultancy, Speaker Bureau/Expert testimony: Genentech/Roche; Advisory/Consultancy, Speaker Bureau/Expert testimony: Takeda/ARIAD; Advisory/Consultancy, Speaker Bureau/Expert testimony: Novartis; Advisory/Consultancy, Speaker Bureau/Expert testimony: Pfizer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. Gentzler", "first_name": "R.", "last_name": "Gentzler", "second_name": "", "title": " Honoraria (self): Rockpointe CME; Advisory/Consultancy: AstraZeneca; Advisory/Consultancy, Research grant/Funding (institution): Pfizer; Research grant/Funding (institution): Merck; Research grant/Funding (institution): Bristol-Myers Squibb; Research grant/Funding (institution): Takeda; Research grant/Funding (institution): Jounce; Research grant/Funding (institution): Helsinn."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "V. Bunn", "first_name": "V.", "last_name": "Bunn", "second_name": "", "title": " Full/Part-time employment: Takeda."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Jin", "first_name": "S.", "last_name": "Jin", "second_name": "", "title": " Full/Part-time employment: Takeda."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Z. Feng", "first_name": "Z.", "last_name": "Feng", "second_name": "", "title": " Full/Part-time employment: Takeda."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Helena A. Yu", "first_name": "Helena", "last_name": "Yu", "second_name": "A.", "country": "United States of America", "city": "New York", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "K. Gold", "first_name": "K.", "last_name": "Gold", "second_name": "", "title": " Advisory/Consultancy: Rakuten; Advisory/Consultancy: AstraZeneca; Research grant/Funding (self): Pfizer; Research grant/Funding (self): Pharmacyclics; Research grant/Funding (self): BerGenBio; Research grant/Funding (self): Daiichi-Sankyo."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Johnson", "first_name": "M.", "last_name": "Johnson", "second_name": "", "title": " Research grant/Funding (institution): BerGenBio, Research grant/Funding (institution): Lilly, Research grant/Funding (institution): EMD Serono, Research grant/Funding (institution): Janssen, Research grant/Funding (institution): Mirati Therapeutics, Research grant/Funding (institution): Genmab, Research grant/Funding (institution): Pfizer, Research grant/Funding (institution): AstraZeneca, Research grant/Funding (institution): Genentech / Roche, Research grant/Funding (institution): Stemcentrix, Research grant/Funding (institution): Novartis, Research grant/Funding (institution): Checkpoint Therapeutics, Research grant/Funding (institution): Array BioPharma, Research grant/Funding (institution): Regeneron, Research grant/Funding (institution): Apexigen, Research grant/Funding (institution): AbbVie, Research grant/Funding (institution): Tarveda, Research grant/Funding (institution): Adaptimmune, Research grant/Funding (institution): Syndax, Research grant/Funding (institution): Neovia, Research grant/Funding (institution): Boehringer Ingelheim, Research grant/Funding (institution): Sanofi, Research grant/Funding (institution): Hengrui Therapeutics Inc."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Koczywas", "first_name": "M.", "last_name": "Koczywas", "second_name": "", "title": " Speaker Bureau/Expert testimony: AstraZeneca; Speaker Bureau/Expert testimony: Celgene."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Steuer", "first_name": "C.", "last_name": "Steuer", "second_name": "", "title": " Honoraria (self): AbbVie; Honoraria (self): Bergen Bio; Honoraria (self): Eli Lilly; Honoraria (self): Armo."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Yang", "first_name": "J.", "last_name": "Yang", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy: Boehringer Ingelheim; Honoraria (self), Advisory/Consultancy: Novartis; Honoraria (self), Advisory/Consultancy: AstraZeneca; Honoraria (self), Advisory/Consultancy: Roche/Genentech; Honoraria (self), Advisory/Consultancy: MSD Oncology; Advisory/Consultancy: Merck Serono; Advisory/Consultancy: Celgene; Advisory/Consultancy: Bayer; Honoraria (self), Advisory/Consultancy: Pfizer; Honoraria (self), Advisory/Consultancy: Ono Pharmaceutical; Honoraria (self), Advisory/Consultancy: Bristol-Myers Squibb; Advisory/Consultancy: Yuhan; Advisory/Consultancy: Hansoh; Advisory/Consultancy: Blueprint Medicines; Advisory/Consultancy: Daiichi Sankyo; Advisory/Consultancy: Amgen; Honoraria (self), Advisory/Consultancy: Takeda Oncology; Advisory/Consultancy: Incyte; Honoraria (self), Advisory/Consultancy: Eli Lilly."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Karam", "first_name": "S.", "last_name": "Karam", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Daiichi Sankyo."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Z. Qi", "first_name": "Z.", "last_name": "Qi", "second_name": "", "title": " Full/Part-time employment: Daiichi Sankyo."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Yu", "first_name": "C.", "last_name": "Yu", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Daiichi Sankyo."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Oliver Gautschi", "first_name": "Oliver", "last_name": "Gautschi", "second_name": "", "country": "Switzerland", "city": "Luzern", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Menis", "first_name": "J.", "last_name": "Menis", "second_name": "", "title": " Travel/Accommodation/Expenses: Bristol-Myers Squibb; Travel/Accommodation/Expenses: AstraZeneca; Advisory/Consultancy, Travel/Accommodation/Expenses: msd; Advisory/Consultancy: Roche; Advisory/Consultancy, Travel/Accommodation/Expenses: Boehringer Ingelheim."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "L. Greillier", "first_name": "L.", "last_name": "Greillier", "second_name": "", "title": " Honoraria (self): AbbVie; Honoraria (self): Novartis; Honoraria (self): MSD; Honoraria (self): AstraZeneca; Honoraria (self): roche; Honoraria (self): BMS; Honoraria (self): Boehringer Ingelheim; Honoraria (self): Pfizer; Honoraria (self): Takeda."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Decroisette", "first_name": "C.", "last_name": "Decroisette", "second_name": "", "title": " Advisory/Consultancy: Roche; Advisory/Consultancy: BMS; Advisory/Consultancy: MSD; Advisory/Consultancy: AstraZeneca; Advisory/Consultancy: Pfizer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. Califano", "first_name": "R.", "last_name": "Califano", "second_name": "", "title": " Honoraria (self), Research grant/Funding (institution): Bristol-Myers Squibb; Honoraria (self), Research grant/Funding (institution): AstraZeneca; Honoraria (self), Research grant/Funding (institution): Pfizer; Honoraria (self), Research grant/Funding (institution): Roche; Honoraria (self): Boehringer Ingelheim; Research grant/Funding (institution): AbbVie; Honoraria (self), Research grant/Funding (institution): MSD; Honoraria (self): Bayer; Honoraria (self), Research grant/Funding (institution): Takeda; Honoraria (self), Research grant/Funding (institution): Novartis; Honoraria (self), Research grant/Funding (institution): Eli Lilly; Research grant/Funding (institution): Clovis; Shareholder/Stockholder/Stock options: The Christie Private Care."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Jonathan W. Goldman", "first_name": "Jonathan", "last_name": "Goldman", "second_name": "W.", "country": "C", "city": "Santa Monica", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Y. Chen", "first_name": "Y.", "last_name": "Chen", "second_name": "", "title": " Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (institution): AstraZeneca; Advisory/Consultancy, Speaker Bureau/Expert testimony: Genentech; Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (institution): Bristol-Myers Squibb; Speaker Bureau/Expert testimony: Merck; Advisory/Consultancy, Speaker Bureau/Expert testimony: Novartis; Advisory/Consultancy, Speaker Bureau/Expert testimony: Takeda; Speaker Bureau/Expert testimony: Eli-Lilly; Speaker Bureau/Expert testimony: Guardant Health; Advisory/Consultancy: Pfizer; Advisory/Consultancy: Array Biopharma; Research grant/Funding (institution): Ipsen; Research grant/Funding (institution): Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Spencer", "first_name": "S.", "last_name": "Spencer", "second_name": "", "title": " Full/Part-time employment: AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Xie", "first_name": "M.", "last_name": "Xie", "second_name": "", "title": " Full/Part-time employment: AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Jones", "first_name": "S.", "last_name": "Jones", "second_name": "", "title": " Full/Part-time employment: AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Franks", "first_name": "A.", "last_name": "Franks", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Y. Shrestha", "first_name": "Y.", "last_name": "Shrestha", "second_name": "", "title": " Full/Part-time employment: AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Mansfield", "first_name": "A.", "last_name": "Mansfield", "second_name": "", "title": " Honoraria (institution): AbbVie; Honoraria (institution): AstraZeneca; Honoraria (institution): BMS; Honoraria (institution): Genentech/Roche; Travel/Accommodation/Expenses: Roche; Research grant/Funding (institution): Novartis; Research grant/Funding (institution): Verily; Non-remunerated activity/ies: Mesothelioma Applied Research Foundation."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. De Boer", "first_name": "R.", "last_name": "De Boer", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy: Roche Australia; Research grant/Funding (institution): Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Smolin", "first_name": "A.", "last_name": "Smolin", "second_name": "", "title": " Advisory/Consultancy: Roche; Advisory/Consultancy: MSD; Advisory/Consultancy: BMS; Advisory/Consultancy: Boehringer Ingelheim; Advisory/Consultancy: AstraZeneca; Advisory/Consultancy: Eli Lilly; Advisory/Consultancy: Takeda; Advisory/Consultancy: BIOCAD; Advisory/Consultancy: Merck KGaA; Advisory/Consultancy: GSK."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Hochmair", "first_name": "J.", "last_name": "Hochmair", "second_name": "", "title": " Advisory/Consultancy: Boehringer Ingelheim; Advisory/Consultancy: Roche; Advisory/Consultancy: BMS; Advisory/Consultancy: MSD; Advisory/Consultancy: Takeda."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Lam", "first_name": "S.", "last_name": "Lam", "second_name": "", "title": " Full/Part-time employment: Genentech."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. McCleland", "first_name": "M.", "last_name": "McCleland", "second_name": "", "title": " Full/Part-time employment: Genentech; Shareholder/Stockholder/Stock options: Roche Holdings."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Cardona", "first_name": "A.", "last_name": "Cardona", "second_name": "", "title": " Full/Part-time employment: Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Morris", "first_name": "S.", "last_name": "Morris", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Hye Ryun Kim", "first_name": "Hye", "last_name": "Kim", "second_name": "Ryun", "country": "Kore", "city": "Seoul", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Navarro", "first_name": "A.", "last_name": "Navarro", "second_name": "", "title": " Advisory/Consultancy, Travel/Accommodation/Expenses: Boehringer Ingelheim; Advisory/Consultancy: Bristol-Myers Squibb; Advisory/Consultancy, Travel/Accommodation/Expenses: Pfizer; Advisory/Consultancy: Roche; Speaker Bureau/Expert testimony: Oryzon Genomics; Research grant/Funding (institution): MSD."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Gottfried", "first_name": "M.", "last_name": "Gottfried", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy: Roche; Honoraria (self), Advisory/Consultancy: Novartis; Honoraria (self), Advisory/Consultancy: Bristol-Myers Squibb; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution): MSD; Honoraria (self), Advisory/Consultancy: AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "K. Cheema", "first_name": "K.", "last_name": "Cheema", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy: AstraZeneca; Honoraria (self), Advisory/Consultancy: Hoffman la Roche; Honoraria (self), Advisory/Consultancy: MSD; Honoraria (self), Advisory/Consultancy: Novartis; Honoraria (self), Advisory/Consultancy: Pfizer; Honoraria (self), Advisory/Consultancy: Takeda; Advisory/Consultancy: Amgen; Advisory/Consultancy: Bristol-Myers Squibb; Advisory/Consultancy: EMD Serono; Advisory/Consultancy: Genomic Health."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Wollner", "first_name": "M.", "last_name": "Wollner", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution): MSD; Honoraria (self), Advisory/Consultancy: AstraZeneca; Honoraria (institution), Speaker Bureau/Expert testimony: Roche; Advisory/Consultancy: Takeda; Advisory/Consultancy, Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: Bristol-Myers Squibb; Advisory/Consultancy, Travel/Accommodation/Expenses: Pfizer; Speaker Bureau/Expert testimony: Boehringer Ingelheim; Speaker Bureau/Expert testimony: Novartis."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "H. Yang", "first_name": "H.", "last_name": "Yang", "second_name": "", "title": " Honoraria (institution), Advisory/Consultancy: Boehringer Ingelheim; Honoraria (institution), Advisory/Consultancy: Novartis; Honoraria (institution), Advisory/Consultancy: AstraZeneca; Honoraria (institution), Advisory/Consultancy: Roche/Genentech; Honoraria (institution), Advisory/Consultancy: Eli Lilly; Honoraria (institution), Advisory/Consultancy, Research grant/Funding (institution): MSD; Honoraria (institution), Advisory/Consultancy: Merck Serono; Honoraria (institution), Advisory/Consultancy: Celgene; Honoraria (institution), Advisory/Consultancy: Bayer; Honoraria (institution), Advisory/Consultancy: Pfizer; Honoraria (institution), Advisory/Consultancy: Ono Pharmaceutical; Honoraria (institution), Advisory/Consultancy: Bristol-Myers Squibb; Honoraria (institution), Advisory/Consultancy: Yuhan; Honoraria (institution), Advisory/Consultancy: Hansoh; Honoraria (institution), Advisory/Consultancy: Blueprint Medicines; Honoraria (institution), Advisory/Consultancy: Daiichi Sankyo; Honoraria (institution), Advisory/Consultancy: Amgen; Honoraria (institution), Advisory/Consultancy: Takeda; Honoraria (institution), Advisory/Consultancy: Incyte; Advisory/Consultancy: Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Orlandi", "first_name": "J.", "last_name": "Orlandi", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Research grant/Funding (self): Roche/Genentech; Advisory/Consultancy: AstraZeneca; Advisory/Consultancy, Research grant/Funding (self): Bristol-Myers Squibb; Advisory/Consultancy: Lilly; Advisory/Consultancy, Research grant/Funding (institution): MSD Oncology; Advisory/Consultancy: Novartis; Advisory/Consultancy, Research grant/Funding (self): Pfizer; Advisory/Consultancy, Research grant/Funding (self): Sanofi; Speaker Bureau/Expert testimony: AstraZeneca/Genentech; Research grant/Funding (self): AstraZeneca/MedImmune; Speaker Bureau/Expert testimony: Roche; Research grant/Funding (self): Amgen; Research grant/Funding (self): Astellas Medivation; Research grant/Funding (self): Boehringer Ingelheim; Research grant/Funding (self): Celltrion; Research grant/Funding (self): mAbxience; Research grant/Funding (self): Nektar."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Luft", "first_name": "A.", "last_name": "Luft", "second_name": "", "title": " Research grant/Funding (institution): MSD."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "P. Kalemkerian", "first_name": "P.", "last_name": "Kalemkerian", "second_name": "", "title": " Research grant/Funding (institution): Merck Sharp & Dohme Corp."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Rudin", "first_name": "M.", "last_name": "Rudin", "second_name": "", "title": " Advisory/Consultancy: AbbVie; Advisory/Consultancy: Amgen; Advisory/Consultancy: Ascentage Pharma; Advisory/Consultancy: AstraZeneca; Advisory/Consultancy: Celgene; Advisory/Consultancy, Research grant/Funding (institution): Daiichi Sankyo; Advisory/Consultancy: Genentech/Roche; Advisory/Consultancy: Harpoon Therapeutics; Advisory/Consultancy: Loxo; Advisory/Consultancy: PharmaMar; Research grant/Funding (institution): Pfizer; Research grant/Funding (institution): Viralytics; Research grant/Funding (institution): Merck Sharp & Dohme Corp."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Hidetoshi Hayashi", "first_name": "Hidetoshi", "last_name": "Hayashi", "second_name": "", "country": "Japan", "city": "Osaka", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "T. Kijima", "first_name": "T.", "last_name": "Kijima", "second_name": "", "title": " Honoraria (self): Ono Pharmaceutical Co."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "K. Aoe", "first_name": "K.", "last_name": "Aoe", "second_name": "", "title": " Speaker Bureau/Expert testimony, Research grant/Funding (institution): Ono Pharmaceutical Co."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "N. Fujimoto", "first_name": "N.", "last_name": "Fujimoto", "second_name": "", "title": " Honoraria (self): Ono Pharmaceutical Co."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Christina Thirlwell", "first_name": "Christina", "last_name": "Thirlwell", "second_name": "", "country": "United Kingdom", "city": "London", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Yihebali Chi", "first_name": "Yihebali", "last_name": "Chi", "second_name": "", "country": "China", "city": "Beijing", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Yansong Lin", "first_name": "Yansong", "last_name": "Lin", "second_name": "", "country": "China", "city": "Beijing", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Eric J. Sherman", "first_name": "Eric", "last_name": "Sherman", "second_name": "J.", "country": "United States of America", "city": "New York", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "P. Xia", "first_name": "P.", "last_name": "Xia", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Philips Healthcare; Research grant/Funding (institution): Advanced Oncotherapy."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "H. Chung", "first_name": "H.", "last_name": "Chung", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (institution): Bristol-Myers Squibb; Advisory/Consultancy: CUE Biopharma; Advisory/Consultancy, Research grant/Funding (institution): Ignyta; Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: Mirati Therapeutics; Research grant/Funding (institution), Travel/Accommodation/Expenses: AstraZeneca; Research grant/Funding (institution): IRX Therapeutics; Research grant/Funding (institution): Eli Lilly; Research grant/Funding (institution): Lion Biotechnologies; Research grant/Funding (institution): Merck; Research grant/Funding (institution): Pfizer; Research grant/Funding (institution): Regeneron."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "L. Foote", "first_name": "L.", "last_name": "Foote", "second_name": "", "title": " Licensing/Royalties: Bionix; Travel/Accommodation/Expenses: Hitachi Chemical."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Yom", "first_name": "S.", "last_name": "Yom", "second_name": "", "title": " Research grant/Funding (institution): BioMimetix; Research grant/Funding (institution): Bristol-Myers Squibb; Research grant/Funding (institution): Genentech; Research grant/Funding (institution): Merck."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Wong", "first_name": "J.", "last_name": "Wong", "second_name": "", "title": " Research grant/Funding (institution): Merck; Research grant/Funding (institution): Novartis."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Koyfman", "first_name": "S.", "last_name": "Koyfman", "second_name": "", "title": " Research grant/Funding (institution): Merck Sharp & Dohme."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Khan", "first_name": "S.", "last_name": "Khan", "second_name": "", "title": " Honoraria (institution), Advisory/Consultancy: Ariad; Honoraria (self), Advisory/Consultancy: EMD Serono; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Genentech/Roche; Honoraria (self), Speaker Bureau/Expert testimony: Genzyme; Advisory/Consultancy, Research grant/Funding (institution): Bayer/Onyx; Advisory/Consultancy: Foundation Medicine; Advisory/Consultancy, Research grant/Funding (institution): Guardant Health; Advisory/Consultancy, Speaker Bureau/Expert testimony: Takeda; Research grant/Funding (institution): AbbVie; Research grant/Funding (institution): Bristol-Myers Squibb; Research grant/Funding (institution): Celldex; Research grant/Funding (institution): Formation Biologics; Research grant/Funding (institution): Gilead Sciences; Research grant/Funding (institution): Loxo; Research grant/Funding (institution): Merck; Research grant/Funding (institution), Travel/Accommodation/Expenses: Novartis; Research grant/Funding (institution): Pfizer; Research grant/Funding (institution): Threshold Pharmaceuticals."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "T. Le", "first_name": "T.", "last_name": "Le", "second_name": "", "title": " Advisory/Consultancy: Merck; Shareholder/Stockholder/Stock options: Aldea; Travel/Accommodation/Expenses: Genentech; Advisory/Consultancy: Grail."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Y. Takeda", "first_name": "Y.", "last_name": "Takeda", "second_name": "", "title": " Research grant/Funding (institution): Taiho Phamaceutical Co."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Hirano", "first_name": "J.", "last_name": "Hirano", "second_name": "", "title": " Full/Part-time employment: Ono Pharmaceutical Co."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Daniel C. C. Christoph", "first_name": "Daniel", "last_name": "Christoph", "second_name": "C. C.", "country": "Germany", "city": "Essen", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "P. Fendler", "first_name": "P.", "last_name": "Fendler", "second_name": "", "title": " Advisory/Consultancy: BTG; Advisory/Consultancy: Endocyte; Advisory/Consultancy: Ipsen; Honoraria (self): RadioMedix."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "L. Kessler", "first_name": "L.", "last_name": "Kessler", "second_name": "", "title": " Honoraria (self): Sanofi."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Metzenmacher", "first_name": "M.", "last_name": "Metzenmacher", "second_name": "", "title": " Honoraria (self): Boehringer Ingelheim; Honoraria (self): Bristol-Myers Squibb; Honoraria (self): Merck, Sharp & Dohme; Honoraria (self): Roche; Honoraria (self): Takeda."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "T. Hager", "first_name": "T.", "last_name": "Hager", "second_name": "", "title": " Honoraria (self): Bristol-Myers Squibb; Honoraria (self): Chugai; Honoraria (self): Merck, Sharp & Dohme; Honoraria (self): Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "K. Herrmann", "first_name": "K.", "last_name": "Herrmann", "second_name": "", "title": " Non-remunerated activity/ies: ABX; Honoraria (self): Adacap; Honoraria (self): Amgen; Honoraria (self): Bayer; Honoraria (self), Research grant/Funding (institution): BTG; Honoraria (self): Curium; Honoraria (self): Endocyte; Honoraria (self): GE Healthcare; Honoraria (self): Ipsen; Honoraria (self): Novartis; Honoraria (self): Siemens Healthineers; Honoraria (self): Sirtex, Honoraria (self), Non-remunerated activity/ies: Sofie Biosciences; Honoraria (self): ymabs."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "T. Kurata", "first_name": "T.", "last_name": "Kurata", "second_name": "", "title": " Honoraria (self), Research grant/Funding (institution): AstraZeneca; Honoraria (self): Eli Lilly; Honoraria (self), Research grant/Funding (institution): MSD; Honoraria (self): Ono; Honoraria (self): Boehringer Ingelheim; Honoraria (self), Research grant/Funding (institution): Bristol-Myers Squibb; Honoraria (self), Research grant/Funding (institution): Chugai; Research grant/Funding (institution): Novartis; Research grant/Funding (institution): Takeda."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "F. Vansteenkiste", "first_name": "F.", "last_name": "Vansteenkiste", "second_name": "", "title": " Advisory/Consultancy: Boehringer Ingelheim; Advisory/Consultancy: AstraZeneca; Advisory/Consultancy: MSD; Advisory/Consultancy: Novartis; Advisory/Consultancy: Roche; Advisory/Consultancy: Pfizer; Advisory/Consultancy: Bristol-Myers Squibb."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. Spigel", "first_name": "R.", "last_name": "Spigel", "second_name": "", "title": " Honoraria (institution), Research grant/Funding (institution): AstraZeneca; Research grant/Funding (institution): Aeglea Biotherapeutics; Research grant/Funding (institution): Agios; Research grant/Funding (institution): Astellas Pharma; Research grant/Funding (institution): Bind Therapeutics; Honoraria (institution), Research grant/Funding (institution): Bristol-Myers Squibb; Honoraria (institution), Research grant/Funding (institution): Celgene; Research grant/Funding (institution): Celldex Therapeutics; Research grant/Funding (institution): Clovis; Research grant/Funding (institution): Daiichi Sankyo; Research grant/Funding (institution): Eisai; Research grant/Funding (institution): Eli Lilly; Honoraria (institution), Research grant/Funding (institution): EMD Serono; Honoraria (institution), Research grant/Funding (institution): Roche/Genentech; Research grant/Funding (institution): G1 Therapeutics; Honoraria (institution), Research grant/Funding (institution): GlaxoSmithKline; Research grant/Funding (institution): Grail; Research grant/Funding (institution): ImClone Systems; Honoraria (institution), Research grant/Funding (institution): Ipsen; Research grant/Funding (institution): Janssen; Research grant/Funding (institution): Merck; Research grant/Funding (institution): Nektar Therapeutics; Research grant/Funding (institution): Neon Therapeutics; Honoraria (institution), Research grant/Funding (institution): Novartis; Honoraria (institution), Research grant/Funding (institution): Takeda Pharmaceuticals; Research grant/Funding (institution): Tesaro; Research grant/Funding (institution): Transgene; Research grant/Funding (institution): UT Southwestern; Research grant/Funding (institution): Cyteir Therapeutics; Research grant/Funding (institution): Apollomics; Research grant/Funding (institution): Elevation Oncology; Honoraria (institution): Aptitude Health; Honoraria (institution): Bayer; Honoraria (institution): Dracen Pharmaceuticals; Honoraria (institution): Exelixis; Honoraria (institution): Iksuda Therapeutics; Honoraria (institution): Intellisphere; Honoraria (institution): Jazz Pharmaceuticals; Honoraria (institution): Mirati Therapeutics; Honoraria (institution): Molecular Templates; Honoraria (institution): Puma Biotechnology."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Senan", "first_name": "S.", "last_name": "Senan", "second_name": "", "title": " Honoraria (self), Research grant/Funding (institution): AstraZeneca; Research grant/Funding (institution): ViewRay Inc."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Naidoo", "first_name": "J.", "last_name": "Naidoo", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: AstraZeneca; Advisory/Consultancy, Research grant/Funding (institution): Roche/Genentech; Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Bristol-Myers Squibb; Research grant/Funding (institution): Merck."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Rimner", "first_name": "A.", "last_name": "Rimner", "second_name": "", "title": " Research grant/Funding (institution): Varian Medical Systems; Honoraria (self), Research grant/Funding (institution): AstraZeneca; Honoraria (self), Research grant/Funding (institution): Merck; Research grant/Funding (institution): Boehringer Ingelheim; Research grant/Funding (institution): Pfizer; Honoraria (self): Research to Practice; Honoraria (self): Cybrexa; Honoraria (self): More Health; Non-remunerated activity/ies: Philips/Elektra."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "E. Gray", "first_name": "E.", "last_name": "Gray", "second_name": "", "title": " Advisory/Consultancy: AstraZeneca; Research grant/Funding (institution): Genentech; Advisory/Consultancy, Research grant/Funding (institution): Merck; Advisory/Consultancy, Research grant/Funding (institution): Bristol-Myers Squibb; Advisory/Consultancy, Research grant/Funding (institution): Merck KGaA; Advisory/Consultancy, Research grant/Funding (institution): Novartis; Research grant/Funding (institution): Boehringer Ingelheim."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Newton", "first_name": "M.", "last_name": "Newton", "second_name": "", "title": " Full/Part-time employment: AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "L. Wang", "first_name": "L.", "last_name": "Wang", "second_name": "", "title": " Full/Part-time employment: AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "P. Thiyagarajah", "first_name": "P.", "last_name": "Thiyagarajah", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Beatriz Soldevilla", "first_name": "Beatriz", "last_name": "Soldevilla", "second_name": "", "country": "Spain", "city": "Madrid", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Paula Jimenez Fonseca", "first_name": "Paula", "last_name": "Fonseca", "second_name": "Jimenez", "country": "Spain", "city": "Oviedo", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "T. Alonso", "first_name": "T.", "last_name": "Alonso", "second_name": "", "title": " Advisory/Consultancy: Roche, Astellas, Bayer, Ipsen, Pfizer, Sanofi, Janssen-Cilag, MSD, BMS, Eisai; Speaker Bureau/Expert testimony: Ipsen, Pfizer, BMS, Eisai; Leadership role, Clinical Trials: Roche, AstraZeneca, GSK-Novartis, Clovis, Astellas, Bayer, Ipsen, Pfizer, Janssen-Cilag, MSD, BMS, Eisai."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Sanchez Canovas", "first_name": "M.", "last_name": "Canovas", "second_name": "Sanchez", "title": " Travel/Accommodation/Expenses: Sanofi, MSD, Esteve, Amgen, Servier, Angelini, Leo Pharma; Research grant/Funding (self): LeoPharma; Speaker Bureau/Expert testimony: KyowaKirin."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Gallego Plazas", "first_name": "J.", "last_name": "Plazas", "second_name": "Gallego", "title": " Speaker Bureau/Expert testimony: Lilly, Amgen; Advisory/Consultancy: BMS, Ipsen, Roche, Servier, Merck; Travel/Accommodation/Expenses: Novartis, Amgen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Constance Lamy", "first_name": "Constance", "last_name": "Lamy", "second_name": "", "country": "France", "city": "Villejuif", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Broutin", "first_name": "S.", "last_name": "Broutin", "second_name": "", "title": " Research grant/Funding (institution): Novartis."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Piero Ferolla", "first_name": "Piero", "last_name": "Ferolla", "second_name": "", "country": "Italy", "city": "Perugia", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Berruti", "first_name": "A.", "last_name": "Berruti", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy: Ipsen; Honoraria (self), Advisory/Consultancy: Novartis; Honoraria (self), Advisory/Consultancy: Pfizer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "F. Spada", "first_name": "F.", "last_name": "Spada", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: Ipsen; Advisory/Consultancy, Speaker Bureau/Expert testimony: AAA; Advisory/Consultancy, Speaker Bureau/Expert testimony: Novartis; Advisory/Consultancy, Speaker Bureau/Expert testimony: Merck."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "P. Brizzi", "first_name": "P.", "last_name": "Brizzi", "second_name": "", "title": " Advisory/Consultancy: Ipsen; Advisory/Consultancy: Novartis; Advisory/Consultancy: Celgene."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "T. Ibrahim", "first_name": "T.", "last_name": "Ibrahim", "second_name": "", "title": " Advisory/Consultancy: Eisai; Research grant/Funding (institution): Novartis."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Colao", "first_name": "A.", "last_name": "Colao", "second_name": "", "title": " Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (self): Novartis; Advisory/Consultancy, Speaker Bureau/Expert testimony: Ipsen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Faggiano", "first_name": "A.", "last_name": "Faggiano", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (institution): Ipsen; Advisory/Consultancy, Research grant/Funding (institution): Novartis."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Giuffrida", "first_name": "D.", "last_name": "Giuffrida", "second_name": "", "title": " Advisory/Consultancy: AstraZeneca; Advisory/Consultancy: Celgene; Advisory/Consultancy: Ipsen; Speaker Bureau/Expert testimony: Pfizer; Travel/Accommodation/Expenses: Novartis; Travel/Accommodation/Expenses: Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Ghizzoni", "first_name": "S.", "last_name": "Ghizzoni", "second_name": "", "title": " Full/Part-time employment: Ipsen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Houchard", "first_name": "A.", "last_name": "Houchard", "second_name": "", "title": " Full/Part-time employment: Ipsen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "N. Fazio", "first_name": "N.", "last_name": "Fazio", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution): Novartis; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution): Ipsen; Honoraria (self), Advisory/Consultancy: Pfizer; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution): Merck Serono; Honoraria (self), Advisory/Consultancy: Advanced Accelerator Applications; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution): MSD."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "I. Borbath", "first_name": "I.", "last_name": "Borbath", "second_name": "", "title": " Advisory/Consultancy: Pfizer; Advisory/Consultancy, Research grant/Funding (self): Novartis; Advisory/Consultancy, Research grant/Funding (self): Ipsen; Research grant/Funding (self): Bayer; Research grant/Funding (self): Celgene."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "T. Shah", "first_name": "T.", "last_name": "Shah", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Travel/Accommodation/Expenses: Ipsen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "F. Pape", "first_name": "F.", "last_name": "Pape", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (self): Ipsen; Honoraria (self), Research grant/Funding (self): Novartis."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Truong Thanh", "first_name": "M.", "last_name": "Thanh", "second_name": "Truong", "title": " Full/Part-time employment: Ipsen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "P. Ruszniewski", "first_name": "P.", "last_name": "Ruszniewski", "second_name": "", "title": " Advisory/Consultancy: Novartis; Advisory/Consultancy: Ipsen; Advisory/Consultancy: AAA; Advisory/Consultancy: ITM; Advisory/Consultancy: Keocyt."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Antonia", "first_name": "J.", "last_name": "Antonia", "second_name": "", "title": " Advisory/Consultancy, Travel/Accommodation/Expenses: Bristol-Myers Squibb; Advisory/Consultancy: CBMG; Advisory/Consultancy: AstraZeneca; Advisory/Consultancy: Memgen; Advisory/Consultancy, Travel/Accommodation/Expenses: RAPT; Advisory/Consultancy: Venn; Advisory/Consultancy, Travel/Accommodation/Expenses: Achilles Therapeutics; Advisory/Consultancy, Travel/Accommodation/Expenses: Celsius; Advisory/Consultancy: Samyang Biopharma; Advisory/Consultancy, Travel/Accommodation/Expenses: GlaxoSmithKline; Advisory/Consultancy, Travel/Accommodation/Expenses: Amgen; Travel/Accommodation/Expenses: Merck; Research grant/Funding (institution): Novartis."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Junichi Shimizu", "first_name": "Junichi", "last_name": "Shimizu", "second_name": "", "country": "Japan", "city": "Nagoya", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "H. Harada", "first_name": "H.", "last_name": "Harada", "second_name": "", "title": " Honoraria (self): AstraZeneca K."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Sacha I. Rothschild", "first_name": "Sacha", "last_name": "Rothschild", "second_name": "I.", "country": "Switzerland", "city": "Basel", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Zippelius", "first_name": "A.", "last_name": "Zippelius", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (institution): Roche; Advisory/Consultancy: MSD; Advisory/Consultancy: BMS; Research grant/Funding (institution): Beyondsprings; Research grant/Funding (institution): Secarna; Research grant/Funding (institution): Crescendo."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Savic Prince", "first_name": "S.", "last_name": "Prince", "second_name": "Savic", "title": " Advisory/Consultancy: MSD; Advisory/Consultancy: AstraZeneca; Advisory/Consultancy: Boehringer Ingelheim; Advisory/Consultancy: Roche; Advisory/Consultancy: Pfizer; Advisory/Consultancy: Thermo Fisher Scientific."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Betticher", "first_name": "D.", "last_name": "Betticher", "second_name": "", "title": " Advisory/Consultancy: MSD; Advisory/Consultancy: Roche; Advisory/Consultancy: Pfizer; Advisory/Consultancy: Janssen-Cilag; Advisory/Consultancy: Novartis."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Joerger", "first_name": "M.", "last_name": "Joerger", "second_name": "", "title": " Non-remunerated activity/ies: ESMO Press & Media Affairs Committee."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Britschgi", "first_name": "C.", "last_name": "Britschgi", "second_name": "", "title": " Advisory/Consultancy, Travel/Accommodation/Expenses: AstraZeneca; Advisory/Consultancy: Pfizer; Advisory/Consultancy: Roche; Advisory/Consultancy, Travel/Accommodation/Expenses: Takeda; Advisory/Consultancy: Janssen-Cilag; Advisory/Consultancy: Boehringer Ingelheim."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "T. Mark", "first_name": "T.", "last_name": "Mark", "second_name": "", "title": " Advisory/Consultancy: BMS; Advisory/Consultancy: Roche; Advisory/Consultancy, Research grant/Funding (institution): AstraZeneca; Advisory/Consultancy: MSD; Advisory/Consultancy: Takeda."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "W. Janthur", "first_name": "W.", "last_name": "Janthur", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy: Roche; Advisory/Consultancy: Boehringer Ingelheim; Advisory/Consultancy: Takeda; Honoraria (self), Advisory/Consultancy: MSD; Advisory/Consultancy: Novartis."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. Froesch", "first_name": "R.", "last_name": "Froesch", "second_name": "", "title": " Advisory/Consultancy: Roche; Advisory/Consultancy: Takeda; Advisory/Consultancy: Boehringer Ingelheim; Advisory/Consultancy: BMS; Advisory/Consultancy: Pfizer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Pless", "first_name": "M.", "last_name": "Pless", "second_name": "", "title": " Advisory/Consultancy: Abbvie; Advisory/Consultancy, Travel/Accommodation/Expenses: AstraZeneca; Advisory/Consultancy, Travel/Accommodation/Expenses: Boehringer Ingelheim; Advisory/Consultancy, Travel/Accommodation/Expenses: BMS; Advisory/Consultancy: Eisai; Advisory/Consultancy: MSD; Advisory/Consultancy: Novartis; Advisory/Consultancy: Pfizer; Advisory/Consultancy: Roche; Advisory/Consultancy: Takeda; Advisory/Consultancy: MSD; Travel/Accommodation/Expenses: Vifor; Honoraria (institution): Janssen-Cilag."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Martin Sebastian", "first_name": "Martin", "last_name": "Sebastian", "second_name": "", "country": "Germany", "city": "Frankfurt am Main", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Helen J. Gogas", "first_name": "Helen", "last_name": "Gogas", "second_name": "J.", "country": "Greece", "city": "Athens", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Alexander J. Stratigos", "first_name": "Alexander", "last_name": "Stratigos", "second_name": "J.", "country": "Greece", "city": "Athens", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Sekulic", "first_name": "A.", "last_name": "Sekulic", "second_name": "", "title": " Advisory/Consultancy: Regeneron Pharmaceuticals, Inc ; Advisory/Consultancy: Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "K. Peris", "first_name": "K.", "last_name": "Peris", "second_name": "", "title": " Advisory/Consultancy, outside the submitted work: AbbVie; Advisory/Consultancy, outside the submitted work: Leo Pharma; Advisory/Consultancy, outside the submitted work: Janssen; Advisory/Consultancy, outside the submitted work: Almirall; Advisory/Consultancy, outside the submitted work: Lilly; Advisory/Consultancy, outside the submitted work: Galderma; Advisory/Consultancy, outside the submitted work: Novartis; Advisory/Consultancy, outside the submitted work: Pierre Fabre; Advisory/Consultancy, outside the submitted work: Sanofi."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "O. Bechter", "first_name": "O.", "last_name": "Bechter", "second_name": "", "title": " Advisory/Consultancy: Novartis; Advisory/Consultancy: BMS; Advisory/Consultancy: MSD; Advisory/Consultancy: Pierre Fabre; Advisory/Consultancy: Ultimovacs."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Lewis", "first_name": "D.", "last_name": "Lewis", "second_name": "", "title": " Research grant/Funding (self): University of Colorado; Research grant/Funding (self), Grants and personal fees: Regeneron Pharmaceuticals, Inc."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Chang", "first_name": "S.", "last_name": "Chang", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (self): Regeneron Pharmaceuticals, Inc."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "L. Licitra", "first_name": "L.", "last_name": "Licitra", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (institution), Received funding (for Institution) for clinical studies and research: AstraZeneca; Advisory/Consultancy, Research grant/Funding (institution), Received funding (for Institution) for clinical studies and research: Boehringer Ingelheim; Advisory/Consultancy, Research grant/Funding (institution), Received funding (for Institution) for clinical studies and research: Eisai; Advisory/Consultancy, Research grant/Funding (institution), Received funding (for Institution) for clinical studies and research: Merck Serono; Advisory/Consultancy, Research grant/Funding (institution), Received funding (for Institution) for clinical studies and research: MSD; Advisory/Consultancy, Research grant/Funding (institution), Received funding (for Institution) for clinical studies and research: Novartis; Advisory/Consultancy, Research grant/Funding (institution), Received funding (for Institution) for clinical studies and research: Roche; Advisory/Consultancy: Bayer; Advisory/Consultancy, Research grant/Funding (institution): Bristol-Myers Squibb; Advisory/Consultancy, Research grant/Funding (institution): Debiopharm; Advisory/Consultancy: Sobi; Research grant/Funding (institution): Celgene; Research grant/Funding (institution): Exelixis; Research grant/Funding (institution): Pfizer; Research grant/Funding (institution): Medpace; Research grant/Funding (institution): IRX Therapeutics; Advisory/Consultancy: Ipsen; Advisory/Consultancy: Incyte Biosciences; Advisory/Consultancy: Doxa Pharma; Advisory/Consultancy: Amgen; Advisory/Consultancy: Nanobiotics SA; Advisory/Consultancy: GlaxoSmithKline; Speaker Bureau/Expert testimony: AccMed; Speaker Bureau/Expert testimony: Medical Science Fundation G."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Ulrich", "first_name": "C.", "last_name": "Ulrich", "second_name": "", "title": " Advisory/Consultancy, Speaker Bureau/Expert testimony: Roche; Advisory/Consultancy, Speaker Bureau/Expert testimony: Sanofi; Advisory/Consultancy, Speaker Bureau/Expert testimony: Regeneron Pharmaceuticals, Inc."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Hauschild", "first_name": "A.", "last_name": "Hauschild", "second_name": "", "title": " Research grant/Funding (institution), and personal fees: Amgen; Research grant/Funding (institution), And personal fees: BMS; Research grant/Funding (institution), and personal fees: MerckSerono; Research grant/Funding (institution), and personal fees: MSD/Merck; Research grant/Funding (institution), and personal fees: Philogen; Research grant/Funding (institution), and personal fees: Pierre Fabre; Research grant/Funding (institution), and personal fees: Provectus; Research grant/Funding (institution), and personal fees: Regeneron Pharmaceuticals, Inc."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. Migden", "first_name": "R.", "last_name": "Migden", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (self), Travel/Accommodation/Expenses: Regeneron Pharmaceuticals, Inc."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Li", "first_name": "S.", "last_name": "Li", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Regeneron Pharmaceuticals, Inc."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "T. Bowler", "first_name": "T.", "last_name": "Bowler", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Regeneron Pharmaceuticals, Inc."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "G. Fury", "first_name": "G.", "last_name": "Fury", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Licensing/Royalties, Full/Part-time employment, Patent holder: of Regeneron Pharmaceuticals, Inc."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Julie Delyon", "first_name": "Julie", "last_name": "Delyon", "second_name": "", "country": "France", "city": "Paris", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "V. Heidelberger", "first_name": "V.", "last_name": "Heidelberger", "second_name": "", "title": " Travel/Accommodation/Expenses: UCB Pharma; Travel/Accommodation/Expenses: MSD."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "G. Carcelain", "first_name": "G.", "last_name": "Carcelain", "second_name": "", "title": " Advisory/Consultancy, Speaker Bureau/Expert testimony: MSD; Speaker Bureau/Expert testimony: Gilead; Speaker Bureau/Expert testimony: ViiV Healthcare."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Mourah", "first_name": "S.", "last_name": "Mourah", "second_name": "", "title": " Advisory/Consultancy: Novartis; Advisory/Consultancy, Research grant/Funding (institution): Biocartis; Advisory/Consultancy: Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Battistella", "first_name": "M.", "last_name": "Battistella", "second_name": "", "title": " Advisory/Consultancy: BMS; Travel/Accommodation/Expenses: Roche; Research grant/Funding (institution): Takeda; Advisory/Consultancy: Innate Pharma; Advisory/Consultancy, Speaker Bureau/Expert testimony: Kyowa Kirin."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Kalijn Bol", "first_name": "Kalijn", "last_name": "Bol", "second_name": "", "country": "Netherlands", "city": "Nijmegen", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "B. de Groot", "first_name": "B.", "last_name": "de Groot", "second_name": "", "title": " Advisory/Consultancy: BMS; Advisory/Consultancy: MSD; Advisory/Consultancy: Novartis; Advisory/Consultancy: Pierre Fabre; Advisory/Consultancy: Servier."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. Gerritsen", "first_name": "R.", "last_name": "Gerritsen", "second_name": "", "title": " Advisory/Consultancy, Speaker Bureau/Expert testimony: MSD; Advisory/Consultancy: BMS; Advisory/Consultancy: IMS Health; Advisory/Consultancy: IQVIA; Advisory/Consultancy, Research grant/Funding (institution): Janssen-Cilag; Advisory/Consultancy, Research grant/Funding (institution): Sanofi; Research grant/Funding (institution): Astellas; Research grant/Funding (institution): Bayer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Salvador Martin Algarra", "first_name": "Salvador", "last_name": "Algarra", "second_name": "Martin", "country": "Spain", "city": "Pamplona", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Peter K. Lau", "first_name": "Peter", "last_name": "Lau", "second_name": "K.", "country": "W", "city": "Nedlands", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Kee", "first_name": "D.", "last_name": "Kee", "second_name": "", "title": " Honoraria (self), Travel/Accommodation/Expenses: Bristol-Myers Squibb; Advisory/Consultancy: Novartis."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "P. Neeson", "first_name": "P.", "last_name": "Neeson", "second_name": "", "title": " Research grant/Funding (self): Bristol-Myers Squibb."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "G. McArthur", "first_name": "G.", "last_name": "McArthur", "second_name": "", "title": " Research grant/Funding (institution), Principal Investigator of clinical trials with the following commercial entities (all revenues payed to my institution as reimbursement for trial- costs): Bristol-Myers Squibb; Research grant/Funding (institution), Principal Investigator of clinical trials with the following commercial entities (all revenues payed to my institution as reimbursement for trial- costs): Array BioPharm; Research grant/Funding (institution), Principal Investigator of clinical trials with the following commercial entities (all revenues payed to my institution as reimbursement for trial- costs): Amgen; Research grant/Funding (institution), Principal Investigator of clinical trials with the following commercial entities (all revenues payed to my institution as reimbursement for trial- costs): Pfizer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Judith M. Versluis", "first_name": "Judith", "last_name": "Versluis", "second_name": "M.", "country": "Netherlands", "city": "Amsterdam", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "L. Zimmer", "first_name": "L.", "last_name": "Zimmer", "second_name": "", "title": " Advisory/Consultancy, Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: BMS; Advisory/Consultancy, Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: MSD; Advisory/Consultancy, Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: Pierre Fabre; Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (self), Travel/Accommodation/Expenses: Novartis; Advisory/Consultancy, Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: Sanofi; Travel/Accommodation/Expenses: Amgen; Travel/Accommodation/Expenses: Sunpharma."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "E. Kapiteijn", "first_name": "E.", "last_name": "Kapiteijn", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (institution): Bristol-Myers Squibb; Advisory/Consultancy: Merck; Advisory/Consultancy: Novartis; Travel/Accommodation/Expenses: Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Allayous", "first_name": "C.", "last_name": "Allayous", "second_name": "", "title": " Travel/Accommodation/Expenses: Amgen; Travel/Accommodation/Expenses: Bristol-Myers Squibb; Travel/Accommodation/Expenses: Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Hepner", "first_name": "A.", "last_name": "Hepner", "second_name": "", "title": " Honoraria (institution): Novartis; Advisory/Consultancy: L."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Mangana", "first_name": "J.", "last_name": "Mangana", "second_name": "", "title": " Honoraria (institution), Advisory/Consultancy: Amgen; Honoraria (institution), Travel/Accommodation/Expenses: Bristol-Myers Squibb; Honoraria (institution), Advisory/Consultancy, Travel/Accommodation/Expenses: Merck Sharp & Dohme; Honoraria (institution), Advisory/Consultancy: Merck-Pfizer; Honoraria (institution): Novartis; Honoraria (institution), Advisory/Consultancy, Travel/Accommodation/Expenses: Pierre Fabre; Travel/Accommodation/Expenses: L'Oreal; Travel/Accommodation/Expenses: Ultrasun."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Y. Jansen", "first_name": "Y.", "last_name": "Jansen", "second_name": "", "title": " Travel/Accommodation/Expenses: Bristol-Myers Squibb; Travel/Accommodation/Expenses: MSD; Travel/Accommodation/Expenses: Pfizer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "V. Atkinson", "first_name": "V.", "last_name": "Atkinson", "second_name": "", "title": " Honoraria (institution), Advisory/Consultancy, Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: Bristol-Myers Squibb; Honoraria (institution), Advisory/Consultancy, Speaker Bureau/Expert testimony: Merck Serono; Honoraria (institution), Advisory/Consultancy, Speaker Bureau/Expert testimony, Travel/Accommodation/Expenses: MSD; Honoraria (institution), Advisory/Consultancy, Speaker Bureau/Expert testimony: Novartis; Honoraria (institution), Advisory/Consultancy, Travel/Accommodation/Expenses: Pierre Fabre; Honoraria (institution), Advisory/Consultancy, Speaker Bureau/Expert testimony: Roche; Travel/Accommodation/Expenses: OncoSec."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "E. de Vries", "first_name": "E.", "last_name": "de Vries", "second_name": "", "title": " Advisory/Consultancy: Daiichi Sankyo; Advisory/Consultancy: NSABP; Advisory/Consultancy: Sanofi; Research grant/Funding (institution): Amgen; Research grant/Funding (institution): AstraZeneca; Research grant/Funding (institution): Bayer; Research grant/Funding (institution): Chugai Pharma; Research grant/Funding (institution): CytomX Therapeutics; Research grant/Funding (institution): G1 Therapeutics; Research grant/Funding (institution): Genentech; Research grant/Funding (institution): Nordic Nanavector; Research grant/Funding (institution): Radius Health; Research grant/Funding (institution): Regeneron; Research grant/Funding (institution): Roche; Research grant/Funding (institution): Servier; Research grant/Funding (institution): Synthon; Non-remunerated activity/ies, Chair ESMO Cancer Medicines Working Group: ESMO; Non-remunerated activity/ies, Chair RECIST committee: RECIST; Non-remunerated activity/ies, Member ESMO-MCBS working group: ESMO-MCBS."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Anna M. Di Giacomo", "first_name": "Anna", "last_name": "Di Giacomo", "second_name": "M.", "country": "Italy", "city": "Siena", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "P. Quaglino", "first_name": "P.", "last_name": "Quaglino", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Educational Activities: Bristol-Myers Squibb; Honoraria (self), Advisory/Consultancy, Educational Activities: MSD; Honoraria (self), Advisory/Consultancy, Educational Activities: Novartis; Honoraria (self), Advisory/Consultancy, Educational Activities: Pierre Fabre; Honoraria (self), Advisory/Consultancy, Educational Activities: Igea; Honoraria (self), Advisory/Consultancy, Educational Activities: Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "P. Marchetti", "first_name": "P.", "last_name": "Marchetti", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (self): Roche; Advisory/Consultancy, Research grant/Funding (self): Pfizer; Advisory/Consultancy, Research grant/Funding (self): Novartis; Advisory/Consultancy, Research grant/Funding (self): MSD; Advisory/Consultancy, Research grant/Funding (self): BMS; Advisory/Consultancy, Research grant/Funding (self): AstraZeneca; Research grant/Funding (self): Boehringer; Research grant/Funding (self): Celgene."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. Danielli", "first_name": "R.", "last_name": "Danielli", "second_name": "", "title": " Advisory/Consultancy: Merck Serono."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Inge-Marie Svane", "first_name": "Inge-Marie", "last_name": "Svane", "second_name": "", "country": "Denmark", "city": "Herlev", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "H. Andersen", "first_name": "H.", "last_name": "Andersen", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Officer/Board of Directors: IO Biotech."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Wolchok", "first_name": "D.", "last_name": "Wolchok", "second_name": "", "title": " Advisory/Consultancy, Shareholder/Stockholder/Stock options: BeiGene; Shareholder/Stockholder/Stock options: Linneaus Therapeutics; Advisory/Consultancy, Shareholder/Stockholder/Stock options: Arsenal-Caprion; Advisory/Consultancy: AstraZeneca; Research grant/Funding (self): Sephora; Advisory/Consultancy: Amgen Inc."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Hodi", "first_name": "S.", "last_name": "Hodi", "second_name": "", "title": " Honoraria (self), Honoraria (institution), Research grant/Funding (institution): Bristol-Myers Squibb; Honoraria (self), Advisory/Consultancy: Merck & Co."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "K. Grossmann", "first_name": "K.", "last_name": "Grossmann", "second_name": "", "title": " Advisory/Consultancy: Bristol-Myers Squibb Company; Advisory/Consultancy: Prometheus Biosciences; Advisory/Consultancy: Roche/Genentech."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Wagstaff", "first_name": "J.", "last_name": "Wagstaff", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Speaker Bureau/Expert testimony: Bristol-Myers Squibb Company."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Chesney", "first_name": "J.", "last_name": "Chesney", "second_name": "", "title": " Research grant/Funding (institution): Bristol-Myers Squibb Company."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Pavlick", "first_name": "C.", "last_name": "Pavlick", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (institution): Bristol-Myers Squibb Company; Advisory/Consultancy, Research grant/Funding (institution): Regeneron; Advisory/Consultancy: Array BioPharma; Advisory/Consultancy: Jounce Therapeutics; Research grant/Funding (institution): Seattle Genetics; Research grant/Funding (institution): Merck & Co."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Re", "first_name": "S.", "last_name": "Re", "second_name": "", "title": " Full/Part-time employment: Bristol-Myers Squibb Company."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Postow", "first_name": "A.", "last_name": "Postow", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution): Bristol-Myers Squibb Company; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution): Merck & Co."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Cara Haymaker", "first_name": "Cara", "last_name": "Haymaker", "second_name": "", "country": "T", "city": "Houston", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "I. Andtbacka", "first_name": "I.", "last_name": "Andtbacka", "second_name": "", "title": " Advisory/Consultancy: Aduro; Advisory/Consultancy: Merck and Co; Advisory/Consultancy: Novartis; Advisory/Consultancy: OncoSec; Advisory/Consultancy: Pfizer; Advisory/Consultancy: Takara."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Chunduru", "first_name": "S.", "last_name": "Chunduru", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Idera Pharmaceuticals."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "I. Puzanov", "first_name": "I.", "last_name": "Puzanov", "second_name": "", "title": " Advisory/Consultancy: Amgen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Markowitz", "first_name": "J.", "last_name": "Markowitz", "second_name": "", "title": " Research grant/Funding (institution): Morphogenesis; Research grant/Funding (institution): Jackson Labs; Advisory/Consultancy: Newlink Genetics; Advisory/Consultancy: Array Biopharma."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Diab", "first_name": "A.", "last_name": "Diab", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (self): Idera Pharmaceuticals; Advisory/Consultancy, Research grant/Funding (self): Nektar Therapeutics; Advisory/Consultancy, Research grant/Funding (self): Bristol-Myers Squibb; Advisory/Consultancy: Jounce Therapeutics; Advisory/Consultancy: Novartis; Advisory/Consultancy: Array BioPharma."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Fiona Thistlethwaite", "first_name": "Fiona", "last_name": "Thistlethwaite", "second_name": "", "country": "United Kingdom", "city": "Manchester", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Pedro Romero", "first_name": "Pedro", "last_name": "Romero", "second_name": "", "country": "Switzerland", "city": "Epalinges", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Anders H. Kverneland", "first_name": "Anders", "last_name": "Kverneland", "second_name": "H.", "country": "Denmark", "city": "Herlev", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Ulka N. Vaishampayan", "first_name": "Ulka", "last_name": "Vaishampayan", "second_name": "N.", "country": "United States of America", "city": "Ann Arbor", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "V. Velcheti", "first_name": "V.", "last_name": "Velcheti", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy: Merck; Honoraria (self), Advisory/Consultancy: Novartis; Honoraria (self), Advisory/Consultancy: Foundation Medicine; Honoraria (self), Advisory/Consultancy: AstraZeneca; Honoraria (self), Advisory/Consultancy: BMS; Honoraria (self), Advisory/Consultancy: Genentech; Honoraria (self), Advisory/Consultancy: EMD Serono."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Hoimes", "first_name": "J.", "last_name": "Hoimes", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution): BMS; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution): Genentech; Honoraria (self), Advisory/Consultancy: Eisai; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution): Seattle Genetics; Honoraria (self), Advisory/Consultancy, Research grant/Funding (institution): Astellas; Honoraria (self), Advisory/Consultancy: Foundation Medicine; Research grant/Funding (institution): Alkermes; Research grant/Funding (institution): Merck; Research grant/Funding (institution): 2bPrecise."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "F. McDermott", "first_name": "F.", "last_name": "McDermott", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (institution): BMS; Advisory/Consultancy, Research grant/Funding (institution): Pfizer; Advisory/Consultancy, Research grant/Funding (institution): Merck; Advisory/Consultancy, Research grant/Funding (institution): Alkermes; Advisory/Consultancy: EMD Serono; Advisory/Consultancy: Eli Lilly; Advisory/Consultancy: Iovance; Advisory/Consultancy: Eisai; Research grant/Funding (institution): Genentech; Research grant/Funding (institution): Exelixis; Research grant/Funding (institution): X4 Pharma; Leadership role: GU Committee Eastern Cooperative Oncology Group; Leadership role: Renal Cell Carcinoma Task Force, National Cancer Institute; Leadership role: Melanoma Breakthrough Consortium Melanoma Research Foundation; Leadership role: Cancer Immunotherapy Guidelines Kidney Task Force Society for Immunotherapy of Cancer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Chu", "first_name": "C.", "last_name": "Chu", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (institution): AbbVie; Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (institution): AstraZeneca; Advisory/Consultancy, Research grant/Funding (institution): BI; Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (institution): BMS; Advisory/Consultancy, Research grant/Funding (institution): Eli Lilly; Advisory/Consultancy: Eisai; Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (institution): Merck; Advisory/Consultancy, Research grant/Funding (institution): Novartis; Advisory/Consultancy, Research grant/Funding (institution): Pfizer; Advisory/Consultancy, Research grant/Funding (institution): Roche; Advisory/Consultancy, Speaker Bureau/Expert testimony: Takeda; Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (institution): Bayer; Officer/Board of Directors: Epizyme; Research grant/Funding (institution): Alkermes; Research grant/Funding (institution): Amgen; Research grant/Funding (institution): Apollomics; Research grant/Funding (institution): Astellas; Research grant/Funding (institution): Debio; Research grant/Funding (institution): Esperas; Research grant/Funding (institution): Exactis; Research grant/Funding (institution): GSK; Research grant/Funding (institution): Spectrum; Research grant/Funding (institution): Takeda and TP Therapeutics; Leadership role: IND Committee and Lung Committee of Canadian Clinical Trials Group; Non-remunerated activity/ies: Canadian Mesothelioma Foundation; Non-remunerated activity/ies: Princess Margaret Cancer Centre; Leadership role: Merck KGaA."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "H. Hirte", "first_name": "H.", "last_name": "Hirte", "second_name": "", "title": " Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (institution): AstraZeneca; Advisory/Consultancy, Research grant/Funding (institution): Merck; Research grant/Funding (institution): BI; Research grant/Funding (institution): GSK; Research grant/Funding (institution): Clovis; Research grant/Funding (institution): Roche; Research grant/Funding (institution): Immunogen; Research grant/Funding (institution): Immunovac; Research grant/Funding (institution): Alkermes; Leadership role: Canadian Cancer Trials Group (CCTG) - Gynecologic Disease Site Committee; Leadership role: Gynecologic Oncologists of Canada (GOC); Leadership role: Canadian Association of Medical Oncologists (CAMO)."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "K. Curtis", "first_name": "K.", "last_name": "Curtis", "second_name": "", "title": " Full/Part-time employment: Synoes; Research grant/Funding (self): Alkermes."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Y. Du", "first_name": "Y.", "last_name": "Du", "second_name": "", "title": " Full/Part-time employment: Alkermes, Inc."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "I. Bidollari", "first_name": "I.", "last_name": "Bidollari", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Alkermes, Inc."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "B. Dezube", "first_name": "B.", "last_name": "Dezube", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Alkermes, Inc."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Losey", "first_name": "C.", "last_name": "Losey", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Alkermes, Inc."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Ernstoff", "first_name": "S.", "last_name": "Ernstoff", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Leadership role, Research grant/Funding (institution): BMS; Advisory/Consultancy, Research grant/Funding (institution): Alkermes; Advisory/Consultancy, Research grant/Funding (institution): Merck; Advisory/Consultancy, Research grant/Funding (institution): EMD Serono; Advisory/Consultancy: ImmuNext; Advisory/Consultancy: OmniSeq."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Sheela Rao", "first_name": "Sheela", "last_name": "Rao", "second_name": "", "country": "United Kingdom", "city": "London", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Capdevila", "first_name": "J.", "last_name": "Capdevila", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (institution): Advanced Accelerator Applications; Advisory/Consultancy: Amgen; Advisory/Consultancy, Research grant/Funding (institution): Bayer; Advisory/Consultancy, Research grant/Funding (institution): Eisai; Advisory/Consultancy: Exelixis; Advisory/Consultancy: Ipsen; Advisory/Consultancy: Merck Serono; Advisory/Consultancy, Research grant/Funding (institution): Novartis; Advisory/Consultancy, Research grant/Funding (institution): Pfizer; Research grant/Funding (institution): AstraZeneca; Advisory/Consultancy: Sanofi."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Kim", "first_name": "S.", "last_name": "Kim", "second_name": "", "title": " Research grant/Funding (institution): Bioproject Pharma; Research grant/Funding (institution): Chugai; Research grant/Funding (institution): Roche; Honoraria (institution), Advisory/Consultancy, Research grant/Funding (institution): Sanofi; Honoraria (institution), Advisory/Consultancy, Research grant/Funding (institution): Servier; Honoraria (institution), Advisory/Consultancy: Amgen; Honoraria (institution), Advisory/Consultancy: Bayer; Honoraria (institution), Advisory/Consultancy: Ipsen; Honoraria (institution), Advisory/Consultancy: MSD."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "L. Dahan", "first_name": "L.", "last_name": "Dahan", "second_name": "", "title": " Honoraria (institution): Amgen; Honoraria (institution): Sanofi; Honoraria (institution): Servier."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "G. Spindler", "first_name": "G.", "last_name": "Spindler", "second_name": "", "title": " Honoraria (institution), Non-remunerated activity/ies: Amgen; Honoraria (institution), Non-remunerated activity/ies: Merck Serono; Honoraria (institution), Non-remunerated activity/ies: Nordic Drugs BV; Honoraria (institution), Non-remunerated activity/ies: Roche/Genentech."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Arnold", "first_name": "D.", "last_name": "Arnold", "second_name": "", "title": " Honoraria (institution), Advisory/Consultancy, Travel/Accommodation/Expenses: Bayer; Honoraria (institution), Advisory/Consultancy, Travel/Accommodation/Expenses: Merck Serono; Honoraria (institution), Research grant/Funding (institution), Travel/Accommodation/Expenses: Roche/Genentech; Honoraria (institution), Advisory/Consultancy: Servier; Honoraria (institution), Advisory/Consultancy: Terumo; Advisory/Consultancy: Biocompatibles; Advisory/Consultancy: Helsinn Therapeutics; Advisory/Consultancy: Roche; Research grant/Funding (institution): Sanofi."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Cornfeld", "first_name": "M.", "last_name": "Cornfeld", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Incyte."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Jones", "first_name": "M.", "last_name": "Jones", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Incyte."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Tian", "first_name": "C.", "last_name": "Tian", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Incyte."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Catlett", "first_name": "M.", "last_name": "Catlett", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Incyte."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "P. Spano", "first_name": "P.", "last_name": "Spano", "second_name": "", "title": " Honoraria (institution): AstraZeneca; Honoraria (institution), Advisory/Consultancy: Biogaran; Honoraria (institution): Bristol-Myers Squibb; Honoraria (institution): Gilead Sciences; Honoraria (institution): Leo Pharma; Honoraria (institution): Lilly; Honoraria (institution): Mylan; Honoraria (institution): Myriad Genetics; Honoraria (institution): Novartis; Honoraria (institution): Pfizer; Honoraria (institution): Pierre Fabre; Advisory/Consultancy: MSD; Advisory/Consultancy: Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Lakshmi Rajdev", "first_name": "Lakshmi", "last_name": "Rajdev", "second_name": "", "country": "United States of America", "city": "New York", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. Baiocchi", "first_name": "R.", "last_name": "Baiocchi", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy, Leadership role, Research grant/Funding (self): Prelude Tx, Viracta."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Lee", "first_name": "S.", "last_name": "Lee", "second_name": "", "title": " Research grant/Funding (institution): Bristol-Myers Squibb."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Petri Bono", "first_name": "Petri", "last_name": "Bono", "second_name": "", "country": "Finland", "city": "Turku", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Jalkanen", "first_name": "M.", "last_name": "Jalkanen", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment, Officer/Board of Directors: Faron Pharmaceuticals LTD."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Jalkanen", "first_name": "S.", "last_name": "Jalkanen", "second_name": "", "title": " Advisory/Consultancy, Spouse/Financial dependant: Faron Pharmaceuticals LTD."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Karvonen", "first_name": "M.", "last_name": "Karvonen", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Faron Pharmaceuticals LTD."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "F. Sanmamed", "first_name": "F.", "last_name": "Sanmamed", "second_name": "", "title": " Research grant/Funding (self): Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "I. Moreno", "first_name": "I.", "last_name": "Moreno", "second_name": "", "title": " Speaker Bureau/Expert testimony: BMS."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "I. Spanggaard", "first_name": "I.", "last_name": "Spanggaard", "second_name": "", "title": " Research grant/Funding (institution): Puma Biotech; Leadership role, Board Member: Danish Society of Clin Oncol."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Rohrberg", "first_name": "S.", "last_name": "Rohrberg", "second_name": "", "title": " Research grant/Funding (institution): Puma; Research grant/Funding (institution), Clinical Trial: Roche; Research grant/Funding (institution), Clinical Trial: BMS; Research grant/Funding (institution), Clinical Trial: Genentech; Research grant/Funding (institution), Clinical Trial: Orion; Research grant/Funding (institution), Clinical Trial: Catargia; Research grant/Funding (institution), Clinical Trial: Pfizer; Research grant/Funding (institution), Clinical Trial: Cellgen; Research grant/Funding (institution), Clinical Trial: Loxo; Research grant/Funding (institution), Clinical Trial: Eli Lilly; Research grant/Funding (institution), Clinical Trial: Symphogen; Research grant/Funding (institution), Clinical Trial: Alligator Bioscience; Research grant/Funding (institution), Clinical Trial: Genmab; Research grant/Funding (institution), Clinical Trial: Incyte; Research grant/Funding (institution), Clinical Trial: Novartis; Research grant/Funding (institution), Clinical Trial: Amgen; Research grant/Funding (institution), Clinical Trial: Bayer."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. McIntyre", "first_name": "C.", "last_name": "McIntyre", "second_name": "", "title": " Full/Part-time employment: Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "O. Krieter", "first_name": "O.", "last_name": "Krieter", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Lichtenegger", "first_name": "S.", "last_name": "Lichtenegger", "second_name": "", "title": " Speaker Bureau/Expert testimony, Speaker honoraria while in academia: Novartis; Shareholder/Stockholder/Stock options, Full/Part-time employment: Roche; Research grant/Funding (institution), Clinical trial funding while in academia: BMS; Research grant/Funding (institution), Research funding while in academia: Miltenyi."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Daniel D. Karp", "first_name": "Daniel", "last_name": "Karp", "second_name": "D.", "country": "T", "city": "Houston", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Kanwal Raghav", "first_name": "Kanwal", "last_name": "Raghav", "second_name": "", "country": "T", "city": "Houston", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Joe Whittaker", "first_name": "Joe", "last_name": "Whittaker", "second_name": "", "country": "United Kingdom", "city": "Cambridge", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Phil Febbo", "first_name": "Phil", "last_name": "Febbo", "second_name": "", "country": "United States of America", "city": "San Diego", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Bernard Doger de Spéville", "first_name": "Bernard", "last_name": "de Spéville", "second_name": "Doger", "country": "Spain", "city": "Madrid", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Wilko Weichert", "first_name": "Wilko", "last_name": "Weichert", "second_name": "", "country": "Germany", "city": "Munich", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Pierre Blanchard", "first_name": "Pierre", "last_name": "Blanchard", "second_name": "", "country": "France", "city": "Villejuif", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Laura D. Locati", "first_name": "Laura", "last_name": "Locati", "second_name": "D.", "country": "Italy", "city": "Milan", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "James C. Chow", "first_name": "James", "last_name": "Chow", "second_name": "C.", "country": "Hong Kong PRC", "city": "Kowloon", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Christian Borel", "first_name": "Christian", "last_name": "Borel", "second_name": "", "country": "France", "city": "Strasbourg", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "X. Sun", "first_name": "X.", "last_name": "Sun", "second_name": "", "title": " Honoraria (self), Travel/Accommodation/Expenses: Novartis; Honoraria (self): Merck; Advisory/Consultancy: BMS."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Coutte", "first_name": "A.", "last_name": "Coutte", "second_name": "", "title": " Honoraria (self): Merck; Honoraria (self): Takeda; Honoraria (self): BMS; Honoraria (self): Roche; Honoraria (self): Sanofi."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "G. Bera", "first_name": "G.", "last_name": "Bera", "second_name": "", "title": " Advisory/Consultancy, Travel/Accommodation/Expenses: Sanofi; Advisory/Consultancy, Travel/Accommodation/Expenses: Astellas; Advisory/Consultancy, Travel/Accommodation/Expenses: Janssen; Advisory/Consultancy, Travel/Accommodation/Expenses: BMS."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "S. Zanetta", "first_name": "S.", "last_name": "Zanetta", "second_name": "", "title": " Travel/Accommodation/Expenses: Ipsen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Alfonsi", "first_name": "M.", "last_name": "Alfonsi", "second_name": "", "title": " Honoraria (self), Advisory/Consultancy: Merck; Honoraria (self), Advisory/Consultancy: Novartis; Advisory/Consultancy: BMS; Advisory/Consultancy: EMD Serono."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "G. Janoray", "first_name": "G.", "last_name": "Janoray", "second_name": "", "title": " Advisory/Consultancy: BMS."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "T. Chatellier", "first_name": "T.", "last_name": "Chatellier", "second_name": "", "title": " Advisory/Consultancy, Travel/Accommodation/Expenses: Roche; Advisory/Consultancy, Travel/Accommodation/Expenses: BMS."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Bourhis", "first_name": "J.", "last_name": "Bourhis", "second_name": "", "title": " Advisory/Consultancy: Merck; Advisory/Consultancy: MSD; Advisory/Consultancy: AstraZeneca; Advisory/Consultancy: BMS."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Richard Greil", "first_name": "Richard", "last_name": "Greil", "second_name": "", "country": "Austria", "city": "Salzburg", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "D. Rischin", "first_name": "D.", "last_name": "Rischin", "second_name": "", "title": " Travel/Accommodation/Expenses: Merck; Research grant/Funding (self): Genentech/Roche, Merck, Regeneron, Bristol-Myers Squibb, GlaxoSmithKline, Sanofi."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "G. de Castro", "first_name": "G.", "last_name": "de Castro", "second_name": "", "title": " Advisory/Consultancy: Teva, Boehringer Ingelheim, Pfizer, Bayer, Roche, Merck Sharp & Dohme, Bristol-Myers Squibb, AstraZeneca, Yuhan; Speaker Bureau/Expert testimony: AstraZeneca, Bayer, Novartis, Roche, Merck Serono, Bristol-Myers Squibb, Merck Sharp & Dohme, Boehringer Ingelheim, Pfizer; Travel/Accommodation/Expenses: Merck Sharp & Dohme, Novartis, Pfizer, Roche, AstraZeneca, Boehringer Ingelheim, Bayer, Bristol-Myers Squibb; Honoraria (self): AstraZeneca, Pfizer, Merck Sharp & Dohme, Bristol-Myers Squibb, Novartis, Roche, Boehringer Ingelheim."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "N. Baste", "first_name": "N.", "last_name": "Baste", "second_name": "", "title": " Advisory/Consultancy: Bristol-Myers Squibb, Merck Serono, Nanobiotix; Travel/Accommodation/Expenses: Bristol-Myers Squibb, Merck Serono, Nanobiotix, AstraZeneca, GlaxoSmithKline, MSD."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "P. Neupane", "first_name": "P.", "last_name": "Neupane", "second_name": "", "title": " Advisory/Consultancy: Pfizer/EMD Serono; Research grant/Funding (self): Merck Sharp & Dohme, Bristol-Myers Squibb."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "T. Fuereder", "first_name": "T.", "last_name": "Fuereder", "second_name": "", "title": " Honoraria (self): MSD, Merck Darmstadt, Roche, Bristol-Myers Squibb, Accord Healthcare, Sanofi, Boehringer Ingelheim; Advisory/Consultancy: MSD, Merck Darmstadt, Amgen, Pfizer, Sanofi; Research grant/Funding (institution): MSD, Merck Darmstadt, Bristol-Myers Squibb; Travel/Accommodation/Expenses: Roche, MSD, Bristol-Myers Squibb."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Hughes", "first_name": "M.", "last_name": "Hughes", "second_name": "", "title": " Advisory/Consultancy: MSD Oncology, Bristol-Myers Squibb, Roche, Pfizer, Boehringer Ingelheim, AstraZeneca, Eisai; Research grant/Funding (institution): Amgen."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "N. Ngamphaiboon", "first_name": "N.", "last_name": "Ngamphaiboon", "second_name": "", "title": " Advisory/Consultancy: Roche, MSD, Amgen, Novartis, Boehringer Ingelheim, Taiho Pharmaceutical; Speaker Bureau/Expert testimony: Roche, AstraZeneca, Eisai, Amgen, MSD, Novartis; Travel/Accommodation/Expenses: Roche, MSD, Amgen, Novartis, Merck, Eisai, Taiho Pharmaceutical; Honoraria (self): Roche, AstraZeneca, Eisai, Amgen, MSD, Novartis; Research grant/Funding (self): MSD, Pfizer, Roche, AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "T. Rordorf", "first_name": "T.", "last_name": "Rordorf", "second_name": "", "title": " Advisory/Consultancy: MSD, Bristol-Myers Squibb."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Z. Wan Ishak", "first_name": "Z.", "last_name": "Ishak", "second_name": "Wan", "title": " Honoraria (self): MSD Ltd, Eisai Korea, Eisai Malaysia, Mundipharma, Merck Serono, Roche Myanmar, Eli Lilly Malaysia, Roche Malaysia, Pfizer Malaysia, Amgen Malaysia; Advisory/Consultancy: Eli Lilly Malaysia, Merck Serono Malaysia, Roche Malaysia, Mundi Pharma Malaysia, Boehringer Ingelheim Malaysia; Speaker Bureau/Expert testimony: Roche Malaysia, Eli Lilly Malaysia, Boehringer Ingelheim Malaysia; Research grant/Funding (institution): Roche, Amgen, Merck; Travel/Accommodation/Expenses: MSD Ltd, Eisai Korea, Disai Malaysia, Mundipharma, Merck Serono, Roche Myanmar, Eli Lilly Malaysia, Roche Malaysia, Pfizer Malaysia, Amgen Malaysia, Amgen Malaysia, Eli Lilly Malaysia, Merck Serono Malaysia, Mundi Pharma Malaysia, Boehringer Ingelheim Mal."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Lin", "first_name": "J.", "last_name": "Lin", "second_name": "", "title": " Full/Part-time employment: Merck."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "B. Gumuscu", "first_name": "B.", "last_name": "Gumuscu", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Merck."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "B. Burtness", "first_name": "B.", "last_name": "Burtness", "second_name": "", "title": " Advisory/Consultancy: Merck, Debiopharm Group, AstraZeneca, Bristol-Myers Squibb, Alligator Bioscience, Aduro Biotech, GlaxoSmithKline, Celgene, CUE Biopharma, Maverick therapeutics, Rakuten, Nanobiotix, Macrogenics, ALX Oncology; Travel/Accommodation/Expenses: Merck, Debiopharm Group, Boehringer Ingelheim; Honoraria (self): AstraZeneca; Research grant/Funding (institution): Merck, Aduro Biotech, Formation Biologics, Bristol-Myers Squibb, Exelixis."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Charu Aggarwal", "first_name": "Charu", "last_name": "Aggarwal", "second_name": "", "country": "United States of America", "city": "Philadelphia", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "F. Saba", "first_name": "F.", "last_name": "Saba", "second_name": "", "title": " Advisory/Consultancy: Merck; Advisory/Consultancy: Bristol-Myers Squibb; Advisory/Consultancy: Rakuten; Advisory/Consultancy: Biontech; Advisory/Consultancy: Aduro; Advisory/Consultancy: Pfizer; Advisory/Consultancy: GlaxoSmithKline."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "P. Algazi", "first_name": "P.", "last_name": "Algazi", "second_name": "", "title": " Research grant/Funding (institution): AstraZeneca; Research grant/Funding (institution): GlaxoSmithKline; Research grant/Funding (institution): Novartis; Advisory/Consultancy, Travel/Accommodation/Expenses, Shareholder/Stockholder/Stock options: OncoSec; Advisory/Consultancy, Shareholder/Stockholder/Stock options: Valitor; Honoraria (self), Research grant/Funding (institution): Regeneron; Honoraria (self): Array; Research grant/Funding (institution): Acerta; Research grant/Funding (institution): Amgen; Research grant/Funding (institution): Bristol-Myers Squibb; Research grant/Funding (institution): Dynavax; Research grant/Funding (institution): Genentech; Research grant/Funding (institution): Idera Pharma; Research grant/Funding (institution): Incyte; Research grant/Funding (institution): ISA; Research grant/Funding (institution): Loxo Oncology; Research grant/Funding (institution): Merck; Research grant/Funding (institution): Pfizer; Research grant/Funding (institution): Sensei; Research grant/Funding (institution): Tessa."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Sukari", "first_name": "A.", "last_name": "Sukari", "second_name": "", "title": " Shareholder/Stockholder/Stock options: Immunomedics; Advisory/Consultancy, Speaker Bureau/Expert testimony, Research grant/Funding (institution): Eisai; Advisory/Consultancy: Bayer; Speaker Bureau/Expert testimony: Merck."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "T. Seiwert", "first_name": "T.", "last_name": "Seiwert", "second_name": "", "title": " Advisory/Consultancy: AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Haigentz", "first_name": "M.", "last_name": "Haigentz", "second_name": "", "title": " Advisory/Consultancy: Amgen; Advisory/Consultancy: Genentech; Advisory/Consultancy: Takeda; Advisory/Consultancy: AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "M. Porosnicu", "first_name": "M.", "last_name": "Porosnicu", "second_name": "", "title": " Research grant/Funding (institution), I have an investigator initiated clinical trial: AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Boyer", "first_name": "J.", "last_name": "Boyer", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Inovio."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Caroline Even", "first_name": "Caroline", "last_name": "Even", "second_name": "", "country": "France", "city": "Villejuif", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Daste", "first_name": "A.", "last_name": "Daste", "second_name": "", "title": " Advisory/Consultancy, Travel/Accommodation/Expenses: BMS; Advisory/Consultancy, Travel/Accommodation/Expenses: AstraZeneca; Advisory/Consultancy, Travel/Accommodation/Expenses: Merck Serono; Advisory/Consultancy: MSD."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Fayette", "first_name": "J.", "last_name": "Fayette", "second_name": "", "title": " Advisory/Consultancy: MSD; Advisory/Consultancy: BMS; Advisory/Consultancy: AstraZeneca; Advisory/Consultancy: Roche; Advisory/Consultancy: Servier; Advisory/Consultancy: Merck Serono."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Toullec", "first_name": "C.", "last_name": "Toullec", "second_name": "", "title": " Honoraria (self), Travel/Accommodation/Expenses: Merck Serono; Honoraria (self), Travel/Accommodation/Expenses: Sanofi; Honoraria (self), Travel/Accommodation/Expenses: MSD; Honoraria (self), Travel/Accommodation/Expenses: Ipsen; Honoraria (self), Travel/Accommodation/Expenses: Amgen; Honoraria (self), Travel/Accommodation/Expenses: Servier; Honoraria (self), Travel/Accommodation/Expenses: BMS."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "C. Johnson", "first_name": "C.", "last_name": "Johnson", "second_name": "", "title": " Travel/Accommodation/Expenses: BMS."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Guigay", "first_name": "J.", "last_name": "Guigay", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (institution): Merck Serono; Advisory/Consultancy, Research grant/Funding (institution): BMS; Advisory/Consultancy: Innate Pharma; Advisory/Consultancy: AstraZeneca."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "O. Saavedra Santa Gadea", "first_name": "O.", "last_name": "Santa Gadea", "second_name": "Saavedra", "title": " Travel/Accommodation/Expenses: MSD; Travel/Accommodation/Expenses: Kyowa Kirin."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. Dienstmann", "first_name": "R.", "last_name": "Dienstmann", "second_name": "", "title": " Advisory/Consultancy, Speaker Bureau/Expert testimony: Roche; Advisory/Consultancy: Boehringer Ingelheim; Speaker Bureau/Expert testimony: Ipsen; Speaker Bureau/Expert testimony: Amgen; Speaker Bureau/Expert testimony: Servier; Speaker Bureau/Expert testimony: Sanofi; Speaker Bureau/Expert testimony: Merck Sharp and Dohme; Research grant/Funding (institution): Merck; Research grant/Funding (institution): Pierre Fabre."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Renata Ferrarotto", "first_name": "Renata", "last_name": "Ferrarotto", "second_name": "", "country": "T", "city": "Houston", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "P. Rodriguez", "first_name": "P.", "last_name": "Rodriguez", "second_name": "", "title": " Advisory/Consultancy: Cue Biopharma; Speaker Bureau/Expert testimony: Clinical Care Options."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "B. Xia", "first_name": "B.", "last_name": "Xia", "second_name": "", "title": " Advisory/Consultancy: AstraZeneca; Advisory/Consultancy: Genentech."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Perez", "first_name": "A.", "last_name": "Perez", "second_name": "", "title": " Advisory/Consultancy: Regeneron; Advisory/Consultancy: Kimera Labs."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "E. Winquist", "first_name": "E.", "last_name": "Winquist", "second_name": "", "title": " Honoraria (self): Amgen; Honoraria (self): AstraZeneca; Honoraria (self): Bayer; Honoraria (self): Eisai; Honoraria (self): Merck; Honoraria (self): Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "J. Hotte", "first_name": "J.", "last_name": "Hotte", "second_name": "", "title": " Research grant/Funding (institution): Ayala Pharmaceuticals."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "R. Metcalf", "first_name": "R.", "last_name": "Metcalf", "second_name": "", "title": " Advisory/Consultancy: AstraZeneca; Advisory/Consultancy, Travel/Accommodation/Expenses: BMS; Advisory/Consultancy: Bayer; Advisory/Consultancy: Roche."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "B. Gordon", "first_name": "B.", "last_name": "Gordon", "second_name": "", "title": " Shareholder/Stockholder/Stock options, Full/Part-time employment: Ayala Pharmaceuticals; Advisory/Consultancy: Molecular Templates; Advisory/Consultancy: Intellia."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "G. Gordon", "first_name": "G.", "last_name": "Gordon", "second_name": "", "title": " Advisory/Consultancy, Full/Part-time employment: Ayala Pharmaceuticals; Advisory/Consultancy: Agios; Advisory/Consultancy: Heron; Advisory/Consultancy: Jounce; Advisory/Consultancy: Brickell; Advisory/Consultancy: Onkure; Advisory/Consultancy: Aethlon; Advisory/Consultancy: Zenatlis; Advisory/Consultancy: Prevacept."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "A. Ho", "first_name": "A.", "last_name": "Ho", "second_name": "", "title": " Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Ayala Pharmaceuticals; Advisory/Consultancy, Research grant/Funding (institution), Travel/Accommodation/Expenses: Merck; Research grant/Funding (institution): Novartis; Research grant/Funding (institution): Eisai; Advisory/Consultancy, Research grant/Funding (institution): Bristol Meyer Squibb; Advisory/Consultancy, Research grant/Funding (institution): AstraZeneca; Advisory/Consultancy, Research grant/Funding (institution): Genentech/Roche; Research grant/Funding (institution): Celldex; Research grant/Funding (institution): Bayer; Research grant/Funding (institution): Lilly; Research grant/Funding (institution): Astellas; Research grant/Funding (institution): Daichi; Research grant/Funding (institution): Allos; Research grant/Funding (institution): Pfizer; Honoraria (self): Sanofi Genzyme; Honoraria (self): Sun Pharma; Honoraria (self): Regeneron; Research grant/Funding (institution), Travel/Accommodation/Expenses: TRM; Research grant/Funding (institution), Travel/Accommodation/Expenses: Kura; Travel/Accommodation/Expenses: Ignyta; Travel/Accommodation/Expenses: Jansen; Advisory/Consultancy: Curevac; Speaker Bureau/Expert testimony: Medscape."}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Fernado Lopez-Rios", "first_name": "Fernado", "last_name": "Lopez-Rios", "second_name": "", "country": "Spain", "city": "Madrid", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Emile E. Voest", "first_name": "Emile", "last_name": "Voest", "second_name": "E.", "country": "Netherlands", "city": "Amsterdam", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Shumei Kato", "first_name": "Shumei", "last_name": "Kato", "second_name": "", "country": "C", "city": "San Diego", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Natalie Cook", "first_name": "Natalie", "last_name": "Cook", "second_name": "", "country": "Cambridgeshir", "city": "Manchester", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Kenneth Kehl", "first_name": "Kenneth", "last_name": "Kehl", "second_name": "", "country": "United States of America", "city": "Boston", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Michael B. Atkins", "first_name": "Michael", "last_name": "Atkins", "second_name": "B.", "country": "United States of America", "city": "Washington", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Nizar Tannir", "first_name": "Nizar", "last_name": "Tannir", "second_name": "", "country": "T", "city": "Houston", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "George D. Demetri", "first_name": "George", "last_name": "Demetri", "second_name": "D.", "country": "M", "city": "Boston", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Renate Haidinger", "first_name": "Renate", "last_name": "Haidinger", "second_name": "", "country": "Germany", "city": "Hohenbrunn", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Jorge Camarero", "first_name": "Jorge", "last_name": "Camarero", "second_name": "", "country": "Spain", "city": "Madrid", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Oriol Solà-Morales", "first_name": "Oriol", "last_name": "Solà-Morales", "second_name": "", "country": "Spain", "city": "Sant Cugat del Valles", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Kamal Haider", "first_name": "Kamal", "last_name": "Haider", "second_name": "", "country": "Canada", "city": "Saskatoon", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Markus Möhler", "first_name": "Markus", "last_name": "Möhler", "second_name": "", "country": "Germany", "city": "Mainz", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Ruben Martin Payo", "first_name": "Ruben", "last_name": "Payo", "second_name": "Martin", "country": "Spain", "city": "Oviedo", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Martijn P. Lolkema", "first_name": "Martijn", "last_name": "Lolkema", "second_name": "P.", "country": "Netherlands", "city": "Rotterdam", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Liza Van Lent", "first_name": "Liza", "last_name": "Van Lent", "second_name": "", "country": "Netherlands", "city": "Rotterdam", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Fanny Leenhardt", "first_name": "Fanny", "last_name": "Leenhardt", "second_name": "", "country": "France", "city": "Montpellier", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Michelle Hannan", "first_name": "Michelle", "last_name": "Hannan", "second_name": "", "country": "Ireland", "city": "Waterford", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Martine Puts", "first_name": "Martine", "last_name": "Puts", "second_name": "", "country": "Canada", "city": "Toronto", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Kristen Haase", "first_name": "Kristen", "last_name": "Haase", "second_name": "", "country": "Canada", "city": "Saskatoon", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Jenny Welford", "first_name": "Jenny", "last_name": "Welford", "second_name": "", "country": "United Kingdom", "city": "Newcastle-upon-Tyne", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Karin B. Dieperink", "first_name": "Karin", "last_name": "Dieperink", "second_name": "B.", "country": "Denmark", "city": "Odense C", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Virpi Sulosaari", "first_name": "Virpi", "last_name": "Sulosaari", "second_name": "", "country": "Finland", "city": "Turku", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Rebecca Verity", "first_name": "Rebecca", "last_name": "Verity", "second_name": "", "country": "United Kingdom", "city": "London", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Delphine Mathivon", "first_name": "Delphine", "last_name": "Mathivon", "second_name": "", "country": "France", "city": "Villejuif", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Ana Rodriguez-ortega", "first_name": "Ana", "last_name": "Rodriguez-ortega", "second_name": "", "country": "Spain", "city": "Hospitalet de Llobregat", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Julia Ruíz Pato", "first_name": "Julia", "last_name": "Pato", "second_name": "Ruíz", "country": "Spain", "city": "Barcelona", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Charlotta M. Bergstrom", "first_name": "Charlotta", "last_name": "Bergstrom", "second_name": "M.", "country": "Sweden", "city": "Stockholm", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Terry Hanan", "first_name": "Terry", "last_name": "Hanan", "second_name": "", "country": "Ireland", "city": "Dublin", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Celia Díez de los Ríos de la Serna", "first_name": "Celia", "last_name": "Díez  la Serna", "second_name": " de los Ríos de", "country": "Spain", "city": "Barcelona", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Estela Carrasco", "first_name": "Estela", "last_name": "Carrasco", "second_name": "", "country": "Spain", "city": "Barcelona", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Laura Bascuñana Sanchez", "first_name": "Laura", "last_name": "Sanchez", "second_name": "Bascuñana", "country": "Spain", "city": "Barcelona", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "René Schwendimann", "first_name": "René", "last_name": "Schwendimann", "second_name": "", "country": "Switzerland", "city": "Basel", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Patrick Crombez", "first_name": "Patrick", "last_name": "Crombez", "second_name": "", "country": "Belgium", "city": "Brussels", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Philippa Jupp", "first_name": "Philippa", "last_name": "Jupp", "second_name": "", "country": "United Kingdom", "city": "London", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Elise Deluche", "first_name": "Elise", "last_name": "Deluche", "second_name": "", "country": "CEDE", "city": "Limoges", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Julio C. De la Torre-Montero", "first_name": "Julio", "last_name": "De la Torre-Montero", "second_name": "C.", "country": "Spain", "city": "Madrid", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Cindy Franssen", "first_name": "Cindy", "last_name": "Franssen", "second_name": "", "country": "Belgium", "city": "Brussels", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Marilys Corbex", "first_name": "Marilys", "last_name": "Corbex", "second_name": "", "country": "Switzerland", "city": "Geneva", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Nicolas Schmit", "first_name": "Nicolas", "last_name": "Schmit", "second_name": "", "country": "Belgium", "city": "Brussels", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Anthony Fauci", "first_name": "Anthony", "last_name": "Fauci", "second_name": "", "country": "United States of America", "city": "Bethesda", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Antoni Ribas", "first_name": "Antoni", "last_name": "Ribas", "second_name": "", "country": "C", "city": "Los Angeles", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Gabriella Pravettoni", "first_name": "Gabriella", "last_name": "Pravettoni", "second_name": "", "country": "Italy", "city": "Milan", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Freddie Bray", "first_name": "Freddie", "last_name": "Bray", "second_name": "", "country": "CEDEX ", "city": "Lyon", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Graham Warren", "first_name": "Graham", "last_name": "Warren", "second_name": "", "country": "United States of America", "city": "Charleston", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Nir Peled", "first_name": "Nir", "last_name": "Peled", "second_name": "", "country": "Israel", "city": "Beer Sheva", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Kris Nackaerts", "first_name": "Kris", "last_name": "Nackaerts", "second_name": "", "country": "Belgium", "city": "Leuven", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Pierre Massion", "first_name": "Pierre", "last_name": "Massion", "second_name": "", "country": "United States of America", "city": "Nashville", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Hans U. Kauczor", "first_name": "Hans", "last_name": "Kauczor", "second_name": "U.", "country": "Germany", "city": "Heidelberg", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Irene Braña", "first_name": "Irene", "last_name": "Braña", "second_name": "", "country": "Spain", "city": "Barcelona", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Francesco Pignatti", "first_name": "Francesco", "last_name": "Pignatti", "second_name": "", "country": "Netherlands", "city": "Amsterdam", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Sonia Garcia Perez", "first_name": "Sonia", "last_name": "Perez", "second_name": "Garcia", "country": "Spain", "city": "Madrid", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Marc Van Den Bulcke", "first_name": "Marc", "last_name": "Van Den Bulcke", "second_name": "", "country": "Belgium", "city": "Brussel", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Vlad V. Voiculescu", "first_name": "Vlad", "last_name": "Voiculescu", "second_name": "V.", "country": "Romania", "city": "Bucharest", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Isabelle Lebrocquy", "first_name": "Isabelle", "last_name": "Lebrocquy", "second_name": "", "country": "Netherlands", "city": "Den Haag", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Richard Simcock", "first_name": "Richard", "last_name": "Simcock", "second_name": "", "country": "United Kingdom", "city": "Brighton", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Lorna Zadravec Zaletel", "first_name": "Lorna", "last_name": "Zaletel", "second_name": "Zadravec", "country": "Slovenia", "city": "Ljubljana", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Carmen Adelaida Montalban Millan", "first_name": "Carmen", "last_name": "Millan", "second_name": "Adelaida Montalban", "country": "Spain", "city": "Madrid", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "André Ilbawi", "first_name": "André", "last_name": "Ilbawi", "second_name": "", "country": "Switzerland", "city": "Geneva", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Dario Trapani", "first_name": "Dario", "last_name": "Trapani", "second_name": "", "country": "Italy", "city": "Milan", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Filip Meheus", "first_name": "Filip", "last_name": "Meheus", "second_name": "", "country": "France", "city": "Lyon", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Melanie Bertram", "first_name": "Melanie", "last_name": "Bertram", "second_name": "", "country": "Switzerland", "city": "Geneva", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Florian Scotté", "first_name": "Florian", "last_name": "Scotté", "second_name": "", "country": "France", "city": "Villejuif", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Paolo Bossi", "first_name": "Paolo", "last_name": "Bossi", "second_name": "", "country": "Italy", "city": "Brescia", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Vincent Sibaud", "first_name": "Vincent", "last_name": "Sibaud", "second_name": "", "country": "Haute-Garonn", "city": "Toulouse", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Corina Van den Hurk", "first_name": "Corina", "last_name": "Van den Hurk", "second_name": "", "country": "Netherlands", "city": "Utrecht", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Demetris Papamichael", "first_name": "Demetris", "last_name": "Papamichael", "second_name": "", "country": "Nicosi", "city": "Nicosia", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Etienne Brain", "first_name": "Etienne", "last_name": "Brain", "second_name": "", "country": "France", "city": "Saint-Cloud", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Isacco Montroni", "first_name": "Isacco", "last_name": "Montroni", "second_name": "", "country": "Italy", "city": "Faenza", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Hans Wildiers", "first_name": "Hans", "last_name": "Wildiers", "second_name": "", "country": "Belgium", "city": "Leuven", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Anita O'Donovan", "first_name": "Anita", "last_name": "O'Donovan", "second_name": "", "country": "Ireland", "city": "Dublin", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Suzanne Festen", "first_name": "Suzanne", "last_name": "Festen", "second_name": "", "country": "Netherlands", "city": "Groningen", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Agata I. Polinska", "first_name": "Agata", "last_name": "Polinska", "second_name": "I.", "country": "Poland", "city": "Warsaw", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Darja Molan", "first_name": "Darja", "last_name": "Molan", "second_name": "", "country": "Slovenia", "city": "Ljubljana", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Rodrigo Dienstmann", "first_name": "Rodrigo", "last_name": "Dienstmann", "second_name": "", "country": "Spain", "city": "Barcelona", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "John Rowell", "first_name": "John", "last_name": "Rowell", "second_name": "", "country": "France", "city": "Villejuif", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Joanna Fratczak - Kazana", "first_name": "Joanna", "last_name": "Kazana", "second_name": "Fratczak -", "country": "Poland", "city": "Warsaw", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Daniel Stark", "first_name": "Daniel", "last_name": "Stark", "second_name": "", "country": "Yorkshir", "city": "Leeds", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Emmanouil Saloustros", "first_name": "Emmanouil", "last_name": "Saloustros", "second_name": "", "country": "Greece", "city": "Larissa", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Andrea Ferrari", "first_name": "Andrea", "last_name": "Ferrari", "second_name": "", "country": "Italy", "city": "Milan", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Nathalie Gaspar", "first_name": "Nathalie", "last_name": "Gaspar", "second_name": "", "country": "France", "city": "Villejuif", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Ivana Bozovic Spasojevic", "first_name": "Ivana", "last_name": "Spasojevic", "second_name": "Bozovic", "country": "Serbia", "city": "Belgrade", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Natacha Bolanos Fernandez", "first_name": "Natacha", "last_name": "Fernandez", "second_name": "Bolanos", "country": "Spain", "city": "Madrid", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Jana Pelouchova", "first_name": "Jana", "last_name": "Pelouchova", "second_name": "", "country": "", "city": "Prague", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Florian Strasser", "first_name": "Florian", "last_name": "Strasser", "second_name": "", "country": "Switzerland", "city": "St. Gallen", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Fabian Bolin", "first_name": "Fabian", "last_name": "Bolin", "second_name": "", "country": "Sweden", "city": "Stockholm", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Hulda Hjalmardóttir", "first_name": "Hulda", "last_name": "Hjalmardóttir", "second_name": "", "country": "Iceland", "city": "Reykjavik", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Ayse Bora", "first_name": "Ayse", "last_name": "Bora", "second_name": "", "country": "Turkey", "city": "Istanbul", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Robert Greene", "first_name": "Robert", "last_name": "Greene", "second_name": "", "country": "Belgium", "city": "Brussels", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Steven Le Gouill", "first_name": "Steven", "last_name": "Le Gouill", "second_name": "", "country": "France", "city": "Nantes", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Jonas Bergh", "first_name": "Jonas", "last_name": "Bergh", "second_name": "", "country": "Soln", "city": "Solna", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Fergus Sweeney", "first_name": "Fergus", "last_name": "Sweeney", "second_name": "", "country": "Netherlands", "city": "Amsterdam", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Anastassia Negrouk", "first_name": "Anastassia", "last_name": "Negrouk", "second_name": "", "country": "Belgium", "city": "Brussels", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Hans Joachim E. Schmoll", "first_name": "Hans", "last_name": "Schmoll", "second_name": "Joachim E.", "country": "Germany", "city": "Halle (Saale)", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Anna Sophie Berghoff", "first_name": "Anna", "last_name": "Berghoff", "second_name": "Sophie", "country": "Austria", "city": "Vienna", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Manel Esteller", "first_name": "Manel", "last_name": "Esteller", "second_name": "", "country": "Spain", "city": "Badalona", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Andrea Sottoriva", "first_name": "Andrea", "last_name": "Sottoriva", "second_name": "", "country": "United Kingdom", "city": "Sutton", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Philippe G. Aftimos", "first_name": "Philippe", "last_name": "Aftimos", "second_name": "G.", "country": "Belgium", "city": "Brussels", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Anna Falanga", "first_name": "Anna", "last_name": "Falanga", "second_name": "", "country": "Italy", "city": "Bergamo", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Christof Vulsteke", "first_name": "Christof", "last_name": "Vulsteke", "second_name": "", "country": "Belgium", "city": "Gent", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Stefan Rauh", "first_name": "Stefan", "last_name": "Rauh", "second_name": "", "country": "Luxembourg", "city": "Esch sur Alzette", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Hendrik K. Van Halteren", "first_name": "Hendrik", "last_name": "Van Halteren", "second_name": "K.", "country": "Netherlands", "city": "Goes", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Dominique Farge", "first_name": "Dominique", "last_name": "Farge", "second_name": "", "country": "France", "city": "Paris", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Stefan Sleijfer", "first_name": "Stefan", "last_name": "Sleijfer", "second_name": "", "country": "Netherlands", "city": "Rotterdam", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Michiel H. Strijbos", "first_name": "Michiel", "last_name": "Strijbos", "second_name": "H.", "country": "Belgium", "city": "Wilrijk", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Michal Rosen-Zvi", "first_name": "Michal", "last_name": "Rosen-Zvi", "second_name": "", "country": "Israel", "city": "Haifa", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Marco Marsella", "first_name": "Marco", "last_name": "Marsella", "second_name": "", "country": "Belgium", "city": "Brussels", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Mariarosaria Taddeo", "first_name": "Mariarosaria", "last_name": "Taddeo", "second_name": "", "country": "United Kingdom", "city": "Oxford", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Lori Pierce", "first_name": "Lori", "last_name": "Pierce", "second_name": "", "country": "United States of America", "city": "Alexandria", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Susan Domchek", "first_name": "Susan", "last_name": "Domchek", "second_name": "", "country": "United States of America", "city": "Philadelphia", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Jennifer Ligibel", "first_name": "Jennifer", "last_name": "Ligibel", "second_name": "", "country": "United States of America", "city": "Boston", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Radu A. Vidra", "first_name": "Radu", "last_name": "Vidra", "second_name": "A.", "country": "Romania", "city": "Cluj-Napoca", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Gabor Lakatos", "first_name": "Gabor", "last_name": "Lakatos", "second_name": "", "country": "Hungary", "city": "Budapest", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Ioannis Gioulbasanis", "first_name": "Ioannis", "last_name": "Gioulbasanis", "second_name": "", "country": "G", "city": "Larissa", "title": ""}
{"id": "65f2e3e3-8c1c-4bce-aaf4-8df8b66402cd", "event_id": "95271c09-7598-40e8-91b5-61712e726e86", "full_name": "Jann Arends", "first_name": "Jann", "last_name": "Arends", "second_name": "", "country": "Germany", "city": "Freiburg im Breisgau", "title": ""}
